id	sid	tid	token	lemma	pos
ajlm-2895	1	1	abstract	abstract	ADJ
ajlm-2895	1	2	introduction	introduction	NOUN
ajlm-2895	1	3	methods	method	NOUN
ajlm-2895	1	4	results	result	VERB
ajlm-2895	1	5	discussion	discussion	NOUN
ajlm-2895	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2895	1	7	references	reference	NOUN
ajlm-2895	1	8	about	about	ADP
ajlm-2895	1	9	the	the	DET
ajlm-2895	1	10	author(s	author(s	NOUN
ajlm-2895	1	11	)	)	PUNCT
ajlm-2895	1	12	odilon	odilon	ADP
ajlm-2895	1	13	d.	d.	PROPN
ajlm-2895	1	14	kaboré	kaboré	PROPN
ajlm-2895	1	15	laboratory	laboratory	PROPN
ajlm-2895	1	16	of	of	ADP
ajlm-2895	1	17	bacteriology	bacteriology	NOUN
ajlm-2895	1	18	and	and	CCONJ
ajlm-2895	1	19	virology	virology	NOUN
ajlm-2895	1	20	,	,	PUNCT
ajlm-2895	1	21	sourô	sourô	PROPN
ajlm-2895	1	22	sanou	sanou	NOUN
ajlm-2895	1	23	university	university	NOUN
ajlm-2895	1	24	teaching	teaching	NOUN
ajlm-2895	1	25	hospital	hospital	NOUN
ajlm-2895	1	26	,	,	PUNCT
ajlm-2895	1	27	bobo	bobo	NOUN
ajlm-2895	1	28	-	-	PUNCT
ajlm-2895	1	29	dioulasso	dioulasso	PROPN
ajlm-2895	1	30	,	,	PUNCT
ajlm-2895	1	31	burkina	burkina	PROPN
ajlm-2895	1	32	faso	faso	PROPN
ajlm-2895	1	33	burkina	burkina	PROPN
ajlm-2895	1	34	faso	faso	PROPN
ajlm-2895	1	35	national	national	PROPN
ajlm-2895	1	36	reference	reference	PROPN
ajlm-2895	1	37	laboratory	laboratory	NOUN
ajlm-2895	1	38	for	for	ADP
ajlm-2895	1	39	antimicrobial	antimicrobial	ADJ
ajlm-2895	1	40	resistance	resistance	NOUN
ajlm-2895	1	41	,	,	PUNCT
ajlm-2895	1	42	bobo	bobo	NOUN
ajlm-2895	1	43	-	-	PUNCT
ajlm-2895	1	44	dioulasso	dioulasso	PROPN
ajlm-2895	1	45	,	,	PUNCT
ajlm-2895	1	46	burkina	burkina	PROPN
ajlm-2895	1	47	faso	faso	PROPN
ajlm-2895	1	48	laboratory	laboratory	NOUN
ajlm-2895	1	49	of	of	ADP
ajlm-2895	1	50	emerging	emerge	VERB
ajlm-2895	1	51	and	and	CCONJ
ajlm-2895	1	52	re	re	ADJ
ajlm-2895	1	53	-	-	ADJ
ajlm-2895	1	54	emerging	emerge	VERB
ajlm-2895	1	55	pathogens	pathogen	NOUN
ajlm-2895	1	56	,	,	PUNCT
ajlm-2895	1	57	school	school	NOUN
ajlm-2895	1	58	of	of	ADP
ajlm-2895	1	59	health	health	NOUN
ajlm-2895	1	60	sciences	sciences	PROPN
ajlm-2895	1	61	,	,	PUNCT
ajlm-2895	1	62	nazi	nazi	PROPN
ajlm-2895	1	63	boni	boni	PROPN
ajlm-2895	1	64	university	university	PROPN
ajlm-2895	1	65	,	,	PUNCT
ajlm-2895	1	66	bobo	bobo	NOUN
ajlm-2895	1	67	-	-	PUNCT
ajlm-2895	1	68	dioulasso	dioulasso	PROPN
ajlm-2895	1	69	,	,	PUNCT
ajlm-2895	1	70	burkina	burkina	PROPN
ajlm-2895	1	71	faso	faso	PROPN
ajlm-2895	1	72	higher	high	ADJ
ajlm-2895	1	73	institute	institute	PROPN
ajlm-2895	1	74	of	of	ADP
ajlm-2895	1	75	health	health	PROPN
ajlm-2895	1	76	sciences	sciences	PROPN
ajlm-2895	1	77	,	,	PUNCT
ajlm-2895	1	78	nazi	nazi	PROPN
ajlm-2895	1	79	boni	boni	PROPN
ajlm-2895	1	80	university	university	PROPN
ajlm-2895	1	81	,	,	PUNCT
ajlm-2895	1	82	bobo	bobo	NOUN
ajlm-2895	1	83	-	-	PUNCT
ajlm-2895	1	84	dioulasso	dioulasso	PROPN
ajlm-2895	1	85	,	,	PUNCT
ajlm-2895	1	86	burkina	burkina	PROPN
ajlm-2895	1	87	faso	faso	PROPN
ajlm-2895	1	88	mélissa	mélissa	PROPN
ajlm-2895	1	89	j.	j.	PROPN
ajlm-2895	1	90	gonfouli	gonfouli	PROPN
ajlm-2895	1	91	laboratory	laboratory	PROPN
ajlm-2895	1	92	of	of	ADP
ajlm-2895	1	93	emerging	emerge	VERB
ajlm-2895	1	94	and	and	CCONJ
ajlm-2895	1	95	re	re	ADJ
ajlm-2895	1	96	-	-	ADJ
ajlm-2895	1	97	emerging	emerge	VERB
ajlm-2895	1	98	pathogens	pathogen	NOUN
ajlm-2895	1	99	,	,	PUNCT
ajlm-2895	1	100	school	school	NOUN
ajlm-2895	1	101	of	of	ADP
ajlm-2895	1	102	health	health	NOUN
ajlm-2895	1	103	sciences	sciences	PROPN
ajlm-2895	1	104	,	,	PUNCT
ajlm-2895	1	105	nazi	nazi	PROPN
ajlm-2895	1	106	boni	boni	PROPN
ajlm-2895	1	107	university	university	PROPN
ajlm-2895	1	108	,	,	PUNCT
ajlm-2895	1	109	bobo	bobo	NOUN
ajlm-2895	1	110	-	-	PUNCT
ajlm-2895	1	111	dioulasso	dioulasso	PROPN
ajlm-2895	1	112	,	,	PUNCT
ajlm-2895	1	113	burkina	burkina	PROPN
ajlm-2895	1	114	faso	faso	PROPN
ajlm-2895	1	115	merci	merci	PROPN
ajlm-2895	1	116	muhigwa	muhigwa	PROPN
ajlm-2895	1	117	laboratory	laboratory	NOUN
ajlm-2895	1	118	of	of	ADP
ajlm-2895	1	119	emerging	emerge	VERB
ajlm-2895	1	120	and	and	CCONJ
ajlm-2895	1	121	re	re	ADJ
ajlm-2895	1	122	-	-	ADJ
ajlm-2895	1	123	emerging	emerge	VERB
ajlm-2895	1	124	pathogens	pathogen	NOUN
ajlm-2895	1	125	,	,	PUNCT
ajlm-2895	1	126	school	school	NOUN
ajlm-2895	1	127	of	of	ADP
ajlm-2895	1	128	health	health	NOUN
ajlm-2895	1	129	sciences	sciences	PROPN
ajlm-2895	1	130	,	,	PUNCT
ajlm-2895	1	131	nazi	nazi	PROPN
ajlm-2895	1	132	boni	boni	PROPN
ajlm-2895	1	133	university	university	PROPN
ajlm-2895	1	134	,	,	PUNCT
ajlm-2895	1	135	bobo	bobo	NOUN
ajlm-2895	1	136	-	-	PUNCT
ajlm-2895	1	137	dioulasso	dioulasso	PROPN
ajlm-2895	1	138	,	,	PUNCT
ajlm-2895	1	139	burkina	burkina	PROPN
ajlm-2895	1	140	faso	faso	PROPN
ajlm-2895	1	141	abdourahmane	abdourahmane	PROPN
ajlm-2895	1	142	sow	sow	NOUN
ajlm-2895	1	143	region	region	NOUN
ajlm-2895	1	144	wide	wide	ADJ
ajlm-2895	1	145	laboratory	laboratory	NOUN
ajlm-2895	1	146	services	service	NOUN
ajlm-2895	1	147	,	,	PUNCT
ajlm-2895	1	148	west	west	ADJ
ajlm-2895	1	149	african	african	ADJ
ajlm-2895	1	150	health	health	PROPN
ajlm-2895	1	151	organization	organization	NOUN
ajlm-2895	1	152	,	,	PUNCT
ajlm-2895	1	153	bobo	bobo	NOUN
ajlm-2895	1	154	-	-	PUNCT
ajlm-2895	1	155	dioulasso	dioulasso	PROPN
ajlm-2895	1	156	,	,	PUNCT
ajlm-2895	1	157	burkina	burkina	PROPN
ajlm-2895	1	158	faso	faso	PROPN
ajlm-2895	1	159	fernand	fernand	PROPN
ajlm-2895	1	160	michodigni	michodigni	PROPN
ajlm-2895	1	161	laboratory	laboratory	NOUN
ajlm-2895	1	162	of	of	ADP
ajlm-2895	1	163	emerging	emerge	VERB
ajlm-2895	1	164	and	and	CCONJ
ajlm-2895	1	165	re	re	ADJ
ajlm-2895	1	166	-	-	ADJ
ajlm-2895	1	167	emerging	emerge	VERB
ajlm-2895	1	168	pathogens	pathogen	NOUN
ajlm-2895	1	169	,	,	PUNCT
ajlm-2895	1	170	school	school	NOUN
ajlm-2895	1	171	of	of	ADP
ajlm-2895	1	172	health	health	NOUN
ajlm-2895	1	173	sciences	sciences	PROPN
ajlm-2895	1	174	,	,	PUNCT
ajlm-2895	1	175	nazi	nazi	PROPN
ajlm-2895	1	176	boni	boni	PROPN
ajlm-2895	1	177	university	university	PROPN
ajlm-2895	1	178	,	,	PUNCT
ajlm-2895	1	179	bobo	bobo	NOUN
ajlm-2895	1	180	-	-	PUNCT
ajlm-2895	1	181	dioulasso	dioulasso	PROPN
ajlm-2895	1	182	,	,	PUNCT
ajlm-2895	1	183	burkina	burkina	PROPN
ajlm-2895	1	184	faso	faso	PROPN
ajlm-2895	1	185	andré	andré	VERB
ajlm-2895	1	186	nagalo	nagalo	PROPN
ajlm-2895	1	187	laboratory	laboratory	NOUN
ajlm-2895	1	188	of	of	ADP
ajlm-2895	1	189	emerging	emerge	VERB
ajlm-2895	1	190	and	and	CCONJ
ajlm-2895	1	191	re	re	ADJ
ajlm-2895	1	192	-	-	ADJ
ajlm-2895	1	193	emerging	emerge	VERB
ajlm-2895	1	194	pathogens	pathogen	NOUN
ajlm-2895	1	195	,	,	PUNCT
ajlm-2895	1	196	school	school	NOUN
ajlm-2895	1	197	of	of	ADP
ajlm-2895	1	198	health	health	NOUN
ajlm-2895	1	199	sciences	sciences	PROPN
ajlm-2895	1	200	,	,	PUNCT
ajlm-2895	1	201	nazi	nazi	PROPN
ajlm-2895	1	202	boni	boni	PROPN
ajlm-2895	1	203	university	university	PROPN
ajlm-2895	1	204	,	,	PUNCT
ajlm-2895	1	205	bobo	bobo	NOUN
ajlm-2895	1	206	-	-	PUNCT
ajlm-2895	1	207	dioulasso	dioulasso	PROPN
ajlm-2895	1	208	,	,	PUNCT
ajlm-2895	1	209	burkina	burkina	PROPN
ajlm-2895	1	210	faso	faso	PROPN
ajlm-2895	1	211	jacques	jacques	PROPN
ajlm-2895	1	212	zoungrana	zoungrana	PROPN
ajlm-2895	1	213	laboratory	laboratory	PROPN
ajlm-2895	1	214	of	of	ADP
ajlm-2895	1	215	emerging	emerge	VERB
ajlm-2895	1	216	and	and	CCONJ
ajlm-2895	1	217	re	re	ADJ
ajlm-2895	1	218	-	-	ADJ
ajlm-2895	1	219	emerging	emerge	VERB
ajlm-2895	1	220	pathogens	pathogen	NOUN
ajlm-2895	1	221	,	,	PUNCT
ajlm-2895	1	222	school	school	NOUN
ajlm-2895	1	223	of	of	ADP
ajlm-2895	1	224	health	health	NOUN
ajlm-2895	1	225	sciences	sciences	PROPN
ajlm-2895	1	226	,	,	PUNCT
ajlm-2895	1	227	nazi	nazi	PROPN
ajlm-2895	1	228	boni	boni	PROPN
ajlm-2895	1	229	university	university	PROPN
ajlm-2895	1	230	,	,	PUNCT
ajlm-2895	1	231	bobo	bobo	NOUN
ajlm-2895	1	232	-	-	PUNCT
ajlm-2895	1	233	dioulasso	dioulasso	PROPN
ajlm-2895	1	234	,	,	PUNCT
ajlm-2895	1	235	burkina	burkina	PROPN
ajlm-2895	1	236	faso	faso	PROPN
ajlm-2895	1	237	higher	high	ADJ
ajlm-2895	1	238	institute	institute	PROPN
ajlm-2895	1	239	of	of	ADP
ajlm-2895	1	240	health	health	PROPN
ajlm-2895	1	241	sciences	sciences	PROPN
ajlm-2895	1	242	,	,	PUNCT
ajlm-2895	1	243	nazi	nazi	PROPN
ajlm-2895	1	244	boni	boni	PROPN
ajlm-2895	1	245	university	university	PROPN
ajlm-2895	1	246	,	,	PUNCT
ajlm-2895	1	247	bobo	bobo	NOUN
ajlm-2895	1	248	-	-	PUNCT
ajlm-2895	1	249	dioulasso	dioulasso	PROPN
ajlm-2895	1	250	,	,	PUNCT
ajlm-2895	1	251	burkina	burkina	PROPN
ajlm-2895	1	252	faso	faso	PROPN
ajlm-2895	1	253	department	department	PROPN
ajlm-2895	1	254	of	of	ADP
ajlm-2895	1	255	infectious	infectious	ADJ
ajlm-2895	1	256	and	and	CCONJ
ajlm-2895	1	257	tropical	tropical	ADJ
ajlm-2895	1	258	diseases	disease	NOUN
ajlm-2895	1	259	,	,	PUNCT
ajlm-2895	1	260	sourô	sourô	NOUN
ajlm-2895	1	261	sanou	sanou	NOUN
ajlm-2895	1	262	university	university	NOUN
ajlm-2895	1	263	teaching	teaching	NOUN
ajlm-2895	1	264	hospital	hospital	NOUN
ajlm-2895	1	265	,	,	PUNCT
ajlm-2895	1	266	bobo	bobo	NOUN
ajlm-2895	1	267	-	-	PUNCT
ajlm-2895	1	268	dioulasso	dioulasso	PROPN
ajlm-2895	1	269	,	,	PUNCT
ajlm-2895	1	270	burkina	burkina	PROPN
ajlm-2895	1	271	faso	faso	PROPN
ajlm-2895	1	272	arsène	arsène	PROPN
ajlm-2895	1	273	hema	hema	PROPN
ajlm-2895	1	274	department	department	PROPN
ajlm-2895	1	275	of	of	ADP
ajlm-2895	1	276	quality	quality	NOUN
ajlm-2895	1	277	,	,	PUNCT
ajlm-2895	2	1	sourô	sourô	NOUN
ajlm-2895	2	2	sanou	sanou	NOUN
ajlm-2895	2	3	university	university	NOUN
ajlm-2895	2	4	teaching	teaching	NOUN
ajlm-2895	2	5	hospital	hospital	NOUN
ajlm-2895	2	6	,	,	PUNCT
ajlm-2895	2	7	bobo	bobo	NOUN
ajlm-2895	2	8	-	-	PUNCT
ajlm-2895	2	9	dioulasso	dioulasso	PROPN
ajlm-2895	2	10	,	,	PUNCT
ajlm-2895	2	11	burkina	burkina	PROPN
ajlm-2895	2	12	faso	faso	PROPN
ajlm-2895	2	13	augustin	augustin	PROPN
ajlm-2895	2	14	konkobo	konkobo	PROPN
ajlm-2895	2	15	laboratory	laboratory	PROPN
ajlm-2895	2	16	of	of	ADP
ajlm-2895	2	17	emerging	emerge	VERB
ajlm-2895	2	18	and	and	CCONJ
ajlm-2895	2	19	re	re	ADJ
ajlm-2895	2	20	-	-	ADJ
ajlm-2895	2	21	emerging	emerge	VERB
ajlm-2895	2	22	pathogens	pathogen	NOUN
ajlm-2895	2	23	,	,	PUNCT
ajlm-2895	2	24	school	school	NOUN
ajlm-2895	2	25	of	of	ADP
ajlm-2895	2	26	health	health	NOUN
ajlm-2895	2	27	sciences	sciences	PROPN
ajlm-2895	2	28	,	,	PUNCT
ajlm-2895	2	29	nazi	nazi	PROPN
ajlm-2895	2	30	boni	boni	PROPN
ajlm-2895	2	31	university	university	PROPN
ajlm-2895	2	32	,	,	PUNCT
ajlm-2895	2	33	bobo	bobo	NOUN
ajlm-2895	2	34	-	-	PUNCT
ajlm-2895	2	35	dioulasso	dioulasso	PROPN
ajlm-2895	2	36	,	,	PUNCT
ajlm-2895	2	37	burkina	burkina	PROPN
ajlm-2895	2	38	faso	faso	PROPN
ajlm-2895	2	39	centre	centre	PROPN
ajlm-2895	2	40	muraz	muraz	NOUN
ajlm-2895	2	41	,	,	PUNCT
ajlm-2895	2	42	bobo	bobo	NOUN
ajlm-2895	2	43	-	-	PUNCT
ajlm-2895	2	44	dioulasso	dioulasso	PROPN
ajlm-2895	2	45	,	,	PUNCT
ajlm-2895	2	46	burkina	burkina	PROPN
ajlm-2895	2	47	faso	faso	PROPN
ajlm-2895	2	48	hervé	hervé	PROPN
ajlm-2895	2	49	kafando	kafando	PROPN
ajlm-2895	2	50	laboratory	laboratory	PROPN
ajlm-2895	2	51	of	of	ADP
ajlm-2895	2	52	emerging	emerge	VERB
ajlm-2895	2	53	and	and	CCONJ
ajlm-2895	2	54	re	re	ADJ
ajlm-2895	2	55	-	-	ADJ
ajlm-2895	2	56	emerging	emerge	VERB
ajlm-2895	2	57	pathogens	pathogen	NOUN
ajlm-2895	2	58	,	,	PUNCT
ajlm-2895	2	59	school	school	NOUN
ajlm-2895	2	60	of	of	ADP
ajlm-2895	2	61	health	health	NOUN
ajlm-2895	2	62	sciences	sciences	PROPN
ajlm-2895	2	63	,	,	PUNCT
ajlm-2895	2	64	nazi	nazi	PROPN
ajlm-2895	2	65	boni	boni	PROPN
ajlm-2895	2	66	university	university	PROPN
ajlm-2895	2	67	,	,	PUNCT
ajlm-2895	2	68	bobo	bobo	NOUN
ajlm-2895	2	69	-	-	PUNCT
ajlm-2895	2	70	dioulasso	dioulasso	PROPN
ajlm-2895	2	71	,	,	PUNCT
ajlm-2895	2	72	burkina	burkina	PROPN
ajlm-2895	2	73	faso	faso	PROPN
ajlm-2895	2	74	adama	adama	PROPN
ajlm-2895	2	75	ouattara	ouattara	PROPN
ajlm-2895	2	76	higher	high	ADJ
ajlm-2895	2	77	institute	institute	PROPN
ajlm-2895	2	78	of	of	ADP
ajlm-2895	2	79	health	health	PROPN
ajlm-2895	2	80	sciences	sciences	PROPN
ajlm-2895	2	81	,	,	PUNCT
ajlm-2895	2	82	nazi	nazi	PROPN
ajlm-2895	2	83	boni	boni	PROPN
ajlm-2895	2	84	university	university	PROPN
ajlm-2895	2	85	,	,	PUNCT
ajlm-2895	2	86	bobo	bobo	NOUN
ajlm-2895	2	87	-	-	PUNCT
ajlm-2895	2	88	dioulasso	dioulasso	PROPN
ajlm-2895	2	89	,	,	PUNCT
ajlm-2895	2	90	burkina	burkina	PROPN
ajlm-2895	2	91	faso	faso	PROPN
ajlm-2895	2	92	division	division	NOUN
ajlm-2895	2	93	of	of	ADP
ajlm-2895	2	94	urology	urology	NOUN
ajlm-2895	2	95	,	,	PUNCT
ajlm-2895	2	96	sourô	sourô	PROPN
ajlm-2895	2	97	sanou	sanou	NOUN
ajlm-2895	2	98	university	university	NOUN
ajlm-2895	2	99	teaching	teaching	NOUN
ajlm-2895	2	100	hospital	hospital	NOUN
ajlm-2895	2	101	,	,	PUNCT
ajlm-2895	2	102	bobo	bobo	NOUN
ajlm-2895	2	103	-	-	PUNCT
ajlm-2895	2	104	dioulasso	dioulasso	PROPN
ajlm-2895	2	105	,	,	PUNCT
ajlm-2895	2	106	burkina	burkina	PROPN
ajlm-2895	2	107	faso	faso	PROPN
ajlm-2895	2	108	armel	armel	PROPN
ajlm-2895	2	109	poda	poda	PROPN
ajlm-2895	2	110	laboratory	laboratory	NOUN
ajlm-2895	2	111	of	of	ADP
ajlm-2895	2	112	emerging	emerge	VERB
ajlm-2895	2	113	and	and	CCONJ
ajlm-2895	2	114	re	re	ADJ
ajlm-2895	2	115	-	-	ADJ
ajlm-2895	2	116	emerging	emerge	VERB
ajlm-2895	2	117	pathogens	pathogen	NOUN
ajlm-2895	2	118	,	,	PUNCT
ajlm-2895	2	119	school	school	NOUN
ajlm-2895	2	120	of	of	ADP
ajlm-2895	2	121	health	health	NOUN
ajlm-2895	2	122	sciences	sciences	PROPN
ajlm-2895	2	123	,	,	PUNCT
ajlm-2895	2	124	nazi	nazi	PROPN
ajlm-2895	2	125	boni	boni	PROPN
ajlm-2895	2	126	university	university	PROPN
ajlm-2895	2	127	,	,	PUNCT
ajlm-2895	2	128	bobo	bobo	NOUN
ajlm-2895	2	129	-	-	PUNCT
ajlm-2895	2	130	dioulasso	dioulasso	PROPN
ajlm-2895	2	131	,	,	PUNCT
ajlm-2895	2	132	burkina	burkina	PROPN
ajlm-2895	2	133	faso	faso	PROPN
ajlm-2895	2	134	higher	high	ADJ
ajlm-2895	2	135	institute	institute	PROPN
ajlm-2895	2	136	of	of	ADP
ajlm-2895	2	137	health	health	PROPN
ajlm-2895	2	138	sciences	sciences	PROPN
ajlm-2895	2	139	,	,	PUNCT
ajlm-2895	2	140	nazi	nazi	PROPN
ajlm-2895	2	141	boni	boni	PROPN
ajlm-2895	2	142	university	university	PROPN
ajlm-2895	2	143	,	,	PUNCT
ajlm-2895	2	144	bobo	bobo	NOUN
ajlm-2895	2	145	-	-	PUNCT
ajlm-2895	2	146	dioulasso	dioulasso	PROPN
ajlm-2895	2	147	,	,	PUNCT
ajlm-2895	2	148	burkina	burkina	PROPN
ajlm-2895	2	149	faso	faso	PROPN
ajlm-2895	2	150	department	department	PROPN
ajlm-2895	2	151	of	of	ADP
ajlm-2895	2	152	infectious	infectious	ADJ
ajlm-2895	2	153	and	and	CCONJ
ajlm-2895	2	154	tropical	tropical	ADJ
ajlm-2895	2	155	diseases	disease	NOUN
ajlm-2895	2	156	,	,	PUNCT
ajlm-2895	2	157	sourô	sourô	NOUN
ajlm-2895	3	1	sanou	sanou	NOUN
ajlm-2895	3	2	university	university	NOUN
ajlm-2895	3	3	teaching	teaching	NOUN
ajlm-2895	3	4	hospital	hospital	NOUN
ajlm-2895	3	5	,	,	PUNCT
ajlm-2895	3	6	bobo	bobo	NOUN
ajlm-2895	3	7	-	-	PUNCT
ajlm-2895	3	8	dioulasso	dioulasso	PROPN
ajlm-2895	3	9	,	,	PUNCT
ajlm-2895	3	10	burkina	burkina	PROPN
ajlm-2895	3	11	faso	faso	PROPN
ajlm-2895	3	12	sylvain	sylvain	PROPN
ajlm-2895	3	13	godreuil	godreuil	PROPN
ajlm-2895	3	14	joint	joint	ADJ
ajlm-2895	3	15	research	research	NOUN
ajlm-2895	3	16	unit	unit	NOUN
ajlm-2895	3	17	,	,	PUNCT
ajlm-2895	3	18	research	research	NOUN
ajlm-2895	3	19	institute	institute	PROPN
ajlm-2895	3	20	for	for	ADP
ajlm-2895	3	21	development	development	NOUN
ajlm-2895	3	22	,	,	PUNCT
ajlm-2895	3	23	national	national	ADJ
ajlm-2895	3	24	center	center	NOUN
ajlm-2895	3	25	for	for	ADP
ajlm-2895	3	26	scientific	scientific	ADJ
ajlm-2895	3	27	research	research	NOUN
ajlm-2895	3	28	,	,	PUNCT
ajlm-2895	3	29	inserm	inserm	NOUN
ajlm-2895	3	30	,	,	PUNCT
ajlm-2895	3	31	faculty	faculty	NOUN
ajlm-2895	3	32	of	of	ADP
ajlm-2895	3	33	infectious	infectious	ADJ
ajlm-2895	3	34	diseases	disease	NOUN
ajlm-2895	3	35	and	and	CCONJ
ajlm-2895	3	36	vectors	vector	NOUN
ajlm-2895	3	37	:	:	PUNCT
ajlm-2895	3	38	ecology	ecology	NOUN
ajlm-2895	3	39	,	,	PUNCT
ajlm-2895	3	40	genetics	genetic	NOUN
ajlm-2895	3	41	,	,	PUNCT
ajlm-2895	3	42	evolution	evolution	NOUN
ajlm-2895	3	43	and	and	CCONJ
ajlm-2895	3	44	control	control	NOUN
ajlm-2895	3	45	,	,	PUNCT
ajlm-2895	3	46	university	university	NOUN
ajlm-2895	3	47	of	of	ADP
ajlm-2895	3	48	montpellier	montpellier	NOUN
ajlm-2895	3	49	,	,	PUNCT
ajlm-2895	3	50	montpellier	montpellier	NOUN
ajlm-2895	3	51	,	,	PUNCT
ajlm-2895	3	52	france	france	PROPN
ajlm-2895	3	53	abdoul	abdoul	PROPN
ajlm-2895	3	54	-	-	PUNCT
ajlm-2895	3	55	salam	salam	PROPN
ajlm-2895	3	56	ouedraogo	ouedraogo	PROPN
ajlm-2895	3	57	laboratory	laboratory	NOUN
ajlm-2895	3	58	of	of	ADP
ajlm-2895	3	59	bacteriology	bacteriology	NOUN
ajlm-2895	3	60	and	and	CCONJ
ajlm-2895	3	61	virology	virology	NOUN
ajlm-2895	3	62	,	,	PUNCT
ajlm-2895	3	63	sourô	sourô	PROPN
ajlm-2895	3	64	sanou	sanou	NOUN
ajlm-2895	3	65	university	university	NOUN
ajlm-2895	3	66	teaching	teaching	NOUN
ajlm-2895	3	67	hospital	hospital	NOUN
ajlm-2895	3	68	,	,	PUNCT
ajlm-2895	3	69	bobo	bobo	NOUN
ajlm-2895	3	70	-	-	PUNCT
ajlm-2895	3	71	dioulasso	dioulasso	PROPN
ajlm-2895	3	72	,	,	PUNCT
ajlm-2895	3	73	burkina	burkina	PROPN
ajlm-2895	3	74	faso	faso	PROPN
ajlm-2895	3	75	burkina	burkina	PROPN
ajlm-2895	3	76	faso	faso	PROPN
ajlm-2895	3	77	national	national	PROPN
ajlm-2895	3	78	reference	reference	PROPN
ajlm-2895	3	79	laboratory	laboratory	NOUN
ajlm-2895	3	80	for	for	ADP
ajlm-2895	3	81	antimicrobial	antimicrobial	ADJ
ajlm-2895	3	82	resistance	resistance	NOUN
ajlm-2895	3	83	,	,	PUNCT
ajlm-2895	3	84	bobo	bobo	NOUN
ajlm-2895	3	85	-	-	PUNCT
ajlm-2895	3	86	dioulasso	dioulasso	PROPN
ajlm-2895	3	87	,	,	PUNCT
ajlm-2895	3	88	burkina	burkina	PROPN
ajlm-2895	3	89	faso	faso	PROPN
ajlm-2895	3	90	laboratory	laboratory	NOUN
ajlm-2895	3	91	of	of	ADP
ajlm-2895	3	92	emerging	emerge	VERB
ajlm-2895	3	93	and	and	CCONJ
ajlm-2895	3	94	re	re	ADJ
ajlm-2895	3	95	-	-	ADJ
ajlm-2895	3	96	emerging	emerge	VERB
ajlm-2895	3	97	pathogens	pathogen	NOUN
ajlm-2895	3	98	,	,	PUNCT
ajlm-2895	3	99	school	school	NOUN
ajlm-2895	3	100	of	of	ADP
ajlm-2895	3	101	health	health	NOUN
ajlm-2895	3	102	sciences	sciences	PROPN
ajlm-2895	3	103	,	,	PUNCT
ajlm-2895	3	104	nazi	nazi	PROPN
ajlm-2895	3	105	boni	boni	PROPN
ajlm-2895	3	106	university	university	PROPN
ajlm-2895	3	107	,	,	PUNCT
ajlm-2895	3	108	bobo	bobo	NOUN
ajlm-2895	3	109	-	-	PUNCT
ajlm-2895	3	110	dioulasso	dioulasso	PROPN
ajlm-2895	3	111	,	,	PUNCT
ajlm-2895	3	112	burkina	burkina	PROPN
ajlm-2895	3	113	faso	faso	PROPN
ajlm-2895	3	114	higher	high	ADJ
ajlm-2895	3	115	institute	institute	PROPN
ajlm-2895	3	116	of	of	ADP
ajlm-2895	3	117	health	health	PROPN
ajlm-2895	3	118	sciences	sciences	PROPN
ajlm-2895	3	119	,	,	PUNCT
ajlm-2895	3	120	nazi	nazi	PROPN
ajlm-2895	3	121	boni	boni	PROPN
ajlm-2895	3	122	university	university	PROPN
ajlm-2895	3	123	,	,	PUNCT
ajlm-2895	3	124	bobo	bobo	NOUN
ajlm-2895	3	125	-	-	PUNCT
ajlm-2895	3	126	dioulasso	dioulasso	PROPN
ajlm-2895	3	127	,	,	PUNCT
ajlm-2895	3	128	burkina	burkina	PROPN
ajlm-2895	3	129	faso	faso	PROPN
ajlm-2895	3	130	centre	centre	PROPN
ajlm-2895	3	131	muraz	muraz	NOUN
ajlm-2895	3	132	,	,	PUNCT
ajlm-2895	3	133	bobo	bobo	NOUN
ajlm-2895	3	134	-	-	PUNCT
ajlm-2895	3	135	dioulasso	dioulasso	PROPN
ajlm-2895	3	136	,	,	PUNCT
ajlm-2895	3	137	burkina	burkina	PROPN
ajlm-2895	3	138	faso	faso	PROPN
ajlm-2895	3	139	citation	citation	PROPN
ajlm-2895	3	140	kaboré	kaboré	PROPN
ajlm-2895	3	141	od	od	PROPN
ajlm-2895	3	142	,	,	PUNCT
ajlm-2895	3	143	gonfouli	gonfouli	PROPN
ajlm-2895	3	144	mj	mj	PROPN
ajlm-2895	3	145	,	,	PUNCT
ajlm-2895	3	146	muhigwa	muhigwa	PROPN
ajlm-2895	3	147	m	m	PROPN
ajlm-2895	3	148	,	,	PUNCT
ajlm-2895	3	149	et	et	PROPN
ajlm-2895	3	150	al	al	PROPN
ajlm-2895	3	151	.	.	PROPN
ajlm-2895	4	1	in	in	ADP
ajlm-2895	4	2	vitro	vitro	X
ajlm-2895	4	3	antibacterial	antibacterial	ADJ
ajlm-2895	4	4	activity	activity	NOUN
ajlm-2895	4	5	of	of	ADP
ajlm-2895	4	6	tigecycline	tigecycline	NOUN
ajlm-2895	4	7	against	against	ADP
ajlm-2895	4	8	multidrug	multidrug	NOUN
ajlm-2895	4	9	-	-	PUNCT
ajlm-2895	4	10	resistant	resistant	ADJ
ajlm-2895	4	11	bacteria	bacteria	NOUN
ajlm-2895	4	12	isolated	isolate	VERB
ajlm-2895	4	13	at	at	ADP
ajlm-2895	4	14	the	the	DET
ajlm-2895	4	15	sourô	sourô	PROPN
ajlm-2895	4	16	sanou	sanou	PROPN
ajlm-2895	4	17	university	university	NOUN
ajlm-2895	4	18	teaching	teaching	NOUN
ajlm-2895	4	19	hospital	hospital	NOUN
ajlm-2895	4	20	in	in	ADP
ajlm-2895	4	21	bobo	bobo	NOUN
ajlm-2895	4	22	-	-	PUNCT
ajlm-2895	4	23	dioulasso	dioulasso	PROPN
ajlm-2895	4	24	,	,	PUNCT
ajlm-2895	4	25	burkina	burkina	PROPN
ajlm-2895	4	26	faso	faso	PROPN
ajlm-2895	4	27	.	.	PUNCT
ajlm-2895	5	1	afr	afr	PROPN
ajlm-2895	5	2	j	j	PROPN
ajlm-2895	5	3	lab	lab	PROPN
ajlm-2895	5	4	med	me	VERB
ajlm-2895	5	5	.	.	PUNCT
ajlm-2895	6	1	2024;14(1	2024;14(1	NUM
ajlm-2895	6	2	)	)	PUNCT
ajlm-2895	6	3	,	,	PUNCT
ajlm-2895	6	4	a2895	a2895	PROPN
ajlm-2895	6	5	.	.	PUNCT
ajlm-2895	6	6	https://doi.org/10.4102/ajlm.v14i1.2895	https://doi.org/10.4102/ajlm.v14i1.2895	PROPN
ajlm-2895	6	7	original	original	ADJ
ajlm-2895	6	8	research	research	NOUN
ajlm-2895	6	9	in	in	ADP
ajlm-2895	6	10	vitro	vitro	X
ajlm-2895	6	11	antibacterial	antibacterial	ADJ
ajlm-2895	6	12	activity	activity	NOUN
ajlm-2895	6	13	of	of	ADP
ajlm-2895	6	14	tigecycline	tigecycline	NOUN
ajlm-2895	6	15	against	against	ADP
ajlm-2895	6	16	multidrug	multidrug	NOUN
ajlm-2895	6	17	-	-	PUNCT
ajlm-2895	6	18	resistant	resistant	ADJ
ajlm-2895	6	19	bacteria	bacteria	NOUN
ajlm-2895	6	20	isolated	isolate	VERB
ajlm-2895	6	21	at	at	ADP
ajlm-2895	6	22	the	the	DET
ajlm-2895	6	23	sourô	sourô	PROPN
ajlm-2895	6	24	sanou	sanou	PROPN
ajlm-2895	6	25	university	university	NOUN
ajlm-2895	6	26	teaching	teaching	NOUN
ajlm-2895	6	27	hospital	hospital	NOUN
ajlm-2895	6	28	in	in	ADP
ajlm-2895	6	29	bobo	bobo	NOUN
ajlm-2895	6	30	-	-	PUNCT
ajlm-2895	6	31	dioulasso	dioulasso	PROPN
ajlm-2895	6	32	,	,	PUNCT
ajlm-2895	6	33	burkina	burkina	PROPN
ajlm-2895	6	34	faso	faso	PROPN
ajlm-2895	6	35	odilon	odilon	VERB
ajlm-2895	6	36	d.	d.	PROPN
ajlm-2895	6	37	kaboré	kaboré	PROPN
ajlm-2895	6	38	,	,	PUNCT
ajlm-2895	6	39	mélissa	mélissa	VERB
ajlm-2895	6	40	j.	j.	PROPN
ajlm-2895	6	41	gonfouli	gonfouli	PROPN
ajlm-2895	6	42	,	,	PUNCT
ajlm-2895	6	43	merci	merci	PROPN
ajlm-2895	6	44	muhigwa	muhigwa	NOUN
ajlm-2895	6	45	,	,	PUNCT
ajlm-2895	6	46	abdourahmane	abdourahmane	NOUN
ajlm-2895	6	47	sow	sow	NOUN
ajlm-2895	6	48	,	,	PUNCT
ajlm-2895	6	49	fernand	fernand	PROPN
ajlm-2895	6	50	michodigni	michodigni	NOUN
ajlm-2895	6	51	,	,	PUNCT
ajlm-2895	6	52	andré	andré	ADJ
ajlm-2895	6	53	nagalo	nagalo	NOUN
ajlm-2895	6	54	,	,	PUNCT
ajlm-2895	6	55	jacques	jacques	PROPN
ajlm-2895	6	56	zoungrana	zoungrana	PROPN
ajlm-2895	6	57	,	,	PUNCT
ajlm-2895	6	58	arsène	arsène	PROPN
ajlm-2895	6	59	hema	hema	PROPN
ajlm-2895	6	60	,	,	PUNCT
ajlm-2895	6	61	augustin	augustin	PROPN
ajlm-2895	6	62	konkobo	konkobo	PROPN
ajlm-2895	6	63	,	,	PUNCT
ajlm-2895	6	64	hervé	hervé	NOUN
ajlm-2895	6	65	kafando	kafando	PROPN
ajlm-2895	6	66	,	,	PUNCT
ajlm-2895	6	67	adama	adama	PROPN
ajlm-2895	6	68	ouattara	ouattara	NOUN
ajlm-2895	6	69	,	,	PUNCT
ajlm-2895	6	70	armel	armel	NOUN
ajlm-2895	6	71	poda	poda	PROPN
ajlm-2895	6	72	,	,	PUNCT
ajlm-2895	6	73	sylvain	sylvain	PROPN
ajlm-2895	6	74	godreuil	godreuil	PROPN
ajlm-2895	6	75	,	,	PUNCT
ajlm-2895	6	76	abdoul	abdoul	PROPN
ajlm-2895	6	77	-	-	PUNCT
ajlm-2895	6	78	salam	salam	PROPN
ajlm-2895	6	79	ouedraogo	ouedraogo	PROPN
ajlm-2895	6	80	received	receive	VERB
ajlm-2895	6	81	:	:	PUNCT
ajlm-2895	6	82	07	07	NUM
ajlm-2895	6	83	june	june	PROPN
ajlm-2895	6	84	2025	2025	NUM
ajlm-2895	6	85	;	;	PUNCT
ajlm-2895	6	86	accepted	accept	VERB
ajlm-2895	6	87	:	:	PUNCT
ajlm-2895	6	88	14	14	NUM
ajlm-2895	6	89	oct	oct	PROPN
ajlm-2895	6	90	.	.	PROPN
ajlm-2895	6	91	2025	2025	NUM
ajlm-2895	6	92	;	;	PUNCT
ajlm-2895	6	93	published	publish	VERB
ajlm-2895	6	94	:	:	PUNCT
ajlm-2895	6	95	18	18	NUM
ajlm-2895	6	96	dec	dec	PROPN
ajlm-2895	6	97	.	.	PROPN
ajlm-2895	7	1	2025	2025	NUM
ajlm-2895	7	2	copyright	copyright	NOUN
ajlm-2895	7	3	:	:	PUNCT
ajlm-2895	7	4	©	©	PROPN
ajlm-2895	7	5	2025	2025	NUM
ajlm-2895	7	6	.	.	PUNCT
ajlm-2895	8	1	the	the	DET
ajlm-2895	8	2	author(s	author(s	PROPN
ajlm-2895	8	3	)	)	PUNCT
ajlm-2895	8	4	.	.	PUNCT
ajlm-2895	9	1	licensee	licensee	NOUN
ajlm-2895	9	2	:	:	PUNCT
ajlm-2895	9	3	aosis	aosis	NOUN
ajlm-2895	9	4	.	.	PUNCT
ajlm-2895	10	1	this	this	DET
ajlm-2895	10	2	work	work	NOUN
ajlm-2895	10	3	is	be	AUX
ajlm-2895	10	4	licensed	license	VERB
ajlm-2895	10	5	under	under	ADP
ajlm-2895	10	6	the	the	DET
ajlm-2895	10	7	creative	creative	ADJ
ajlm-2895	10	8	commons	common	NOUN
ajlm-2895	10	9	attribution	attribution	NOUN
ajlm-2895	10	10	4.0	4.0	NUM
ajlm-2895	10	11	international	international	NOUN
ajlm-2895	10	12	(	(	PUNCT
ajlm-2895	10	13	cc	cc	NOUN
ajlm-2895	10	14	by	by	ADP
ajlm-2895	10	15	4.0	4.0	NUM
ajlm-2895	10	16	)	)	PUNCT
ajlm-2895	10	17	license	license	NOUN
ajlm-2895	10	18	(	(	PUNCT
ajlm-2895	10	19	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
ajlm-2895	10	20	)	)	PUNCT
ajlm-2895	10	21	.	.	PUNCT
ajlm-2895	11	1	abstract	abstract	ADJ
ajlm-2895	11	2	background	background	NOUN
ajlm-2895	11	3	:	:	PUNCT
ajlm-2895	11	4	tigecycline	tigecycline	ADJ
ajlm-2895	11	5	,	,	PUNCT
ajlm-2895	11	6	an	an	DET
ajlm-2895	11	7	antibiotic	antibiotic	ADJ
ajlm-2895	11	8	effective	effective	ADJ
ajlm-2895	11	9	against	against	ADP
ajlm-2895	11	10	multidrug	multidrug	NOUN
ajlm-2895	11	11	-	-	PUNCT
ajlm-2895	11	12	resistant	resistant	ADJ
ajlm-2895	11	13	bacteria	bacteria	NOUN
ajlm-2895	11	14	(	(	PUNCT
ajlm-2895	11	15	mdrb	mdrb	NOUN
ajlm-2895	11	16	)	)	PUNCT
ajlm-2895	11	17	,	,	PUNCT
ajlm-2895	11	18	remains	remain	VERB
ajlm-2895	11	19	inaccessible	inaccessible	ADJ
ajlm-2895	11	20	in	in	ADP
ajlm-2895	11	21	burkina	burkina	PROPN
ajlm-2895	11	22	faso	faso	PROPN
ajlm-2895	11	23	’s	’s	PART
ajlm-2895	11	24	hospitals	hospital	NOUN
ajlm-2895	11	25	for	for	ADP
ajlm-2895	11	26	urgent	urgent	ADJ
ajlm-2895	11	27	care	care	NOUN
ajlm-2895	11	28	.	.	PUNCT
ajlm-2895	12	1	given	give	VERB
ajlm-2895	12	2	the	the	DET
ajlm-2895	12	3	resulting	result	VERB
ajlm-2895	12	4	therapeutic	therapeutic	ADJ
ajlm-2895	12	5	challenges	challenge	NOUN
ajlm-2895	12	6	and	and	CCONJ
ajlm-2895	12	7	mortality	mortality	NOUN
ajlm-2895	12	8	in	in	ADP
ajlm-2895	12	9	emergency	emergency	NOUN
ajlm-2895	12	10	services	service	NOUN
ajlm-2895	12	11	,	,	PUNCT
ajlm-2895	12	12	evidence	evidence	NOUN
ajlm-2895	12	13	-	-	PUNCT
ajlm-2895	12	14	based	base	VERB
ajlm-2895	12	15	study	study	NOUN
ajlm-2895	12	16	of	of	ADP
ajlm-2895	12	17	tigecycline	tigecycline	PROPN
ajlm-2895	12	18	’s	’s	PART
ajlm-2895	12	19	efficacy	efficacy	NOUN
ajlm-2895	12	20	on	on	ADP
ajlm-2895	12	21	local	local	ADJ
ajlm-2895	12	22	bacterial	bacterial	ADJ
ajlm-2895	12	23	clinical	clinical	ADJ
ajlm-2895	12	24	isolates	isolate	NOUN
ajlm-2895	12	25	is	be	AUX
ajlm-2895	12	26	necessary	necessary	ADJ
ajlm-2895	12	27	before	before	ADP
ajlm-2895	12	28	recommending	recommend	VERB
ajlm-2895	12	29	its	its	PRON
ajlm-2895	12	30	use	use	NOUN
ajlm-2895	12	31	.	.	PUNCT
ajlm-2895	13	1	objective	objective	NOUN
ajlm-2895	13	2	:	:	PUNCT
ajlm-2895	14	1	this	this	DET
ajlm-2895	14	2	study	study	NOUN
ajlm-2895	14	3	aimed	aim	VERB
ajlm-2895	14	4	to	to	PART
ajlm-2895	14	5	evaluate	evaluate	VERB
ajlm-2895	14	6	the	the	DET
ajlm-2895	14	7	activity	activity	NOUN
ajlm-2895	14	8	of	of	ADP
ajlm-2895	14	9	tigecycline	tigecycline	NOUN
ajlm-2895	14	10	on	on	ADP
ajlm-2895	14	11	mdrb	mdrb	NOUN
ajlm-2895	14	12	isolates	isolate	NOUN
ajlm-2895	14	13	at	at	ADP
ajlm-2895	14	14	the	the	DET
ajlm-2895	14	15	sourô	sourô	PROPN
ajlm-2895	14	16	sanou	sanou	PROPN
ajlm-2895	14	17	university	university	NOUN
ajlm-2895	14	18	teaching	teaching	NOUN
ajlm-2895	14	19	hospital	hospital	NOUN
ajlm-2895	14	20	laboratory	laboratory	NOUN
ajlm-2895	14	21	,	,	PUNCT
ajlm-2895	14	22	burkina	burkina	PROPN
ajlm-2895	14	23	faso	faso	PROPN
ajlm-2895	14	24	.	.	PUNCT
ajlm-2895	15	1	methods	method	NOUN
ajlm-2895	15	2	:	:	PUNCT
ajlm-2895	15	3	this	this	PRON
ajlm-2895	15	4	was	be	AUX
ajlm-2895	15	5	a	a	DET
ajlm-2895	15	6	cross	cross	ADJ
ajlm-2895	15	7	-	-	ADJ
ajlm-2895	15	8	sectional	sectional	ADJ
ajlm-2895	15	9	study	study	NOUN
ajlm-2895	15	10	with	with	ADP
ajlm-2895	15	11	prospective	prospective	ADJ
ajlm-2895	15	12	and	and	CCONJ
ajlm-2895	15	13	consecutive	consecutive	ADJ
ajlm-2895	15	14	sampling	sampling	NOUN
ajlm-2895	15	15	of	of	ADP
ajlm-2895	15	16	mdrbs	mdrb	NOUN
ajlm-2895	15	17	.	.	PUNCT
ajlm-2895	16	1	the	the	DET
ajlm-2895	16	2	latter	latter	ADJ
ajlm-2895	16	3	included	include	VERB
ajlm-2895	16	4	extended	extend	VERB
ajlm-2895	16	5	-	-	PUNCT
ajlm-2895	16	6	spectrum	spectrum	NOUN
ajlm-2895	16	7	β	β	NOUN
ajlm-2895	16	8	-	-	PUNCT
ajlm-2895	16	9	lactamase	lactamase	ADJ
ajlm-2895	16	10	-	-	PUNCT
ajlm-2895	16	11	producing	produce	VERB
ajlm-2895	16	12	enterobacterales	enterobacterale	NOUN
ajlm-2895	16	13	(	(	PUNCT
ajlm-2895	16	14	esbl	esbl	NOUN
ajlm-2895	16	15	-	-	PUNCT
ajlm-2895	16	16	e	e	NOUN
ajlm-2895	16	17	)	)	PUNCT
ajlm-2895	16	18	,	,	PUNCT
ajlm-2895	16	19	carbapenem	carbapenem	NOUN
ajlm-2895	16	20	-	-	PUNCT
ajlm-2895	16	21	resistant	resistant	ADJ
ajlm-2895	16	22	strains	strain	NOUN
ajlm-2895	16	23	(	(	PUNCT
ajlm-2895	16	24	crs	crs	PROPN
ajlm-2895	16	25	)	)	PUNCT
ajlm-2895	16	26	,	,	PUNCT
ajlm-2895	16	27	and	and	CCONJ
ajlm-2895	16	28	methicillin	methicillin	NOUN
ajlm-2895	16	29	-	-	PUNCT
ajlm-2895	16	30	resistant	resistant	ADJ
ajlm-2895	16	31	staphylococcus	staphylococcus	NOUN
ajlm-2895	16	32	aureus	aureus	NOUN
ajlm-2895	16	33	(	(	PUNCT
ajlm-2895	16	34	mrsa	mrsa	NOUN
ajlm-2895	16	35	)	)	PUNCT
ajlm-2895	16	36	,	,	PUNCT
ajlm-2895	16	37	which	which	PRON
ajlm-2895	16	38	were	be	AUX
ajlm-2895	16	39	isolated	isolate	VERB
ajlm-2895	16	40	from	from	ADP
ajlm-2895	16	41	urine	urine	NOUN
ajlm-2895	16	42	,	,	PUNCT
ajlm-2895	16	43	blood	blood	NOUN
ajlm-2895	16	44	,	,	PUNCT
ajlm-2895	16	45	pus	pus	NOUN
ajlm-2895	16	46	and	and	CCONJ
ajlm-2895	16	47	puncture	puncture	NOUN
ajlm-2895	16	48	fluids	fluid	NOUN
ajlm-2895	16	49	between	between	ADP
ajlm-2895	16	50	01	01	NUM
ajlm-2895	16	51	june	june	PROPN
ajlm-2895	16	52	2022	2022	NUM
ajlm-2895	16	53	and	and	CCONJ
ajlm-2895	16	54	31	31	NUM
ajlm-2895	16	55	august	august	PROPN
ajlm-2895	16	56	2022	2022	NUM
ajlm-2895	16	57	.	.	PUNCT
ajlm-2895	17	1	antimicrobial	antimicrobial	ADJ
ajlm-2895	17	2	susceptibility	susceptibility	NOUN
ajlm-2895	17	3	testing	testing	NOUN
ajlm-2895	17	4	was	be	AUX
ajlm-2895	17	5	conducted	conduct	VERB
ajlm-2895	17	6	using	use	VERB
ajlm-2895	17	7	the	the	DET
ajlm-2895	17	8	modified	modified	ADJ
ajlm-2895	17	9	kirby	kirby	PROPN
ajlm-2895	17	10	-	-	PUNCT
ajlm-2895	17	11	bauer	bauer	PROPN
ajlm-2895	17	12	method	method	NOUN
ajlm-2895	17	13	,	,	PUNCT
ajlm-2895	17	14	and	and	CCONJ
ajlm-2895	17	15	the	the	DET
ajlm-2895	17	16	results	result	NOUN
ajlm-2895	17	17	were	be	AUX
ajlm-2895	17	18	interpreted	interpret	VERB
ajlm-2895	17	19	according	accord	VERB
ajlm-2895	17	20	to	to	ADP
ajlm-2895	17	21	the	the	DET
ajlm-2895	17	22	standard	standard	NOUN
ajlm-2895	17	23	set	set	VERB
ajlm-2895	17	24	by	by	ADP
ajlm-2895	17	25	the	the	DET
ajlm-2895	17	26	european	european	PROPN
ajlm-2895	17	27	committee	committee	PROPN
ajlm-2895	17	28	on	on	ADP
ajlm-2895	17	29	antimicrobial	antimicrobial	ADJ
ajlm-2895	17	30	susceptibility	susceptibility	NOUN
ajlm-2895	17	31	testing	testing	NOUN
ajlm-2895	17	32	in	in	ADP
ajlm-2895	17	33	2021	2021	NUM
ajlm-2895	17	34	.	.	PUNCT
ajlm-2895	18	1	results	result	NOUN
ajlm-2895	18	2	:	:	PUNCT
ajlm-2895	18	3	a	a	DET
ajlm-2895	18	4	total	total	NOUN
ajlm-2895	18	5	of	of	ADP
ajlm-2895	18	6	117	117	NUM
ajlm-2895	18	7	mdrbs	mdrb	NOUN
ajlm-2895	18	8	,	,	PUNCT
ajlm-2895	18	9	including	include	VERB
ajlm-2895	18	10	93	93	NUM
ajlm-2895	18	11	enterobacterales	enterobacterale	NOUN
ajlm-2895	18	12	,	,	PUNCT
ajlm-2895	18	13	15	15	NUM
ajlm-2895	18	14	carbapenem	carbapenem	NOUN
ajlm-2895	18	15	-	-	PUNCT
ajlm-2895	18	16	resistant	resistant	ADJ
ajlm-2895	18	17	acinetobacter	acinetobacter	ADJ
ajlm-2895	18	18	baumannii	baumannii	ADJ
ajlm-2895	18	19	(	(	PUNCT
ajlm-2895	18	20	crab	crab	NOUN
ajlm-2895	18	21	)	)	PUNCT
ajlm-2895	18	22	,	,	PUNCT
ajlm-2895	18	23	and	and	CCONJ
ajlm-2895	18	24	9	9	NUM
ajlm-2895	18	25	mrsas	mrsa	NOUN
ajlm-2895	18	26	were	be	AUX
ajlm-2895	18	27	collected	collect	VERB
ajlm-2895	18	28	.	.	PUNCT
ajlm-2895	19	1	the	the	DET
ajlm-2895	19	2	proportion	proportion	NOUN
ajlm-2895	19	3	of	of	ADP
ajlm-2895	19	4	esbl	esbl	NOUN
ajlm-2895	19	5	-	-	PUNCT
ajlm-2895	19	6	e	e	NOUN
ajlm-2895	19	7	was	be	AUX
ajlm-2895	19	8	58	58	NUM
ajlm-2895	19	9	%	%	NOUN
ajlm-2895	19	10	(	(	PUNCT
ajlm-2895	19	11	68/117	68/117	NUM
ajlm-2895	19	12	)	)	PUNCT
ajlm-2895	19	13	,	,	PUNCT
ajlm-2895	19	14	followed	follow	VERB
ajlm-2895	19	15	by	by	ADP
ajlm-2895	19	16	crs	crs	PROPN
ajlm-2895	19	17	(	(	PUNCT
ajlm-2895	19	18	34	34	NUM
ajlm-2895	19	19	%	%	NOUN
ajlm-2895	19	20	,	,	PUNCT
ajlm-2895	19	21	40/117	40/117	NUM
ajlm-2895	19	22	)	)	PUNCT
ajlm-2895	19	23	and	and	CCONJ
ajlm-2895	19	24	mrsa	mrsa	NOUN
ajlm-2895	19	25	(	(	PUNCT
ajlm-2895	19	26	8	8	NUM
ajlm-2895	19	27	%	%	NOUN
ajlm-2895	19	28	,	,	PUNCT
ajlm-2895	19	29	9/117	9/117	NUM
ajlm-2895	19	30	)	)	PUNCT
ajlm-2895	19	31	.	.	PUNCT
ajlm-2895	20	1	the	the	DET
ajlm-2895	20	2	activity	activity	NOUN
ajlm-2895	20	3	of	of	ADP
ajlm-2895	20	4	tigecycline	tigecycline	NOUN
ajlm-2895	20	5	was	be	AUX
ajlm-2895	20	6	95.5	95.5	NUM
ajlm-2895	20	7	%	%	NOUN
ajlm-2895	20	8	(	(	PUNCT
ajlm-2895	20	9	43/45	43/45	NUM
ajlm-2895	20	10	)	)	PUNCT
ajlm-2895	20	11	on	on	ADP
ajlm-2895	20	12	esbl	esbl	NOUN
ajlm-2895	20	13	-	-	PUNCT
ajlm-2895	20	14	e	e	NOUN
ajlm-2895	20	15	,	,	PUNCT
ajlm-2895	20	16	72.5	72.5	NUM
ajlm-2895	20	17	%	%	NOUN
ajlm-2895	20	18	(	(	PUNCT
ajlm-2895	20	19	29/40	29/40	NUM
ajlm-2895	20	20	)	)	PUNCT
ajlm-2895	20	21	on	on	ADP
ajlm-2895	20	22	crs	crs	PROPN
ajlm-2895	20	23	(	(	PUNCT
ajlm-2895	20	24	including	include	VERB
ajlm-2895	20	25	10/15	10/15	NUM
ajlm-2895	20	26	crab	crab	NOUN
ajlm-2895	20	27	)	)	PUNCT
ajlm-2895	20	28	,	,	PUNCT
ajlm-2895	20	29	and	and	CCONJ
ajlm-2895	20	30	89	89	NUM
ajlm-2895	20	31	%	%	NOUN
ajlm-2895	20	32	(	(	PUNCT
ajlm-2895	20	33	8/9	8/9	NUM
ajlm-2895	20	34	)	)	PUNCT
ajlm-2895	20	35	on	on	ADP
ajlm-2895	20	36	mrsa	mrsa	NOUN
ajlm-2895	20	37	.	.	PUNCT
ajlm-2895	21	1	conclusion	conclusion	NOUN
ajlm-2895	21	2	:	:	PUNCT
ajlm-2895	21	3	the	the	DET
ajlm-2895	21	4	activity	activity	NOUN
ajlm-2895	21	5	of	of	ADP
ajlm-2895	21	6	tigecycline	tigecycline	NOUN
ajlm-2895	21	7	was	be	AUX
ajlm-2895	21	8	highly	highly	ADV
ajlm-2895	21	9	effective	effective	ADJ
ajlm-2895	21	10	on	on	ADP
ajlm-2895	21	11	esbl	esbl	NOUN
ajlm-2895	21	12	-	-	PUNCT
ajlm-2895	21	13	e	e	NOUN
ajlm-2895	21	14	,	,	PUNCT
ajlm-2895	21	15	carbapenem	carbapenem	X
ajlm-2895	21	16	resistant	resistant	ADJ
ajlm-2895	21	17	enterobacterales	enterobacterale	NOUN
ajlm-2895	21	18	and	and	CCONJ
ajlm-2895	21	19	mrsa	mrsa	NOUN
ajlm-2895	21	20	,	,	PUNCT
ajlm-2895	21	21	and	and	CCONJ
ajlm-2895	21	22	moderate	moderate	ADJ
ajlm-2895	21	23	on	on	ADP
ajlm-2895	21	24	crab	crab	NOUN
ajlm-2895	21	25	.	.	PUNCT
ajlm-2895	22	1	what	what	PRON
ajlm-2895	22	2	this	this	DET
ajlm-2895	22	3	study	study	NOUN
ajlm-2895	22	4	adds	add	VERB
ajlm-2895	22	5	:	:	PUNCT
ajlm-2895	22	6	this	this	PRON
ajlm-2895	22	7	was	be	AUX
ajlm-2895	22	8	the	the	DET
ajlm-2895	22	9	first	first	ADJ
ajlm-2895	22	10	report	report	NOUN
ajlm-2895	22	11	on	on	ADP
ajlm-2895	22	12	the	the	DET
ajlm-2895	22	13	evaluation	evaluation	NOUN
ajlm-2895	22	14	of	of	ADP
ajlm-2895	22	15	tigecycline	tigecycline	ADJ
ajlm-2895	22	16	activity	activity	NOUN
ajlm-2895	22	17	on	on	ADP
ajlm-2895	22	18	mdrbs	mdrb	NOUN
ajlm-2895	22	19	in	in	ADP
ajlm-2895	22	20	burkina	burkina	PROPN
ajlm-2895	22	21	faso	faso	PROPN
ajlm-2895	22	22	.	.	PUNCT
ajlm-2895	23	1	this	this	DET
ajlm-2895	23	2	non	non	ADJ
ajlm-2895	23	3	-	-	ADJ
ajlm-2895	23	4	marketed	marketed	ADJ
ajlm-2895	23	5	antibiotic	antibiotic	NOUN
ajlm-2895	23	6	in	in	ADP
ajlm-2895	23	7	burkina	burkina	PROPN
ajlm-2895	23	8	faso	faso	PROPN
ajlm-2895	23	9	could	could	AUX
ajlm-2895	23	10	represent	represent	VERB
ajlm-2895	23	11	an	an	DET
ajlm-2895	23	12	alternative	alternative	NOUN
ajlm-2895	23	13	to	to	ADP
ajlm-2895	23	14	spare	spare	ADJ
ajlm-2895	23	15	carbapenems	carbapenem	NOUN
ajlm-2895	23	16	in	in	ADP
ajlm-2895	23	17	the	the	DET
ajlm-2895	23	18	treatment	treatment	NOUN
ajlm-2895	23	19	of	of	ADP
ajlm-2895	23	20	esbl	esbl	NOUN
ajlm-2895	23	21	-	-	PUNCT
ajlm-2895	23	22	e	e	NOUN
ajlm-2895	23	23	infections	infection	NOUN
ajlm-2895	23	24	,	,	PUNCT
ajlm-2895	23	25	and	and	CCONJ
ajlm-2895	23	26	a	a	DET
ajlm-2895	23	27	last	last	ADJ
ajlm-2895	23	28	resort	resort	NOUN
ajlm-2895	23	29	antibiotic	antibiotic	ADJ
ajlm-2895	23	30	against	against	ADP
ajlm-2895	23	31	susceptible	susceptible	ADJ
ajlm-2895	23	32	crs	crs	PROPN
ajlm-2895	23	33	infections	infection	NOUN
ajlm-2895	23	34	in	in	ADP
ajlm-2895	23	35	burkina	burkina	PROPN
ajlm-2895	23	36	faso	faso	PROPN
ajlm-2895	23	37	’s	’s	PART
ajlm-2895	23	38	hospitals	hospital	NOUN
ajlm-2895	23	39	.	.	PUNCT
ajlm-2895	24	1	keywords	keyword	NOUN
ajlm-2895	24	2	:	:	PUNCT
ajlm-2895	24	3	acinetobacter	acinetobacter	ADV
ajlm-2895	24	4	baumannii	baumannii	PROPN
ajlm-2895	24	5	;	;	PUNCT
ajlm-2895	24	6	burkina	burkina	PROPN
ajlm-2895	24	7	faso	faso	PROPN
ajlm-2895	24	8	;	;	PUNCT
ajlm-2895	24	9	enterobacterales	enterobacterale	NOUN
ajlm-2895	24	10	;	;	PUNCT
ajlm-2895	24	11	extended	extend	VERB
ajlm-2895	24	12	-	-	PUNCT
ajlm-2895	24	13	spectrum	spectrum	NOUN
ajlm-2895	24	14	β	β	NOUN
ajlm-2895	24	15	-	-	PUNCT
ajlm-2895	24	16	lactamase	lactamase	ADJ
ajlm-2895	24	17	-	-	PUNCT
ajlm-2895	24	18	producing	produce	VERB
ajlm-2895	24	19	enterobacterales	enterobacterale	NOUN
ajlm-2895	24	20	;	;	PUNCT
ajlm-2895	24	21	in	in	ADP
ajlm-2895	24	22	vitro	vitro	X
ajlm-2895	24	23	;	;	PUNCT
ajlm-2895	24	24	methicillin	methicillin	NOUN
ajlm-2895	24	25	-	-	PUNCT
ajlm-2895	24	26	resistant	resistant	ADJ
ajlm-2895	24	27	staphylococcus	staphylococcus	NOUN
ajlm-2895	24	28	aureus	aureus	NOUN
ajlm-2895	24	29	;	;	PUNCT
ajlm-2895	24	30	multidrug	multidrug	NOUN
ajlm-2895	24	31	-	-	PUNCT
ajlm-2895	24	32	resistant	resistant	ADJ
ajlm-2895	24	33	bacteria	bacteria	NOUN
ajlm-2895	24	34	;	;	PUNCT
ajlm-2895	24	35	tigecycline	tigecycline	ADJ
ajlm-2895	24	36	.	.	PUNCT
ajlm-2895	25	1	introduction	introduction	NOUN
ajlm-2895	25	2	antimicrobial	antimicrobial	ADJ
ajlm-2895	25	3	resistance	resistance	NOUN
ajlm-2895	25	4	(	(	PUNCT
ajlm-2895	25	5	amr	amr	NOUN
ajlm-2895	25	6	)	)	PUNCT
ajlm-2895	25	7	has	have	AUX
ajlm-2895	25	8	emerged	emerge	VERB
ajlm-2895	25	9	as	as	ADP
ajlm-2895	25	10	one	one	NUM
ajlm-2895	25	11	of	of	ADP
ajlm-2895	25	12	the	the	DET
ajlm-2895	25	13	leading	lead	VERB
ajlm-2895	25	14	public	public	ADJ
ajlm-2895	25	15	health	health	NOUN
ajlm-2895	25	16	threats	threat	NOUN
ajlm-2895	25	17	of	of	ADP
ajlm-2895	25	18	the	the	DET
ajlm-2895	25	19	21st	21st	ADJ
ajlm-2895	25	20	century	century	NOUN
ajlm-2895	25	21	,	,	PUNCT
ajlm-2895	25	22	and	and	CCONJ
ajlm-2895	25	23	poses	pose	VERB
ajlm-2895	25	24	an	an	DET
ajlm-2895	25	25	economic	economic	ADJ
ajlm-2895	25	26	burden	burden	NOUN
ajlm-2895	25	27	to	to	ADP
ajlm-2895	25	28	the	the	DET
ajlm-2895	25	29	healthcare	healthcare	NOUN
ajlm-2895	25	30	system	system	NOUN
ajlm-2895	25	31	because	because	SCONJ
ajlm-2895	25	32	of	of	ADP
ajlm-2895	25	33	long	long	ADJ
ajlm-2895	25	34	hospitalisations	hospitalisation	NOUN
ajlm-2895	25	35	and	and	CCONJ
ajlm-2895	25	36	higher	high	ADJ
ajlm-2895	25	37	morbidity	morbidity	NOUN
ajlm-2895	25	38	and	and	CCONJ
ajlm-2895	25	39	mortality.1	mortality.1	NOUN
ajlm-2895	25	40	in	in	ADP
ajlm-2895	25	41	2019	2019	NUM
ajlm-2895	25	42	,	,	PUNCT
ajlm-2895	25	43	there	there	PRON
ajlm-2895	25	44	were	be	VERB
ajlm-2895	25	45	approximately	approximately	ADV
ajlm-2895	25	46	4.95	4.95	NUM
ajlm-2895	25	47	million	million	NUM
ajlm-2895	25	48	deaths	death	NOUN
ajlm-2895	25	49	associated	associate	VERB
ajlm-2895	25	50	with	with	ADP
ajlm-2895	25	51	antimicrobial	antimicrobial	ADJ
ajlm-2895	25	52	resistance	resistance	NOUN
ajlm-2895	25	53	,	,	PUNCT
ajlm-2895	25	54	including	include	VERB
ajlm-2895	25	55	1.27	1.27	NUM
ajlm-2895	25	56	million	million	NUM
ajlm-2895	25	57	attributable	attributable	ADJ
ajlm-2895	25	58	to	to	PART
ajlm-2895	25	59	multidrug	multidrug	VERB
ajlm-2895	25	60	-	-	PUNCT
ajlm-2895	25	61	resistant	resistant	ADJ
ajlm-2895	25	62	bacteria	bacteria	NOUN
ajlm-2895	25	63	(	(	PUNCT
ajlm-2895	25	64	mdrb	mdrb	NOUN
ajlm-2895	25	65	)	)	PUNCT
ajlm-2895	25	66	.	.	PUNCT
ajlm-2895	26	1	the	the	DET
ajlm-2895	26	2	low	low	ADJ
ajlm-2895	26	3	-	-	PUNCT
ajlm-2895	26	4	income	income	NOUN
ajlm-2895	26	5	countries	country	NOUN
ajlm-2895	26	6	of	of	ADP
ajlm-2895	26	7	sub	sub	ADJ
ajlm-2895	26	8	-	-	ADJ
ajlm-2895	26	9	saharan	saharan	ADJ
ajlm-2895	26	10	africa	africa	PROPN
ajlm-2895	26	11	are	be	AUX
ajlm-2895	26	12	the	the	DET
ajlm-2895	26	13	most	most	ADV
ajlm-2895	26	14	affected	affected	ADJ
ajlm-2895	26	15	,	,	PUNCT
ajlm-2895	26	16	with	with	SCONJ
ajlm-2895	26	17	an	an	DET
ajlm-2895	26	18	estimated	estimate	VERB
ajlm-2895	26	19	mortality	mortality	NOUN
ajlm-2895	26	20	of	of	ADP
ajlm-2895	26	21	27.3	27.3	NUM
ajlm-2895	26	22	deaths	death	NOUN
ajlm-2895	26	23	per	per	ADP
ajlm-2895	26	24	100	100	NUM
ajlm-2895	26	25	000	000	NUM
ajlm-2895	26	26	inhabitants.2	inhabitants.2	VERB
ajlm-2895	26	27	the	the	DET
ajlm-2895	26	28	most	most	ADV
ajlm-2895	26	29	problematic	problematic	ADJ
ajlm-2895	26	30	mdrbs	mdrb	NOUN
ajlm-2895	26	31	encompass	encompass	VERB
ajlm-2895	26	32	extended	extend	VERB
ajlm-2895	26	33	-	-	PUNCT
ajlm-2895	26	34	spectrum	spectrum	NOUN
ajlm-2895	26	35	β	β	NOUN
ajlm-2895	26	36	-	-	NOUN
ajlm-2895	26	37	lactamases	lactamase	NOUN
ajlm-2895	26	38	(	(	PUNCT
ajlm-2895	26	39	esbl)-producing	esbl)-produce	VERB
ajlm-2895	26	40	enterobacterales	enterobacterale	NOUN
ajlm-2895	26	41	(	(	PUNCT
ajlm-2895	26	42	esbl	esbl	NOUN
ajlm-2895	26	43	-	-	PUNCT
ajlm-2895	26	44	e	e	NOUN
ajlm-2895	26	45	)	)	PUNCT
ajlm-2895	26	46	,	,	PUNCT
ajlm-2895	26	47	carbapenemase	carbapenemase	NOUN
ajlm-2895	26	48	-	-	PUNCT
ajlm-2895	26	49	producing	produce	VERB
ajlm-2895	26	50	enterobacterales	enterobacterale	NOUN
ajlm-2895	26	51	(	(	PUNCT
ajlm-2895	26	52	known	know	VERB
ajlm-2895	26	53	as	as	ADP
ajlm-2895	26	54	carbapenem	carbapenem	NOUN
ajlm-2895	26	55	-	-	PUNCT
ajlm-2895	26	56	resistant	resistant	ADJ
ajlm-2895	26	57	enterobacterales	enterobacterale	NOUN
ajlm-2895	26	58	,	,	PUNCT
ajlm-2895	26	59	carbapenem	carbapenem	NOUN
ajlm-2895	26	60	-	-	PUNCT
ajlm-2895	26	61	resistant	resistant	ADJ
ajlm-2895	26	62	acinetobacter	acinetobacter	ADJ
ajlm-2895	26	63	baumannii	baumannii	ADJ
ajlm-2895	26	64	(	(	PUNCT
ajlm-2895	26	65	crab	crab	NOUN
ajlm-2895	26	66	)	)	PUNCT
ajlm-2895	26	67	,	,	PUNCT
ajlm-2895	26	68	and	and	CCONJ
ajlm-2895	26	69	pseudomonas	pseudomona	NOUN
ajlm-2895	26	70	aeruginosa	aeruginosa	NOUN
ajlm-2895	26	71	.	.	PUNCT
ajlm-2895	27	1	in	in	ADP
ajlm-2895	27	2	addition	addition	NOUN
ajlm-2895	27	3	to	to	ADP
ajlm-2895	27	4	vancomycin	vancomycin	NOUN
ajlm-2895	27	5	-	-	PUNCT
ajlm-2895	27	6	resistant	resistant	ADJ
ajlm-2895	27	7	enterococcus	enterococcus	NOUN
ajlm-2895	27	8	and	and	CCONJ
ajlm-2895	27	9	methicillin	methicillin	NOUN
ajlm-2895	27	10	-	-	PUNCT
ajlm-2895	27	11	resistant	resistant	ADJ
ajlm-2895	27	12	staphylococcus	staphylococcus	NOUN
ajlm-2895	27	13	aureus	aureus	NOUN
ajlm-2895	27	14	(	(	PUNCT
ajlm-2895	27	15	mrsa	mrsa	NOUN
ajlm-2895	27	16	)	)	PUNCT
ajlm-2895	27	17	,	,	PUNCT
ajlm-2895	27	18	they	they	PRON
ajlm-2895	27	19	constitute	constitute	VERB
ajlm-2895	27	20	a	a	DET
ajlm-2895	27	21	class	class	NOUN
ajlm-2895	27	22	of	of	ADP
ajlm-2895	27	23	‘	'	PUNCT
ajlm-2895	27	24	superbugs	superbug	NOUN
ajlm-2895	27	25	’	'	PUNCT
ajlm-2895	27	26	called	call	VERB
ajlm-2895	27	27	eskape	eskape	NOUN
ajlm-2895	27	28	,	,	PUNCT
ajlm-2895	27	29	an	an	DET
ajlm-2895	27	30	acronym	acronym	NOUN
ajlm-2895	27	31	with	with	ADP
ajlm-2895	27	32	dual	dual	ADJ
ajlm-2895	27	33	significance	significance	NOUN
ajlm-2895	27	34	reflecting	reflect	VERB
ajlm-2895	27	35	both	both	CCONJ
ajlm-2895	27	36	the	the	DET
ajlm-2895	27	37	first	first	ADJ
ajlm-2895	27	38	letter	letter	NOUN
ajlm-2895	27	39	of	of	ADP
ajlm-2895	27	40	the	the	DET
ajlm-2895	27	41	bacterial	bacterial	ADJ
ajlm-2895	27	42	name	name	NOUN
ajlm-2895	27	43	and	and	CCONJ
ajlm-2895	27	44	their	their	PRON
ajlm-2895	27	45	ability	ability	NOUN
ajlm-2895	27	46	to	to	PART
ajlm-2895	27	47	evade	evade	VERB
ajlm-2895	27	48	the	the	DET
ajlm-2895	27	49	bactericidal	bactericidal	ADJ
ajlm-2895	27	50	effects	effect	NOUN
ajlm-2895	27	51	of	of	ADP
ajlm-2895	27	52	antibiotics.3,4	antibiotics.3,4	NOUN
ajlm-2895	27	53	given	give	VERB
ajlm-2895	27	54	the	the	DET
ajlm-2895	27	55	global	global	ADJ
ajlm-2895	27	56	surge	surge	NOUN
ajlm-2895	27	57	in	in	ADP
ajlm-2895	27	58	esbl	esbl	NOUN
ajlm-2895	27	59	-	-	PUNCT
ajlm-2895	27	60	e	e	NOUN
ajlm-2895	27	61	and	and	CCONJ
ajlm-2895	27	62	carbapenem	carbapenem	NOUN
ajlm-2895	27	63	-	-	PUNCT
ajlm-2895	27	64	resistant	resistant	ADJ
ajlm-2895	27	65	organisms	organism	NOUN
ajlm-2895	27	66	,	,	PUNCT
ajlm-2895	27	67	it	it	PRON
ajlm-2895	27	68	is	be	AUX
ajlm-2895	27	69	imperative	imperative	ADJ
ajlm-2895	27	70	to	to	PART
ajlm-2895	27	71	find	find	VERB
ajlm-2895	27	72	alternative	alternative	ADJ
ajlm-2895	27	73	treatments	treatment	NOUN
ajlm-2895	27	74	to	to	ADP
ajlm-2895	27	75	carbapenems	carbapenem	NOUN
ajlm-2895	27	76	and	and	CCONJ
ajlm-2895	27	77	develop	develop	VERB
ajlm-2895	27	78	novel	novel	ADJ
ajlm-2895	27	79	therapeutic	therapeutic	ADJ
ajlm-2895	27	80	agents	agent	NOUN
ajlm-2895	27	81	to	to	PART
ajlm-2895	27	82	combat	combat	NOUN
ajlm-2895	27	83	infections	infection	NOUN
ajlm-2895	27	84	caused	cause	VERB
ajlm-2895	27	85	by	by	ADP
ajlm-2895	27	86	these	these	DET
ajlm-2895	27	87	resistant	resistant	ADJ
ajlm-2895	27	88	bacteria	bacteria	NOUN
ajlm-2895	27	89	.	.	PUNCT
ajlm-2895	28	1	new	new	ADJ
ajlm-2895	28	2	antibiotics	antibiotic	NOUN
ajlm-2895	28	3	have	have	AUX
ajlm-2895	28	4	been	be	AUX
ajlm-2895	28	5	introduced	introduce	VERB
ajlm-2895	28	6	into	into	ADP
ajlm-2895	28	7	the	the	DET
ajlm-2895	28	8	market	market	NOUN
ajlm-2895	28	9	of	of	ADP
ajlm-2895	28	10	developed	develop	VERB
ajlm-2895	28	11	countries	country	NOUN
ajlm-2895	28	12	over	over	ADP
ajlm-2895	28	13	the	the	DET
ajlm-2895	28	14	last	last	ADJ
ajlm-2895	28	15	two	two	NUM
ajlm-2895	28	16	decades	decade	NOUN
ajlm-2895	28	17	to	to	PART
ajlm-2895	28	18	improve	improve	VERB
ajlm-2895	28	19	the	the	DET
ajlm-2895	28	20	treatment	treatment	NOUN
ajlm-2895	28	21	regimens	regimen	NOUN
ajlm-2895	28	22	of	of	ADP
ajlm-2895	28	23	mdrb	mdrb	NOUN
ajlm-2895	28	24	infections,5,6,7	infections,5,6,7	PUNCT
ajlm-2895	28	25	but	but	CCONJ
ajlm-2895	28	26	remain	remain	VERB
ajlm-2895	28	27	inaccessible	inaccessible	ADJ
ajlm-2895	28	28	in	in	ADP
ajlm-2895	28	29	lowand	lowand	ADJ
ajlm-2895	28	30	middle	middle	ADJ
ajlm-2895	28	31	-	-	PUNCT
ajlm-2895	28	32	income	income	NOUN
ajlm-2895	28	33	countries	country	NOUN
ajlm-2895	28	34	affected	affect	VERB
ajlm-2895	28	35	by	by	ADP
ajlm-2895	28	36	high	high	ADJ
ajlm-2895	28	37	rates	rate	NOUN
ajlm-2895	28	38	of	of	ADP
ajlm-2895	28	39	therapeutic	therapeutic	ADJ
ajlm-2895	28	40	deadlocks	deadlock	NOUN
ajlm-2895	28	41	linked	link	VERB
ajlm-2895	28	42	to	to	ADP
ajlm-2895	28	43	superbug	superbug	NOUN
ajlm-2895	28	44	infections.2,8	infections.2,8	PROPN
ajlm-2895	28	45	one	one	NUM
ajlm-2895	28	46	of	of	ADP
ajlm-2895	28	47	these	these	DET
ajlm-2895	28	48	new	new	ADJ
ajlm-2895	28	49	antibiotics	antibiotic	NOUN
ajlm-2895	28	50	is	be	AUX
ajlm-2895	28	51	tigecycline	tigecycline	ADJ
ajlm-2895	28	52	,	,	PUNCT
ajlm-2895	28	53	a	a	DET
ajlm-2895	28	54	semisynthetic	semisynthetic	ADJ
ajlm-2895	28	55	9	9	NUM
ajlm-2895	28	56	-	-	PUNCT
ajlm-2895	28	57	tertbutyl	tertbutyl	NOUN
ajlm-2895	28	58	-	-	PUNCT
ajlm-2895	28	59	glycylamido	glycylamido	NOUN
ajlm-2895	28	60	derivative	derivative	NOUN
ajlm-2895	28	61	of	of	ADP
ajlm-2895	28	62	minocycline	minocycline	NOUN
ajlm-2895	28	63	,	,	PUNCT
ajlm-2895	28	64	which	which	PRON
ajlm-2895	28	65	acts	act	VERB
ajlm-2895	28	66	by	by	ADP
ajlm-2895	28	67	higher	high	ADJ
ajlm-2895	28	68	binding	bind	VERB
ajlm-2895	28	69	affinity	affinity	NOUN
ajlm-2895	28	70	to	to	ADP
ajlm-2895	28	71	the	the	DET
ajlm-2895	28	72	30s	30	NOUN
ajlm-2895	28	73	ribosomal	ribosomal	NOUN
ajlm-2895	28	74	subunit	subunit	NOUN
ajlm-2895	28	75	of	of	ADP
ajlm-2895	28	76	bacteria	bacteria	NOUN
ajlm-2895	28	77	and	and	CCONJ
ajlm-2895	28	78	by	by	ADP
ajlm-2895	28	79	blocking	block	VERB
ajlm-2895	28	80	entry	entry	NOUN
ajlm-2895	28	81	of	of	ADP
ajlm-2895	28	82	amino	amino	NOUN
ajlm-2895	28	83	-	-	PUNCT
ajlm-2895	28	84	acyl	acyl	NOUN
ajlm-2895	28	85	trna	trna	NOUN
ajlm-2895	28	86	molecules	molecule	NOUN
ajlm-2895	28	87	into	into	ADP
ajlm-2895	28	88	the	the	DET
ajlm-2895	28	89	a	a	DET
ajlm-2895	28	90	site	site	NOUN
ajlm-2895	28	91	of	of	ADP
ajlm-2895	28	92	ribosomes	ribosome	NOUN
ajlm-2895	28	93	.	.	PUNCT
ajlm-2895	29	1	amino	amino	NOUN
ajlm-2895	29	2	acid	acid	NOUN
ajlm-2895	29	3	residues	residue	NOUN
ajlm-2895	29	4	are	be	AUX
ajlm-2895	29	5	prevented	prevent	VERB
ajlm-2895	29	6	from	from	ADP
ajlm-2895	29	7	becoming	becoming	AUX
ajlm-2895	29	8	incorporated	incorporate	VERB
ajlm-2895	29	9	into	into	ADP
ajlm-2895	29	10	elongating	elongate	VERB
ajlm-2895	29	11	peptide	peptide	ADJ
ajlm-2895	29	12	chains	chain	NOUN
ajlm-2895	29	13	,	,	PUNCT
ajlm-2895	29	14	thus	thus	ADV
ajlm-2895	29	15	leading	lead	VERB
ajlm-2895	29	16	to	to	ADP
ajlm-2895	29	17	inhibition	inhibition	NOUN
ajlm-2895	29	18	of	of	ADP
ajlm-2895	29	19	protein	protein	NOUN
ajlm-2895	29	20	synthesis	synthesis	NOUN
ajlm-2895	29	21	.	.	PUNCT
ajlm-2895	30	1	in	in	ADP
ajlm-2895	30	2	addition	addition	NOUN
ajlm-2895	30	3	,	,	PUNCT
ajlm-2895	30	4	the	the	DET
ajlm-2895	30	5	glycylamido	glycylamido	NOUN
ajlm-2895	30	6	side	side	NOUN
ajlm-2895	30	7	chain	chain	NOUN
ajlm-2895	30	8	at	at	ADP
ajlm-2895	30	9	the	the	DET
ajlm-2895	30	10	9th	9th	ADJ
ajlm-2895	30	11	position	position	NOUN
ajlm-2895	30	12	on	on	ADP
ajlm-2895	30	13	the	the	DET
ajlm-2895	30	14	d	d	NOUN
ajlm-2895	30	15	-	-	PUNCT
ajlm-2895	30	16	ring	ring	NOUN
ajlm-2895	30	17	results	result	NOUN
ajlm-2895	30	18	in	in	ADP
ajlm-2895	30	19	enhanced	enhanced	ADJ
ajlm-2895	30	20	activity	activity	NOUN
ajlm-2895	30	21	and	and	CCONJ
ajlm-2895	30	22	allows	allow	VERB
ajlm-2895	30	23	the	the	DET
ajlm-2895	30	24	molecule	molecule	NOUN
ajlm-2895	30	25	to	to	PART
ajlm-2895	30	26	resist	resist	VERB
ajlm-2895	30	27	efflux	efflux	NOUN
ajlm-2895	30	28	pumps	pump	NOUN
ajlm-2895	30	29	compared	compare	VERB
ajlm-2895	30	30	to	to	ADP
ajlm-2895	30	31	classical	classical	ADJ
ajlm-2895	30	32	tetracyclines.9	tetracyclines.9	NOUN
ajlm-2895	30	33	this	this	DET
ajlm-2895	30	34	antibiotic	antibiotic	NOUN
ajlm-2895	30	35	inhibits	inhibit	VERB
ajlm-2895	30	36	the	the	DET
ajlm-2895	30	37	growth	growth	NOUN
ajlm-2895	30	38	of	of	ADP
ajlm-2895	30	39	multiple	multiple	ADJ
ajlm-2895	30	40	resistant	resistant	ADJ
ajlm-2895	30	41	gram	gram	NOUN
ajlm-2895	30	42	-	-	PUNCT
ajlm-2895	30	43	positive	positive	ADJ
ajlm-2895	30	44	,	,	PUNCT
ajlm-2895	30	45	gram	gram	NOUN
ajlm-2895	30	46	-	-	PUNCT
ajlm-2895	30	47	negative	negative	ADJ
ajlm-2895	30	48	and	and	CCONJ
ajlm-2895	30	49	anaerobic	anaerobic	ADJ
ajlm-2895	30	50	bacteria	bacteria	NOUN
ajlm-2895	30	51	,	,	PUNCT
ajlm-2895	30	52	and	and	CCONJ
ajlm-2895	30	53	atypical	atypical	ADJ
ajlm-2895	30	54	bacteria	bacteria	NOUN
ajlm-2895	30	55	,	,	PUNCT
ajlm-2895	30	56	including	include	VERB
ajlm-2895	30	57	mrsa	mrsa	NOUN
ajlm-2895	30	58	and	and	CCONJ
ajlm-2895	30	59	esbl	esbl	NOUN
ajlm-2895	30	60	-	-	PUNCT
ajlm-2895	30	61	e	e	NOUN
ajlm-2895	30	62	,	,	PUNCT
ajlm-2895	30	63	but	but	CCONJ
ajlm-2895	30	64	it	it	PRON
ajlm-2895	30	65	remains	remain	VERB
ajlm-2895	30	66	vulnerable	vulnerable	ADJ
ajlm-2895	30	67	to	to	ADP
ajlm-2895	30	68	the	the	DET
ajlm-2895	30	69	chromosomally	chromosomally	ADV
ajlm-2895	30	70	-	-	PUNCT
ajlm-2895	30	71	encoded	encode	VERB
ajlm-2895	30	72	multidrug	multidrug	NOUN
ajlm-2895	30	73	efflux	efflux	NOUN
ajlm-2895	30	74	pumps	pump	NOUN
ajlm-2895	30	75	of	of	ADP
ajlm-2895	30	76	pseudomonas	pseudomona	NOUN
ajlm-2895	30	77	aeruginosa	aeruginosa	NOUN
ajlm-2895	30	78	and	and	CCONJ
ajlm-2895	30	79	proteae	proteae	ADJ
ajlm-2895	30	80	sub	sub	NOUN
ajlm-2895	30	81	-	-	NOUN
ajlm-2895	30	82	species.10,11	species.10,11	NOUN
ajlm-2895	30	83	in	in	ADP
ajlm-2895	30	84	2005	2005	NUM
ajlm-2895	30	85	,	,	PUNCT
ajlm-2895	30	86	tigecycline	tigecycline	PROPN
ajlm-2895	30	87	was	be	AUX
ajlm-2895	30	88	approved	approve	VERB
ajlm-2895	30	89	by	by	ADP
ajlm-2895	30	90	the	the	DET
ajlm-2895	30	91	us	us	PROPN
ajlm-2895	30	92	food	food	NOUN
ajlm-2895	30	93	and	and	CCONJ
ajlm-2895	30	94	drug	drug	PROPN
ajlm-2895	30	95	administration	administration	NOUN
ajlm-2895	30	96	(	(	PUNCT
ajlm-2895	30	97	fda),12,13	fda),12,13	PROPN
ajlm-2895	30	98	and	and	CCONJ
ajlm-2895	30	99	the	the	DET
ajlm-2895	30	100	european	european	PROPN
ajlm-2895	30	101	commission	commission	PROPN
ajlm-2895	30	102	granted	grant	VERB
ajlm-2895	30	103	a	a	DET
ajlm-2895	30	104	valid	valid	ADJ
ajlm-2895	30	105	marketing	marketing	NOUN
ajlm-2895	30	106	authorisation	authorisation	NOUN
ajlm-2895	30	107	throughout	throughout	ADP
ajlm-2895	30	108	the	the	DET
ajlm-2895	30	109	european	european	PROPN
ajlm-2895	30	110	union	union	PROPN
ajlm-2895	30	111	for	for	ADP
ajlm-2895	30	112	tigecycline	tigecycline	PROPN
ajlm-2895	30	113	(	(	PUNCT
ajlm-2895	30	114	tygacil	tygacil	NOUN
ajlm-2895	30	115	®	®	PROPN
ajlm-2895	30	116	)	)	PUNCT
ajlm-2895	30	117	on	on	ADP
ajlm-2895	30	118	24	24	NUM
ajlm-2895	30	119	april	april	PROPN
ajlm-2895	30	120	2006.14	2006.14	NUM
ajlm-2895	30	121	despite	despite	SCONJ
ajlm-2895	30	122	being	be	AUX
ajlm-2895	30	123	available	available	ADJ
ajlm-2895	30	124	in	in	ADP
ajlm-2895	30	125	developed	develop	VERB
ajlm-2895	30	126	countries	country	NOUN
ajlm-2895	30	127	and	and	CCONJ
ajlm-2895	30	128	proven	prove	VERB
ajlm-2895	30	129	effective	effective	ADJ
ajlm-2895	30	130	against	against	ADP
ajlm-2895	30	131	mdrb	mdrb	NOUN
ajlm-2895	30	132	in	in	ADP
ajlm-2895	30	133	many	many	ADJ
ajlm-2895	30	134	studies	study	NOUN
ajlm-2895	30	135	,	,	PUNCT
ajlm-2895	30	136	this	this	DET
ajlm-2895	30	137	life	life	NOUN
ajlm-2895	30	138	-	-	PUNCT
ajlm-2895	30	139	saving	save	VERB
ajlm-2895	30	140	antibiotic	antibiotic	NOUN
ajlm-2895	30	141	remains	remain	VERB
ajlm-2895	30	142	inaccessible	inaccessible	ADJ
ajlm-2895	30	143	for	for	ADP
ajlm-2895	30	144	urgent	urgent	ADJ
ajlm-2895	30	145	treatments	treatment	NOUN
ajlm-2895	30	146	in	in	ADP
ajlm-2895	30	147	the	the	DET
ajlm-2895	30	148	hospitals	hospital	NOUN
ajlm-2895	30	149	of	of	ADP
ajlm-2895	30	150	burkina	burkina	PROPN
ajlm-2895	30	151	faso	faso	PROPN
ajlm-2895	30	152	,	,	PUNCT
ajlm-2895	30	153	resulting	result	VERB
ajlm-2895	30	154	in	in	ADP
ajlm-2895	30	155	preventable	preventable	ADJ
ajlm-2895	30	156	deaths	death	NOUN
ajlm-2895	30	157	caused	cause	VERB
ajlm-2895	30	158	by	by	ADP
ajlm-2895	30	159	therapeutic	therapeutic	ADJ
ajlm-2895	30	160	deadlocks.5,12,15	deadlocks.5,12,15	NOUN
ajlm-2895	30	161	in	in	ADP
ajlm-2895	30	162	this	this	DET
ajlm-2895	30	163	regard	regard	NOUN
ajlm-2895	30	164	,	,	PUNCT
ajlm-2895	30	165	the	the	DET
ajlm-2895	30	166	current	current	ADJ
ajlm-2895	30	167	priority	priority	NOUN
ajlm-2895	30	168	for	for	ADP
ajlm-2895	30	169	the	the	DET
ajlm-2895	30	170	hospitals	hospital	NOUN
ajlm-2895	30	171	in	in	ADP
ajlm-2895	30	172	burkina	burkina	PROPN
ajlm-2895	30	173	faso	faso	PROPN
ajlm-2895	30	174	is	be	AUX
ajlm-2895	30	175	to	to	PART
ajlm-2895	30	176	find	find	VERB
ajlm-2895	30	177	alternatives	alternative	NOUN
ajlm-2895	30	178	to	to	PART
ajlm-2895	30	179	reduce	reduce	VERB
ajlm-2895	30	180	the	the	DET
ajlm-2895	30	181	overuse	overuse	NOUN
ajlm-2895	30	182	of	of	ADP
ajlm-2895	30	183	carbapenems	carbapenem	NOUN
ajlm-2895	30	184	in	in	ADP
ajlm-2895	30	185	esbl	esbl	NOUN
ajlm-2895	30	186	-	-	PUNCT
ajlm-2895	30	187	e	e	NOUN
ajlm-2895	30	188	infections	infection	NOUN
ajlm-2895	30	189	,	,	PUNCT
ajlm-2895	30	190	while	while	SCONJ
ajlm-2895	30	191	exploring	explore	VERB
ajlm-2895	30	192	effective	effective	ADJ
ajlm-2895	30	193	antibiotic	antibiotic	ADJ
ajlm-2895	30	194	regimens	regimen	NOUN
ajlm-2895	30	195	to	to	PART
ajlm-2895	30	196	treat	treat	VERB
ajlm-2895	30	197	carbapenem	carbapenem	NOUN
ajlm-2895	30	198	-	-	PUNCT
ajlm-2895	30	199	resistant	resistant	ADJ
ajlm-2895	30	200	organisms	organism	NOUN
ajlm-2895	30	201	in	in	ADP
ajlm-2895	30	202	therapeutic	therapeutic	ADJ
ajlm-2895	30	203	deadlock	deadlock	NOUN
ajlm-2895	30	204	contexts	contexts	NOUN
ajlm-2895	30	205	.	.	PUNCT
ajlm-2895	31	1	this	this	DET
ajlm-2895	31	2	study	study	NOUN
ajlm-2895	31	3	aimed	aim	VERB
ajlm-2895	31	4	to	to	PART
ajlm-2895	31	5	evaluate	evaluate	VERB
ajlm-2895	31	6	the	the	DET
ajlm-2895	31	7	activity	activity	NOUN
ajlm-2895	31	8	of	of	ADP
ajlm-2895	31	9	tigecycline	tigecycline	NOUN
ajlm-2895	31	10	on	on	ADP
ajlm-2895	31	11	mdrb	mdrb	NOUN
ajlm-2895	31	12	isolated	isolate	VERB
ajlm-2895	31	13	from	from	ADP
ajlm-2895	31	14	clinical	clinical	ADJ
ajlm-2895	31	15	samples	sample	NOUN
ajlm-2895	31	16	at	at	ADP
ajlm-2895	31	17	the	the	DET
ajlm-2895	31	18	referral	referral	ADJ
ajlm-2895	31	19	healthcare	healthcare	PROPN
ajlm-2895	31	20	centre	centre	PROPN
ajlm-2895	31	21	in	in	ADP
ajlm-2895	31	22	bobo	bobo	NOUN
ajlm-2895	31	23	-	-	PUNCT
ajlm-2895	31	24	dioulasso	dioulasso	ADJ
ajlm-2895	31	25	.	.	PUNCT
ajlm-2895	32	1	the	the	DET
ajlm-2895	32	2	expected	expect	VERB
ajlm-2895	32	3	results	result	NOUN
ajlm-2895	32	4	will	will	AUX
ajlm-2895	32	5	allow	allow	VERB
ajlm-2895	32	6	us	we	PRON
ajlm-2895	32	7	to	to	PART
ajlm-2895	32	8	authorise	authorise	VERB
ajlm-2895	32	9	the	the	DET
ajlm-2895	32	10	supply	supply	NOUN
ajlm-2895	32	11	of	of	ADP
ajlm-2895	32	12	tigecycline	tigecycline	NOUN
ajlm-2895	32	13	in	in	ADP
ajlm-2895	32	14	the	the	DET
ajlm-2895	32	15	reserve	reserve	NOUN
ajlm-2895	32	16	antibiotics	antibiotic	NOUN
ajlm-2895	32	17	for	for	ADP
ajlm-2895	32	18	the	the	DET
ajlm-2895	32	19	treatment	treatment	NOUN
ajlm-2895	32	20	of	of	ADP
ajlm-2895	32	21	patients	patient	NOUN
ajlm-2895	32	22	in	in	ADP
ajlm-2895	32	23	the	the	DET
ajlm-2895	32	24	therapeutic	therapeutic	ADJ
ajlm-2895	32	25	deadlocks	deadlock	NOUN
ajlm-2895	32	26	.	.	PUNCT
ajlm-2895	33	1	methods	method	NOUN
ajlm-2895	33	2	ethical	ethical	ADJ
ajlm-2895	33	3	considerations	consideration	NOUN
ajlm-2895	33	4	the	the	DET
ajlm-2895	33	5	study	study	NOUN
ajlm-2895	33	6	was	be	AUX
ajlm-2895	33	7	conducted	conduct	VERB
ajlm-2895	33	8	as	as	ADP
ajlm-2895	33	9	part	part	NOUN
ajlm-2895	33	10	of	of	ADP
ajlm-2895	33	11	the	the	DET
ajlm-2895	33	12	routine	routine	ADJ
ajlm-2895	33	13	diagnosis	diagnosis	NOUN
ajlm-2895	33	14	of	of	ADP
ajlm-2895	33	15	bacterial	bacterial	ADJ
ajlm-2895	33	16	infections	infection	NOUN
ajlm-2895	33	17	under	under	ADP
ajlm-2895	33	18	the	the	DET
ajlm-2895	33	19	authorisation	authorisation	NOUN
ajlm-2895	33	20	of	of	ADP
ajlm-2895	33	21	the	the	DET
ajlm-2895	33	22	ethics	ethic	NOUN
ajlm-2895	33	23	committee	committee	PROPN
ajlm-2895	33	24	for	for	ADP
ajlm-2895	33	25	research	research	NOUN
ajlm-2895	33	26	at	at	ADP
ajlm-2895	33	27	the	the	DET
ajlm-2895	33	28	national	national	ADJ
ajlm-2895	33	29	reference	reference	PROPN
ajlm-2895	33	30	laboratory	laboratory	NOUN
ajlm-2895	33	31	for	for	ADP
ajlm-2895	33	32	antimicrobial	antimicrobial	ADJ
ajlm-2895	33	33	resistance	resistance	NOUN
ajlm-2895	33	34	(	(	PUNCT
ajlm-2895	33	35	approval	approval	NOUN
ajlm-2895	33	36	number	number	NOUN
ajlm-2895	33	37	:	:	PUNCT
ajlm-2895	33	38	n	n	CCONJ
ajlm-2895	33	39	°	°	PROPN
ajlm-2895	33	40	2022	2022	NUM
ajlm-2895	33	41	-	-	SYM
ajlm-2895	33	42	06	06	NUM
ajlm-2895	33	43	-	-	PUNCT
ajlm-2895	33	44	053mshp	053mshp	PROPN
ajlm-2895	33	45	/	/	SYM
ajlm-2895	33	46	sg	sg	PROPN
ajlm-2895	33	47	/	/	SYM
ajlm-2895	33	48	chuss	chuss	NOUN
ajlm-2895	33	49	/	/	SYM
ajlm-2895	33	50	dg	dg	PROPN
ajlm-2895	33	51	/	/	SYM
ajlm-2895	33	52	dl	dl	PROPN
ajlm-2895	33	53	/	/	SYM
ajlm-2895	33	54	sbv	sbv	PROPN
ajlm-2895	33	55	/	/	SYM
ajlm-2895	33	56	lnr	lnr	PROPN
ajlm-2895	33	57	-	-	PUNCT
ajlm-2895	33	58	ram	ram	NOUN
ajlm-2895	33	59	)	)	PUNCT
ajlm-2895	33	60	,	,	PUNCT
ajlm-2895	33	61	in	in	ADP
ajlm-2895	33	62	line	line	NOUN
ajlm-2895	33	63	with	with	ADP
ajlm-2895	33	64	the	the	DET
ajlm-2895	33	65	declaration	declaration	NOUN
ajlm-2895	33	66	of	of	ADP
ajlm-2895	33	67	helsinki	helsinki	PROPN
ajlm-2895	33	68	.	.	PUNCT
ajlm-2895	34	1	the	the	DET
ajlm-2895	34	2	anonymity	anonymity	NOUN
ajlm-2895	34	3	of	of	ADP
ajlm-2895	34	4	the	the	DET
ajlm-2895	34	5	participants	participant	NOUN
ajlm-2895	34	6	involved	involve	VERB
ajlm-2895	34	7	in	in	ADP
ajlm-2895	34	8	the	the	DET
ajlm-2895	34	9	study	study	NOUN
ajlm-2895	34	10	was	be	AUX
ajlm-2895	34	11	maintained	maintain	VERB
ajlm-2895	34	12	in	in	ADP
ajlm-2895	34	13	this	this	DET
ajlm-2895	34	14	study	study	NOUN
ajlm-2895	34	15	.	.	PUNCT
ajlm-2895	35	1	only	only	ADV
ajlm-2895	35	2	the	the	DET
ajlm-2895	35	3	laboratory	laboratory	NOUN
ajlm-2895	35	4	number	number	NOUN
ajlm-2895	35	5	was	be	AUX
ajlm-2895	35	6	mentioned	mention	VERB
ajlm-2895	35	7	to	to	PART
ajlm-2895	35	8	guarantee	guarantee	VERB
ajlm-2895	35	9	confidentiality	confidentiality	NOUN
ajlm-2895	35	10	.	.	PUNCT
ajlm-2895	36	1	no	no	DET
ajlm-2895	36	2	specific	specific	ADJ
ajlm-2895	36	3	declaration	declaration	NOUN
ajlm-2895	36	4	of	of	ADP
ajlm-2895	36	5	informed	informed	ADJ
ajlm-2895	36	6	consent	consent	NOUN
ajlm-2895	36	7	was	be	AUX
ajlm-2895	36	8	required	require	VERB
ajlm-2895	36	9	from	from	ADP
ajlm-2895	36	10	the	the	DET
ajlm-2895	36	11	patients	patient	NOUN
ajlm-2895	36	12	,	,	PUNCT
ajlm-2895	36	13	as	as	SCONJ
ajlm-2895	36	14	the	the	DET
ajlm-2895	36	15	experiments	experiment	NOUN
ajlm-2895	36	16	were	be	AUX
ajlm-2895	36	17	part	part	NOUN
ajlm-2895	36	18	of	of	ADP
ajlm-2895	36	19	the	the	DET
ajlm-2895	36	20	routine	routine	ADJ
ajlm-2895	36	21	diagnosis	diagnosis	NOUN
ajlm-2895	36	22	supervised	supervise	VERB
ajlm-2895	36	23	by	by	ADP
ajlm-2895	36	24	the	the	DET
ajlm-2895	36	25	burkina	burkina	PROPN
ajlm-2895	36	26	faso	faso	PROPN
ajlm-2895	36	27	ministry	ministry	PROPN
ajlm-2895	36	28	of	of	ADP
ajlm-2895	36	29	health	health	PROPN
ajlm-2895	36	30	and	and	CCONJ
ajlm-2895	36	31	public	public	ADJ
ajlm-2895	36	32	hygiene	hygiene	NOUN
ajlm-2895	36	33	,	,	PUNCT
ajlm-2895	36	34	which	which	PRON
ajlm-2895	36	35	has	have	VERB
ajlm-2895	36	36	the	the	DET
ajlm-2895	36	37	authority	authority	NOUN
ajlm-2895	36	38	to	to	PART
ajlm-2895	36	39	process	process	VERB
ajlm-2895	36	40	patient	patient	ADJ
ajlm-2895	36	41	data	datum	NOUN
ajlm-2895	36	42	for	for	ADP
ajlm-2895	36	43	public	public	ADJ
ajlm-2895	36	44	health	health	NOUN
ajlm-2895	36	45	surveillance	surveillance	NOUN
ajlm-2895	36	46	purposes	purpose	NOUN
ajlm-2895	36	47	.	.	PUNCT
ajlm-2895	37	1	the	the	DET
ajlm-2895	37	2	outcomes	outcome	NOUN
ajlm-2895	37	3	of	of	ADP
ajlm-2895	37	4	this	this	DET
ajlm-2895	37	5	work	work	NOUN
ajlm-2895	37	6	will	will	AUX
ajlm-2895	37	7	be	be	AUX
ajlm-2895	37	8	used	use	VERB
ajlm-2895	37	9	to	to	PART
ajlm-2895	37	10	improve	improve	VERB
ajlm-2895	37	11	antibiotic	antibiotic	ADJ
ajlm-2895	37	12	prescriptions	prescription	NOUN
ajlm-2895	37	13	in	in	ADP
ajlm-2895	37	14	patients	patient	NOUN
ajlm-2895	37	15	with	with	ADP
ajlm-2895	37	16	mdrb	mdrb	NOUN
ajlm-2895	37	17	in	in	ADP
ajlm-2895	37	18	burkina	burkina	PROPN
ajlm-2895	37	19	faso	faso	PROPN
ajlm-2895	37	20	’s	’s	PART
ajlm-2895	37	21	hospitals	hospital	NOUN
ajlm-2895	37	22	.	.	PUNCT
ajlm-2895	38	1	study	study	NOUN
ajlm-2895	38	2	design	design	NOUN
ajlm-2895	38	3	,	,	PUNCT
ajlm-2895	38	4	period	period	NOUN
ajlm-2895	38	5	,	,	PUNCT
ajlm-2895	38	6	population	population	NOUN
ajlm-2895	38	7	and	and	CCONJ
ajlm-2895	38	8	site	site	NOUN
ajlm-2895	38	9	this	this	PRON
ajlm-2895	38	10	was	be	AUX
ajlm-2895	38	11	a	a	DET
ajlm-2895	38	12	cross	cross	ADJ
ajlm-2895	38	13	-	-	ADJ
ajlm-2895	38	14	sectional	sectional	ADJ
ajlm-2895	38	15	study	study	NOUN
ajlm-2895	38	16	with	with	ADP
ajlm-2895	38	17	a	a	DET
ajlm-2895	38	18	prospective	prospective	ADJ
ajlm-2895	38	19	design	design	NOUN
ajlm-2895	38	20	that	that	PRON
ajlm-2895	38	21	used	use	VERB
ajlm-2895	38	22	consecutive	consecutive	ADJ
ajlm-2895	38	23	sampling	sampling	NOUN
ajlm-2895	38	24	of	of	ADP
ajlm-2895	38	25	mdrb	mdrb	NOUN
ajlm-2895	38	26	clinical	clinical	ADJ
ajlm-2895	38	27	isolates	isolate	NOUN
ajlm-2895	38	28	esbl	esbl	NOUN
ajlm-2895	38	29	-	-	PUNCT
ajlm-2895	38	30	e	e	NOUN
ajlm-2895	38	31	,	,	PUNCT
ajlm-2895	38	32	carbapenem	carbapenem	NOUN
ajlm-2895	38	33	-	-	PUNCT
ajlm-2895	38	34	resistant	resistant	ADJ
ajlm-2895	38	35	strains	strain	NOUN
ajlm-2895	38	36	(	(	PUNCT
ajlm-2895	38	37	crs	crs	PROPN
ajlm-2895	38	38	)	)	PUNCT
ajlm-2895	38	39	and	and	CCONJ
ajlm-2895	38	40	mrsa	mrsa	NOUN
ajlm-2895	38	41	from	from	ADP
ajlm-2895	38	42	patients	patient	NOUN
ajlm-2895	38	43	between	between	ADP
ajlm-2895	38	44	01	01	NUM
ajlm-2895	38	45	june	june	PROPN
ajlm-2895	38	46	2022	2022	NUM
ajlm-2895	38	47	and	and	CCONJ
ajlm-2895	38	48	31	31	NUM
ajlm-2895	38	49	august	august	PROPN
ajlm-2895	38	50	2022	2022	NUM
ajlm-2895	38	51	.	.	PUNCT
ajlm-2895	39	1	bacteriological	bacteriological	ADJ
ajlm-2895	39	2	analysis	analysis	NOUN
ajlm-2895	39	3	was	be	AUX
ajlm-2895	39	4	carried	carry	VERB
ajlm-2895	39	5	out	out	ADP
ajlm-2895	39	6	at	at	ADP
ajlm-2895	39	7	the	the	DET
ajlm-2895	39	8	bacteriology	bacteriology	NOUN
ajlm-2895	39	9	laboratory	laboratory	NOUN
ajlm-2895	39	10	of	of	ADP
ajlm-2895	39	11	sourô	sourô	PROPN
ajlm-2895	39	12	sanou	sanou	PROPN
ajlm-2895	39	13	university	university	NOUN
ajlm-2895	39	14	teaching	teaching	NOUN
ajlm-2895	39	15	hospital	hospital	NOUN
ajlm-2895	39	16	,	,	PUNCT
ajlm-2895	39	17	bobo	bobo	NOUN
ajlm-2895	39	18	-	-	PUNCT
ajlm-2895	39	19	dioulasso	dioulasso	ADJ
ajlm-2895	39	20	.	.	PUNCT
ajlm-2895	40	1	this	this	DET
ajlm-2895	40	2	laboratory	laboratory	NOUN
ajlm-2895	40	3	hosts	host	NOUN
ajlm-2895	40	4	the	the	DET
ajlm-2895	40	5	burkina	burkina	PROPN
ajlm-2895	40	6	faso	faso	PROPN
ajlm-2895	40	7	national	national	PROPN
ajlm-2895	40	8	reference	reference	PROPN
ajlm-2895	40	9	laboratory	laboratory	NOUN
ajlm-2895	40	10	for	for	ADP
ajlm-2895	40	11	antimicrobial	antimicrobial	ADJ
ajlm-2895	40	12	resistance	resistance	NOUN
ajlm-2895	40	13	.	.	PUNCT
ajlm-2895	41	1	data	datum	NOUN
ajlm-2895	41	2	and	and	CCONJ
ajlm-2895	41	3	clinical	clinical	ADJ
ajlm-2895	41	4	samples	sample	NOUN
ajlm-2895	41	5	collection	collection	NOUN
ajlm-2895	41	6	the	the	DET
ajlm-2895	41	7	participants	participant	NOUN
ajlm-2895	41	8	’	'	PUNCT
ajlm-2895	41	9	demographic	demographic	ADJ
ajlm-2895	41	10	,	,	PUNCT
ajlm-2895	41	11	clinical	clinical	ADJ
ajlm-2895	41	12	service	service	NOUN
ajlm-2895	41	13	and	and	CCONJ
ajlm-2895	41	14	sample	sample	NOUN
ajlm-2895	41	15	types	type	NOUN
ajlm-2895	41	16	data	datum	NOUN
ajlm-2895	41	17	were	be	AUX
ajlm-2895	41	18	collected	collect	VERB
ajlm-2895	41	19	.	.	PUNCT
ajlm-2895	42	1	all	all	DET
ajlm-2895	42	2	patients	patient	NOUN
ajlm-2895	42	3	whose	whose	DET
ajlm-2895	42	4	samples	sample	NOUN
ajlm-2895	42	5	were	be	AUX
ajlm-2895	42	6	positive	positive	ADJ
ajlm-2895	42	7	for	for	ADP
ajlm-2895	42	8	esbl	esbl	NOUN
ajlm-2895	42	9	,	,	PUNCT
ajlm-2895	42	10	crs	crs	PROPN
ajlm-2895	42	11	,	,	PUNCT
ajlm-2895	42	12	and	and	CCONJ
ajlm-2895	42	13	mrsa	mrsa	NOUN
ajlm-2895	42	14	phenotypes	phenotype	NOUN
ajlm-2895	42	15	,	,	PUNCT
ajlm-2895	42	16	except	except	SCONJ
ajlm-2895	42	17	p.	p.	NOUN
ajlm-2895	42	18	aeruginosa	aeruginosa	NOUN
ajlm-2895	42	19	and	and	CCONJ
ajlm-2895	42	20	members	member	NOUN
ajlm-2895	42	21	of	of	ADP
ajlm-2895	42	22	the	the	DET
ajlm-2895	42	23	proteae	proteae	PROPN
ajlm-2895	42	24	tribe	tribe	NOUN
ajlm-2895	42	25	(	(	PUNCT
ajlm-2895	42	26	proteus	proteus	PROPN
ajlm-2895	42	27	spp	spp	PROPN
ajlm-2895	42	28	.	.	PROPN
ajlm-2895	42	29	,	,	PUNCT
ajlm-2895	42	30	providencia	providencia	PROPN
ajlm-2895	42	31	spp	spp	PROPN
ajlm-2895	42	32	.	.	PUNCT
ajlm-2895	42	33	and	and	CCONJ
ajlm-2895	42	34	morganella	morganella	PROPN
ajlm-2895	42	35	morganii	morganii	PROPN
ajlm-2895	42	36	)	)	PUNCT
ajlm-2895	42	37	which	which	PRON
ajlm-2895	42	38	are	be	AUX
ajlm-2895	42	39	intrinsically	intrinsically	ADV
ajlm-2895	42	40	resistant	resistant	ADJ
ajlm-2895	42	41	to	to	ADP
ajlm-2895	42	42	tigecycline,13	tigecycline,13	NOUN
ajlm-2895	42	43	were	be	AUX
ajlm-2895	42	44	enrolled	enrol	VERB
ajlm-2895	42	45	.	.	PUNCT
ajlm-2895	43	1	the	the	DET
ajlm-2895	43	2	samples	sample	NOUN
ajlm-2895	43	3	consisted	consist	VERB
ajlm-2895	43	4	of	of	ADP
ajlm-2895	43	5	urine	urine	NOUN
ajlm-2895	43	6	,	,	PUNCT
ajlm-2895	43	7	pus	pus	NOUN
ajlm-2895	43	8	,	,	PUNCT
ajlm-2895	43	9	puncture	puncture	NOUN
ajlm-2895	43	10	fluids	fluid	NOUN
ajlm-2895	43	11	,	,	PUNCT
ajlm-2895	43	12	and	and	CCONJ
ajlm-2895	43	13	blood	blood	NOUN
ajlm-2895	43	14	.	.	PUNCT
ajlm-2895	44	1	isolation	isolation	NOUN
ajlm-2895	44	2	,	,	PUNCT
ajlm-2895	44	3	identification	identification	NOUN
ajlm-2895	44	4	and	and	CCONJ
ajlm-2895	44	5	antimicrobial	antimicrobial	ADJ
ajlm-2895	44	6	susceptibility	susceptibility	NOUN
ajlm-2895	44	7	testing	testing	NOUN
ajlm-2895	44	8	media	medium	NOUN
ajlm-2895	44	9	used	use	VERB
ajlm-2895	44	10	for	for	ADP
ajlm-2895	44	11	bacterial	bacterial	ADJ
ajlm-2895	44	12	isolation	isolation	NOUN
ajlm-2895	44	13	regarding	regard	VERB
ajlm-2895	44	14	the	the	DET
ajlm-2895	44	15	isolation	isolation	NOUN
ajlm-2895	44	16	of	of	ADP
ajlm-2895	44	17	mdrbs	mdrb	NOUN
ajlm-2895	44	18	from	from	ADP
ajlm-2895	44	19	urine	urine	NOUN
ajlm-2895	44	20	samples	sample	NOUN
ajlm-2895	44	21	,	,	PUNCT
ajlm-2895	44	22	the	the	DET
ajlm-2895	44	23	culture	culture	NOUN
ajlm-2895	44	24	media	medium	NOUN
ajlm-2895	44	25	employed	employ	VERB
ajlm-2895	44	26	in	in	ADP
ajlm-2895	44	27	this	this	DET
ajlm-2895	44	28	process	process	NOUN
ajlm-2895	44	29	were	be	AUX
ajlm-2895	44	30	cystine	cystine	ADJ
ajlm-2895	44	31	lactose	lactose	ADJ
ajlm-2895	44	32	electrolyte	electrolyte	PROPN
ajlm-2895	44	33	deficient	deficient	ADJ
ajlm-2895	44	34	agar	agar	NOUN
ajlm-2895	44	35	,	,	PUNCT
ajlm-2895	44	36	and	and	CCONJ
ajlm-2895	44	37	eosin	eosin	VERB
ajlm-2895	44	38	methylene	methylene	NOUN
ajlm-2895	44	39	blue	blue	ADJ
ajlm-2895	44	40	agar	agar	NOUN
ajlm-2895	44	41	.	.	PUNCT
ajlm-2895	45	1	considering	consider	VERB
ajlm-2895	45	2	bacterial	bacterial	ADJ
ajlm-2895	45	3	isolation	isolation	NOUN
ajlm-2895	45	4	from	from	ADP
ajlm-2895	45	5	blood	blood	NOUN
ajlm-2895	45	6	culture	culture	NOUN
ajlm-2895	45	7	,	,	PUNCT
ajlm-2895	45	8	pus	pus	NOUN
ajlm-2895	45	9	,	,	PUNCT
ajlm-2895	45	10	and	and	CCONJ
ajlm-2895	45	11	serous	serous	ADJ
ajlm-2895	45	12	fluid	fluid	ADJ
ajlm-2895	45	13	cultures	culture	NOUN
ajlm-2895	45	14	,	,	PUNCT
ajlm-2895	45	15	appropriate	appropriate	ADJ
ajlm-2895	45	16	agar	agar	NOUN
ajlm-2895	45	17	plates	plate	NOUN
ajlm-2895	45	18	(	(	PUNCT
ajlm-2895	45	19	enriched	enrich	VERB
ajlm-2895	45	20	chocolate	chocolate	NOUN
ajlm-2895	45	21	,	,	PUNCT
ajlm-2895	45	22	eosin	eosin	NOUN
ajlm-2895	45	23	methylene	methylene	NOUN
ajlm-2895	45	24	blue	blue	NOUN
ajlm-2895	45	25	or	or	CCONJ
ajlm-2895	45	26	chapman	chapman	NOUN
ajlm-2895	45	27	agar	agar	NOUN
ajlm-2895	45	28	)	)	PUNCT
ajlm-2895	45	29	were	be	AUX
ajlm-2895	45	30	selected	select	VERB
ajlm-2895	45	31	based	base	VERB
ajlm-2895	45	32	on	on	ADP
ajlm-2895	45	33	the	the	DET
ajlm-2895	45	34	presumed	presume	VERB
ajlm-2895	45	35	bacterial	bacterial	ADJ
ajlm-2895	45	36	characteristics	characteristic	NOUN
ajlm-2895	45	37	from	from	ADP
ajlm-2895	45	38	a	a	DET
ajlm-2895	45	39	gram	gram	NOUN
ajlm-2895	45	40	stain	stain	NOUN
ajlm-2895	45	41	.	.	PUNCT
ajlm-2895	46	1	bacterial	bacterial	ADJ
ajlm-2895	46	2	identification	identification	NOUN
ajlm-2895	46	3	bacterial	bacterial	ADJ
ajlm-2895	46	4	presumptive	presumptive	ADJ
ajlm-2895	46	5	identification	identification	NOUN
ajlm-2895	46	6	was	be	AUX
ajlm-2895	46	7	based	base	VERB
ajlm-2895	46	8	on	on	ADP
ajlm-2895	46	9	their	their	PRON
ajlm-2895	46	10	morphological	morphological	ADJ
ajlm-2895	46	11	and	and	CCONJ
ajlm-2895	46	12	cultural	cultural	ADJ
ajlm-2895	46	13	characteristics	characteristic	NOUN
ajlm-2895	46	14	.	.	PUNCT
ajlm-2895	47	1	enterobacterales	enterobacterale	NOUN
ajlm-2895	47	2	and	and	CCONJ
ajlm-2895	47	3	non	non	ADJ
ajlm-2895	47	4	-	-	ADJ
ajlm-2895	47	5	fermenting	ferment	VERB
ajlm-2895	47	6	gram	gram	NOUN
ajlm-2895	47	7	-	-	PUNCT
ajlm-2895	47	8	negative	negative	ADJ
ajlm-2895	47	9	bacilli	bacilli	NOUN
ajlm-2895	47	10	were	be	AUX
ajlm-2895	47	11	identified	identify	VERB
ajlm-2895	47	12	using	use	VERB
ajlm-2895	47	13	commercialised	commercialise	VERB
ajlm-2895	47	14	kits	kit	NOUN
ajlm-2895	47	15	,	,	PUNCT
ajlm-2895	47	16	analytical	analytical	ADJ
ajlm-2895	47	17	profile	profile	NOUN
ajlm-2895	47	18	index	index	NOUN
ajlm-2895	47	19	(	(	PUNCT
ajlm-2895	47	20	api	api	NOUN
ajlm-2895	47	21	)	)	PUNCT
ajlm-2895	47	22	20e	20e	NOUN
ajlm-2895	47	23	and	and	CCONJ
ajlm-2895	47	24	api	api	PROPN
ajlm-2895	47	25	20	20	NUM
ajlm-2895	47	26	ne	ne	NOUN
ajlm-2895	47	27	strips	strip	NOUN
ajlm-2895	47	28	(	(	PUNCT
ajlm-2895	47	29	biomérieux	biomérieux	PROPN
ajlm-2895	47	30	,	,	PUNCT
ajlm-2895	47	31	marcy	marcy	NOUN
ajlm-2895	47	32	-	-	PUNCT
ajlm-2895	47	33	l’étoile	l’étoile	PROPN
ajlm-2895	47	34	,	,	PUNCT
ajlm-2895	47	35	france	france	PROPN
ajlm-2895	47	36	)	)	PUNCT
ajlm-2895	47	37	,	,	PUNCT
ajlm-2895	47	38	respectively.16	respectively.16	VERB
ajlm-2895	47	39	for	for	ADP
ajlm-2895	47	40	gram	gram	NOUN
ajlm-2895	47	41	-	-	PUNCT
ajlm-2895	47	42	positive	positive	ADJ
ajlm-2895	47	43	cocci	cocci	NOUN
ajlm-2895	47	44	,	,	PUNCT
ajlm-2895	47	45	catalase	catalase	NOUN
ajlm-2895	47	46	and	and	CCONJ
ajlm-2895	47	47	coagulase	coagulase	NOUN
ajlm-2895	47	48	tests	test	NOUN
ajlm-2895	47	49	were	be	AUX
ajlm-2895	47	50	used	use	VERB
ajlm-2895	47	51	.	.	PUNCT
ajlm-2895	48	1	briefly	briefly	ADV
ajlm-2895	48	2	,	,	PUNCT
ajlm-2895	48	3	the	the	DET
ajlm-2895	48	4	catalase	catalase	NOUN
ajlm-2895	48	5	test	test	NOUN
ajlm-2895	48	6	was	be	AUX
ajlm-2895	48	7	conducted	conduct	VERB
ajlm-2895	48	8	using	use	VERB
ajlm-2895	48	9	the	the	DET
ajlm-2895	48	10	slide	slide	NOUN
ajlm-2895	48	11	method	method	NOUN
ajlm-2895	48	12	with	with	ADP
ajlm-2895	48	13	1	1	NUM
ajlm-2895	48	14	drop	drop	NOUN
ajlm-2895	48	15	of	of	ADP
ajlm-2895	48	16	3	3	NUM
ajlm-2895	48	17	%	%	NOUN
ajlm-2895	48	18	hydrogen	hydrogen	NOUN
ajlm-2895	48	19	peroxide	peroxide	NOUN
ajlm-2895	48	20	to	to	PART
ajlm-2895	48	21	observe	observe	VERB
ajlm-2895	48	22	an	an	DET
ajlm-2895	48	23	immediate	immediate	ADJ
ajlm-2895	48	24	bubble	bubble	NOUN
ajlm-2895	48	25	formation	formation	NOUN
ajlm-2895	48	26	,	,	PUNCT
ajlm-2895	48	27	indicating	indicate	VERB
ajlm-2895	48	28	the	the	DET
ajlm-2895	48	29	presence	presence	NOUN
ajlm-2895	48	30	of	of	ADP
ajlm-2895	48	31	the	the	DET
ajlm-2895	48	32	catalase	catalase	NOUN
ajlm-2895	48	33	enzyme	enzyme	NOUN
ajlm-2895	48	34	.	.	PUNCT
ajlm-2895	49	1	regarding	regard	VERB
ajlm-2895	49	2	the	the	DET
ajlm-2895	49	3	coagulase	coagulase	PROPN
ajlm-2895	49	4	test	test	NOUN
ajlm-2895	49	5	,	,	PUNCT
ajlm-2895	49	6	a	a	DET
ajlm-2895	49	7	lump	lump	NOUN
ajlm-2895	49	8	of	of	ADP
ajlm-2895	49	9	bacterial	bacterial	ADJ
ajlm-2895	49	10	cells	cell	NOUN
ajlm-2895	49	11	was	be	AUX
ajlm-2895	49	12	mixed	mix	VERB
ajlm-2895	49	13	into	into	ADP
ajlm-2895	49	14	a	a	DET
ajlm-2895	49	15	drop	drop	NOUN
ajlm-2895	49	16	of	of	ADP
ajlm-2895	49	17	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-2895	49	18	acid	acid	NOUN
ajlm-2895	49	19	-	-	PUNCT
ajlm-2895	49	20	treated	treat	VERB
ajlm-2895	49	21	rabbit	rabbit	NOUN
ajlm-2895	49	22	plasma	plasma	NOUN
ajlm-2895	49	23	on	on	ADP
ajlm-2895	49	24	a	a	DET
ajlm-2895	49	25	microscope	microscope	NOUN
ajlm-2895	49	26	slide	slide	NOUN
ajlm-2895	49	27	to	to	PART
ajlm-2895	49	28	observe	observe	VERB
ajlm-2895	49	29	the	the	DET
ajlm-2895	49	30	clumping	clumping	NOUN
ajlm-2895	49	31	of	of	ADP
ajlm-2895	49	32	bacterial	bacterial	ADJ
ajlm-2895	49	33	cells	cell	NOUN
ajlm-2895	49	34	within	within	ADP
ajlm-2895	49	35	10	10	NUM
ajlm-2895	49	36	seconds	second	NOUN
ajlm-2895	49	37	.	.	PUNCT
ajlm-2895	50	1	when	when	SCONJ
ajlm-2895	50	2	a	a	DET
ajlm-2895	50	3	sample	sample	NOUN
ajlm-2895	50	4	of	of	ADP
ajlm-2895	50	5	gram	gram	NOUN
ajlm-2895	50	6	-	-	PUNCT
ajlm-2895	50	7	positive	positive	ADJ
ajlm-2895	50	8	cocci	cocci	NOUN
ajlm-2895	50	9	responded	respond	VERB
ajlm-2895	50	10	positively	positively	ADV
ajlm-2895	50	11	to	to	ADP
ajlm-2895	50	12	the	the	DET
ajlm-2895	50	13	catalase	catalase	NOUN
ajlm-2895	50	14	and	and	CCONJ
ajlm-2895	50	15	coagulase	coagulase	NOUN
ajlm-2895	50	16	tests	test	NOUN
ajlm-2895	50	17	,	,	PUNCT
ajlm-2895	50	18	the	the	DET
ajlm-2895	50	19	microorganism	microorganism	NOUN
ajlm-2895	50	20	was	be	AUX
ajlm-2895	50	21	confirmed	confirm	VERB
ajlm-2895	50	22	as	as	ADP
ajlm-2895	50	23	s.	s.	PROPN
ajlm-2895	50	24	aureus	aureus	PROPN
ajlm-2895	50	25	.	.	PUNCT
ajlm-2895	51	1	antimicrobial	antimicrobial	ADJ
ajlm-2895	51	2	susceptibility	susceptibility	NOUN
ajlm-2895	51	3	testing	test	VERB
ajlm-2895	51	4	susceptibility	susceptibility	NOUN
ajlm-2895	51	5	of	of	ADP
ajlm-2895	51	6	each	each	DET
ajlm-2895	51	7	isolate	isolate	NOUN
ajlm-2895	51	8	to	to	ADP
ajlm-2895	51	9	various	various	ADJ
ajlm-2895	51	10	antimicrobial	antimicrobial	ADJ
ajlm-2895	51	11	agents	agent	NOUN
ajlm-2895	51	12	was	be	AUX
ajlm-2895	51	13	determined	determine	VERB
ajlm-2895	51	14	through	through	ADP
ajlm-2895	51	15	the	the	DET
ajlm-2895	51	16	kirby	kirby	PROPN
ajlm-2895	51	17	-	-	PUNCT
ajlm-2895	51	18	bauer	bauer	PROPN
ajlm-2895	51	19	(	(	PUNCT
ajlm-2895	51	20	kb	kb	PROPN
ajlm-2895	51	21	)	)	PUNCT
ajlm-2895	51	22	method	method	NOUN
ajlm-2895	51	23	(	(	PUNCT
ajlm-2895	51	24	disc	disc	NOUN
ajlm-2895	51	25	-	-	PUNCT
ajlm-2895	51	26	diffusion	diffusion	NOUN
ajlm-2895	51	27	method)17	method)17	NOUN
ajlm-2895	51	28	on	on	ADP
ajlm-2895	51	29	mueller	mueller	PROPN
ajlm-2895	51	30	-	-	PUNCT
ajlm-2895	51	31	hinton	hinton	PROPN
ajlm-2895	51	32	agar	agar	NOUN
ajlm-2895	51	33	(	(	PUNCT
ajlm-2895	51	34	mha	mha	NOUN
ajlm-2895	51	35	)	)	PUNCT
ajlm-2895	51	36	plates	plate	NOUN
ajlm-2895	51	37	(	(	PUNCT
ajlm-2895	51	38	biomaxima	biomaxima	PROPN
ajlm-2895	51	39	,	,	PUNCT
ajlm-2895	51	40	lublin	lublin	PROPN
ajlm-2895	51	41	,	,	PUNCT
ajlm-2895	51	42	poland	poland	PROPN
ajlm-2895	51	43	)	)	PUNCT
ajlm-2895	51	44	.	.	PUNCT
ajlm-2895	52	1	briefly	briefly	NOUN
ajlm-2895	52	2	,	,	PUNCT
ajlm-2895	52	3	single	single	ADJ
ajlm-2895	52	4	colonies	colony	NOUN
ajlm-2895	52	5	of	of	ADP
ajlm-2895	52	6	each	each	DET
ajlm-2895	52	7	clinical	clinical	ADJ
ajlm-2895	52	8	isolate	isolate	NOUN
ajlm-2895	52	9	were	be	AUX
ajlm-2895	52	10	suspended	suspend	VERB
ajlm-2895	52	11	in	in	ADP
ajlm-2895	52	12	5	5	NUM
ajlm-2895	52	13	ml	ml	NOUN
ajlm-2895	52	14	sterile	sterile	ADJ
ajlm-2895	52	15	distilled	distil	VERB
ajlm-2895	52	16	water	water	NOUN
ajlm-2895	52	17	.	.	PUNCT
ajlm-2895	53	1	the	the	DET
ajlm-2895	53	2	turbidity	turbidity	NOUN
ajlm-2895	53	3	of	of	ADP
ajlm-2895	53	4	the	the	DET
ajlm-2895	53	5	suspension	suspension	NOUN
ajlm-2895	53	6	was	be	AUX
ajlm-2895	53	7	adjusted	adjust	VERB
ajlm-2895	53	8	to	to	ADP
ajlm-2895	53	9	0.5	0.5	NUM
ajlm-2895	53	10	mcfarland	mcfarland	PROPN
ajlm-2895	53	11	’s	’s	PART
ajlm-2895	53	12	standard	standard	NOUN
ajlm-2895	53	13	and	and	CCONJ
ajlm-2895	53	14	subsequently	subsequently	ADV
ajlm-2895	53	15	spread	spread	VERB
ajlm-2895	53	16	onto	onto	ADP
ajlm-2895	53	17	the	the	DET
ajlm-2895	53	18	surface	surface	NOUN
ajlm-2895	53	19	of	of	ADP
ajlm-2895	53	20	the	the	DET
ajlm-2895	53	21	mha	mha	NOUN
ajlm-2895	53	22	plate	plate	NOUN
ajlm-2895	53	23	using	use	VERB
ajlm-2895	53	24	a	a	DET
ajlm-2895	53	25	sterile	sterile	ADJ
ajlm-2895	53	26	cotton	cotton	NOUN
ajlm-2895	53	27	swab	swab	NOUN
ajlm-2895	53	28	.	.	PUNCT
ajlm-2895	54	1	afterwards	afterwards	ADV
ajlm-2895	54	2	,	,	PUNCT
ajlm-2895	54	3	antibiotic	antibiotic	ADJ
ajlm-2895	54	4	-	-	PUNCT
ajlm-2895	54	5	impregnated	impregnate	VERB
ajlm-2895	54	6	disks	disk	NOUN
ajlm-2895	54	7	were	be	AUX
ajlm-2895	54	8	carefully	carefully	ADV
ajlm-2895	54	9	placed	place	VERB
ajlm-2895	54	10	onto	onto	ADP
ajlm-2895	54	11	an	an	DET
ajlm-2895	54	12	mha	mha	NOUN
ajlm-2895	54	13	plate	plate	NOUN
ajlm-2895	54	14	using	use	VERB
ajlm-2895	54	15	forceps	forceps	NOUN
ajlm-2895	54	16	,	,	PUNCT
ajlm-2895	54	17	and	and	CCONJ
ajlm-2895	54	18	the	the	DET
ajlm-2895	54	19	plates	plate	NOUN
ajlm-2895	54	20	were	be	AUX
ajlm-2895	54	21	then	then	ADV
ajlm-2895	54	22	incubated	incubate	VERB
ajlm-2895	54	23	at	at	ADP
ajlm-2895	54	24	37	37	NUM
ajlm-2895	54	25	°	°	NOUN
ajlm-2895	54	26	c	c	NOUN
ajlm-2895	54	27	overnight	overnight	ADV
ajlm-2895	54	28	.	.	PUNCT
ajlm-2895	55	1	the	the	DET
ajlm-2895	55	2	inhibition	inhibition	NOUN
ajlm-2895	55	3	diameters	diameter	NOUN
ajlm-2895	55	4	of	of	ADP
ajlm-2895	55	5	15	15	NUM
ajlm-2895	55	6	µg	µg	ADV
ajlm-2895	55	7	tigecycline	tigecycline	NOUN
ajlm-2895	55	8	were	be	AUX
ajlm-2895	55	9	measured	measure	VERB
ajlm-2895	55	10	and	and	CCONJ
ajlm-2895	55	11	interpreted	interpret	VERB
ajlm-2895	55	12	as	as	ADP
ajlm-2895	55	13	resistant	resistant	ADJ
ajlm-2895	55	14	or	or	CCONJ
ajlm-2895	55	15	susceptible	susceptible	ADJ
ajlm-2895	55	16	using	use	VERB
ajlm-2895	55	17	standard	standard	ADJ
ajlm-2895	55	18	reference	reference	NOUN
ajlm-2895	55	19	values	value	NOUN
ajlm-2895	55	20	according	accord	VERB
ajlm-2895	55	21	to	to	ADP
ajlm-2895	55	22	ca	ca	NOUN
ajlm-2895	55	23	-	-	PUNCT
ajlm-2895	55	24	sfm	sfm	NOUN
ajlm-2895	55	25	-	-	PUNCT
ajlm-2895	55	26	eucast	eucast	ADJ
ajlm-2895	55	27	2021.18	2021.18	NUM
ajlm-2895	55	28	phenotypic	phenotypic	ADJ
ajlm-2895	55	29	antibiotic	antibiotic	ADJ
ajlm-2895	55	30	-	-	PUNCT
ajlm-2895	55	31	resistance	resistance	NOUN
ajlm-2895	55	32	analysis	analysis	NOUN
ajlm-2895	55	33	extended	extend	VERB
ajlm-2895	55	34	-	-	PUNCT
ajlm-2895	55	35	spectrum	spectrum	NOUN
ajlm-2895	55	36	β	β	NOUN
ajlm-2895	55	37	-	-	PUNCT
ajlm-2895	55	38	lactamase	lactamase	ADJ
ajlm-2895	55	39	detection	detection	NOUN
ajlm-2895	55	40	using	use	VERB
ajlm-2895	55	41	the	the	DET
ajlm-2895	55	42	double	double	ADJ
ajlm-2895	55	43	synergy	synergy	NOUN
ajlm-2895	55	44	test	test	NOUN
ajlm-2895	55	45	the	the	DET
ajlm-2895	55	46	double	double	ADJ
ajlm-2895	55	47	synergy	synergy	NOUN
ajlm-2895	55	48	test	test	NOUN
ajlm-2895	55	49	was	be	AUX
ajlm-2895	55	50	used	use	VERB
ajlm-2895	55	51	for	for	ADP
ajlm-2895	55	52	the	the	DET
ajlm-2895	55	53	detection	detection	NOUN
ajlm-2895	55	54	of	of	ADP
ajlm-2895	55	55	esbl	esbl	NOUN
ajlm-2895	55	56	production	production	NOUN
ajlm-2895	55	57	.	.	PUNCT
ajlm-2895	56	1	briefly	briefly	ADV
ajlm-2895	56	2	,	,	PUNCT
ajlm-2895	56	3	it	it	PRON
ajlm-2895	56	4	consisted	consist	VERB
ajlm-2895	56	5	of	of	ADP
ajlm-2895	56	6	placing	place	VERB
ajlm-2895	56	7	a	a	DET
ajlm-2895	56	8	30	30	NUM
ajlm-2895	56	9	µg	µg	NOUN
ajlm-2895	56	10	disk	disk	NOUN
ajlm-2895	56	11	of	of	ADP
ajlm-2895	56	12	third	third	ADJ
ajlm-2895	56	13	-	-	PUNCT
ajlm-2895	56	14	generation	generation	NOUN
ajlm-2895	56	15	cephalosporin	cephalosporin	NOUN
ajlm-2895	56	16	(	(	PUNCT
ajlm-2895	56	17	cefotaxime	cefotaxime	NOUN
ajlm-2895	56	18	,	,	PUNCT
ajlm-2895	56	19	ceftriaxone	ceftriaxone	PROPN
ajlm-2895	56	20	,	,	PUNCT
ajlm-2895	56	21	ceftazidime	ceftazidime	NOUN
ajlm-2895	56	22	)	)	PUNCT
ajlm-2895	56	23	and/or	and/or	CCONJ
ajlm-2895	56	24	other	other	ADJ
ajlm-2895	56	25	(	(	PUNCT
ajlm-2895	56	26	aztreonam	aztreonam	NOUN
ajlm-2895	56	27	[	[	X
ajlm-2895	56	28	30	30	NUM
ajlm-2895	56	29	µg	µg	NOUN
ajlm-2895	56	30	]	]	PUNCT
ajlm-2895	56	31	or	or	CCONJ
ajlm-2895	56	32	cefepime	cefepime	NOUN
ajlm-2895	57	1	[	[	X
ajlm-2895	57	2	30	30	NUM
ajlm-2895	57	3	µg	µg	NOUN
ajlm-2895	57	4	]	]	PUNCT
ajlm-2895	57	5	at	at	ADP
ajlm-2895	57	6	a	a	DET
ajlm-2895	57	7	distance	distance	NOUN
ajlm-2895	57	8	of	of	ADP
ajlm-2895	57	9	30	30	NUM
ajlm-2895	57	10	mm	mm	NOUN
ajlm-2895	57	11	,	,	PUNCT
ajlm-2895	57	12	centre	centre	NOUN
ajlm-2895	57	13	to	to	ADP
ajlm-2895	57	14	centre	centre	NOUN
ajlm-2895	57	15	,	,	PUNCT
ajlm-2895	57	16	of	of	ADP
ajlm-2895	57	17	an	an	DET
ajlm-2895	57	18	amoxicillin	amoxicillin	NOUN
ajlm-2895	57	19	/	/	SYM
ajlm-2895	57	20	clavulanic	clavulanic	ADJ
ajlm-2895	57	21	acid	acid	NOUN
ajlm-2895	57	22	disk	disk	NOUN
ajlm-2895	57	23	(	(	PUNCT
ajlm-2895	57	24	20	20	NUM
ajlm-2895	57	25	µg/10	µg/10	PROPN
ajlm-2895	57	26	µg	µg	NOUN
ajlm-2895	57	27	)	)	PUNCT
ajlm-2895	57	28	.	.	PUNCT
ajlm-2895	58	1	the	the	DET
ajlm-2895	58	2	production	production	NOUN
ajlm-2895	58	3	of	of	ADP
ajlm-2895	58	4	esbl	esbl	PROPN
ajlm-2895	58	5	resulted	result	VERB
ajlm-2895	58	6	in	in	ADP
ajlm-2895	58	7	very	very	ADV
ajlm-2895	58	8	characteristic	characteristic	ADJ
ajlm-2895	58	9	synergistic	synergistic	ADJ
ajlm-2895	58	10	images	image	NOUN
ajlm-2895	58	11	between	between	ADP
ajlm-2895	58	12	the	the	DET
ajlm-2895	58	13	third	third	ADJ
ajlm-2895	58	14	-	-	PUNCT
ajlm-2895	58	15	generation	generation	NOUN
ajlm-2895	58	16	cephalosporin	cephalosporin	NOUN
ajlm-2895	58	17	disk	disk	NOUN
ajlm-2895	58	18	or	or	CCONJ
ajlm-2895	58	19	aztreonam	aztreonam	NOUN
ajlm-2895	58	20	(	(	PUNCT
ajlm-2895	58	21	30	30	NUM
ajlm-2895	58	22	µg	µg	NOUN
ajlm-2895	58	23	)	)	PUNCT
ajlm-2895	58	24	and	and	CCONJ
ajlm-2895	58	25	amoxicillin	amoxicillin	PROPN
ajlm-2895	58	26	/	/	SYM
ajlm-2895	58	27	clavulanic	clavulanic	ADJ
ajlm-2895	58	28	acid	acid	NOUN
ajlm-2895	58	29	disk	disk	NOUN
ajlm-2895	58	30	(	(	PUNCT
ajlm-2895	58	31	20	20	NUM
ajlm-2895	58	32	µg/10	µg/10	PROPN
ajlm-2895	58	33	µg	µg	ADP
ajlm-2895	58	34	):	):	PUNCT
ajlm-2895	58	35	a	a	DET
ajlm-2895	58	36	so	so	ADV
ajlm-2895	58	37	-	-	PUNCT
ajlm-2895	58	38	called	call	VERB
ajlm-2895	58	39	champagne	champagne	NOUN
ajlm-2895	58	40	cork	cork	NOUN
ajlm-2895	58	41	image.18	image.18	PROPN
ajlm-2895	58	42	carbapenem	carbapenem	NOUN
ajlm-2895	58	43	-	-	PUNCT
ajlm-2895	58	44	resistant	resistant	ADJ
ajlm-2895	58	45	strains	strain	NOUN
ajlm-2895	58	46	detection	detection	NOUN
ajlm-2895	58	47	regarding	regard	VERB
ajlm-2895	58	48	the	the	DET
ajlm-2895	58	49	detection	detection	NOUN
ajlm-2895	58	50	of	of	ADP
ajlm-2895	58	51	carbapenem	carbapenem	NOUN
ajlm-2895	58	52	-	-	PUNCT
ajlm-2895	58	53	resistant	resistant	ADJ
ajlm-2895	58	54	enterobacterales	enterobacterale	NOUN
ajlm-2895	58	55	,	,	PUNCT
ajlm-2895	58	56	any	any	DET
ajlm-2895	58	57	isolate	isolate	NOUN
ajlm-2895	58	58	with	with	ADP
ajlm-2895	58	59	decreased	decrease	VERB
ajlm-2895	58	60	susceptibility	susceptibility	NOUN
ajlm-2895	58	61	to	to	ADP
ajlm-2895	58	62	ertapenem	ertapenem	PROPN
ajlm-2895	58	63	(	(	PUNCT
ajlm-2895	58	64	inhibition	inhibition	NOUN
ajlm-2895	58	65	diameter	diameter	NOUN
ajlm-2895	58	66	<	<	X
ajlm-2895	58	67	25	25	NUM
ajlm-2895	58	68	mm	mm	NOUN
ajlm-2895	58	69	;	;	PUNCT
ajlm-2895	58	70	10	10	NUM
ajlm-2895	58	71	µg	µg	NOUN
ajlm-2895	58	72	)	)	PUNCT
ajlm-2895	58	73	through	through	ADP
ajlm-2895	58	74	agar	agar	NOUN
ajlm-2895	58	75	diffusion	diffusion	NOUN
ajlm-2895	58	76	test	test	NOUN
ajlm-2895	58	77	was	be	AUX
ajlm-2895	58	78	considered	consider	VERB
ajlm-2895	58	79	resistant	resistant	ADJ
ajlm-2895	58	80	.	.	PUNCT
ajlm-2895	59	1	for	for	ADP
ajlm-2895	59	2	a.	a.	NOUN
ajlm-2895	59	3	baumannii	baumannii	PROPN
ajlm-2895	59	4	,	,	PUNCT
ajlm-2895	59	5	a	a	DET
ajlm-2895	59	6	decreased	decrease	VERB
ajlm-2895	59	7	susceptibility	susceptibility	NOUN
ajlm-2895	59	8	to	to	ADP
ajlm-2895	59	9	imipenem	imipenem	PROPN
ajlm-2895	59	10	10	10	NUM
ajlm-2895	59	11	µg	µg	ADV
ajlm-2895	59	12	(	(	PUNCT
ajlm-2895	59	13	inhibition	inhibition	NOUN
ajlm-2895	59	14	diameter	diameter	NOUN
ajlm-2895	59	15	<	<	X
ajlm-2895	59	16	21	21	NUM
ajlm-2895	59	17	mm	mm	NOUN
ajlm-2895	59	18	)	)	PUNCT
ajlm-2895	59	19	or	or	CCONJ
ajlm-2895	59	20	meropenem	meropenem	PROPN
ajlm-2895	59	21	10	10	NUM
ajlm-2895	59	22	µg	µg	ADP
ajlm-2895	59	23	(	(	PUNCT
ajlm-2895	59	24	inhibition	inhibition	NOUN
ajlm-2895	59	25	diameter	diameter	NOUN
ajlm-2895	59	26	<	<	X
ajlm-2895	59	27	15	15	NUM
ajlm-2895	59	28	mm	mm	NOUN
ajlm-2895	59	29	)	)	PUNCT
ajlm-2895	59	30	through	through	ADP
ajlm-2895	59	31	agar	agar	NOUN
ajlm-2895	59	32	diffusion	diffusion	NOUN
ajlm-2895	59	33	test	test	NOUN
ajlm-2895	59	34	was	be	AUX
ajlm-2895	59	35	considered	consider	VERB
ajlm-2895	59	36	resistant.18	resistant.18	VERB
ajlm-2895	59	37	methicillin	methicillin	NOUN
ajlm-2895	59	38	-	-	PUNCT
ajlm-2895	59	39	resistant	resistant	ADJ
ajlm-2895	59	40	s.	s.	PROPN
ajlm-2895	59	41	aureus	aureus	PROPN
ajlm-2895	59	42	detection	detection	NOUN
ajlm-2895	59	43	for	for	ADP
ajlm-2895	59	44	mrsa	mrsa	NOUN
ajlm-2895	59	45	identification	identification	NOUN
ajlm-2895	59	46	,	,	PUNCT
ajlm-2895	59	47	strains	strain	VERB
ajlm-2895	59	48	with	with	ADP
ajlm-2895	59	49	a	a	DET
ajlm-2895	59	50	cefoxitin	cefoxitin	NOUN
ajlm-2895	59	51	(	(	PUNCT
ajlm-2895	59	52	30	30	NUM
ajlm-2895	59	53	µg	µg	NOUN
ajlm-2895	59	54	disk	disk	NOUN
ajlm-2895	59	55	)	)	PUNCT
ajlm-2895	59	56	zone	zone	NOUN
ajlm-2895	59	57	diameter	diameter	NOUN
ajlm-2895	59	58	<	<	X
ajlm-2895	59	59	22	22	NUM
ajlm-2895	59	60	mm	mm	NOUN
ajlm-2895	59	61	were	be	AUX
ajlm-2895	59	62	considered	consider	VERB
ajlm-2895	59	63	as	as	ADP
ajlm-2895	59	64	mrsa	mrsa	NOUN
ajlm-2895	59	65	phenotype.18	phenotype.18	NOUN
ajlm-2895	59	66	activity	activity	NOUN
ajlm-2895	59	67	of	of	ADP
ajlm-2895	59	68	tigecycline	tigecycline	NOUN
ajlm-2895	59	69	on	on	ADP
ajlm-2895	59	70	multidrug	multidrug	NOUN
ajlm-2895	59	71	-	-	PUNCT
ajlm-2895	59	72	resistant	resistant	ADJ
ajlm-2895	59	73	bacteria	bacteria	NOUN
ajlm-2895	59	74	detection	detection	NOUN
ajlm-2895	59	75	we	we	PRON
ajlm-2895	59	76	tested	test	VERB
ajlm-2895	59	77	the	the	DET
ajlm-2895	59	78	activity	activity	NOUN
ajlm-2895	59	79	of	of	ADP
ajlm-2895	59	80	tigecycline	tigecycline	NOUN
ajlm-2895	59	81	(	(	PUNCT
ajlm-2895	59	82	15	15	NUM
ajlm-2895	59	83	µg	µg	NOUN
ajlm-2895	59	84	)	)	PUNCT
ajlm-2895	59	85	on	on	ADP
ajlm-2895	59	86	all	all	DET
ajlm-2895	59	87	mdr	mdr	PROPN
ajlm-2895	59	88	strains	strain	NOUN
ajlm-2895	59	89	of	of	ADP
ajlm-2895	59	90	escherichia	escherichia	NOUN
ajlm-2895	59	91	coli	coli	NOUN
ajlm-2895	59	92	in	in	ADP
ajlm-2895	59	93	accordance	accordance	NOUN
ajlm-2895	59	94	with	with	ADP
ajlm-2895	59	95	the	the	DET
ajlm-2895	59	96	eucast	eucast	ADJ
ajlm-2895	59	97	2021	2021	NUM
ajlm-2895	59	98	guidelines	guideline	NOUN
ajlm-2895	59	99	,	,	PUNCT
ajlm-2895	59	100	and	and	CCONJ
ajlm-2895	59	101	an	an	DET
ajlm-2895	59	102	inhibition	inhibition	NOUN
ajlm-2895	59	103	diameter	diameter	NOUN
ajlm-2895	59	104	≥	≥	NUM
ajlm-2895	59	105	18	18	NUM
ajlm-2895	59	106	mm	mm	NOUN
ajlm-2895	59	107	was	be	AUX
ajlm-2895	59	108	considered	consider	VERB
ajlm-2895	59	109	sensitive	sensitive	ADJ
ajlm-2895	59	110	to	to	AUX
ajlm-2895	59	111	tigecycline	tigecycline	VERB
ajlm-2895	59	112	.	.	PUNCT
ajlm-2895	60	1	for	for	ADP
ajlm-2895	60	2	the	the	DET
ajlm-2895	60	3	other	other	ADJ
ajlm-2895	60	4	species	specie	NOUN
ajlm-2895	60	5	of	of	ADP
ajlm-2895	60	6	enterobacterales	enterobacterale	NOUN
ajlm-2895	60	7	,	,	PUNCT
ajlm-2895	60	8	the	the	DET
ajlm-2895	60	9	inhibition	inhibition	NOUN
ajlm-2895	60	10	diameter	diameter	NOUN
ajlm-2895	60	11	≥	≥	NUM
ajlm-2895	60	12	19	19	NUM
ajlm-2895	60	13	mm	mm	NOUN
ajlm-2895	60	14	has	have	AUX
ajlm-2895	60	15	been	be	AUX
ajlm-2895	60	16	considered	consider	VERB
ajlm-2895	60	17	for	for	ADP
ajlm-2895	60	18	susceptible	susceptible	ADJ
ajlm-2895	60	19	strains	strain	NOUN
ajlm-2895	60	20	as	as	SCONJ
ajlm-2895	60	21	suggested	suggest	VERB
ajlm-2895	60	22	by	by	ADP
ajlm-2895	60	23	the	the	DET
ajlm-2895	60	24	fda	fda	PROPN
ajlm-2895	60	25	(	(	PUNCT
ajlm-2895	60	26	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021821s026s031lbl.pdf	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021821s026s031lbl.pdf	PROPN
ajlm-2895	60	27	)	)	PUNCT
ajlm-2895	60	28	.	.	PUNCT
ajlm-2895	61	1	all	all	DET
ajlm-2895	61	2	mrsa	mrsa	NOUN
ajlm-2895	61	3	strains	strain	VERB
ajlm-2895	61	4	having	have	VERB
ajlm-2895	61	5	an	an	DET
ajlm-2895	61	6	inhibition	inhibition	NOUN
ajlm-2895	61	7	diameter	diameter	NOUN
ajlm-2895	61	8	≥	≥	NOUN
ajlm-2895	61	9	19	19	NUM
ajlm-2895	61	10	mm	mm	NOUN
ajlm-2895	61	11	were	be	AUX
ajlm-2895	61	12	considered	consider	VERB
ajlm-2895	61	13	susceptible	susceptible	ADJ
ajlm-2895	61	14	to	to	ADP
ajlm-2895	61	15	tigecycline.18	tigecycline.18	NOUN
ajlm-2895	61	16	considering	consider	VERB
ajlm-2895	61	17	crab	crab	NOUN
ajlm-2895	61	18	,	,	PUNCT
ajlm-2895	61	19	susceptibility	susceptibility	NOUN
ajlm-2895	61	20	to	to	PART
ajlm-2895	61	21	tigecycline	tigecycline	VERB
ajlm-2895	61	22	was	be	AUX
ajlm-2895	61	23	inferred	infer	VERB
ajlm-2895	61	24	using	use	VERB
ajlm-2895	61	25	the	the	DET
ajlm-2895	61	26	clear	clear	ADJ
ajlm-2895	61	27	zone	zone	NOUN
ajlm-2895	61	28	diameters	diameter	NOUN
ajlm-2895	61	29	suggested	suggest	VERB
ajlm-2895	61	30	by	by	ADP
ajlm-2895	61	31	the	the	DET
ajlm-2895	61	32	fda	fda	PROPN
ajlm-2895	61	33	criteria.19	criteria.19	PROPN
ajlm-2895	61	34	susceptibility	susceptibility	NOUN
ajlm-2895	61	35	to	to	PART
ajlm-2895	61	36	tigecycline	tigecycline	VERB
ajlm-2895	61	37	was	be	AUX
ajlm-2895	61	38	defined	define	VERB
ajlm-2895	61	39	based	base	VERB
ajlm-2895	61	40	on	on	ADP
ajlm-2895	61	41	clear	clear	ADJ
ajlm-2895	61	42	zone	zone	NOUN
ajlm-2895	61	43	diameters	diameter	NOUN
ajlm-2895	61	44	as	as	ADP
ajlm-2895	61	45	susceptible	susceptible	ADJ
ajlm-2895	61	46	(	(	PUNCT
ajlm-2895	61	47	≥	≥	NUM
ajlm-2895	61	48	19	19	NUM
ajlm-2895	61	49	mm	mm	NOUN
ajlm-2895	61	50	)	)	PUNCT
ajlm-2895	61	51	,	,	PUNCT
ajlm-2895	61	52	whereas	whereas	SCONJ
ajlm-2895	61	53	clear	clear	ADJ
ajlm-2895	61	54	zone	zone	NOUN
ajlm-2895	61	55	diameters	diameter	NOUN
ajlm-2895	61	56	<	<	X
ajlm-2895	61	57	19	19	NUM
ajlm-2895	61	58	mm	mm	NOUN
ajlm-2895	61	59	were	be	AUX
ajlm-2895	61	60	considered	consider	VERB
ajlm-2895	61	61	as	as	ADP
ajlm-2895	61	62	resistant	resistant	ADJ
ajlm-2895	61	63	,	,	PUNCT
ajlm-2895	61	64	although	although	SCONJ
ajlm-2895	61	65	fda	fda	PROPN
ajlm-2895	61	66	guidelines	guideline	NOUN
ajlm-2895	61	67	suggest	suggest	VERB
ajlm-2895	61	68	intermediate	intermediate	ADJ
ajlm-2895	61	69	for	for	ADP
ajlm-2895	61	70	15	15	NUM
ajlm-2895	61	71	mm	mm	NOUN
ajlm-2895	61	72	–	–	PUNCT
ajlm-2895	61	73	18	18	NUM
ajlm-2895	61	74	mm	mm	NOUN
ajlm-2895	61	75	,	,	PUNCT
ajlm-2895	61	76	or	or	CCONJ
ajlm-2895	61	77	≤	≤	NUM
ajlm-2895	61	78	14	14	NUM
ajlm-2895	61	79	mm	mm	NOUN
ajlm-2895	61	80	for	for	ADP
ajlm-2895	61	81	resistant.19	resistant.19	NOUN
ajlm-2895	61	82	quality	quality	NOUN
ajlm-2895	61	83	controls	control	VERB
ajlm-2895	61	84	quality	quality	NOUN
ajlm-2895	61	85	control	control	NOUN
ajlm-2895	61	86	of	of	ADP
ajlm-2895	61	87	antimicrobial	antimicrobial	ADJ
ajlm-2895	61	88	susceptibility	susceptibility	NOUN
ajlm-2895	61	89	testing	testing	NOUN
ajlm-2895	61	90	was	be	AUX
ajlm-2895	61	91	assessed	assess	VERB
ajlm-2895	61	92	by	by	ADP
ajlm-2895	61	93	using	use	VERB
ajlm-2895	61	94	reference	reference	NOUN
ajlm-2895	61	95	strains	strain	NOUN
ajlm-2895	61	96	such	such	ADJ
ajlm-2895	61	97	as	as	ADP
ajlm-2895	61	98	e.	e.	PROPN
ajlm-2895	61	99	coli	coli	PROPN
ajlm-2895	61	100	atcc	atcc	PROPN
ajlm-2895	61	101	25922	25922	NUM
ajlm-2895	61	102	,	,	PUNCT
ajlm-2895	61	103	s.	s.	PROPN
ajlm-2895	61	104	aureus	aureus	PROPN
ajlm-2895	61	105	atcc	atcc	PROPN
ajlm-2895	61	106	25929	25929	NUM
ajlm-2895	61	107	,	,	PUNCT
ajlm-2895	61	108	and	and	CCONJ
ajlm-2895	61	109	klebsiella	klebsiella	NOUN
ajlm-2895	61	110	pneumoniae	pneumoniae	ADJ
ajlm-2895	61	111	atcc	atcc	NOUN
ajlm-2895	61	112	700603	700603	NUM
ajlm-2895	61	113	,	,	PUNCT
ajlm-2895	61	114	in	in	ADP
ajlm-2895	61	115	accordance	accordance	NOUN
ajlm-2895	61	116	with	with	ADP
ajlm-2895	61	117	eucast	eucast	ADJ
ajlm-2895	61	118	guidelines.18	guidelines.18	PROPN
ajlm-2895	61	119	data	data	NOUN
ajlm-2895	61	120	processing	processing	NOUN
ajlm-2895	61	121	and	and	CCONJ
ajlm-2895	61	122	analysis	analysis	NOUN
ajlm-2895	61	123	data	datum	NOUN
ajlm-2895	61	124	were	be	AUX
ajlm-2895	61	125	recorded	record	VERB
ajlm-2895	61	126	in	in	ADP
ajlm-2895	61	127	a	a	DET
ajlm-2895	61	128	microsoft	microsoft	PROPN
ajlm-2895	61	129	excel	excel	PROPN
ajlm-2895	61	130	2016	2016	NUM
ajlm-2895	61	131	worksheet	worksheet	NOUN
ajlm-2895	61	132	,	,	PUNCT
ajlm-2895	61	133	which	which	PRON
ajlm-2895	61	134	was	be	AUX
ajlm-2895	61	135	used	use	VERB
ajlm-2895	61	136	to	to	PART
ajlm-2895	61	137	create	create	VERB
ajlm-2895	61	138	graphs	graph	NOUN
ajlm-2895	61	139	and	and	CCONJ
ajlm-2895	61	140	tables	table	NOUN
ajlm-2895	61	141	.	.	PUNCT
ajlm-2895	62	1	statistical	statistical	ADJ
ajlm-2895	62	2	analysis	analysis	NOUN
ajlm-2895	62	3	was	be	AUX
ajlm-2895	62	4	performed	perform	VERB
ajlm-2895	62	5	with	with	ADP
ajlm-2895	62	6	epi	epi	NOUN
ajlm-2895	62	7	info	info	NOUN
ajlm-2895	62	8	7	7	NUM
ajlm-2895	62	9	™	™	ADJ
ajlm-2895	62	10	software	software	NOUN
ajlm-2895	62	11	.	.	PUNCT
ajlm-2895	63	1	the	the	DET
ajlm-2895	63	2	qualitative	qualitative	ADJ
ajlm-2895	63	3	variables	variable	NOUN
ajlm-2895	63	4	were	be	AUX
ajlm-2895	63	5	expressed	express	VERB
ajlm-2895	63	6	in	in	ADP
ajlm-2895	63	7	proportions	proportion	NOUN
ajlm-2895	63	8	,	,	PUNCT
ajlm-2895	63	9	whereas	whereas	SCONJ
ajlm-2895	63	10	the	the	DET
ajlm-2895	63	11	quantitative	quantitative	ADJ
ajlm-2895	63	12	variables	variable	NOUN
ajlm-2895	63	13	were	be	AUX
ajlm-2895	63	14	expressed	express	VERB
ajlm-2895	63	15	in	in	ADP
ajlm-2895	63	16	means	mean	NOUN
ajlm-2895	63	17	with	with	ADP
ajlm-2895	63	18	their	their	PRON
ajlm-2895	63	19	95	95	NUM
ajlm-2895	63	20	%	%	NOUN
ajlm-2895	63	21	confidence	confidence	NOUN
ajlm-2895	63	22	intervals	interval	NOUN
ajlm-2895	63	23	.	.	PUNCT
ajlm-2895	64	1	proportions	proportion	NOUN
ajlm-2895	64	2	of	of	ADP
ajlm-2895	64	3	mdrbs	mdrb	NOUN
ajlm-2895	64	4	sensitive	sensitive	ADJ
ajlm-2895	64	5	or	or	CCONJ
ajlm-2895	64	6	resistant	resistant	ADJ
ajlm-2895	64	7	to	to	ADP
ajlm-2895	64	8	tigecycline	tigecycline	ADV
ajlm-2895	64	9	were	be	AUX
ajlm-2895	64	10	compared	compare	VERB
ajlm-2895	64	11	with	with	ADP
ajlm-2895	64	12	the	the	DET
ajlm-2895	64	13	pearson	pearson	PROPN
ajlm-2895	64	14	chi	chi	PROPN
ajlm-2895	64	15	-	-	PUNCT
ajlm-2895	64	16	square	square	NOUN
ajlm-2895	64	17	test	test	NOUN
ajlm-2895	64	18	when	when	SCONJ
ajlm-2895	64	19	there	there	PRON
ajlm-2895	64	20	was	be	VERB
ajlm-2895	64	21	a	a	DET
ajlm-2895	64	22	normal	normal	ADJ
ajlm-2895	64	23	distribution	distribution	NOUN
ajlm-2895	64	24	;	;	PUNCT
ajlm-2895	64	25	otherwise	otherwise	ADV
ajlm-2895	64	26	,	,	PUNCT
ajlm-2895	64	27	the	the	DET
ajlm-2895	64	28	fisher	fisher	PROPN
ajlm-2895	64	29	’s	’s	PART
ajlm-2895	64	30	exact	exact	ADJ
ajlm-2895	64	31	test	test	NOUN
ajlm-2895	64	32	was	be	AUX
ajlm-2895	64	33	used	use	VERB
ajlm-2895	64	34	.	.	PUNCT
ajlm-2895	65	1	the	the	DET
ajlm-2895	65	2	significance	significance	NOUN
ajlm-2895	65	3	threshold	threshold	NOUN
ajlm-2895	65	4	of	of	ADP
ajlm-2895	65	5	5	5	NUM
ajlm-2895	65	6	%	%	NOUN
ajlm-2895	65	7	was	be	AUX
ajlm-2895	65	8	considered	consider	VERB
ajlm-2895	65	9	for	for	ADP
ajlm-2895	65	10	all	all	DET
ajlm-2895	65	11	statistical	statistical	ADJ
ajlm-2895	65	12	tests	test	NOUN
ajlm-2895	65	13	.	.	PUNCT
ajlm-2895	66	1	results	result	VERB
ajlm-2895	66	2	a	a	DET
ajlm-2895	66	3	total	total	NOUN
ajlm-2895	66	4	of	of	ADP
ajlm-2895	66	5	986	986	NUM
ajlm-2895	66	6	non	non	ADJ
ajlm-2895	66	7	-	-	ADJ
ajlm-2895	66	8	duplicate	duplicate	ADJ
ajlm-2895	66	9	samples	sample	NOUN
ajlm-2895	66	10	were	be	AUX
ajlm-2895	66	11	included	include	VERB
ajlm-2895	66	12	during	during	ADP
ajlm-2895	66	13	the	the	DET
ajlm-2895	66	14	study	study	NOUN
ajlm-2895	66	15	period	period	NOUN
ajlm-2895	66	16	(	(	PUNCT
ajlm-2895	66	17	01	01	NUM
ajlm-2895	66	18	june	june	PROPN
ajlm-2895	66	19	2022	2022	NUM
ajlm-2895	66	20	to	to	ADP
ajlm-2895	66	21	31	31	NUM
ajlm-2895	66	22	august	august	PROPN
ajlm-2895	66	23	2022	2022	NUM
ajlm-2895	66	24	)	)	PUNCT
ajlm-2895	66	25	.	.	PUNCT
ajlm-2895	67	1	the	the	DET
ajlm-2895	67	2	bacteriological	bacteriological	ADJ
ajlm-2895	67	3	yield	yield	NOUN
ajlm-2895	67	4	was	be	AUX
ajlm-2895	67	5	44.52	44.52	NUM
ajlm-2895	67	6	%	%	NOUN
ajlm-2895	67	7	(	(	PUNCT
ajlm-2895	67	8	439/986	439/986	NUM
ajlm-2895	67	9	)	)	PUNCT
ajlm-2895	67	10	positive	positive	ADJ
ajlm-2895	67	11	cultures	culture	NOUN
ajlm-2895	67	12	.	.	PUNCT
ajlm-2895	68	1	amongst	amongst	ADP
ajlm-2895	68	2	the	the	DET
ajlm-2895	68	3	439	439	NUM
ajlm-2895	68	4	positive	positive	ADJ
ajlm-2895	68	5	cultures	culture	NOUN
ajlm-2895	68	6	,	,	PUNCT
ajlm-2895	68	7	117	117	NUM
ajlm-2895	68	8	strains	strain	NOUN
ajlm-2895	68	9	were	be	AUX
ajlm-2895	68	10	mdrbs	mdrb	NOUN
ajlm-2895	68	11	(	(	PUNCT
ajlm-2895	68	12	26.65	26.65	NUM
ajlm-2895	68	13	%	%	NOUN
ajlm-2895	68	14	)	)	PUNCT
ajlm-2895	68	15	,	,	PUNCT
ajlm-2895	68	16	isolated	isolate	VERB
ajlm-2895	68	17	from	from	ADP
ajlm-2895	68	18	117	117	NUM
ajlm-2895	68	19	patients	patient	NOUN
ajlm-2895	68	20	(	(	PUNCT
ajlm-2895	68	21	figure	figure	NOUN
ajlm-2895	68	22	1	1	NUM
ajlm-2895	68	23	)	)	PUNCT
ajlm-2895	68	24	.	.	PUNCT
ajlm-2895	69	1	figure	figure	VERB
ajlm-2895	69	2	1	1	NUM
ajlm-2895	69	3	:	:	PUNCT
ajlm-2895	69	4	distribution	distribution	NOUN
ajlm-2895	69	5	of	of	ADP
ajlm-2895	69	6	non	non	ADJ
ajlm-2895	69	7	-	-	ADJ
ajlm-2895	69	8	duplicate	duplicate	ADJ
ajlm-2895	69	9	clinical	clinical	ADJ
ajlm-2895	69	10	samples	sample	NOUN
ajlm-2895	69	11	and	and	CCONJ
ajlm-2895	69	12	multidrug	multidrug	NOUN
ajlm-2895	69	13	-	-	PUNCT
ajlm-2895	69	14	resistant	resistant	ADJ
ajlm-2895	69	15	bacteria	bacteria	NOUN
ajlm-2895	69	16	(	(	PUNCT
ajlm-2895	69	17	n	n	NOUN
ajlm-2895	69	18	=	=	SYM
ajlm-2895	69	19	117	117	NUM
ajlm-2895	69	20	)	)	PUNCT
ajlm-2895	69	21	isolated	isolate	VERB
ajlm-2895	69	22	,	,	PUNCT
ajlm-2895	69	23	sourô	sourô	NOUN
ajlm-2895	69	24	sanou	sanou	PROPN
ajlm-2895	69	25	university	university	NOUN
ajlm-2895	69	26	teaching	teaching	NOUN
ajlm-2895	69	27	hospital	hospital	NOUN
ajlm-2895	69	28	in	in	ADP
ajlm-2895	69	29	bobo	bobo	NOUN
ajlm-2895	69	30	-	-	PUNCT
ajlm-2895	69	31	dioulasso	dioulasso	PROPN
ajlm-2895	69	32	,	,	PUNCT
ajlm-2895	69	33	burkina	burkina	PROPN
ajlm-2895	69	34	faso	faso	PROPN
ajlm-2895	69	35	,	,	PUNCT
ajlm-2895	69	36	01	01	NUM
ajlm-2895	69	37	june	june	PROPN
ajlm-2895	69	38	2022	2022	NUM
ajlm-2895	69	39	–	–	PUNCT
ajlm-2895	69	40	31	31	NUM
ajlm-2895	69	41	august	august	PROPN
ajlm-2895	69	42	2022	2022	NUM
ajlm-2895	69	43	.	.	PUNCT
ajlm-2895	70	1	patient	patient	ADJ
ajlm-2895	70	2	sociodemographic	sociodemographic	ADJ
ajlm-2895	70	3	characteristics	characteristic	NOUN
ajlm-2895	70	4	out	out	ADP
ajlm-2895	70	5	of	of	ADP
ajlm-2895	70	6	the	the	DET
ajlm-2895	70	7	117	117	NUM
ajlm-2895	70	8	patients	patient	NOUN
ajlm-2895	70	9	observed	observe	VERB
ajlm-2895	70	10	with	with	ADP
ajlm-2895	70	11	mdrbs	mdrb	NOUN
ajlm-2895	70	12	,	,	PUNCT
ajlm-2895	70	13	the	the	DET
ajlm-2895	70	14	male	male	ADJ
ajlm-2895	70	15	gender	gender	NOUN
ajlm-2895	70	16	was	be	AUX
ajlm-2895	70	17	predominant	predominant	ADJ
ajlm-2895	70	18	(	(	PUNCT
ajlm-2895	70	19	53.8	53.8	NUM
ajlm-2895	70	20	%	%	NOUN
ajlm-2895	70	21	)	)	PUNCT
ajlm-2895	70	22	.	.	PUNCT
ajlm-2895	71	1	the	the	DET
ajlm-2895	71	2	average	average	ADJ
ajlm-2895	71	3	age	age	NOUN
ajlm-2895	71	4	of	of	ADP
ajlm-2895	71	5	the	the	DET
ajlm-2895	71	6	117	117	NUM
ajlm-2895	71	7	patients	patient	NOUN
ajlm-2895	71	8	from	from	ADP
ajlm-2895	71	9	whom	whom	PRON
ajlm-2895	71	10	we	we	PRON
ajlm-2895	71	11	isolated	isolate	VERB
ajlm-2895	71	12	mdrbs	mdrb	NOUN
ajlm-2895	71	13	was	be	AUX
ajlm-2895	71	14	41.27	41.27	NUM
ajlm-2895	71	15	±	±	NUM
ajlm-2895	71	16	17.9	17.9	NUM
ajlm-2895	71	17	years	year	NOUN
ajlm-2895	71	18	,	,	PUNCT
ajlm-2895	71	19	ranging	range	VERB
ajlm-2895	71	20	from	from	ADP
ajlm-2895	71	21	1	1	NUM
ajlm-2895	71	22	month	month	NOUN
ajlm-2895	71	23	to	to	ADP
ajlm-2895	71	24	85	85	NUM
ajlm-2895	71	25	years	year	NOUN
ajlm-2895	71	26	.	.	PUNCT
ajlm-2895	72	1	the	the	DET
ajlm-2895	72	2	most	most	ADV
ajlm-2895	72	3	represented	represent	VERB
ajlm-2895	72	4	age	age	NOUN
ajlm-2895	72	5	group	group	NOUN
ajlm-2895	72	6	was	be	AUX
ajlm-2895	72	7	40–50	40–50	NUM
ajlm-2895	72	8	years	year	NOUN
ajlm-2895	72	9	(	(	PUNCT
ajlm-2895	72	10	17.9	17.9	NUM
ajlm-2895	72	11	%	%	NOUN
ajlm-2895	72	12	)	)	PUNCT
ajlm-2895	72	13	,	,	PUNCT
ajlm-2895	72	14	followed	follow	VERB
ajlm-2895	72	15	by	by	ADP
ajlm-2895	72	16	20–30	20–30	NUM
ajlm-2895	72	17	years	year	NOUN
ajlm-2895	72	18	(	(	PUNCT
ajlm-2895	72	19	14.5	14.5	NUM
ajlm-2895	72	20	%	%	NOUN
ajlm-2895	72	21	)	)	PUNCT
ajlm-2895	72	22	.	.	PUNCT
ajlm-2895	73	1	regarding	regard	VERB
ajlm-2895	73	2	the	the	DET
ajlm-2895	73	3	distribution	distribution	NOUN
ajlm-2895	73	4	of	of	ADP
ajlm-2895	73	5	mdrbs	mdrb	NOUN
ajlm-2895	73	6	by	by	ADP
ajlm-2895	73	7	patient	patient	ADJ
ajlm-2895	73	8	origin	origin	NOUN
ajlm-2895	73	9	,	,	PUNCT
ajlm-2895	73	10	80	80	NUM
ajlm-2895	73	11	%	%	NOUN
ajlm-2895	73	12	came	come	VERB
ajlm-2895	73	13	from	from	ADP
ajlm-2895	73	14	various	various	ADJ
ajlm-2895	73	15	hospitalisation	hospitalisation	NOUN
ajlm-2895	73	16	wards	ward	NOUN
ajlm-2895	73	17	of	of	ADP
ajlm-2895	73	18	the	the	DET
ajlm-2895	73	19	sourô	sourô	PROPN
ajlm-2895	73	20	sanou	sanou	PROPN
ajlm-2895	73	21	university	university	NOUN
ajlm-2895	73	22	teaching	teaching	NOUN
ajlm-2895	73	23	hospital	hospital	NOUN
ajlm-2895	73	24	,	,	PUNCT
ajlm-2895	73	25	and	and	CCONJ
ajlm-2895	73	26	20	20	NUM
ajlm-2895	73	27	%	%	NOUN
ajlm-2895	73	28	from	from	ADP
ajlm-2895	73	29	other	other	ADJ
ajlm-2895	73	30	health	health	NOUN
ajlm-2895	73	31	facilities	facility	NOUN
ajlm-2895	73	32	in	in	ADP
ajlm-2895	73	33	the	the	DET
ajlm-2895	73	34	city	city	NOUN
ajlm-2895	73	35	of	of	ADP
ajlm-2895	73	36	bobo	bobo	NOUN
ajlm-2895	73	37	-	-	PUNCT
ajlm-2895	73	38	dioulasso	dioulasso	PROPN
ajlm-2895	73	39	.	.	PUNCT
ajlm-2895	74	1	considering	consider	VERB
ajlm-2895	74	2	the	the	DET
ajlm-2895	74	3	hospitalisation	hospitalisation	NOUN
ajlm-2895	74	4	wards	ward	NOUN
ajlm-2895	74	5	,	,	PUNCT
ajlm-2895	74	6	the	the	DET
ajlm-2895	74	7	urology	urology	NOUN
ajlm-2895	74	8	department	department	NOUN
ajlm-2895	74	9	was	be	AUX
ajlm-2895	74	10	most	most	ADV
ajlm-2895	74	11	represented	represent	VERB
ajlm-2895	74	12	with	with	ADP
ajlm-2895	74	13	14.5	14.5	NUM
ajlm-2895	74	14	%	%	NOUN
ajlm-2895	74	15	,	,	PUNCT
ajlm-2895	74	16	followed	follow	VERB
ajlm-2895	74	17	by	by	ADP
ajlm-2895	74	18	the	the	DET
ajlm-2895	74	19	intensive	intensive	ADJ
ajlm-2895	74	20	care	care	NOUN
ajlm-2895	74	21	unit	unit	NOUN
ajlm-2895	74	22	(	(	PUNCT
ajlm-2895	74	23	12	12	NUM
ajlm-2895	74	24	%	%	NOUN
ajlm-2895	74	25	)	)	PUNCT
ajlm-2895	74	26	.	.	PUNCT
ajlm-2895	75	1	distribution	distribution	NOUN
ajlm-2895	75	2	of	of	ADP
ajlm-2895	75	3	multidrug	multidrug	NOUN
ajlm-2895	75	4	-	-	PUNCT
ajlm-2895	75	5	resistant	resistant	ADJ
ajlm-2895	75	6	bacteria	bacteria	NOUN
ajlm-2895	75	7	(	(	PUNCT
ajlm-2895	75	8	n	n	NOUN
ajlm-2895	75	9	=	=	SYM
ajlm-2895	75	10	117	117	NUM
ajlm-2895	75	11	)	)	PUNCT
ajlm-2895	75	12	according	accord	VERB
ajlm-2895	75	13	to	to	ADP
ajlm-2895	75	14	bacterial	bacterial	ADJ
ajlm-2895	75	15	species	specie	NOUN
ajlm-2895	75	16	out	out	ADP
ajlm-2895	75	17	of	of	ADP
ajlm-2895	75	18	the	the	DET
ajlm-2895	75	19	117	117	NUM
ajlm-2895	75	20	mdr	mdr	PROPN
ajlm-2895	75	21	isolates	isolate	NOUN
ajlm-2895	75	22	,	,	PUNCT
ajlm-2895	75	23	e.	e.	PROPN
ajlm-2895	75	24	coli	coli	PROPN
ajlm-2895	75	25	was	be	AUX
ajlm-2895	75	26	the	the	DET
ajlm-2895	75	27	most	most	ADV
ajlm-2895	75	28	represented	represent	VERB
ajlm-2895	75	29	bacterial	bacterial	ADJ
ajlm-2895	75	30	species	specie	NOUN
ajlm-2895	75	31	(	(	PUNCT
ajlm-2895	75	32	p	p	X
ajlm-2895	75	33	<	<	X
ajlm-2895	75	34	0.018	0.018	NUM
ajlm-2895	75	35	)	)	PUNCT
ajlm-2895	75	36	with	with	ADP
ajlm-2895	75	37	a	a	DET
ajlm-2895	75	38	frequency	frequency	NOUN
ajlm-2895	75	39	of	of	ADP
ajlm-2895	75	40	53	53	NUM
ajlm-2895	75	41	%	%	NOUN
ajlm-2895	75	42	(	(	PUNCT
ajlm-2895	75	43	62/117	62/117	NUM
ajlm-2895	75	44	)	)	PUNCT
ajlm-2895	75	45	,	,	PUNCT
ajlm-2895	75	46	followed	follow	VERB
ajlm-2895	75	47	by	by	ADP
ajlm-2895	75	48	k.	k.	PROPN
ajlm-2895	75	49	pneumoniae	pneumoniae	PROPN
ajlm-2895	75	50	accounting	account	VERB
ajlm-2895	75	51	for	for	ADP
ajlm-2895	75	52	17	17	NUM
ajlm-2895	75	53	%	%	NOUN
ajlm-2895	75	54	(	(	PUNCT
ajlm-2895	75	55	20/117	20/117	NUM
ajlm-2895	75	56	)	)	PUNCT
ajlm-2895	75	57	.	.	PUNCT
ajlm-2895	76	1	as	as	SCONJ
ajlm-2895	76	2	described	describe	VERB
ajlm-2895	76	3	in	in	ADP
ajlm-2895	76	4	figure	figure	NOUN
ajlm-2895	76	5	2	2	NUM
ajlm-2895	76	6	,	,	PUNCT
ajlm-2895	76	7	crab	crab	NOUN
ajlm-2895	76	8	was	be	AUX
ajlm-2895	76	9	isolated	isolate	VERB
ajlm-2895	76	10	with	with	ADP
ajlm-2895	76	11	a	a	DET
ajlm-2895	76	12	frequency	frequency	NOUN
ajlm-2895	76	13	of	of	ADP
ajlm-2895	76	14	13	13	NUM
ajlm-2895	76	15	%	%	NOUN
ajlm-2895	76	16	,	,	PUNCT
ajlm-2895	76	17	mrsa	mrsa	NOUN
ajlm-2895	76	18	at	at	ADP
ajlm-2895	76	19	9	9	NUM
ajlm-2895	76	20	%	%	NOUN
ajlm-2895	76	21	,	,	PUNCT
ajlm-2895	76	22	and	and	CCONJ
ajlm-2895	76	23	k.	k.	PROPN
ajlm-2895	76	24	oxytoca	oxytoca	PROPN
ajlm-2895	76	25	at	at	ADP
ajlm-2895	76	26	5	5	NUM
ajlm-2895	76	27	%	%	NOUN
ajlm-2895	76	28	.	.	PUNCT
ajlm-2895	77	1	figure	figure	VERB
ajlm-2895	77	2	2	2	NUM
ajlm-2895	77	3	:	:	PUNCT
ajlm-2895	77	4	distribution	distribution	NOUN
ajlm-2895	77	5	of	of	ADP
ajlm-2895	77	6	multidrug	multidrug	NOUN
ajlm-2895	77	7	-	-	PUNCT
ajlm-2895	77	8	resistant	resistant	ADJ
ajlm-2895	77	9	bacteria	bacteria	NOUN
ajlm-2895	77	10	according	accord	VERB
ajlm-2895	77	11	to	to	ADP
ajlm-2895	77	12	bacterial	bacterial	ADJ
ajlm-2895	77	13	species	specie	NOUN
ajlm-2895	77	14	,	,	PUNCT
ajlm-2895	77	15	sourô	sourô	PROPN
ajlm-2895	77	16	sanou	sanou	NOUN
ajlm-2895	77	17	university	university	NOUN
ajlm-2895	77	18	teaching	teaching	NOUN
ajlm-2895	77	19	hospital	hospital	NOUN
ajlm-2895	77	20	in	in	ADP
ajlm-2895	77	21	bobo	bobo	NOUN
ajlm-2895	77	22	-	-	PUNCT
ajlm-2895	77	23	dioulasso	dioulasso	PROPN
ajlm-2895	77	24	,	,	PUNCT
ajlm-2895	77	25	burkina	burkina	PROPN
ajlm-2895	77	26	faso	faso	PROPN
ajlm-2895	77	27	,	,	PUNCT
ajlm-2895	77	28	01	01	NUM
ajlm-2895	77	29	june	june	PROPN
ajlm-2895	77	30	2022	2022	NUM
ajlm-2895	77	31	–	–	PUNCT
ajlm-2895	77	32	31	31	NUM
ajlm-2895	77	33	august	august	PROPN
ajlm-2895	77	34	2022	2022	NUM
ajlm-2895	77	35	(	(	PUNCT
ajlm-2895	77	36	n	n	NOUN
ajlm-2895	77	37	=	=	SYM
ajlm-2895	77	38	117	117	NUM
ajlm-2895	77	39	)	)	PUNCT
ajlm-2895	77	40	.	.	PUNCT
ajlm-2895	78	1	distribution	distribution	NOUN
ajlm-2895	78	2	of	of	ADP
ajlm-2895	78	3	multidrug	multidrug	NOUN
ajlm-2895	78	4	-	-	PUNCT
ajlm-2895	78	5	resistant	resistant	ADJ
ajlm-2895	78	6	bacteria	bacteria	NOUN
ajlm-2895	78	7	according	accord	VERB
ajlm-2895	78	8	to	to	ADP
ajlm-2895	78	9	resistance	resistance	NOUN
ajlm-2895	78	10	phenotypes	phenotype	NOUN
ajlm-2895	78	11	out	out	ADP
ajlm-2895	78	12	of	of	ADP
ajlm-2895	78	13	the	the	DET
ajlm-2895	78	14	117	117	NUM
ajlm-2895	78	15	mdrbs	mdrb	NOUN
ajlm-2895	78	16	isolated	isolate	VERB
ajlm-2895	78	17	,	,	PUNCT
ajlm-2895	78	18	the	the	DET
ajlm-2895	78	19	most	most	ADV
ajlm-2895	78	20	predominant	predominant	ADJ
ajlm-2895	78	21	phenotype	phenotype	NOUN
ajlm-2895	78	22	was	be	AUX
ajlm-2895	78	23	esbl	esbl	NOUN
ajlm-2895	78	24	-	-	PUNCT
ajlm-2895	78	25	producing	produce	VERB
ajlm-2895	78	26	enterobacterales	enterobacterale	NOUN
ajlm-2895	78	27	(	(	PUNCT
ajlm-2895	78	28	58	58	NUM
ajlm-2895	78	29	%	%	NOUN
ajlm-2895	78	30	)	)	PUNCT
ajlm-2895	78	31	,	,	PUNCT
ajlm-2895	78	32	including	include	VERB
ajlm-2895	78	33	e.	e.	PROPN
ajlm-2895	78	34	coli	coli	PROPN
ajlm-2895	78	35	(	(	PUNCT
ajlm-2895	78	36	72.58	72.58	NUM
ajlm-2895	78	37	%	%	NOUN
ajlm-2895	78	38	)	)	PUNCT
ajlm-2895	78	39	,	,	PUNCT
ajlm-2895	78	40	followed	follow	VERB
ajlm-2895	78	41	by	by	ADP
ajlm-2895	78	42	k.	k.	PROPN
ajlm-2895	78	43	pneumoniae	pneumoniae	NOUN
ajlm-2895	78	44	with	with	ADP
ajlm-2895	78	45	67	67	NUM
ajlm-2895	78	46	%	%	NOUN
ajlm-2895	78	47	.	.	PUNCT
ajlm-2895	79	1	the	the	DET
ajlm-2895	79	2	resistance	resistance	NOUN
ajlm-2895	79	3	phenotypes	phenotype	NOUN
ajlm-2895	79	4	to	to	ADP
ajlm-2895	79	5	carbapenems	carbapenem	NOUN
ajlm-2895	79	6	(	(	PUNCT
ajlm-2895	79	7	crs	crs	PROPN
ajlm-2895	79	8	)	)	PUNCT
ajlm-2895	79	9	represented	represent	VERB
ajlm-2895	79	10	37	37	NUM
ajlm-2895	79	11	%	%	NOUN
ajlm-2895	79	12	(	(	PUNCT
ajlm-2895	79	13	p	p	X
ajlm-2895	79	14	<	<	X
ajlm-2895	79	15	0.001	0.001	NUM
ajlm-2895	79	16	;	;	PUNCT
ajlm-2895	79	17	esbl	esbl	NOUN
ajlm-2895	79	18	-	-	PUNCT
ajlm-2895	79	19	e	e	NOUN
ajlm-2895	79	20	versus	versus	ADP
ajlm-2895	79	21	crs	crs	PROPN
ajlm-2895	79	22	)	)	PUNCT
ajlm-2895	79	23	.	.	PUNCT
ajlm-2895	80	1	all	all	DET
ajlm-2895	80	2	strains	strain	NOUN
ajlm-2895	80	3	of	of	ADP
ajlm-2895	80	4	a.	a.	NOUN
ajlm-2895	80	5	baumannii	baumannii	PROPN
ajlm-2895	80	6	(	(	PUNCT
ajlm-2895	80	7	n	n	NOUN
ajlm-2895	80	8	=	=	SYM
ajlm-2895	80	9	15	15	NUM
ajlm-2895	80	10	)	)	PUNCT
ajlm-2895	80	11	were	be	AUX
ajlm-2895	80	12	resistant	resistant	ADJ
ajlm-2895	80	13	to	to	ADP
ajlm-2895	80	14	carbapenems	carbapenem	NOUN
ajlm-2895	80	15	.	.	PUNCT
ajlm-2895	81	1	for	for	ADP
ajlm-2895	81	2	mrsa	mrsa	NOUN
ajlm-2895	81	3	,	,	PUNCT
ajlm-2895	81	4	nine	nine	NUM
ajlm-2895	81	5	strains	strain	NOUN
ajlm-2895	81	6	were	be	AUX
ajlm-2895	81	7	isolated	isolate	VERB
ajlm-2895	81	8	,	,	PUNCT
ajlm-2895	81	9	as	as	SCONJ
ajlm-2895	81	10	detailed	detailed	ADJ
ajlm-2895	81	11	in	in	ADP
ajlm-2895	81	12	table	table	NOUN
ajlm-2895	81	13	1	1	NUM
ajlm-2895	81	14	.	.	PUNCT
ajlm-2895	81	15	table	table	NOUN
ajlm-2895	81	16	1	1	NUM
ajlm-2895	81	17	:	:	PUNCT
ajlm-2895	81	18	 	 	SPACE
ajlm-2895	81	19	identification	identification	NOUN
ajlm-2895	81	20	and	and	CCONJ
ajlm-2895	81	21	distribution	distribution	NOUN
ajlm-2895	81	22	of	of	ADP
ajlm-2895	81	23	multidrug	multidrug	NOUN
ajlm-2895	81	24	-	-	PUNCT
ajlm-2895	81	25	resistant	resistant	ADJ
ajlm-2895	81	26	bacteria	bacteria	NOUN
ajlm-2895	81	27	according	accord	VERB
ajlm-2895	81	28	to	to	ADP
ajlm-2895	81	29	resistance	resistance	NOUN
ajlm-2895	81	30	phenotypes	phenotype	NOUN
ajlm-2895	81	31	,	,	PUNCT
ajlm-2895	81	32	sourô	sourô	PROPN
ajlm-2895	81	33	sanou	sanou	NOUN
ajlm-2895	81	34	university	university	NOUN
ajlm-2895	81	35	teaching	teaching	NOUN
ajlm-2895	81	36	hospital	hospital	NOUN
ajlm-2895	81	37	in	in	ADP
ajlm-2895	81	38	bobo	bobo	NOUN
ajlm-2895	81	39	-	-	PUNCT
ajlm-2895	81	40	dioulasso	dioulasso	PROPN
ajlm-2895	81	41	,	,	PUNCT
ajlm-2895	81	42	burkina	burkina	PROPN
ajlm-2895	81	43	faso	faso	PROPN
ajlm-2895	81	44	,	,	PUNCT
ajlm-2895	81	45	01	01	NUM
ajlm-2895	81	46	june	june	PROPN
ajlm-2895	81	47	2022	2022	NUM
ajlm-2895	81	48	–	–	PUNCT
ajlm-2895	81	49	31	31	NUM
ajlm-2895	81	50	august	august	PROPN
ajlm-2895	81	51	2022	2022	NUM
ajlm-2895	81	52	(	(	PUNCT
ajlm-2895	81	53	n	n	NOUN
ajlm-2895	81	54	=	=	SYM
ajlm-2895	81	55	117	117	NUM
ajlm-2895	81	56	)	)	PUNCT
ajlm-2895	81	57	.	.	PUNCT
ajlm-2895	82	1	in	in	ADP
ajlm-2895	82	2	vitro	vitro	X
ajlm-2895	82	3	activity	activity	NOUN
ajlm-2895	82	4	of	of	ADP
ajlm-2895	82	5	tigecycline	tigecycline	NOUN
ajlm-2895	82	6	on	on	ADP
ajlm-2895	82	7	multidrug	multidrug	NOUN
ajlm-2895	82	8	-	-	PUNCT
ajlm-2895	82	9	resistant	resistant	ADJ
ajlm-2895	82	10	bacteria	bacteria	NOUN
ajlm-2895	82	11	species	specie	VERB
ajlm-2895	82	12	nine	nine	NUM
ajlm-2895	82	13	strains	strain	NOUN
ajlm-2895	82	14	of	of	ADP
ajlm-2895	82	15	enterobacterales	enterobacterale	NOUN
ajlm-2895	82	16	,	,	PUNCT
ajlm-2895	82	17	including	include	VERB
ajlm-2895	82	18	6	6	NUM
ajlm-2895	82	19	(	(	PUNCT
ajlm-2895	82	20	66.67	66.67	NUM
ajlm-2895	82	21	%	%	NOUN
ajlm-2895	82	22	)	)	PUNCT
ajlm-2895	82	23	e.	e.	PROPN
ajlm-2895	82	24	coli	coli	PROPN
ajlm-2895	82	25	(	(	PUNCT
ajlm-2895	82	26	2	2	NUM
ajlm-2895	82	27	esbls	esbls	NOUN
ajlm-2895	82	28	and	and	CCONJ
ajlm-2895	82	29	4	4	NUM
ajlm-2895	82	30	crs	crs	PROPN
ajlm-2895	82	31	)	)	PUNCT
ajlm-2895	82	32	and	and	CCONJ
ajlm-2895	82	33	3	3	NUM
ajlm-2895	82	34	(	(	PUNCT
ajlm-2895	82	35	33.33	33.33	NUM
ajlm-2895	82	36	%	%	NOUN
ajlm-2895	82	37	)	)	PUNCT
ajlm-2895	83	1	k.	k.	PROPN
ajlm-2895	83	2	pneumoniae	pneumoniae	ADJ
ajlm-2895	83	3	(	(	PUNCT
ajlm-2895	83	4	1	1	NUM
ajlm-2895	83	5	esbl	esbl	NOUN
ajlm-2895	83	6	and	and	CCONJ
ajlm-2895	83	7	2	2	NUM
ajlm-2895	83	8	crs	crs	PROPN
ajlm-2895	83	9	)	)	PUNCT
ajlm-2895	83	10	,	,	PUNCT
ajlm-2895	83	11	exhibited	exhibit	VERB
ajlm-2895	83	12	resistance	resistance	NOUN
ajlm-2895	83	13	to	to	ADP
ajlm-2895	83	14	tigecycline	tigecycline	VERB
ajlm-2895	83	15	.	.	PUNCT
ajlm-2895	84	1	other	other	ADJ
ajlm-2895	84	2	enterobacteria	enterobacteria	NOUN
ajlm-2895	84	3	,	,	PUNCT
ajlm-2895	84	4	k.	k.	PROPN
ajlm-2895	84	5	oxytoca	oxytoca	PROPN
ajlm-2895	84	6	,	,	PUNCT
ajlm-2895	84	7	raoultella	raoultella	NOUN
ajlm-2895	84	8	terrigena	terrigena	NOUN
ajlm-2895	84	9	,	,	PUNCT
ajlm-2895	84	10	and	and	CCONJ
ajlm-2895	84	11	serratia	serratia	PROPN
ajlm-2895	84	12	marcescens	marcescen	NOUN
ajlm-2895	84	13	,	,	PUNCT
ajlm-2895	84	14	were	be	AUX
ajlm-2895	84	15	all	all	ADV
ajlm-2895	84	16	susceptible	susceptible	ADJ
ajlm-2895	84	17	to	to	ADP
ajlm-2895	84	18	tigecycline	tigecycline	ADJ
ajlm-2895	84	19	.	.	PUNCT
ajlm-2895	85	1	considering	consider	VERB
ajlm-2895	85	2	the	the	DET
ajlm-2895	85	3	strains	strain	NOUN
ajlm-2895	85	4	of	of	ADP
ajlm-2895	85	5	a.	a.	NOUN
ajlm-2895	85	6	baumannii	baumannii	PROPN
ajlm-2895	85	7	,	,	PUNCT
ajlm-2895	85	8	66.67	66.67	NUM
ajlm-2895	85	9	%	%	NOUN
ajlm-2895	85	10	(	(	PUNCT
ajlm-2895	85	11	10/15	10/15	NUM
ajlm-2895	85	12	)	)	PUNCT
ajlm-2895	85	13	were	be	AUX
ajlm-2895	85	14	susceptible	susceptible	ADJ
ajlm-2895	85	15	to	to	ADP
ajlm-2895	85	16	tigecycline	tigecycline	VERB
ajlm-2895	85	17	.	.	PUNCT
ajlm-2895	86	1	there	there	PRON
ajlm-2895	86	2	was	be	VERB
ajlm-2895	86	3	no	no	DET
ajlm-2895	86	4	statistically	statistically	ADV
ajlm-2895	86	5	significant	significant	ADJ
ajlm-2895	86	6	difference	difference	NOUN
ajlm-2895	86	7	in	in	ADP
ajlm-2895	86	8	the	the	DET
ajlm-2895	86	9	distribution	distribution	NOUN
ajlm-2895	86	10	of	of	ADP
ajlm-2895	86	11	in	in	ADP
ajlm-2895	86	12	vitro	vitro	X
ajlm-2895	86	13	activity	activity	NOUN
ajlm-2895	86	14	of	of	ADP
ajlm-2895	86	15	tigecycline	tigecycline	NOUN
ajlm-2895	86	16	on	on	ADP
ajlm-2895	86	17	mdrbs	mdrb	NOUN
ajlm-2895	86	18	species	specie	NOUN
ajlm-2895	86	19	(	(	PUNCT
ajlm-2895	86	20	p	p	X
ajlm-2895	86	21	>	>	X
ajlm-2895	86	22	0.32	0.32	NUM
ajlm-2895	86	23	)	)	PUNCT
ajlm-2895	86	24	,	,	PUNCT
ajlm-2895	86	25	as	as	SCONJ
ajlm-2895	86	26	detailed	detailed	ADJ
ajlm-2895	86	27	in	in	ADP
ajlm-2895	86	28	table	table	NOUN
ajlm-2895	86	29	2	2	NUM
ajlm-2895	86	30	.	.	PUNCT
ajlm-2895	86	31	table	table	NOUN
ajlm-2895	86	32	2	2	NUM
ajlm-2895	86	33	:	:	PUNCT
ajlm-2895	86	34	 	 	SPACE
ajlm-2895	86	35	tigecycline	tigecycline	NOUN
ajlm-2895	86	36	activity	activity	NOUN
ajlm-2895	86	37	according	accord	VERB
ajlm-2895	86	38	to	to	ADP
ajlm-2895	86	39	multidrug	multidrug	NOUN
ajlm-2895	86	40	-	-	PUNCT
ajlm-2895	86	41	resistant	resistant	ADJ
ajlm-2895	86	42	bacteria	bacteria	NOUN
ajlm-2895	86	43	species	specie	NOUN
ajlm-2895	86	44	,	,	PUNCT
ajlm-2895	86	45	sourô	sourô	PROPN
ajlm-2895	86	46	sanou	sanou	NOUN
ajlm-2895	86	47	university	university	NOUN
ajlm-2895	86	48	teaching	teaching	NOUN
ajlm-2895	86	49	hospital	hospital	NOUN
ajlm-2895	86	50	in	in	ADP
ajlm-2895	86	51	bobo	bobo	NOUN
ajlm-2895	86	52	-	-	PUNCT
ajlm-2895	86	53	dioulasso	dioulasso	PROPN
ajlm-2895	86	54	,	,	PUNCT
ajlm-2895	86	55	burkina	burkina	PROPN
ajlm-2895	86	56	faso	faso	PROPN
ajlm-2895	86	57	,	,	PUNCT
ajlm-2895	86	58	01	01	NUM
ajlm-2895	86	59	june	june	PROPN
ajlm-2895	86	60	2022	2022	NUM
ajlm-2895	86	61	–	–	PUNCT
ajlm-2895	86	62	31	31	NUM
ajlm-2895	86	63	august	august	PROPN
ajlm-2895	86	64	2022	2022	NUM
ajlm-2895	86	65	.	.	PUNCT
ajlm-2895	87	1	tigecycline	tigecycline	ADJ
ajlm-2895	87	2	activity	activity	NOUN
ajlm-2895	87	3	against	against	ADP
ajlm-2895	87	4	resistance	resistance	NOUN
ajlm-2895	87	5	phenotypes	phenotype	NOUN
ajlm-2895	87	6	out	out	ADP
ajlm-2895	87	7	of	of	ADP
ajlm-2895	87	8	117	117	NUM
ajlm-2895	87	9	antibiotic	antibiotic	ADJ
ajlm-2895	87	10	-	-	PUNCT
ajlm-2895	87	11	resistant	resistant	ADJ
ajlm-2895	87	12	bacterial	bacterial	ADJ
ajlm-2895	87	13	isolates	isolate	NOUN
ajlm-2895	87	14	,	,	PUNCT
ajlm-2895	87	15	the	the	DET
ajlm-2895	87	16	overall	overall	ADJ
ajlm-2895	87	17	activity	activity	NOUN
ajlm-2895	87	18	of	of	ADP
ajlm-2895	87	19	tigecycline	tigecycline	NOUN
ajlm-2895	87	20	on	on	ADP
ajlm-2895	87	21	all	all	DET
ajlm-2895	87	22	mdrbs	mdrb	NOUN
ajlm-2895	87	23	was	be	AUX
ajlm-2895	87	24	95.33	95.33	NUM
ajlm-2895	87	25	%	%	NOUN
ajlm-2895	87	26	(	(	PUNCT
ajlm-2895	87	27	102/117	102/117	NUM
ajlm-2895	87	28	)	)	PUNCT
ajlm-2895	87	29	with	with	ADP
ajlm-2895	87	30	p	p	NOUN
ajlm-2895	87	31	-	-	PUNCT
ajlm-2895	87	32	value	value	NOUN
ajlm-2895	87	33	<	<	X
ajlm-2895	87	34	0.002	0.002	NUM
ajlm-2895	87	35	.	.	PUNCT
ajlm-2895	88	1	out	out	ADP
ajlm-2895	88	2	of	of	ADP
ajlm-2895	88	3	the	the	DET
ajlm-2895	88	4	68	68	NUM
ajlm-2895	88	5	esbl	esbl	NOUN
ajlm-2895	88	6	-	-	PUNCT
ajlm-2895	88	7	e	e	NOUN
ajlm-2895	88	8	strains	strain	NOUN
ajlm-2895	88	9	,	,	PUNCT
ajlm-2895	88	10	tigecycline	tigecycline	PROPN
ajlm-2895	88	11	was	be	AUX
ajlm-2895	88	12	active	active	ADJ
ajlm-2895	88	13	against	against	ADP
ajlm-2895	88	14	65	65	NUM
ajlm-2895	88	15	(	(	PUNCT
ajlm-2895	88	16	95.59	95.59	NUM
ajlm-2895	88	17	%	%	NOUN
ajlm-2895	88	18	)	)	PUNCT
ajlm-2895	88	19	of	of	ADP
ajlm-2895	88	20	total	total	ADJ
ajlm-2895	88	21	strains	strain	NOUN
ajlm-2895	88	22	.	.	PUNCT
ajlm-2895	89	1	considering	consider	VERB
ajlm-2895	89	2	the	the	DET
ajlm-2895	89	3	40	40	NUM
ajlm-2895	89	4	crs	crs	PROPN
ajlm-2895	89	5	strains	strain	NOUN
ajlm-2895	89	6	,	,	PUNCT
ajlm-2895	89	7	29	29	NUM
ajlm-2895	89	8	(	(	PUNCT
ajlm-2895	89	9	72.50	72.50	NUM
ajlm-2895	89	10	%	%	NOUN
ajlm-2895	89	11	)	)	PUNCT
ajlm-2895	89	12	were	be	AUX
ajlm-2895	89	13	susceptible	susceptible	ADJ
ajlm-2895	89	14	to	to	ADP
ajlm-2895	89	15	tigecycline	tigecycline	VERB
ajlm-2895	89	16	.	.	PUNCT
ajlm-2895	90	1	of	of	ADP
ajlm-2895	90	2	the	the	DET
ajlm-2895	90	3	nine	nine	NUM
ajlm-2895	90	4	mrsa	mrsa	NOUN
ajlm-2895	90	5	isolated	isolate	VERB
ajlm-2895	90	6	,	,	PUNCT
ajlm-2895	90	7	only	only	ADV
ajlm-2895	90	8	one	one	NUM
ajlm-2895	90	9	strain	strain	NOUN
ajlm-2895	90	10	was	be	AUX
ajlm-2895	90	11	resistant	resistant	ADJ
ajlm-2895	90	12	.	.	PUNCT
ajlm-2895	91	1	the	the	DET
ajlm-2895	91	2	activity	activity	NOUN
ajlm-2895	91	3	of	of	ADP
ajlm-2895	91	4	tigecycline	tigecycline	NOUN
ajlm-2895	91	5	against	against	ADP
ajlm-2895	91	6	resistance	resistance	NOUN
ajlm-2895	91	7	phenotypes	phenotype	NOUN
ajlm-2895	91	8	were	be	AUX
ajlm-2895	91	9	described	describe	VERB
ajlm-2895	91	10	in	in	ADP
ajlm-2895	91	11	table	table	NOUN
ajlm-2895	91	12	3	3	NUM
ajlm-2895	91	13	.	.	PUNCT
ajlm-2895	91	14	table	table	NOUN
ajlm-2895	91	15	3	3	NUM
ajlm-2895	91	16	:	:	PUNCT
ajlm-2895	91	17	 	 	SPACE
ajlm-2895	91	18	activity	activity	NOUN
ajlm-2895	91	19	of	of	ADP
ajlm-2895	91	20	tigecycline	tigecycline	NOUN
ajlm-2895	91	21	against	against	ADP
ajlm-2895	91	22	resistance	resistance	NOUN
ajlm-2895	91	23	phenotypes	phenotype	NOUN
ajlm-2895	91	24	,	,	PUNCT
ajlm-2895	91	25	sourô	sourô	PROPN
ajlm-2895	91	26	sanou	sanou	NOUN
ajlm-2895	91	27	university	university	NOUN
ajlm-2895	91	28	teaching	teaching	NOUN
ajlm-2895	91	29	hospital	hospital	NOUN
ajlm-2895	91	30	in	in	ADP
ajlm-2895	91	31	bobo	bobo	NOUN
ajlm-2895	91	32	-	-	PUNCT
ajlm-2895	91	33	dioulasso	dioulasso	PROPN
ajlm-2895	91	34	,	,	PUNCT
ajlm-2895	91	35	burkina	burkina	PROPN
ajlm-2895	91	36	faso	faso	PROPN
ajlm-2895	91	37	,	,	PUNCT
ajlm-2895	91	38	01	01	NUM
ajlm-2895	91	39	june	june	PROPN
ajlm-2895	91	40	2022	2022	NUM
ajlm-2895	91	41	–	–	PUNCT
ajlm-2895	91	42	31	31	NUM
ajlm-2895	91	43	august	august	PROPN
ajlm-2895	91	44	2022	2022	NUM
ajlm-2895	91	45	(	(	PUNCT
ajlm-2895	91	46	n	n	NOUN
ajlm-2895	91	47	=	=	SYM
ajlm-2895	91	48	117	117	NUM
ajlm-2895	91	49	)	)	PUNCT
ajlm-2895	91	50	.	.	PUNCT
ajlm-2895	92	1	tigecycline	tigecycline	PROPN
ajlm-2895	92	2	activity	activity	NOUN
ajlm-2895	92	3	on	on	ADP
ajlm-2895	92	4	the	the	DET
ajlm-2895	92	5	two	two	NUM
ajlm-2895	92	6	predominant	predominant	ADJ
ajlm-2895	92	7	isolates	isolate	NOUN
ajlm-2895	92	8	of	of	ADP
ajlm-2895	92	9	enterobacterales	enterobacterale	NOUN
ajlm-2895	92	10	(	(	PUNCT
ajlm-2895	92	11	e.	e.	PROPN
ajlm-2895	92	12	coli	coli	PROPN
ajlm-2895	92	13	and	and	CCONJ
ajlm-2895	92	14	klebsiella	klebsiella	PROPN
ajlm-2895	92	15	spp	spp	PROPN
ajlm-2895	92	16	.	.	PUNCT
ajlm-2895	92	17	)	)	PUNCT
ajlm-2895	93	1	resistance	resistance	NOUN
ajlm-2895	93	2	phenotypes	phenotype	NOUN
ajlm-2895	93	3	regarding	regard	VERB
ajlm-2895	93	4	the	the	DET
ajlm-2895	93	5	esbl	esbl	NOUN
ajlm-2895	93	6	-	-	PUNCT
ajlm-2895	93	7	producing	produce	VERB
ajlm-2895	93	8	e.	e.	NOUN
ajlm-2895	93	9	coli	coli	NOUN
ajlm-2895	93	10	clinical	clinical	ADJ
ajlm-2895	93	11	isolates	isolate	NOUN
ajlm-2895	93	12	(	(	PUNCT
ajlm-2895	93	13	45	45	NUM
ajlm-2895	93	14	strains	strain	NOUN
ajlm-2895	93	15	)	)	PUNCT
ajlm-2895	93	16	and	and	CCONJ
ajlm-2895	93	17	the	the	DET
ajlm-2895	93	18	17	17	NUM
ajlm-2895	93	19	carbapenem	carbapenem	NOUN
ajlm-2895	93	20	-	-	PUNCT
ajlm-2895	93	21	resistant	resistant	ADJ
ajlm-2895	93	22	e.	e.	PROPN
ajlm-2895	93	23	coli	coli	NOUN
ajlm-2895	93	24	strains	strain	NOUN
ajlm-2895	93	25	,	,	PUNCT
ajlm-2895	93	26	tigecycline	tigecycline	PROPN
ajlm-2895	93	27	was	be	AUX
ajlm-2895	93	28	active	active	ADJ
ajlm-2895	93	29	in	in	ADP
ajlm-2895	93	30	96	96	NUM
ajlm-2895	93	31	%	%	NOUN
ajlm-2895	93	32	esbl	esbl	NOUN
ajlm-2895	93	33	strains	strain	NOUN
ajlm-2895	93	34	(	(	PUNCT
ajlm-2895	93	35	43/45	43/45	NUM
ajlm-2895	93	36	)	)	PUNCT
ajlm-2895	93	37	,	,	PUNCT
ajlm-2895	93	38	while	while	SCONJ
ajlm-2895	93	39	76	76	NUM
ajlm-2895	93	40	%	%	NOUN
ajlm-2895	93	41	crs	crs	PROPN
ajlm-2895	93	42	were	be	AUX
ajlm-2895	93	43	found	find	VERB
ajlm-2895	93	44	to	to	PART
ajlm-2895	93	45	be	be	AUX
ajlm-2895	93	46	susceptible	susceptible	ADJ
ajlm-2895	93	47	to	to	ADP
ajlm-2895	93	48	tigecycline	tigecycline	PROPN
ajlm-2895	93	49	(	(	PUNCT
ajlm-2895	93	50	13/17	13/17	NUM
ajlm-2895	93	51	)	)	PUNCT
ajlm-2895	93	52	,	,	PUNCT
ajlm-2895	93	53	p	p	X
ajlm-2895	93	54	<	<	X
ajlm-2895	93	55	0.04	0.04	NUM
ajlm-2895	93	56	(	(	PUNCT
ajlm-2895	93	57	figure	figure	NOUN
ajlm-2895	93	58	3	3	NUM
ajlm-2895	93	59	)	)	PUNCT
ajlm-2895	93	60	.	.	PUNCT
ajlm-2895	94	1	figure	figure	VERB
ajlm-2895	94	2	3	3	NUM
ajlm-2895	94	3	:	:	PUNCT
ajlm-2895	94	4	tigecycline	tigecycline	ADJ
ajlm-2895	94	5	activity	activity	NOUN
ajlm-2895	94	6	against	against	ADP
ajlm-2895	94	7	(	(	PUNCT
ajlm-2895	94	8	a	a	PRON
ajlm-2895	94	9	)	)	PUNCT
ajlm-2895	94	10	escherichia	escherichia	NOUN
ajlm-2895	94	11	coli	coli	NOUN
ajlm-2895	94	12	resistance	resistance	NOUN
ajlm-2895	94	13	phenotypes	phenotype	NOUN
ajlm-2895	94	14	(	(	PUNCT
ajlm-2895	94	15	n	n	NOUN
ajlm-2895	94	16	=	=	SYM
ajlm-2895	94	17	62	62	NUM
ajlm-2895	94	18	;	;	PUNCT
ajlm-2895	94	19	p	p	X
ajlm-2895	94	20	<	<	X
ajlm-2895	94	21	0.04	0.04	NUM
ajlm-2895	94	22	)	)	PUNCT
ajlm-2895	94	23	and	and	CCONJ
ajlm-2895	94	24	(	(	PUNCT
ajlm-2895	94	25	b	b	X
ajlm-2895	94	26	)	)	PUNCT
ajlm-2895	94	27	klebsiella	klebsiella	PROPN
ajlm-2895	94	28	spp	spp	PROPN
ajlm-2895	94	29	.	.	PROPN
ajlm-2895	94	30	resistance	resistance	NOUN
ajlm-2895	94	31	phenotypes	phenotype	NOUN
ajlm-2895	94	32	(	(	PUNCT
ajlm-2895	94	33	n	n	NOUN
ajlm-2895	94	34	=	=	SYM
ajlm-2895	94	35	27	27	NUM
ajlm-2895	94	36	;	;	PUNCT
ajlm-2895	94	37	p	p	X
ajlm-2895	94	38	<	<	X
ajlm-2895	94	39	0.1	0.1	NUM
ajlm-2895	94	40	)	)	PUNCT
ajlm-2895	94	41	,	,	PUNCT
ajlm-2895	94	42	sourô	sourô	PROPN
ajlm-2895	94	43	sanou	sanou	PROPN
ajlm-2895	94	44	university	university	NOUN
ajlm-2895	94	45	teaching	teaching	NOUN
ajlm-2895	94	46	hospital	hospital	NOUN
ajlm-2895	94	47	in	in	ADP
ajlm-2895	94	48	bobo	bobo	NOUN
ajlm-2895	94	49	-	-	PUNCT
ajlm-2895	94	50	dioulasso	dioulasso	PROPN
ajlm-2895	94	51	,	,	PUNCT
ajlm-2895	94	52	burkina	burkina	PROPN
ajlm-2895	94	53	faso	faso	PROPN
ajlm-2895	94	54	,	,	PUNCT
ajlm-2895	94	55	01	01	NUM
ajlm-2895	94	56	june	june	PROPN
ajlm-2895	94	57	2022	2022	NUM
ajlm-2895	94	58	–	–	PUNCT
ajlm-2895	94	59	31	31	NUM
ajlm-2895	94	60	august	august	PROPN
ajlm-2895	94	61	2022	2022	NUM
ajlm-2895	94	62	.	.	PUNCT
ajlm-2895	95	1	considering	consider	VERB
ajlm-2895	95	2	the	the	DET
ajlm-2895	95	3	klebsiella	klebsiella	PROPN
ajlm-2895	95	4	spp	spp	PROPN
ajlm-2895	95	5	.	.	PUNCT
ajlm-2895	96	1	clinical	clinical	ADJ
ajlm-2895	96	2	isolates	isolate	NOUN
ajlm-2895	96	3	(	(	PUNCT
ajlm-2895	96	4	27	27	NUM
ajlm-2895	96	5	strains	strain	NOUN
ajlm-2895	96	6	)	)	PUNCT
ajlm-2895	96	7	,	,	PUNCT
ajlm-2895	96	8	and	and	CCONJ
ajlm-2895	96	9	the	the	DET
ajlm-2895	96	10	7	7	NUM
ajlm-2895	96	11	carbapenem	carbapenem	NOUN
ajlm-2895	96	12	-	-	PUNCT
ajlm-2895	96	13	resistant	resistant	ADJ
ajlm-2895	96	14	of	of	ADP
ajlm-2895	96	15	k.	k.	PROPN
ajlm-2895	96	16	strains	strain	NOUN
ajlm-2895	96	17	,	,	PUNCT
ajlm-2895	96	18	tigecycline	tigecycline	PROPN
ajlm-2895	96	19	was	be	AUX
ajlm-2895	96	20	active	active	ADJ
ajlm-2895	96	21	on	on	ADP
ajlm-2895	96	22	20	20	NUM
ajlm-2895	96	23	esbl	esbl	PROPN
ajlm-2895	96	24	klebsiella	klebsiella	PROPN
ajlm-2895	96	25	spp	spp	PROPN
ajlm-2895	96	26	.	.	PUNCT
ajlm-2895	97	1	(	(	PUNCT
ajlm-2895	97	2	14	14	NUM
ajlm-2895	97	3	k.	k.	NOUN
ajlm-2895	97	4	pneumoniae	pneumoniae	NOUN
ajlm-2895	97	5	and	and	CCONJ
ajlm-2895	97	6	6	6	NUM
ajlm-2895	97	7	k.	k.	NOUN
ajlm-2895	97	8	oxytoca	oxytoca	PROPN
ajlm-2895	97	9	)	)	PUNCT
ajlm-2895	98	1	while	while	SCONJ
ajlm-2895	98	2	71	71	NUM
ajlm-2895	98	3	%	%	NOUN
ajlm-2895	98	4	carbapenem	carbapenem	NOUN
ajlm-2895	98	5	-	-	PUNCT
ajlm-2895	98	6	resistant	resistant	ADJ
ajlm-2895	98	7	k.	k.	NOUN
ajlm-2895	98	8	pneumoniae	pneumoniae	NOUN
ajlm-2895	98	9	have	have	AUX
ajlm-2895	98	10	been	be	AUX
ajlm-2895	98	11	found	find	VERB
ajlm-2895	98	12	to	to	PART
ajlm-2895	98	13	be	be	AUX
ajlm-2895	98	14	susceptible	susceptible	ADJ
ajlm-2895	98	15	to	to	ADP
ajlm-2895	98	16	tigecycline	tigecycline	PROPN
ajlm-2895	98	17	(	(	PUNCT
ajlm-2895	98	18	5/7	5/7	NUM
ajlm-2895	98	19	)	)	PUNCT
ajlm-2895	98	20	,	,	PUNCT
ajlm-2895	98	21	p	p	X
ajlm-2895	98	22	<	<	X
ajlm-2895	98	23	0.1	0.1	NUM
ajlm-2895	98	24	(	(	PUNCT
ajlm-2895	98	25	figure	figure	NOUN
ajlm-2895	98	26	3	3	NUM
ajlm-2895	98	27	)	)	PUNCT
ajlm-2895	98	28	.	.	PUNCT
ajlm-2895	99	1	discussion	discussion	NOUN
ajlm-2895	99	2	limited	limit	VERB
ajlm-2895	99	3	treatment	treatment	NOUN
ajlm-2895	99	4	options	option	NOUN
ajlm-2895	99	5	for	for	ADP
ajlm-2895	99	6	mdrbs	mdrb	NOUN
ajlm-2895	99	7	represent	represent	VERB
ajlm-2895	99	8	a	a	DET
ajlm-2895	99	9	serious	serious	ADJ
ajlm-2895	99	10	global	global	ADJ
ajlm-2895	99	11	health	health	NOUN
ajlm-2895	99	12	issue	issue	NOUN
ajlm-2895	99	13	,	,	PUNCT
ajlm-2895	99	14	particularly	particularly	ADV
ajlm-2895	99	15	in	in	ADP
ajlm-2895	99	16	lowand	lowand	ADJ
ajlm-2895	99	17	middle	middle	ADJ
ajlm-2895	99	18	-	-	PUNCT
ajlm-2895	99	19	income	income	NOUN
ajlm-2895	99	20	countries	country	NOUN
ajlm-2895	99	21	that	that	PRON
ajlm-2895	99	22	struggle	struggle	VERB
ajlm-2895	99	23	to	to	PART
ajlm-2895	99	24	access	access	VERB
ajlm-2895	99	25	new	new	ADJ
ajlm-2895	99	26	antibiotics	antibiotic	NOUN
ajlm-2895	99	27	to	to	PART
ajlm-2895	99	28	overcome	overcome	VERB
ajlm-2895	99	29	emerging	emerge	VERB
ajlm-2895	99	30	crs	crs	PROPN
ajlm-2895	99	31	,	,	PUNCT
ajlm-2895	99	32	esbl	esbl	PROPN
ajlm-2895	99	33	-	-	PUNCT
ajlm-2895	99	34	e	e	NOUN
ajlm-2895	99	35	,	,	PUNCT
ajlm-2895	99	36	and	and	CCONJ
ajlm-2895	99	37	mrsa	mrsa	NOUN
ajlm-2895	99	38	infections.8	infections.8	PROPN
ajlm-2895	99	39	in	in	ADP
ajlm-2895	99	40	this	this	DET
ajlm-2895	99	41	context	context	NOUN
ajlm-2895	99	42	,	,	PUNCT
ajlm-2895	99	43	we	we	PRON
ajlm-2895	99	44	carried	carry	VERB
ajlm-2895	99	45	out	out	ADP
ajlm-2895	99	46	this	this	DET
ajlm-2895	99	47	study	study	NOUN
ajlm-2895	99	48	to	to	PART
ajlm-2895	99	49	investigate	investigate	VERB
ajlm-2895	99	50	the	the	DET
ajlm-2895	99	51	in	in	ADV
ajlm-2895	99	52	vitro	vitro	X
ajlm-2895	99	53	activity	activity	NOUN
ajlm-2895	99	54	of	of	ADP
ajlm-2895	99	55	tigecycline	tigecycline	NOUN
ajlm-2895	99	56	against	against	ADP
ajlm-2895	99	57	mdrbs	mdrb	NOUN
ajlm-2895	99	58	and	and	CCONJ
ajlm-2895	99	59	to	to	PART
ajlm-2895	99	60	provide	provide	VERB
ajlm-2895	99	61	local	local	ADJ
ajlm-2895	99	62	data	datum	NOUN
ajlm-2895	99	63	to	to	PART
ajlm-2895	99	64	advocate	advocate	VERB
ajlm-2895	99	65	for	for	ADP
ajlm-2895	99	66	the	the	DET
ajlm-2895	99	67	availability	availability	NOUN
ajlm-2895	99	68	of	of	ADP
ajlm-2895	99	69	tigecycline	tigecycline	NOUN
ajlm-2895	99	70	in	in	ADP
ajlm-2895	99	71	the	the	DET
ajlm-2895	99	72	reserve	reserve	NOUN
ajlm-2895	99	73	antibiotics	antibiotic	NOUN
ajlm-2895	99	74	for	for	ADP
ajlm-2895	99	75	the	the	DET
ajlm-2895	99	76	management	management	NOUN
ajlm-2895	99	77	of	of	ADP
ajlm-2895	99	78	therapeutic	therapeutic	ADJ
ajlm-2895	99	79	impasses	impasse	NOUN
ajlm-2895	99	80	.	.	PUNCT
ajlm-2895	100	1	regarding	regard	VERB
ajlm-2895	100	2	the	the	DET
ajlm-2895	100	3	esbl	esbl	NOUN
ajlm-2895	100	4	-	-	PUNCT
ajlm-2895	100	5	e	e	NOUN
ajlm-2895	100	6	,	,	PUNCT
ajlm-2895	100	7	a	a	DET
ajlm-2895	100	8	high	high	ADJ
ajlm-2895	100	9	rate	rate	NOUN
ajlm-2895	100	10	of	of	ADP
ajlm-2895	100	11	tigecycline	tigecycline	ADJ
ajlm-2895	100	12	activity	activity	NOUN
ajlm-2895	100	13	(	(	PUNCT
ajlm-2895	100	14	96	96	NUM
ajlm-2895	100	15	%	%	NOUN
ajlm-2895	100	16	,	,	PUNCT
ajlm-2895	100	17	65/68	65/68	NUM
ajlm-2895	100	18	)	)	PUNCT
ajlm-2895	100	19	was	be	AUX
ajlm-2895	100	20	observed	observe	VERB
ajlm-2895	100	21	in	in	ADP
ajlm-2895	100	22	this	this	DET
ajlm-2895	100	23	study	study	NOUN
ajlm-2895	100	24	.	.	PUNCT
ajlm-2895	101	1	this	this	PRON
ajlm-2895	101	2	is	be	AUX
ajlm-2895	101	3	similar	similar	ADJ
ajlm-2895	101	4	to	to	ADP
ajlm-2895	101	5	that	that	PRON
ajlm-2895	101	6	reported	report	VERB
ajlm-2895	101	7	in	in	ADP
ajlm-2895	101	8	a	a	DET
ajlm-2895	101	9	systematic	systematic	ADJ
ajlm-2895	101	10	review	review	NOUN
ajlm-2895	101	11	in	in	ADP
ajlm-2895	101	12	which	which	PRON
ajlm-2895	101	13	tigecycline	tigecycline	NOUN
ajlm-2895	101	14	was	be	AUX
ajlm-2895	101	15	microbiologically	microbiologically	ADV
ajlm-2895	101	16	active	active	ADJ
ajlm-2895	101	17	against	against	ADP
ajlm-2895	101	18	the	the	DET
ajlm-2895	101	19	majority	majority	NOUN
ajlm-2895	101	20	of	of	ADP
ajlm-2895	101	21	esbl	esbl	NOUN
ajlm-2895	101	22	-	-	PUNCT
ajlm-2895	101	23	e	e	NOUN
ajlm-2895	101	24	,	,	PUNCT
ajlm-2895	101	25	including	include	VERB
ajlm-2895	101	26	more	more	ADJ
ajlm-2895	101	27	than	than	ADP
ajlm-2895	101	28	99	99	NUM
ajlm-2895	101	29	%	%	NOUN
ajlm-2895	101	30	of	of	ADP
ajlm-2895	101	31	1936	1936	NUM
ajlm-2895	101	32	resistant	resistant	ADJ
ajlm-2895	101	33	e.	e.	PROPN
ajlm-2895	101	34	coli	coli	PROPN
ajlm-2895	101	35	isolates.20	isolates.20	PROPN
ajlm-2895	101	36	in	in	ADP
ajlm-2895	101	37	addition	addition	NOUN
ajlm-2895	101	38	,	,	PUNCT
ajlm-2895	101	39	our	our	PRON
ajlm-2895	101	40	results	result	NOUN
ajlm-2895	101	41	were	be	AUX
ajlm-2895	101	42	consistent	consistent	ADJ
ajlm-2895	101	43	with	with	ADP
ajlm-2895	101	44	those	those	PRON
ajlm-2895	101	45	of	of	ADP
ajlm-2895	101	46	zhang	zhang	PROPN
ajlm-2895	101	47	et	et	PROPN
ajlm-2895	101	48	al.21	al.21	PROPN
ajlm-2895	101	49	in	in	ADP
ajlm-2895	101	50	a	a	DET
ajlm-2895	101	51	global	global	ADJ
ajlm-2895	101	52	study	study	NOUN
ajlm-2895	101	53	on	on	ADP
ajlm-2895	101	54	antimicrobial	antimicrobial	ADJ
ajlm-2895	101	55	susceptibility	susceptibility	NOUN
ajlm-2895	101	56	between	between	ADP
ajlm-2895	101	57	2012	2012	NUM
ajlm-2895	101	58	and	and	CCONJ
ajlm-2895	101	59	2016	2016	NUM
ajlm-2895	101	60	.	.	PUNCT
ajlm-2895	102	1	the	the	DET
ajlm-2895	102	2	authors	author	NOUN
ajlm-2895	102	3	observed	observe	VERB
ajlm-2895	102	4	good	good	ADJ
ajlm-2895	102	5	activity	activity	NOUN
ajlm-2895	102	6	of	of	ADP
ajlm-2895	102	7	tigecycline	tigecycline	NOUN
ajlm-2895	102	8	on	on	ADP
ajlm-2895	102	9	98.4	98.4	NUM
ajlm-2895	102	10	%	%	NOUN
ajlm-2895	102	11	of	of	ADP
ajlm-2895	102	12	e.	e.	PROPN
ajlm-2895	102	13	coli	coli	PROPN
ajlm-2895	102	14	and	and	CCONJ
ajlm-2895	102	15	90.4	90.4	NUM
ajlm-2895	102	16	%	%	NOUN
ajlm-2895	102	17	of	of	ADP
ajlm-2895	102	18	serratia	serratia	NOUN
ajlm-2895	102	19	spp.21	spp.21	PROPN
ajlm-2895	102	20	furthermore	furthermore	ADV
ajlm-2895	102	21	,	,	PUNCT
ajlm-2895	102	22	our	our	PRON
ajlm-2895	102	23	observation	observation	NOUN
ajlm-2895	102	24	was	be	AUX
ajlm-2895	102	25	comparable	comparable	ADJ
ajlm-2895	102	26	with	with	ADP
ajlm-2895	102	27	the	the	DET
ajlm-2895	102	28	finding	finding	NOUN
ajlm-2895	102	29	reported	report	VERB
ajlm-2895	102	30	by	by	ADP
ajlm-2895	102	31	morosini	morosini	PROPN
ajlm-2895	102	32	et	et	PROPN
ajlm-2895	102	33	al	al	PROPN
ajlm-2895	102	34	.	.	PROPN
ajlm-2895	103	1	in	in	ADP
ajlm-2895	103	2	spain	spain	PROPN
ajlm-2895	103	3	(	(	PUNCT
ajlm-2895	103	4	93.7%),22	93.7%),22	NOUN
ajlm-2895	103	5	but	but	CCONJ
ajlm-2895	103	6	higher	high	ADJ
ajlm-2895	103	7	than	than	ADP
ajlm-2895	103	8	the	the	DET
ajlm-2895	103	9	one	one	NOUN
ajlm-2895	103	10	mentioned	mention	VERB
ajlm-2895	103	11	by	by	ADP
ajlm-2895	103	12	bazi	bazi	PROPN
ajlm-2895	103	13	et	et	PROPN
ajlm-2895	103	14	al	al	PROPN
ajlm-2895	103	15	.	.	PROPN
ajlm-2895	104	1	for	for	ADP
ajlm-2895	104	2	the	the	DET
ajlm-2895	104	3	esbl	esbl	NOUN
ajlm-2895	104	4	-	-	PUNCT
ajlm-2895	104	5	e	e	X
ajlm-2895	104	6	(	(	PUNCT
ajlm-2895	104	7	76%).23	76%).23	X
ajlm-2895	104	8	globally	globally	ADV
ajlm-2895	104	9	,	,	PUNCT
ajlm-2895	104	10	tigecycline	tigecycline	NOUN
ajlm-2895	104	11	has	have	AUX
ajlm-2895	104	12	excellent	excellent	ADJ
ajlm-2895	104	13	in	in	ADP
ajlm-2895	104	14	vitro	vitro	X
ajlm-2895	104	15	activity	activity	NOUN
ajlm-2895	104	16	against	against	ADP
ajlm-2895	104	17	almost	almost	ADV
ajlm-2895	104	18	all	all	PRON
ajlm-2895	104	19	esbl	esbl	NOUN
ajlm-2895	104	20	-	-	PUNCT
ajlm-2895	104	21	e.20	e.20	PROPN
ajlm-2895	104	22	this	this	DET
ajlm-2895	104	23	property	property	NOUN
ajlm-2895	104	24	allows	allow	VERB
ajlm-2895	104	25	it	it	PRON
ajlm-2895	104	26	to	to	PART
ajlm-2895	104	27	evade	evade	VERB
ajlm-2895	104	28	many	many	ADJ
ajlm-2895	104	29	common	common	ADJ
ajlm-2895	104	30	resistance	resistance	NOUN
ajlm-2895	104	31	mechanisms	mechanism	NOUN
ajlm-2895	104	32	,	,	PUNCT
ajlm-2895	104	33	making	make	VERB
ajlm-2895	104	34	it	it	PRON
ajlm-2895	104	35	a	a	DET
ajlm-2895	104	36	suitable	suitable	ADJ
ajlm-2895	104	37	alternative	alternative	NOUN
ajlm-2895	104	38	for	for	ADP
ajlm-2895	104	39	the	the	DET
ajlm-2895	104	40	treatment	treatment	NOUN
ajlm-2895	104	41	of	of	ADP
ajlm-2895	104	42	many	many	ADJ
ajlm-2895	104	43	serious	serious	ADJ
ajlm-2895	104	44	and	and	CCONJ
ajlm-2895	104	45	life	life	NOUN
ajlm-2895	104	46	-	-	PUNCT
ajlm-2895	104	47	threatening	threaten	VERB
ajlm-2895	104	48	infections	infection	NOUN
ajlm-2895	104	49	for	for	ADP
ajlm-2895	104	50	which	which	PRON
ajlm-2895	104	51	other	other	ADJ
ajlm-2895	104	52	antibiotics	antibiotic	NOUN
ajlm-2895	104	53	are	be	AUX
ajlm-2895	104	54	no	no	ADV
ajlm-2895	104	55	longer	long	ADV
ajlm-2895	104	56	appropriate.24	appropriate.24	NOUN
ajlm-2895	104	57	as	as	ADP
ajlm-2895	104	58	a	a	DET
ajlm-2895	104	59	result	result	NOUN
ajlm-2895	104	60	,	,	PUNCT
ajlm-2895	104	61	tigecycline	tigecycline	NOUN
ajlm-2895	104	62	might	might	AUX
ajlm-2895	104	63	circumvent	circumvent	VERB
ajlm-2895	104	64	the	the	DET
ajlm-2895	104	65	overuse	overuse	NOUN
ajlm-2895	104	66	of	of	ADP
ajlm-2895	104	67	carbapenems	carbapenem	NOUN
ajlm-2895	104	68	during	during	ADP
ajlm-2895	104	69	the	the	DET
ajlm-2895	104	70	era	era	NOUN
ajlm-2895	104	71	of	of	ADP
ajlm-2895	104	72	mdr	mdr	PROPN
ajlm-2895	104	73	in	in	ADP
ajlm-2895	104	74	esbl	esbl	PROPN
ajlm-2895	104	75	-	-	PUNCT
ajlm-2895	104	76	e	e	PROPN
ajlm-2895	104	77	in	in	ADP
ajlm-2895	104	78	burkina	burkina	PROPN
ajlm-2895	104	79	faso	faso	PROPN
ajlm-2895	104	80	’s	’s	PART
ajlm-2895	104	81	hospitals	hospital	NOUN
ajlm-2895	104	82	,	,	PUNCT
ajlm-2895	104	83	as	as	SCONJ
ajlm-2895	104	84	demonstrated	demonstrate	VERB
ajlm-2895	104	85	in	in	ADP
ajlm-2895	104	86	a	a	DET
ajlm-2895	104	87	previous	previous	ADJ
ajlm-2895	104	88	study	study	NOUN
ajlm-2895	104	89	in	in	ADP
ajlm-2895	104	90	thailand.25	thailand.25	PROPN
ajlm-2895	104	91	considering	consider	VERB
ajlm-2895	104	92	carbapenem	carbapenem	NOUN
ajlm-2895	104	93	-	-	PUNCT
ajlm-2895	104	94	resistant	resistant	ADJ
ajlm-2895	104	95	gram	gram	NOUN
ajlm-2895	104	96	-	-	PUNCT
ajlm-2895	104	97	negative	negative	ADJ
ajlm-2895	104	98	bacteria	bacteria	NOUN
ajlm-2895	104	99	,	,	PUNCT
ajlm-2895	104	100	we	we	PRON
ajlm-2895	104	101	observed	observe	VERB
ajlm-2895	104	102	a	a	DET
ajlm-2895	104	103	susceptibility	susceptibility	NOUN
ajlm-2895	104	104	of	of	ADP
ajlm-2895	104	105	72.5	72.5	NUM
ajlm-2895	104	106	%	%	NOUN
ajlm-2895	104	107	(	(	PUNCT
ajlm-2895	104	108	29/40	29/40	NUM
ajlm-2895	104	109	)	)	PUNCT
ajlm-2895	104	110	to	to	PART
ajlm-2895	104	111	tigecycline	tigecycline	VERB
ajlm-2895	104	112	.	.	PUNCT
ajlm-2895	105	1	this	this	DET
ajlm-2895	105	2	finding	finding	NOUN
ajlm-2895	105	3	is	be	AUX
ajlm-2895	105	4	higher	high	ADJ
ajlm-2895	105	5	than	than	ADP
ajlm-2895	105	6	that	that	PRON
ajlm-2895	105	7	reported	report	VERB
ajlm-2895	105	8	by	by	ADP
ajlm-2895	105	9	bazi	bazi	PROPN
ajlm-2895	105	10	et	et	PROPN
ajlm-2895	105	11	al	al	PROPN
ajlm-2895	105	12	.	.	PROPN
ajlm-2895	106	1	in	in	ADP
ajlm-2895	106	2	morocco,23	morocco,23	NOUN
ajlm-2895	106	3	and	and	CCONJ
ajlm-2895	106	4	others	other	NOUN
ajlm-2895	106	5	in	in	ADP
ajlm-2895	106	6	réunion	réunion	NOUN
ajlm-2895	106	7	island.26	island.26	VERB
ajlm-2895	106	8	the	the	DET
ajlm-2895	106	9	authors	author	NOUN
ajlm-2895	106	10	in	in	ADP
ajlm-2895	106	11	morocco	morocco	PROPN
ajlm-2895	106	12	found	find	VERB
ajlm-2895	106	13	an	an	DET
ajlm-2895	106	14	overall	overall	ADJ
ajlm-2895	106	15	susceptibility	susceptibility	NOUN
ajlm-2895	106	16	rate	rate	NOUN
ajlm-2895	106	17	of	of	ADP
ajlm-2895	106	18	57	57	NUM
ajlm-2895	106	19	%	%	NOUN
ajlm-2895	106	20	of	of	ADP
ajlm-2895	106	21	carbapenem	carbapenem	NOUN
ajlm-2895	106	22	-	-	PUNCT
ajlm-2895	106	23	resistant	resistant	ADJ
ajlm-2895	106	24	gram	gram	NOUN
ajlm-2895	106	25	-	-	PUNCT
ajlm-2895	106	26	negative	negative	ADJ
ajlm-2895	106	27	bacteria	bacteria	NOUN
ajlm-2895	106	28	to	to	PART
ajlm-2895	106	29	tigecycline	tigecycline	VERB
ajlm-2895	106	30	,	,	PUNCT
ajlm-2895	106	31	and	and	CCONJ
ajlm-2895	106	32	those	those	PRON
ajlm-2895	106	33	in	in	ADP
ajlm-2895	106	34	réunion	réunion	NOUN
ajlm-2895	106	35	,	,	PUNCT
ajlm-2895	106	36	67	67	NUM
ajlm-2895	106	37	%	%	NOUN
ajlm-2895	106	38	.	.	PUNCT
ajlm-2895	107	1	these	these	DET
ajlm-2895	107	2	differences	difference	NOUN
ajlm-2895	107	3	could	could	AUX
ajlm-2895	107	4	be	be	AUX
ajlm-2895	107	5	explained	explain	VERB
ajlm-2895	107	6	by	by	ADP
ajlm-2895	107	7	the	the	DET
ajlm-2895	107	8	long	long	ADJ
ajlm-2895	107	9	-	-	PUNCT
ajlm-2895	107	10	term	term	NOUN
ajlm-2895	107	11	routine	routine	ADJ
ajlm-2895	107	12	use	use	NOUN
ajlm-2895	107	13	of	of	ADP
ajlm-2895	107	14	tigecycline	tigecycline	NOUN
ajlm-2895	107	15	in	in	ADP
ajlm-2895	107	16	these	these	DET
ajlm-2895	107	17	countries	country	NOUN
ajlm-2895	107	18	compared	compare	VERB
ajlm-2895	107	19	to	to	ADP
ajlm-2895	107	20	burkina	burkina	PROPN
ajlm-2895	107	21	faso	faso	PROPN
ajlm-2895	107	22	,	,	PUNCT
ajlm-2895	107	23	where	where	SCONJ
ajlm-2895	107	24	it	it	PRON
ajlm-2895	107	25	has	have	AUX
ajlm-2895	107	26	not	not	PART
ajlm-2895	107	27	yet	yet	ADV
ajlm-2895	107	28	been	be	AUX
ajlm-2895	107	29	marketed	market	VERB
ajlm-2895	107	30	.	.	PUNCT
ajlm-2895	108	1	indeed	indeed	ADV
ajlm-2895	108	2	,	,	PUNCT
ajlm-2895	108	3	carbapenem	carbapenem	NOUN
ajlm-2895	108	4	-	-	PUNCT
ajlm-2895	108	5	resistant	resistant	ADJ
ajlm-2895	108	6	gram	gram	NOUN
ajlm-2895	108	7	-	-	PUNCT
ajlm-2895	108	8	negative	negative	ADJ
ajlm-2895	108	9	bacteria	bacteria	NOUN
ajlm-2895	108	10	employ	employ	VERB
ajlm-2895	108	11	several	several	ADJ
ajlm-2895	108	12	resistance	resistance	NOUN
ajlm-2895	108	13	mechanisms	mechanism	NOUN
ajlm-2895	108	14	,	,	PUNCT
ajlm-2895	108	15	including	include	VERB
ajlm-2895	108	16	decreased	decrease	VERB
ajlm-2895	108	17	expression	expression	NOUN
ajlm-2895	108	18	of	of	ADP
ajlm-2895	108	19	outer	outer	ADJ
ajlm-2895	108	20	membrane	membrane	NOUN
ajlm-2895	108	21	porins	porin	NOUN
ajlm-2895	108	22	,	,	PUNCT
ajlm-2895	108	23	modification	modification	NOUN
ajlm-2895	108	24	of	of	ADP
ajlm-2895	108	25	the	the	DET
ajlm-2895	108	26	tigecycline	tigecycline	NOUN
ajlm-2895	108	27	’s	’s	PART
ajlm-2895	108	28	target	target	NOUN
ajlm-2895	108	29	site	site	NOUN
ajlm-2895	108	30	,	,	PUNCT
ajlm-2895	108	31	and	and	CCONJ
ajlm-2895	108	32	overexpression	overexpression	NOUN
ajlm-2895	108	33	of	of	ADP
ajlm-2895	108	34	efflux	efflux	NOUN
ajlm-2895	108	35	pumps	pump	NOUN
ajlm-2895	108	36	to	to	PART
ajlm-2895	108	37	inactivate	inactivate	VERB
ajlm-2895	108	38	tigecycline.27	tigecycline.27	PROPN
ajlm-2895	108	39	therefore	therefore	ADV
ajlm-2895	108	40	,	,	PUNCT
ajlm-2895	108	41	the	the	DET
ajlm-2895	108	42	strength	strength	NOUN
ajlm-2895	108	43	of	of	ADP
ajlm-2895	108	44	the	the	DET
ajlm-2895	108	45	selection	selection	NOUN
ajlm-2895	108	46	pressure	pressure	NOUN
ajlm-2895	108	47	for	for	ADP
ajlm-2895	108	48	tigecycline	tigecycline	NOUN
ajlm-2895	108	49	would	would	AUX
ajlm-2895	108	50	be	be	AUX
ajlm-2895	108	51	an	an	DET
ajlm-2895	108	52	important	important	ADJ
ajlm-2895	108	53	parameter	parameter	NOUN
ajlm-2895	108	54	contributing	contribute	VERB
ajlm-2895	108	55	to	to	ADP
ajlm-2895	108	56	the	the	DET
ajlm-2895	108	57	complexity	complexity	NOUN
ajlm-2895	108	58	of	of	ADP
ajlm-2895	108	59	resistance	resistance	NOUN
ajlm-2895	108	60	evolution	evolution	NOUN
ajlm-2895	108	61	in	in	ADP
ajlm-2895	108	62	localities	locality	NOUN
ajlm-2895	108	63	where	where	SCONJ
ajlm-2895	108	64	it	it	PRON
ajlm-2895	108	65	is	be	AUX
ajlm-2895	108	66	widely	widely	ADV
ajlm-2895	108	67	used.28	used.28	NOUN
ajlm-2895	108	68	regarding	regard	VERB
ajlm-2895	108	69	carbapenem	carbapenem	NOUN
ajlm-2895	108	70	-	-	PUNCT
ajlm-2895	108	71	resistant	resistant	ADJ
ajlm-2895	108	72	enterobacterales	enterobacterale	NOUN
ajlm-2895	108	73	,	,	PUNCT
ajlm-2895	108	74	tigecycline	tigecycline	ADJ
ajlm-2895	108	75	activity	activity	NOUN
ajlm-2895	108	76	was	be	AUX
ajlm-2895	108	77	higher	high	ADJ
ajlm-2895	108	78	with	with	ADP
ajlm-2895	108	79	carbapenem	carbapenem	NOUN
ajlm-2895	108	80	-	-	PUNCT
ajlm-2895	108	81	resistant	resistant	ADJ
ajlm-2895	108	82	e.	e.	PROPN
ajlm-2895	108	83	coli	coli	PROPN
ajlm-2895	108	84	(	(	PUNCT
ajlm-2895	108	85	13/17	13/17	NUM
ajlm-2895	108	86	,	,	PUNCT
ajlm-2895	108	87	76	76	NUM
ajlm-2895	108	88	%	%	NOUN
ajlm-2895	108	89	)	)	PUNCT
ajlm-2895	108	90	than	than	ADP
ajlm-2895	108	91	that	that	PRON
ajlm-2895	108	92	observed	observe	VERB
ajlm-2895	108	93	with	with	ADP
ajlm-2895	108	94	carbapenem	carbapenem	NOUN
ajlm-2895	108	95	-	-	PUNCT
ajlm-2895	108	96	resistant	resistant	ADJ
ajlm-2895	108	97	k.	k.	NOUN
ajlm-2895	108	98	pneumoniae	pneumoniae	NOUN
ajlm-2895	108	99	(	(	PUNCT
ajlm-2895	108	100	crkp	crkp	NOUN
ajlm-2895	108	101	;	;	PUNCT
ajlm-2895	108	102	5/7	5/7	NUM
ajlm-2895	108	103	,	,	PUNCT
ajlm-2895	108	104	71	71	NUM
ajlm-2895	108	105	%	%	NOUN
ajlm-2895	108	106	)	)	PUNCT
ajlm-2895	108	107	,	,	PUNCT
ajlm-2895	108	108	and	and	CCONJ
ajlm-2895	108	109	this	this	DET
ajlm-2895	108	110	observation	observation	NOUN
ajlm-2895	108	111	is	be	AUX
ajlm-2895	108	112	supported	support	VERB
ajlm-2895	108	113	by	by	ADP
ajlm-2895	108	114	numerous	numerous	ADJ
ajlm-2895	108	115	studies.29,30,31	studies.29,30,31	PROPN
ajlm-2895	108	116	for	for	ADP
ajlm-2895	108	117	example	example	NOUN
ajlm-2895	108	118	,	,	PUNCT
ajlm-2895	108	119	fatima	fatima	PROPN
ajlm-2895	108	120	et	et	PROPN
ajlm-2895	108	121	al	al	PROPN
ajlm-2895	108	122	.	.	PROPN
ajlm-2895	109	1	in	in	ADP
ajlm-2895	109	2	pakistan	pakistan	PROPN
ajlm-2895	109	3	reported	report	VERB
ajlm-2895	109	4	a	a	DET
ajlm-2895	109	5	better	well	ADJ
ajlm-2895	109	6	activity	activity	NOUN
ajlm-2895	109	7	of	of	ADP
ajlm-2895	109	8	tigecycline	tigecycline	NOUN
ajlm-2895	109	9	on	on	ADP
ajlm-2895	109	10	97	97	NUM
ajlm-2895	109	11	%	%	NOUN
ajlm-2895	109	12	(	(	PUNCT
ajlm-2895	109	13	34/35	34/35	NUM
ajlm-2895	109	14	)	)	PUNCT
ajlm-2895	109	15	for	for	ADP
ajlm-2895	109	16	carbapenem	carbapenem	NOUN
ajlm-2895	109	17	-	-	PUNCT
ajlm-2895	109	18	resistant	resistant	ADJ
ajlm-2895	109	19	e.	e.	PROPN
ajlm-2895	109	20	coli	coli	NOUN
ajlm-2895	109	21	versus	versus	ADP
ajlm-2895	109	22	86.3	86.3	NUM
ajlm-2895	109	23	%	%	NOUN
ajlm-2895	109	24	(	(	PUNCT
ajlm-2895	109	25	88/102	88/102	NUM
ajlm-2895	109	26	)	)	PUNCT
ajlm-2895	109	27	for	for	ADP
ajlm-2895	109	28	crkp.30	crkp.30	NOUN
ajlm-2895	109	29	the	the	DET
ajlm-2895	109	30	same	same	ADJ
ajlm-2895	109	31	trends	trend	NOUN
ajlm-2895	109	32	were	be	AUX
ajlm-2895	109	33	observed	observe	VERB
ajlm-2895	109	34	by	by	ADP
ajlm-2895	109	35	wang	wang	PROPN
ajlm-2895	109	36	et	et	PROPN
ajlm-2895	109	37	al	al	PROPN
ajlm-2895	109	38	.	.	PROPN
ajlm-2895	110	1	in	in	ADP
ajlm-2895	110	2	china	china	PROPN
ajlm-2895	110	3	,	,	PUNCT
ajlm-2895	110	4	with	with	ADP
ajlm-2895	110	5	significantly	significantly	ADV
ajlm-2895	110	6	higher	high	ADJ
ajlm-2895	110	7	susceptibility	susceptibility	NOUN
ajlm-2895	110	8	rates	rate	NOUN
ajlm-2895	110	9	of	of	ADP
ajlm-2895	110	10	97.73	97.73	NUM
ajlm-2895	110	11	%	%	NOUN
ajlm-2895	110	12	for	for	ADP
ajlm-2895	110	13	carbapenem	carbapenem	NOUN
ajlm-2895	110	14	-	-	PUNCT
ajlm-2895	110	15	resistant	resistant	ADJ
ajlm-2895	110	16	e.	e.	PROPN
ajlm-2895	110	17	coli	coli	NOUN
ajlm-2895	110	18	compared	compare	VERB
ajlm-2895	110	19	to	to	ADP
ajlm-2895	110	20	64.86	64.86	NUM
ajlm-2895	110	21	%	%	NOUN
ajlm-2895	110	22	for	for	ADP
ajlm-2895	110	23	crkp.32	crkp.32	NOUN
ajlm-2895	110	24	likewise	likewise	ADV
ajlm-2895	110	25	,	,	PUNCT
ajlm-2895	110	26	an	an	DET
ajlm-2895	110	27	increasing	increase	VERB
ajlm-2895	110	28	prevalence	prevalence	NOUN
ajlm-2895	110	29	of	of	ADP
ajlm-2895	110	30	crkp	crkp	PROPN
ajlm-2895	110	31	isolates	isolate	NOUN
ajlm-2895	110	32	was	be	AUX
ajlm-2895	110	33	reported	report	VERB
ajlm-2895	110	34	from	from	ADP
ajlm-2895	110	35	china	china	PROPN
ajlm-2895	110	36	to	to	PART
ajlm-2895	110	37	cause	cause	VERB
ajlm-2895	110	38	decreased	decrease	VERB
ajlm-2895	110	39	tigecycline	tigecycline	NOUN
ajlm-2895	110	40	susceptibility.33	susceptibility.33	PROPN
ajlm-2895	110	41	however	however	ADV
ajlm-2895	110	42	,	,	PUNCT
ajlm-2895	110	43	the	the	DET
ajlm-2895	110	44	lower	low	ADJ
ajlm-2895	110	45	susceptibility	susceptibility	NOUN
ajlm-2895	110	46	rates	rate	NOUN
ajlm-2895	110	47	observed	observe	VERB
ajlm-2895	110	48	in	in	ADP
ajlm-2895	110	49	our	our	PRON
ajlm-2895	110	50	study	study	NOUN
ajlm-2895	110	51	compared	compare	VERB
ajlm-2895	110	52	to	to	ADP
ajlm-2895	110	53	others	other	NOUN
ajlm-2895	110	54	may	may	AUX
ajlm-2895	110	55	be	be	AUX
ajlm-2895	110	56	because	because	SCONJ
ajlm-2895	110	57	of	of	ADP
ajlm-2895	110	58	our	our	PRON
ajlm-2895	110	59	small	small	ADJ
ajlm-2895	110	60	sample	sample	NOUN
ajlm-2895	110	61	size.32	size.32	ADJ
ajlm-2895	110	62	regarding	regard	VERB
ajlm-2895	110	63	the	the	DET
ajlm-2895	110	64	efflux	efflux	NOUN
ajlm-2895	110	65	-	-	PUNCT
ajlm-2895	110	66	mediated	mediate	VERB
ajlm-2895	110	67	mechanisms	mechanism	NOUN
ajlm-2895	110	68	in	in	ADP
ajlm-2895	110	69	crkp	crkp	NOUN
ajlm-2895	110	70	,	,	PUNCT
ajlm-2895	110	71	including	include	VERB
ajlm-2895	110	72	high	high	ADJ
ajlm-2895	110	73	expression	expression	NOUN
ajlm-2895	110	74	of	of	ADP
ajlm-2895	110	75	the	the	DET
ajlm-2895	110	76	acrab	acrab	ADJ
ajlm-2895	110	77	-	-	PUNCT
ajlm-2895	110	78	tolc	tolc	ADJ
ajlm-2895	110	79	and	and	CCONJ
ajlm-2895	110	80	oqxab	oqxab	PROPN
ajlm-2895	110	81	efflux	efflux	NOUN
ajlm-2895	110	82	pumps	pump	NOUN
ajlm-2895	110	83	,	,	PUNCT
ajlm-2895	110	84	appears	appear	VERB
ajlm-2895	110	85	to	to	PART
ajlm-2895	110	86	play	play	VERB
ajlm-2895	110	87	a	a	DET
ajlm-2895	110	88	key	key	ADJ
ajlm-2895	110	89	role	role	NOUN
ajlm-2895	110	90	in	in	ADP
ajlm-2895	110	91	tigecycline	tigecycline	ADJ
ajlm-2895	110	92	resistance.34,35	resistance.34,35	NOUN
ajlm-2895	110	93	in	in	ADP
ajlm-2895	110	94	our	our	PRON
ajlm-2895	110	95	study	study	NOUN
ajlm-2895	110	96	,	,	PUNCT
ajlm-2895	110	97	the	the	DET
ajlm-2895	110	98	susceptibility	susceptibility	NOUN
ajlm-2895	110	99	rate	rate	NOUN
ajlm-2895	110	100	for	for	ADP
ajlm-2895	110	101	crab	crab	NOUN
ajlm-2895	110	102	with	with	ADP
ajlm-2895	110	103	tigecycline	tigecycline	NOUN
ajlm-2895	110	104	was	be	AUX
ajlm-2895	110	105	66	66	NUM
ajlm-2895	110	106	%	%	NOUN
ajlm-2895	110	107	.	.	PUNCT
ajlm-2895	111	1	this	this	PRON
ajlm-2895	111	2	is	be	AUX
ajlm-2895	111	3	similar	similar	ADJ
ajlm-2895	111	4	to	to	ADP
ajlm-2895	111	5	those	those	PRON
ajlm-2895	111	6	reported	report	VERB
ajlm-2895	111	7	by	by	ADP
ajlm-2895	111	8	bazi	bazi	PROPN
ajlm-2895	111	9	et	et	PROPN
ajlm-2895	111	10	al	al	PROPN
ajlm-2895	111	11	.	.	PROPN
ajlm-2895	112	1	(	(	PUNCT
ajlm-2895	112	2	66	66	NUM
ajlm-2895	112	3	%	%	NOUN
ajlm-2895	112	4	)	)	PUNCT
ajlm-2895	112	5	in	in	ADP
ajlm-2895	112	6	morocco23	morocco23	NOUN
ajlm-2895	112	7	and	and	CCONJ
ajlm-2895	112	8	by	by	ADP
ajlm-2895	112	9	navon	navon	PROPN
ajlm-2895	112	10	-	-	PUNCT
ajlm-2895	112	11	venezia	venezia	NOUN
ajlm-2895	112	12	,	,	PUNCT
ajlm-2895	112	13	leavitt	leavitt	NOUN
ajlm-2895	112	14	,	,	PUNCT
ajlm-2895	112	15	and	and	CCONJ
ajlm-2895	112	16	carmeli	carmeli	NOUN
ajlm-2895	112	17	(	(	PUNCT
ajlm-2895	112	18	66	66	NUM
ajlm-2895	112	19	%	%	NOUN
ajlm-2895	112	20	)	)	PUNCT
ajlm-2895	112	21	in	in	ADP
ajlm-2895	112	22	israel.36	israel.36	NOUN
ajlm-2895	112	23	however	however	ADV
ajlm-2895	112	24	,	,	PUNCT
ajlm-2895	112	25	our	our	PRON
ajlm-2895	112	26	observation	observation	NOUN
ajlm-2895	112	27	was	be	AUX
ajlm-2895	112	28	lower	low	ADJ
ajlm-2895	112	29	than	than	ADP
ajlm-2895	112	30	that	that	PRON
ajlm-2895	112	31	of	of	ADP
ajlm-2895	112	32	nahid	nahid	PROPN
ajlm-2895	112	33	et	et	PROPN
ajlm-2895	112	34	al	al	PROPN
ajlm-2895	112	35	.	.	PROPN
ajlm-2895	113	1	in	in	ADP
ajlm-2895	113	2	south	south	PROPN
ajlm-2895	113	3	africa	africa	PROPN
ajlm-2895	113	4	.	.	PUNCT
ajlm-2895	114	1	the	the	DET
ajlm-2895	114	2	authors	author	NOUN
ajlm-2895	114	3	reported	report	VERB
ajlm-2895	114	4	a	a	DET
ajlm-2895	114	5	susceptibility	susceptibility	NOUN
ajlm-2895	114	6	of	of	ADP
ajlm-2895	114	7	75.8	75.8	NUM
ajlm-2895	114	8	%	%	NOUN
ajlm-2895	114	9	to	to	PART
ajlm-2895	114	10	tigecycline	tigecycline	VERB
ajlm-2895	114	11	on	on	ADP
ajlm-2895	114	12	crab.37	crab.37	VERB
ajlm-2895	114	13	the	the	DET
ajlm-2895	114	14	lower	low	ADJ
ajlm-2895	114	15	rate	rate	NOUN
ajlm-2895	114	16	of	of	ADP
ajlm-2895	114	17	the	the	DET
ajlm-2895	114	18	susceptibility	susceptibility	NOUN
ajlm-2895	114	19	that	that	PRON
ajlm-2895	114	20	we	we	PRON
ajlm-2895	114	21	found	find	VERB
ajlm-2895	114	22	must	must	AUX
ajlm-2895	114	23	be	be	AUX
ajlm-2895	114	24	counterbalanced	counterbalance	VERB
ajlm-2895	114	25	by	by	ADP
ajlm-2895	114	26	the	the	DET
ajlm-2895	114	27	influence	influence	NOUN
ajlm-2895	114	28	of	of	ADP
ajlm-2895	114	29	culture	culture	NOUN
ajlm-2895	114	30	media	medium	NOUN
ajlm-2895	114	31	and	and	CCONJ
ajlm-2895	114	32	testing	testing	NOUN
ajlm-2895	114	33	technique	technique	NOUN
ajlm-2895	114	34	,	,	PUNCT
ajlm-2895	114	35	which	which	PRON
ajlm-2895	114	36	often	often	ADV
ajlm-2895	114	37	shows	show	VERB
ajlm-2895	114	38	false	false	ADJ
ajlm-2895	114	39	-	-	PUNCT
ajlm-2895	114	40	intermediate	intermediate	ADJ
ajlm-2895	114	41	or	or	CCONJ
ajlm-2895	114	42	false	false	ADJ
ajlm-2895	114	43	-	-	PUNCT
ajlm-2895	114	44	resistant	resistant	ADJ
ajlm-2895	114	45	results	result	NOUN
ajlm-2895	114	46	in	in	ADP
ajlm-2895	114	47	tigecycline	tigecycline	ADJ
ajlm-2895	114	48	susceptibility	susceptibility	NOUN
ajlm-2895	114	49	testing.38	testing.38	PROPN
ajlm-2895	114	50	previous	previous	ADJ
ajlm-2895	114	51	studies	study	NOUN
ajlm-2895	114	52	found	find	VERB
ajlm-2895	114	53	some	some	DET
ajlm-2895	114	54	discrepancies	discrepancy	NOUN
ajlm-2895	114	55	between	between	ADP
ajlm-2895	114	56	different	different	ADJ
ajlm-2895	114	57	antimicrobial	antimicrobial	ADJ
ajlm-2895	114	58	susceptibility	susceptibility	NOUN
ajlm-2895	114	59	testing	testing	NOUN
ajlm-2895	114	60	methods39	methods39	NOUN
ajlm-2895	114	61	and	and	CCONJ
ajlm-2895	114	62	the	the	DET
ajlm-2895	114	63	mha	mha	NOUN
ajlm-2895	114	64	composition	composition	NOUN
ajlm-2895	114	65	(	(	PUNCT
ajlm-2895	114	66	mha	mha	NOUN
ajlm-2895	114	67	from	from	ADP
ajlm-2895	114	68	oxoid	oxoid	PROPN
ajlm-2895	114	69	versus	versus	ADP
ajlm-2895	114	70	mha	mha	PROPN
ajlm-2895	114	71	from	from	ADP
ajlm-2895	114	72	hopebio).40	hopebio).40	PROPN
ajlm-2895	114	73	accordingly	accordingly	ADV
ajlm-2895	114	74	,	,	PUNCT
ajlm-2895	114	75	broth	broth	ADJ
ajlm-2895	114	76	microdilution	microdilution	NOUN
ajlm-2895	114	77	is	be	AUX
ajlm-2895	114	78	the	the	DET
ajlm-2895	114	79	reference	reference	NOUN
ajlm-2895	114	80	method	method	NOUN
ajlm-2895	114	81	for	for	ADP
ajlm-2895	114	82	testing	testing	NOUN
ajlm-2895	114	83	tigecycline	tigecycline	NOUN
ajlm-2895	114	84	susceptibility	susceptibility	NOUN
ajlm-2895	114	85	,	,	PUNCT
ajlm-2895	114	86	and	and	CCONJ
ajlm-2895	114	87	a	a	DET
ajlm-2895	114	88	recent	recent	ADJ
ajlm-2895	114	89	study	study	NOUN
ajlm-2895	114	90	reported	report	VERB
ajlm-2895	114	91	that	that	SCONJ
ajlm-2895	114	92	broth	broth	ADJ
ajlm-2895	114	93	microdilution	microdilution	NOUN
ajlm-2895	114	94	confirmed	confirm	VERB
ajlm-2895	114	95	91	91	NUM
ajlm-2895	114	96	%	%	NOUN
ajlm-2895	114	97	susceptible	susceptible	ADJ
ajlm-2895	114	98	crab	crab	NOUN
ajlm-2895	114	99	strains	strain	NOUN
ajlm-2895	114	100	to	to	PART
ajlm-2895	114	101	tigecycline	tigecycline	ADV
ajlm-2895	114	102	yielded	yield	VERB
ajlm-2895	114	103	categorical	categorical	ADJ
ajlm-2895	114	104	agreement	agreement	NOUN
ajlm-2895	114	105	of	of	ADP
ajlm-2895	114	106	87.3	87.3	NUM
ajlm-2895	114	107	%	%	NOUN
ajlm-2895	114	108	for	for	ADP
ajlm-2895	114	109	crab	crab	NOUN
ajlm-2895	114	110	with	with	ADP
ajlm-2895	114	111	kb	kb	PROPN
ajlm-2895	114	112	,	,	PUNCT
ajlm-2895	114	113	suggesting	suggest	VERB
ajlm-2895	114	114	that	that	SCONJ
ajlm-2895	114	115	the	the	DET
ajlm-2895	114	116	kb	kb	PROPN
ajlm-2895	114	117	method	method	NOUN
ajlm-2895	114	118	often	often	ADV
ajlm-2895	114	119	shows	show	VERB
ajlm-2895	114	120	false	false	ADJ
ajlm-2895	114	121	-	-	PUNCT
ajlm-2895	114	122	resistant	resistant	ADJ
ajlm-2895	114	123	results.38	results.38	NOUN
ajlm-2895	114	124	in	in	ADP
ajlm-2895	114	125	addition	addition	NOUN
ajlm-2895	114	126	,	,	PUNCT
ajlm-2895	114	127	it	it	PRON
ajlm-2895	114	128	has	have	AUX
ajlm-2895	114	129	been	be	AUX
ajlm-2895	114	130	reported	report	VERB
ajlm-2895	114	131	that	that	SCONJ
ajlm-2895	114	132	disk	disk	NOUN
ajlm-2895	114	133	diffusion	diffusion	NOUN
ajlm-2895	114	134	(	(	PUNCT
ajlm-2895	114	135	used	use	VERB
ajlm-2895	114	136	in	in	ADP
ajlm-2895	114	137	our	our	PRON
ajlm-2895	114	138	study	study	NOUN
ajlm-2895	114	139	)	)	PUNCT
ajlm-2895	114	140	and	and	CCONJ
ajlm-2895	114	141	e	e	X
ajlm-2895	114	142	-	-	NOUN
ajlm-2895	114	143	test	test	NOUN
ajlm-2895	114	144	have	have	VERB
ajlm-2895	114	145	a	a	DET
ajlm-2895	114	146	poor	poor	ADJ
ajlm-2895	114	147	correlation	correlation	NOUN
ajlm-2895	114	148	with	with	ADP
ajlm-2895	114	149	broth	broth	ADJ
ajlm-2895	114	150	microdilution	microdilution	NOUN
ajlm-2895	114	151	as	as	ADP
ajlm-2895	114	152	the	the	DET
ajlm-2895	114	153	reference	reference	NOUN
ajlm-2895	114	154	method	method	NOUN
ajlm-2895	114	155	,	,	PUNCT
ajlm-2895	114	156	especially	especially	ADV
ajlm-2895	114	157	for	for	ADP
ajlm-2895	114	158	a.	a.	NOUN
ajlm-2895	114	159	baumannii	baumannii	PROPN
ajlm-2895	114	160	.	.	PUNCT
ajlm-2895	115	1	the	the	DET
ajlm-2895	115	2	content	content	NOUN
ajlm-2895	115	3	of	of	ADP
ajlm-2895	115	4	manganese	manganese	NOUN
ajlm-2895	115	5	,	,	PUNCT
ajlm-2895	115	6	zinc	zinc	NOUN
ajlm-2895	115	7	,	,	PUNCT
ajlm-2895	115	8	and	and	CCONJ
ajlm-2895	115	9	magnesium	magnesium	NOUN
ajlm-2895	115	10	in	in	ADP
ajlm-2895	115	11	different	different	ADJ
ajlm-2895	115	12	mha	mha	NOUN
ajlm-2895	115	13	may	may	AUX
ajlm-2895	115	14	also	also	ADV
ajlm-2895	115	15	explain	explain	VERB
ajlm-2895	115	16	these	these	DET
ajlm-2895	115	17	discrepancies	discrepancy	NOUN
ajlm-2895	115	18	in	in	ADP
ajlm-2895	115	19	tigecycline	tigecycline	NOUN
ajlm-2895	115	20	inhibition	inhibition	NOUN
ajlm-2895	115	21	diameters.40,41	diameters.40,41	ADV
ajlm-2895	115	22	however	however	ADV
ajlm-2895	115	23	,	,	PUNCT
ajlm-2895	115	24	caution	caution	NOUN
ajlm-2895	115	25	should	should	AUX
ajlm-2895	115	26	be	be	AUX
ajlm-2895	115	27	taken	take	VERB
ajlm-2895	115	28	in	in	ADP
ajlm-2895	115	29	interpreting	interpret	VERB
ajlm-2895	115	30	false	false	ADJ
ajlm-2895	115	31	resistance	resistance	NOUN
ajlm-2895	115	32	phenotypes	phenotype	NOUN
ajlm-2895	115	33	through	through	ADP
ajlm-2895	115	34	the	the	DET
ajlm-2895	115	35	disk	disk	NOUN
ajlm-2895	115	36	diffusion	diffusion	NOUN
ajlm-2895	115	37	assay	assay	VERB
ajlm-2895	115	38	in	in	ADP
ajlm-2895	115	39	our	our	PRON
ajlm-2895	115	40	study	study	NOUN
ajlm-2895	115	41	,	,	PUNCT
ajlm-2895	115	42	which	which	PRON
ajlm-2895	115	43	may	may	AUX
ajlm-2895	115	44	exclude	exclude	VERB
ajlm-2895	115	45	wrong	wrong	ADJ
ajlm-2895	115	46	inhibitory	inhibitory	ADJ
ajlm-2895	115	47	activity	activity	NOUN
ajlm-2895	115	48	of	of	ADP
ajlm-2895	115	49	tigecycline	tigecycline	NOUN
ajlm-2895	115	50	as	as	ADP
ajlm-2895	115	51	the	the	DET
ajlm-2895	115	52	only	only	ADJ
ajlm-2895	115	53	therapeutic	therapeutic	ADJ
ajlm-2895	115	54	option	option	NOUN
ajlm-2895	115	55	in	in	ADP
ajlm-2895	115	56	a	a	DET
ajlm-2895	115	57	field	field	NOUN
ajlm-2895	115	58	where	where	SCONJ
ajlm-2895	115	59	multi	multi	NOUN
ajlm-2895	115	60	-	-	NOUN
ajlm-2895	115	61	resistance	resistance	NOUN
ajlm-2895	115	62	is	be	AUX
ajlm-2895	115	63	predominant.42,43,44	predominant.42,43,44	ADJ
ajlm-2895	115	64	in	in	ADP
ajlm-2895	115	65	cases	case	NOUN
ajlm-2895	115	66	of	of	ADP
ajlm-2895	115	67	resistance	resistance	NOUN
ajlm-2895	115	68	,	,	PUNCT
ajlm-2895	115	69	it	it	PRON
ajlm-2895	115	70	would	would	AUX
ajlm-2895	115	71	be	be	AUX
ajlm-2895	115	72	advisable	advisable	ADJ
ajlm-2895	115	73	to	to	PART
ajlm-2895	115	74	carry	carry	VERB
ajlm-2895	115	75	out	out	ADP
ajlm-2895	115	76	the	the	DET
ajlm-2895	115	77	antimicrobial	antimicrobial	ADJ
ajlm-2895	115	78	susceptibility	susceptibility	NOUN
ajlm-2895	115	79	testing	testing	NOUN
ajlm-2895	115	80	in	in	ADP
ajlm-2895	115	81	a	a	DET
ajlm-2895	115	82	liquid	liquid	ADJ
ajlm-2895	115	83	medium	medium	NOUN
ajlm-2895	115	84	using	use	VERB
ajlm-2895	115	85	the	the	DET
ajlm-2895	115	86	vitek-2	vitek-2	PROPN
ajlm-2895	115	87	compact	compact	ADJ
ajlm-2895	115	88	(	(	PUNCT
ajlm-2895	115	89	biomérieux	biomérieux	PROPN
ajlm-2895	115	90	,	,	PUNCT
ajlm-2895	115	91	marcy	marcy	NOUN
ajlm-2895	115	92	-	-	PUNCT
ajlm-2895	115	93	l’étoile	l’étoile	NOUN
ajlm-2895	115	94	,	,	PUNCT
ajlm-2895	115	95	france)45	france)45	NOUN
ajlm-2895	115	96	to	to	PART
ajlm-2895	115	97	provide	provide	VERB
ajlm-2895	115	98	reliable	reliable	ADJ
ajlm-2895	115	99	results	result	NOUN
ajlm-2895	115	100	to	to	ADP
ajlm-2895	115	101	the	the	DET
ajlm-2895	115	102	clinician	clinician	NOUN
ajlm-2895	115	103	.	.	PUNCT
ajlm-2895	116	1	regarding	regard	VERB
ajlm-2895	116	2	the	the	DET
ajlm-2895	116	3	mrsa	mrsa	NOUN
ajlm-2895	116	4	strains	strain	NOUN
ajlm-2895	116	5	isolated	isolate	VERB
ajlm-2895	116	6	in	in	ADP
ajlm-2895	116	7	our	our	PRON
ajlm-2895	116	8	study	study	NOUN
ajlm-2895	116	9	,	,	PUNCT
ajlm-2895	116	10	we	we	PRON
ajlm-2895	116	11	observed	observe	VERB
ajlm-2895	116	12	that	that	SCONJ
ajlm-2895	116	13	one	one	NUM
ajlm-2895	116	14	(	(	PUNCT
ajlm-2895	116	15	1/9	1/9	NUM
ajlm-2895	116	16	)	)	PUNCT
ajlm-2895	116	17	strain	strain	NOUN
ajlm-2895	116	18	was	be	AUX
ajlm-2895	116	19	resistant	resistant	ADJ
ajlm-2895	116	20	to	to	ADP
ajlm-2895	116	21	tigecycline	tigecycline	NOUN
ajlm-2895	116	22	(	(	PUNCT
ajlm-2895	116	23	11	11	NUM
ajlm-2895	116	24	%	%	NOUN
ajlm-2895	116	25	)	)	PUNCT
ajlm-2895	116	26	.	.	PUNCT
ajlm-2895	117	1	this	this	DET
ajlm-2895	117	2	observation	observation	NOUN
ajlm-2895	117	3	was	be	AUX
ajlm-2895	117	4	consistent	consistent	ADJ
ajlm-2895	117	5	with	with	ADP
ajlm-2895	117	6	the	the	DET
ajlm-2895	117	7	finding	finding	NOUN
ajlm-2895	117	8	of	of	ADP
ajlm-2895	117	9	che	che	PROPN
ajlm-2895	117	10	hamzah	hamzah	PROPN
ajlm-2895	117	11	et	et	PROPN
ajlm-2895	117	12	al	al	PROPN
ajlm-2895	117	13	.	.	PROPN
ajlm-2895	118	1	in	in	ADP
ajlm-2895	118	2	terengganu	terengganu	PROPN
ajlm-2895	118	3	,	,	PUNCT
ajlm-2895	118	4	malaysia	malaysia	PROPN
ajlm-2895	118	5	,	,	PUNCT
ajlm-2895	118	6	who	who	PRON
ajlm-2895	118	7	found	find	VERB
ajlm-2895	118	8	a	a	DET
ajlm-2895	118	9	sensitivity	sensitivity	NOUN
ajlm-2895	118	10	of	of	ADP
ajlm-2895	118	11	94	94	NUM
ajlm-2895	118	12	%	%	NOUN
ajlm-2895	118	13	(	(	PUNCT
ajlm-2895	118	14	85/90	85/90	NUM
ajlm-2895	118	15	)	)	PUNCT
ajlm-2895	118	16	to	to	PART
ajlm-2895	118	17	tigecycline	tigecycline	VERB
ajlm-2895	118	18	on	on	ADP
ajlm-2895	118	19	mrsa.46	mrsa.46	NOUN
ajlm-2895	118	20	by	by	ADP
ajlm-2895	118	21	contrast	contrast	NOUN
ajlm-2895	118	22	,	,	PUNCT
ajlm-2895	118	23	the	the	DET
ajlm-2895	118	24	susceptibility	susceptibility	NOUN
ajlm-2895	118	25	rate	rate	NOUN
ajlm-2895	118	26	that	that	PRON
ajlm-2895	118	27	our	our	PRON
ajlm-2895	118	28	study	study	NOUN
ajlm-2895	118	29	found	find	VERB
ajlm-2895	118	30	(	(	PUNCT
ajlm-2895	118	31	89	89	NUM
ajlm-2895	118	32	%	%	NOUN
ajlm-2895	118	33	)	)	PUNCT
ajlm-2895	118	34	is	be	AUX
ajlm-2895	118	35	lower	low	ADJ
ajlm-2895	118	36	than	than	ADP
ajlm-2895	118	37	that	that	PRON
ajlm-2895	118	38	observed	observe	VERB
ajlm-2895	118	39	by	by	ADP
ajlm-2895	118	40	other	other	ADJ
ajlm-2895	118	41	authors	author	NOUN
ajlm-2895	118	42	who	who	PRON
ajlm-2895	118	43	reported	report	VERB
ajlm-2895	118	44	a	a	DET
ajlm-2895	118	45	high	high	ADJ
ajlm-2895	118	46	susceptibility	susceptibility	NOUN
ajlm-2895	118	47	of	of	ADP
ajlm-2895	118	48	mrsa	mrsa	NOUN
ajlm-2895	118	49	to	to	PART
ajlm-2895	118	50	tigecycline	tigecycline	VERB
ajlm-2895	118	51	(	(	PUNCT
ajlm-2895	118	52	>	>	X
ajlm-2895	118	53	99.9	99.9	NUM
ajlm-2895	118	54	%	%	NOUN
ajlm-2895	118	55	)	)	PUNCT
ajlm-2895	118	56	amongst	amongst	ADP
ajlm-2895	118	57	7098	7098	NUM
ajlm-2895	118	58	s.	s.	PROPN
ajlm-2895	118	59	aureus	aureus	PROPN
ajlm-2895	118	60	isolates.47,48	isolates.47,48	PROPN
ajlm-2895	118	61	similarly	similarly	ADV
ajlm-2895	118	62	,	,	PUNCT
ajlm-2895	118	63	khalili	khalili	PROPN
ajlm-2895	118	64	et	et	PROPN
ajlm-2895	118	65	al	al	PROPN
ajlm-2895	118	66	.	.	PROPN
ajlm-2895	118	67	reported	report	VERB
ajlm-2895	118	68	a	a	DET
ajlm-2895	118	69	susceptibility	susceptibility	NOUN
ajlm-2895	118	70	of	of	ADP
ajlm-2895	118	71	100	100	NUM
ajlm-2895	118	72	%	%	NOUN
ajlm-2895	118	73	on	on	ADP
ajlm-2895	118	74	99	99	NUM
ajlm-2895	118	75	mrsa	mrsa	NOUN
ajlm-2895	118	76	tested	test	VERB
ajlm-2895	118	77	with	with	ADP
ajlm-2895	118	78	the	the	DET
ajlm-2895	118	79	kb	kb	PROPN
ajlm-2895	118	80	method	method	NOUN
ajlm-2895	118	81	in	in	ADP
ajlm-2895	118	82	tehran	tehran	PROPN
ajlm-2895	118	83	,	,	PUNCT
ajlm-2895	118	84	iran.49	iran.49	ADV
ajlm-2895	118	85	however	however	ADV
ajlm-2895	118	86	,	,	PUNCT
ajlm-2895	118	87	the	the	DET
ajlm-2895	118	88	lower	low	ADJ
ajlm-2895	118	89	number	number	NOUN
ajlm-2895	118	90	of	of	ADP
ajlm-2895	118	91	mrsa	mrsa	NOUN
ajlm-2895	118	92	isolates	isolate	NOUN
ajlm-2895	118	93	(	(	PUNCT
ajlm-2895	118	94	<	<	X
ajlm-2895	118	95	30	30	NUM
ajlm-2895	118	96	)	)	PUNCT
ajlm-2895	118	97	and	and	CCONJ
ajlm-2895	118	98	the	the	DET
ajlm-2895	118	99	kb	kb	PROPN
ajlm-2895	118	100	method	method	NOUN
ajlm-2895	118	101	used	use	VERB
ajlm-2895	118	102	in	in	ADP
ajlm-2895	118	103	our	our	PRON
ajlm-2895	118	104	study	study	NOUN
ajlm-2895	118	105	may	may	AUX
ajlm-2895	118	106	reduce	reduce	VERB
ajlm-2895	118	107	the	the	DET
ajlm-2895	118	108	susceptibility	susceptibility	NOUN
ajlm-2895	118	109	rate	rate	NOUN
ajlm-2895	118	110	,	,	PUNCT
ajlm-2895	118	111	which	which	PRON
ajlm-2895	118	112	does	do	AUX
ajlm-2895	118	113	not	not	PART
ajlm-2895	118	114	allow	allow	VERB
ajlm-2895	118	115	us	we	PRON
ajlm-2895	118	116	to	to	PART
ajlm-2895	118	117	draw	draw	VERB
ajlm-2895	118	118	a	a	DET
ajlm-2895	118	119	definitive	definitive	ADJ
ajlm-2895	118	120	conclusion	conclusion	NOUN
ajlm-2895	118	121	about	about	ADP
ajlm-2895	118	122	the	the	DET
ajlm-2895	118	123	activity	activity	NOUN
ajlm-2895	118	124	of	of	ADP
ajlm-2895	118	125	tigecycline	tigecycline	NOUN
ajlm-2895	118	126	on	on	ADP
ajlm-2895	118	127	mrsa	mrsa	NOUN
ajlm-2895	118	128	.	.	PUNCT
ajlm-2895	119	1	despite	despite	SCONJ
ajlm-2895	119	2	the	the	DET
ajlm-2895	119	3	relatively	relatively	ADV
ajlm-2895	119	4	low	low	ADJ
ajlm-2895	119	5	rate	rate	NOUN
ajlm-2895	119	6	of	of	ADP
ajlm-2895	119	7	tigecycline	tigecycline	ADJ
ajlm-2895	119	8	susceptibility	susceptibility	NOUN
ajlm-2895	119	9	on	on	ADP
ajlm-2895	119	10	mrsa	mrsa	NOUN
ajlm-2895	119	11	in	in	ADP
ajlm-2895	119	12	our	our	PRON
ajlm-2895	119	13	study	study	NOUN
ajlm-2895	119	14	compared	compare	VERB
ajlm-2895	119	15	to	to	ADP
ajlm-2895	119	16	others	other	NOUN
ajlm-2895	119	17	,	,	PUNCT
ajlm-2895	119	18	resistance	resistance	NOUN
ajlm-2895	119	19	to	to	ADP
ajlm-2895	119	20	tigecycline	tigecycline	NOUN
ajlm-2895	119	21	is	be	AUX
ajlm-2895	119	22	barely	barely	ADV
ajlm-2895	119	23	found	find	VERB
ajlm-2895	119	24	in	in	ADP
ajlm-2895	119	25	s.	s.	PROPN
ajlm-2895	119	26	aureus	aureus	PROPN
ajlm-2895	119	27	worldwide,47,49,50	worldwide,47,49,50	PROPN
ajlm-2895	119	28	and	and	CCONJ
ajlm-2895	119	29	this	this	DET
ajlm-2895	119	30	molecule	molecule	NOUN
ajlm-2895	119	31	could	could	AUX
ajlm-2895	119	32	be	be	AUX
ajlm-2895	119	33	considered	consider	VERB
ajlm-2895	119	34	as	as	ADP
ajlm-2895	119	35	an	an	DET
ajlm-2895	119	36	alternative	alternative	ADJ
ajlm-2895	119	37	antibiotic	antibiotic	ADJ
ajlm-2895	119	38	for	for	ADP
ajlm-2895	119	39	most	most	ADJ
ajlm-2895	119	40	mrsa	mrsa	NOUN
ajlm-2895	119	41	infections	infection	NOUN
ajlm-2895	119	42	to	to	PART
ajlm-2895	119	43	decrease	decrease	VERB
ajlm-2895	119	44	the	the	DET
ajlm-2895	119	45	risk	risk	NOUN
ajlm-2895	119	46	of	of	ADP
ajlm-2895	119	47	resistance	resistance	NOUN
ajlm-2895	119	48	to	to	ADP
ajlm-2895	119	49	vancomycin	vancomycin	PROPN
ajlm-2895	119	50	,	,	PUNCT
ajlm-2895	119	51	which	which	PRON
ajlm-2895	119	52	remains	remain	VERB
ajlm-2895	119	53	the	the	DET
ajlm-2895	119	54	last	last	ADJ
ajlm-2895	119	55	-	-	PUNCT
ajlm-2895	119	56	resort	resort	NOUN
ajlm-2895	119	57	antibiotic	antibiotic	NOUN
ajlm-2895	119	58	for	for	ADP
ajlm-2895	119	59	the	the	DET
ajlm-2895	119	60	treatment	treatment	NOUN
ajlm-2895	119	61	of	of	ADP
ajlm-2895	119	62	mrsa	mrsa	NOUN
ajlm-2895	119	63	infections	infection	NOUN
ajlm-2895	119	64	.	.	PUNCT
ajlm-2895	120	1	strengths	strength	NOUN
ajlm-2895	120	2	and	and	CCONJ
ajlm-2895	120	3	limitations	limitation	NOUN
ajlm-2895	120	4	this	this	PRON
ajlm-2895	120	5	was	be	AUX
ajlm-2895	120	6	the	the	DET
ajlm-2895	120	7	first	first	ADJ
ajlm-2895	120	8	study	study	NOUN
ajlm-2895	120	9	documented	document	VERB
ajlm-2895	120	10	in	in	ADP
ajlm-2895	120	11	burkina	burkina	PROPN
ajlm-2895	120	12	faso	faso	PROPN
ajlm-2895	120	13	,	,	PUNCT
ajlm-2895	120	14	that	that	PRON
ajlm-2895	120	15	investigated	investigate	VERB
ajlm-2895	120	16	tigecycline	tigecycline	NOUN
ajlm-2895	120	17	activity	activity	NOUN
ajlm-2895	120	18	on	on	ADP
ajlm-2895	120	19	mdrbs	mdrb	NOUN
ajlm-2895	120	20	and	and	CCONJ
ajlm-2895	120	21	could	could	AUX
ajlm-2895	120	22	guide	guide	VERB
ajlm-2895	120	23	public	public	ADJ
ajlm-2895	120	24	health	health	NOUN
ajlm-2895	120	25	policy	policy	NOUN
ajlm-2895	120	26	.	.	PUNCT
ajlm-2895	121	1	this	this	PRON
ajlm-2895	121	2	was	be	AUX
ajlm-2895	121	3	a	a	DET
ajlm-2895	121	4	laboratory	laboratory	NOUN
ajlm-2895	121	5	-	-	PUNCT
ajlm-2895	121	6	based	base	VERB
ajlm-2895	121	7	study	study	NOUN
ajlm-2895	121	8	with	with	ADP
ajlm-2895	121	9	a	a	DET
ajlm-2895	121	10	limited	limited	ADJ
ajlm-2895	121	11	sample	sample	NOUN
ajlm-2895	121	12	size	size	NOUN
ajlm-2895	121	13	and	and	CCONJ
ajlm-2895	121	14	locations	location	NOUN
ajlm-2895	121	15	.	.	PUNCT
ajlm-2895	122	1	it	it	PRON
ajlm-2895	122	2	should	should	AUX
ajlm-2895	122	3	be	be	AUX
ajlm-2895	122	4	supported	support	VERB
ajlm-2895	122	5	by	by	ADP
ajlm-2895	122	6	further	further	ADJ
ajlm-2895	122	7	clinical	clinical	ADJ
ajlm-2895	122	8	evaluations	evaluation	NOUN
ajlm-2895	122	9	of	of	ADP
ajlm-2895	122	10	the	the	DET
ajlm-2895	122	11	efficacy	efficacy	NOUN
ajlm-2895	122	12	and	and	CCONJ
ajlm-2895	122	13	adverse	adverse	ADJ
ajlm-2895	122	14	effects	effect	NOUN
ajlm-2895	122	15	of	of	ADP
ajlm-2895	122	16	tigecycline	tigecycline	NOUN
ajlm-2895	122	17	with	with	ADP
ajlm-2895	122	18	multiple	multiple	ADJ
ajlm-2895	122	19	doses	dose	NOUN
ajlm-2895	122	20	.	.	PUNCT
ajlm-2895	123	1	recommendations	recommendation	NOUN
ajlm-2895	123	2	the	the	DET
ajlm-2895	123	3	authors	author	NOUN
ajlm-2895	123	4	recommend	recommend	VERB
ajlm-2895	123	5	that	that	SCONJ
ajlm-2895	123	6	the	the	DET
ajlm-2895	123	7	direction	direction	NOUN
ajlm-2895	123	8	of	of	ADP
ajlm-2895	123	9	sourô	sourô	PROPN
ajlm-2895	123	10	sanou	sanou	PROPN
ajlm-2895	123	11	university	university	NOUN
ajlm-2895	123	12	teaching	teaching	NOUN
ajlm-2895	123	13	hospital	hospital	NOUN
ajlm-2895	123	14	should	should	AUX
ajlm-2895	123	15	make	make	VERB
ajlm-2895	123	16	tigecycline	tigecycline	ADJ
ajlm-2895	123	17	available	available	ADJ
ajlm-2895	123	18	for	for	ADP
ajlm-2895	123	19	treatment	treatment	NOUN
ajlm-2895	123	20	of	of	ADP
ajlm-2895	123	21	infections	infection	NOUN
ajlm-2895	123	22	caused	cause	VERB
ajlm-2895	123	23	by	by	ADP
ajlm-2895	123	24	esbl	esbl	NOUN
ajlm-2895	123	25	-	-	PUNCT
ajlm-2895	123	26	e	e	NOUN
ajlm-2895	123	27	,	,	PUNCT
ajlm-2895	123	28	carbapenem	carbapenem	NOUN
ajlm-2895	123	29	-	-	PUNCT
ajlm-2895	123	30	resistant	resistant	ADJ
ajlm-2895	123	31	bacteria	bacteria	NOUN
ajlm-2895	123	32	,	,	PUNCT
ajlm-2895	123	33	or	or	CCONJ
ajlm-2895	123	34	mrsa	mrsa	NOUN
ajlm-2895	123	35	strains	strain	VERB
ajlm-2895	123	36	.	.	PUNCT
ajlm-2895	124	1	we	we	PRON
ajlm-2895	124	2	also	also	ADV
ajlm-2895	124	3	request	request	VERB
ajlm-2895	124	4	the	the	DET
ajlm-2895	124	5	hospital	hospital	NOUN
ajlm-2895	124	6	practitioners	practitioner	NOUN
ajlm-2895	124	7	to	to	PART
ajlm-2895	124	8	use	use	VERB
ajlm-2895	124	9	tigecycline	tigecycline	NOUN
ajlm-2895	124	10	as	as	ADP
ajlm-2895	124	11	a	a	DET
ajlm-2895	124	12	reserve	reserve	NOUN
ajlm-2895	124	13	antibiotic	antibiotic	ADJ
ajlm-2895	124	14	to	to	PART
ajlm-2895	124	15	treat	treat	VERB
ajlm-2895	124	16	mdrb	mdrb	NOUN
ajlm-2895	124	17	strains	strain	NOUN
ajlm-2895	124	18	.	.	PUNCT
ajlm-2895	125	1	we	we	PRON
ajlm-2895	125	2	urge	urge	VERB
ajlm-2895	125	3	the	the	DET
ajlm-2895	125	4	other	other	ADJ
ajlm-2895	125	5	hospitals	hospital	NOUN
ajlm-2895	125	6	in	in	ADP
ajlm-2895	125	7	the	the	DET
ajlm-2895	125	8	country	country	NOUN
ajlm-2895	125	9	to	to	PART
ajlm-2895	125	10	conduct	conduct	VERB
ajlm-2895	125	11	their	their	PRON
ajlm-2895	125	12	own	own	ADJ
ajlm-2895	125	13	studies	study	NOUN
ajlm-2895	125	14	to	to	PART
ajlm-2895	125	15	evaluate	evaluate	VERB
ajlm-2895	125	16	the	the	DET
ajlm-2895	125	17	effectiveness	effectiveness	NOUN
ajlm-2895	125	18	of	of	ADP
ajlm-2895	125	19	tigecycline	tigecycline	NOUN
ajlm-2895	125	20	against	against	ADP
ajlm-2895	125	21	clinical	clinical	ADJ
ajlm-2895	125	22	resistant	resistant	ADJ
ajlm-2895	125	23	bacteria	bacteria	NOUN
ajlm-2895	125	24	(	(	PUNCT
ajlm-2895	125	25	esbl	esbl	NOUN
ajlm-2895	125	26	-	-	PUNCT
ajlm-2895	125	27	e	e	PROPN
ajlm-2895	125	28	,	,	PUNCT
ajlm-2895	125	29	crs	crs	NOUN
ajlm-2895	125	30	and	and	CCONJ
ajlm-2895	125	31	mrsa	mrsa	NOUN
ajlm-2895	125	32	)	)	PUNCT
ajlm-2895	125	33	before	before	ADP
ajlm-2895	125	34	considering	consider	VERB
ajlm-2895	125	35	it	it	PRON
ajlm-2895	125	36	as	as	ADP
ajlm-2895	125	37	a	a	DET
ajlm-2895	125	38	reserve	reserve	NOUN
ajlm-2895	125	39	antibiotic	antibiotic	ADJ
ajlm-2895	125	40	.	.	PUNCT
ajlm-2895	126	1	conclusion	conclusion	NOUN
ajlm-2895	126	2	in	in	ADP
ajlm-2895	126	3	this	this	DET
ajlm-2895	126	4	current	current	ADJ
ajlm-2895	126	5	study	study	NOUN
ajlm-2895	126	6	,	,	PUNCT
ajlm-2895	126	7	the	the	DET
ajlm-2895	126	8	activity	activity	NOUN
ajlm-2895	126	9	of	of	ADP
ajlm-2895	126	10	tigecycline	tigecycline	NOUN
ajlm-2895	126	11	was	be	AUX
ajlm-2895	126	12	highly	highly	ADV
ajlm-2895	126	13	effective	effective	ADJ
ajlm-2895	126	14	in	in	ADP
ajlm-2895	126	15	vitro	vitro	X
ajlm-2895	126	16	against	against	ADP
ajlm-2895	126	17	esbl	esbl	NOUN
ajlm-2895	126	18	-	-	PUNCT
ajlm-2895	126	19	e	e	NOUN
ajlm-2895	126	20	and	and	CCONJ
ajlm-2895	126	21	moderate	moderate	ADJ
ajlm-2895	126	22	against	against	ADP
ajlm-2895	126	23	carbapenem	carbapenem	NOUN
ajlm-2895	126	24	-	-	PUNCT
ajlm-2895	126	25	resistant	resistant	ADJ
ajlm-2895	126	26	enterobacterales	enterobacterale	NOUN
ajlm-2895	126	27	and	and	CCONJ
ajlm-2895	126	28	crab	crab	NOUN
ajlm-2895	126	29	and	and	CCONJ
ajlm-2895	126	30	on	on	ADP
ajlm-2895	126	31	mrsa	mrsa	NOUN
ajlm-2895	126	32	.	.	PUNCT
ajlm-2895	127	1	therefore	therefore	ADV
ajlm-2895	127	2	,	,	PUNCT
ajlm-2895	127	3	tigecycline	tigecycline	PROPN
ajlm-2895	127	4	was	be	AUX
ajlm-2895	127	5	recommended	recommend	VERB
ajlm-2895	127	6	as	as	ADP
ajlm-2895	127	7	an	an	DET
ajlm-2895	127	8	option	option	NOUN
ajlm-2895	127	9	for	for	ADP
ajlm-2895	127	10	the	the	DET
ajlm-2895	127	11	treatment	treatment	NOUN
ajlm-2895	127	12	of	of	ADP
ajlm-2895	127	13	mdrb	mdrb	NOUN
ajlm-2895	127	14	infections	infection	NOUN
ajlm-2895	127	15	in	in	ADP
ajlm-2895	127	16	the	the	DET
ajlm-2895	127	17	hospitals	hospital	NOUN
ajlm-2895	127	18	of	of	ADP
ajlm-2895	127	19	burkina	burkina	PROPN
ajlm-2895	127	20	faso	faso	PROPN
ajlm-2895	127	21	.	.	PUNCT
ajlm-2895	128	1	however	however	ADV
ajlm-2895	128	2	,	,	PUNCT
ajlm-2895	128	3	it	it	PRON
ajlm-2895	128	4	should	should	AUX
ajlm-2895	128	5	be	be	AUX
ajlm-2895	128	6	used	use	VERB
ajlm-2895	128	7	in	in	ADP
ajlm-2895	128	8	combination	combination	NOUN
ajlm-2895	128	9	therapies	therapy	NOUN
ajlm-2895	128	10	to	to	PART
ajlm-2895	128	11	mitigate	mitigate	VERB
ajlm-2895	128	12	resistance	resistance	NOUN
ajlm-2895	128	13	,	,	PUNCT
ajlm-2895	128	14	a	a	DET
ajlm-2895	128	15	common	common	ADJ
ajlm-2895	128	16	drawback	drawback	NOUN
ajlm-2895	128	17	of	of	ADP
ajlm-2895	128	18	monotherapy	monotherapy	NOUN
ajlm-2895	128	19	against	against	ADP
ajlm-2895	128	20	crs	crs	PROPN
ajlm-2895	128	21	.	.	PUNCT
ajlm-2895	129	1	furthermore	furthermore	ADV
ajlm-2895	129	2	,	,	PUNCT
ajlm-2895	129	3	the	the	DET
ajlm-2895	129	4	presence	presence	NOUN
ajlm-2895	129	5	of	of	ADP
ajlm-2895	129	6	resistance	resistance	NOUN
ajlm-2895	129	7	phenotypes	phenotype	NOUN
ajlm-2895	129	8	amongst	amongst	ADP
ajlm-2895	129	9	the	the	DET
ajlm-2895	129	10	mdrbs	mdrb	NOUN
ajlm-2895	129	11	reported	report	VERB
ajlm-2895	129	12	in	in	ADP
ajlm-2895	129	13	this	this	DET
ajlm-2895	129	14	study	study	NOUN
ajlm-2895	129	15	,	,	PUNCT
ajlm-2895	129	16	even	even	ADV
ajlm-2895	129	17	before	before	ADP
ajlm-2895	129	18	the	the	DET
ajlm-2895	129	19	official	official	ADJ
ajlm-2895	129	20	introduction	introduction	NOUN
ajlm-2895	129	21	of	of	ADP
ajlm-2895	129	22	tigecycline	tigecycline	NOUN
ajlm-2895	129	23	in	in	ADP
ajlm-2895	129	24	burkina	burkina	PROPN
ajlm-2895	129	25	faso	faso	PROPN
ajlm-2895	129	26	’s	’s	PART
ajlm-2895	129	27	hospitals	hospital	NOUN
ajlm-2895	129	28	,	,	PUNCT
ajlm-2895	129	29	necessitates	necessitate	VERB
ajlm-2895	129	30	its	its	PRON
ajlm-2895	129	31	usage	usage	NOUN
ajlm-2895	129	32	as	as	ADP
ajlm-2895	129	33	a	a	DET
ajlm-2895	129	34	reserve	reserve	NOUN
ajlm-2895	129	35	antibiotic	antibiotic	NOUN
ajlm-2895	129	36	.	.	PUNCT
ajlm-2895	130	1	finally	finally	ADV
ajlm-2895	130	2	,	,	PUNCT
ajlm-2895	130	3	despite	despite	SCONJ
ajlm-2895	130	4	the	the	DET
ajlm-2895	130	5	fda	fda	PROPN
ajlm-2895	130	6	’s	’s	PART
ajlm-2895	130	7	warning	warning	NOUN
ajlm-2895	130	8	of	of	ADP
ajlm-2895	130	9	an	an	DET
ajlm-2895	130	10	increased	increase	VERB
ajlm-2895	130	11	mortality	mortality	NOUN
ajlm-2895	130	12	risk	risk	NOUN
ajlm-2895	130	13	associated	associate	VERB
ajlm-2895	130	14	with	with	ADP
ajlm-2895	130	15	the	the	DET
ajlm-2895	130	16	use	use	NOUN
ajlm-2895	130	17	of	of	ADP
ajlm-2895	130	18	tigecycline,51	tigecycline,51	NOUN
ajlm-2895	130	19	this	this	DET
ajlm-2895	130	20	non	non	ADJ
ajlm-2895	130	21	-	-	ADJ
ajlm-2895	130	22	marketed	marketed	ADJ
ajlm-2895	130	23	antibiotic	antibiotic	NOUN
ajlm-2895	130	24	in	in	ADP
ajlm-2895	130	25	burkina	burkina	PROPN
ajlm-2895	130	26	faso	faso	PROPN
ajlm-2895	130	27	could	could	AUX
ajlm-2895	130	28	represent	represent	VERB
ajlm-2895	130	29	a	a	DET
ajlm-2895	130	30	suitable	suitable	ADJ
ajlm-2895	130	31	therapeutic	therapeutic	ADJ
ajlm-2895	130	32	alternative	alternative	NOUN
ajlm-2895	130	33	to	to	ADP
ajlm-2895	130	34	spare	spare	ADJ
ajlm-2895	130	35	carbapenems	carbapenem	NOUN
ajlm-2895	130	36	in	in	ADP
ajlm-2895	130	37	the	the	DET
ajlm-2895	130	38	treatment	treatment	NOUN
ajlm-2895	130	39	of	of	ADP
ajlm-2895	130	40	esbl	esbl	NOUN
ajlm-2895	130	41	-	-	PUNCT
ajlm-2895	130	42	e	e	NOUN
ajlm-2895	130	43	infections	infection	NOUN
ajlm-2895	130	44	.	.	PUNCT
ajlm-2895	131	1	acknowledgements	acknowledgement	NOUN
ajlm-2895	131	2	we	we	PRON
ajlm-2895	131	3	are	be	AUX
ajlm-2895	131	4	grateful	grateful	ADJ
ajlm-2895	131	5	to	to	ADP
ajlm-2895	131	6	madam	madam	PROPN
ajlm-2895	131	7	salimata	salimata	PROPN
ajlm-2895	131	8	ouattara	ouattara	PROPN
ajlm-2895	131	9	,	,	PUNCT
ajlm-2895	131	10	djamilatou	djamilatou	NOUN
ajlm-2895	131	11	diéssongo	diéssongo	PROPN
ajlm-2895	131	12	and	and	CCONJ
ajlm-2895	131	13	adama	adama	PROPN
ajlm-2895	131	14	kaboré	kaboré	VERB
ajlm-2895	131	15	for	for	ADP
ajlm-2895	131	16	their	their	PRON
ajlm-2895	131	17	technical	technical	ADJ
ajlm-2895	131	18	assistance	assistance	NOUN
ajlm-2895	131	19	.	.	PUNCT
ajlm-2895	132	1	competing	compete	VERB
ajlm-2895	132	2	interests	interest	NOUN
ajlm-2895	132	3	the	the	DET
ajlm-2895	132	4	authors	author	NOUN
ajlm-2895	132	5	declare	declare	VERB
ajlm-2895	132	6	that	that	SCONJ
ajlm-2895	132	7	they	they	PRON
ajlm-2895	132	8	have	have	VERB
ajlm-2895	132	9	no	no	DET
ajlm-2895	132	10	financial	financial	ADJ
ajlm-2895	132	11	or	or	CCONJ
ajlm-2895	132	12	personal	personal	ADJ
ajlm-2895	132	13	relationships	relationship	NOUN
ajlm-2895	132	14	that	that	PRON
ajlm-2895	132	15	may	may	AUX
ajlm-2895	132	16	have	have	AUX
ajlm-2895	132	17	inappropriately	inappropriately	ADV
ajlm-2895	132	18	influenced	influence	VERB
ajlm-2895	132	19	them	they	PRON
ajlm-2895	132	20	in	in	ADP
ajlm-2895	132	21	writing	write	VERB
ajlm-2895	132	22	this	this	DET
ajlm-2895	132	23	article	article	NOUN
ajlm-2895	132	24	.	.	PUNCT
ajlm-2895	133	1	credit	credit	NOUN
ajlm-2895	133	2	authorship	authorship	NOUN
ajlm-2895	133	3	contribution	contribution	NOUN
ajlm-2895	133	4	odilon	odilon	NOUN
ajlm-2895	133	5	d.	d.	PROPN
ajlm-2895	133	6	kaboré	kaboré	PROPN
ajlm-2895	133	7	and	and	CCONJ
ajlm-2895	133	8	abdoul	abdoul	PROPN
ajlm-2895	133	9	-	-	PUNCT
ajlm-2895	133	10	salam	salam	PROPN
ajlm-2895	133	11	ouedraogo	ouedraogo	PROPN
ajlm-2895	133	12	:	:	PUNCT
ajlm-2895	133	13	conceptualisation	conceptualisation	NOUN
ajlm-2895	133	14	.	.	PUNCT
ajlm-2895	134	1	abdourahmane	abdourahmane	NOUN
ajlm-2895	134	2	sow	sow	NOUN
ajlm-2895	134	3	,	,	PUNCT
ajlm-2895	134	4	sylvain	sylvain	PROPN
ajlm-2895	134	5	godreuil	godreuil	PROPN
ajlm-2895	134	6	:	:	PUNCT
ajlm-2895	134	7	methodology	methodology	NOUN
ajlm-2895	134	8	and	and	CCONJ
ajlm-2895	134	9	data	datum	NOUN
ajlm-2895	134	10	curation	curation	NOUN
ajlm-2895	134	11	.	.	PUNCT
ajlm-2895	135	1	mélissa	mélissa	VERB
ajlm-2895	135	2	j.	j.	PROPN
ajlm-2895	135	3	gonfouli	gonfouli	PROPN
ajlm-2895	135	4	,	,	PUNCT
ajlm-2895	135	5	merci	merci	PROPN
ajlm-2895	135	6	muhigwa	muhigwa	NOUN
ajlm-2895	135	7	,	,	PUNCT
ajlm-2895	135	8	odilon	odilon	ADP
ajlm-2895	135	9	d.	d.	PROPN
ajlm-2895	135	10	kaboré	kaboré	PROPN
ajlm-2895	135	11	:	:	PUNCT
ajlm-2895	135	12	writing	write	VERB
ajlm-2895	135	13	original	original	ADJ
ajlm-2895	135	14	draft	draft	NOUN
ajlm-2895	135	15	.	.	PUNCT
ajlm-2895	136	1	odilon	odilon	PROPN
ajlm-2895	136	2	d.	d.	PROPN
ajlm-2895	136	3	kaboré	kaboré	PROPN
ajlm-2895	136	4	,	,	PUNCT
ajlm-2895	136	5	mélissa	mélissa	VERB
ajlm-2895	136	6	j.	j.	PROPN
ajlm-2895	136	7	gonfouli	gonfouli	PROPN
ajlm-2895	136	8	,	,	PUNCT
ajlm-2895	136	9	merci	merci	PROPN
ajlm-2895	136	10	muhigwa	muhigwa	NOUN
ajlm-2895	136	11	,	,	PUNCT
ajlm-2895	136	12	abdourahmane	abdourahmane	NOUN
ajlm-2895	136	13	sow	sow	NOUN
ajlm-2895	136	14	,	,	PUNCT
ajlm-2895	136	15	adama	adama	PROPN
ajlm-2895	136	16	ouattara	ouattara	NOUN
ajlm-2895	136	17	,	,	PUNCT
ajlm-2895	136	18	andré	andré	ADJ
ajlm-2895	136	19	nagalo	nagalo	NOUN
ajlm-2895	136	20	,	,	PUNCT
ajlm-2895	136	21	hervé	hervé	NOUN
ajlm-2895	136	22	kafando	kafando	PROPN
ajlm-2895	136	23	,	,	PUNCT
ajlm-2895	136	24	augustin	augustin	PROPN
ajlm-2895	136	25	konkobo	konkobo	PROPN
ajlm-2895	136	26	,	,	PUNCT
ajlm-2895	136	27	jacques	jacques	PROPN
ajlm-2895	136	28	zoungrana	zoungrana	PROPN
ajlm-2895	136	29	,	,	PUNCT
ajlm-2895	136	30	arsène	arsène	PROPN
ajlm-2895	136	31	hema	hema	PROPN
ajlm-2895	136	32	,	,	PUNCT
ajlm-2895	136	33	armel	armel	NOUN
ajlm-2895	136	34	poda	poda	NOUN
ajlm-2895	136	35	,	,	PUNCT
ajlm-2895	136	36	abdoul	abdoul	PROPN
ajlm-2895	136	37	-	-	PUNCT
ajlm-2895	136	38	salam	salam	PROPN
ajlm-2895	136	39	ouedraogo	ouedraogo	PROPN
ajlm-2895	136	40	and	and	CCONJ
ajlm-2895	136	41	fernand	fernand	PROPN
ajlm-2895	136	42	michodigni	michodigni	NOUN
ajlm-2895	136	43	:	:	PUNCT
ajlm-2895	136	44	writing	write	VERB
ajlm-2895	136	45	review	review	NOUN
ajlm-2895	136	46	&	&	CCONJ
ajlm-2895	136	47	editing	editing	NOUN
ajlm-2895	136	48	.	.	PUNCT
ajlm-2895	137	1	all	all	DET
ajlm-2895	137	2	authors	author	NOUN
ajlm-2895	137	3	reviewed	review	VERB
ajlm-2895	137	4	the	the	DET
ajlm-2895	137	5	article	article	NOUN
ajlm-2895	137	6	,	,	PUNCT
ajlm-2895	137	7	contributed	contribute	VERB
ajlm-2895	137	8	to	to	ADP
ajlm-2895	137	9	the	the	DET
ajlm-2895	137	10	discussion	discussion	NOUN
ajlm-2895	137	11	of	of	ADP
ajlm-2895	137	12	results	result	NOUN
ajlm-2895	137	13	,	,	PUNCT
ajlm-2895	137	14	approved	approve	VERB
ajlm-2895	137	15	the	the	DET
ajlm-2895	137	16	final	final	ADJ
ajlm-2895	137	17	version	version	NOUN
ajlm-2895	137	18	for	for	ADP
ajlm-2895	137	19	submission	submission	NOUN
ajlm-2895	137	20	and	and	CCONJ
ajlm-2895	137	21	publication	publication	NOUN
ajlm-2895	137	22	,	,	PUNCT
ajlm-2895	137	23	and	and	CCONJ
ajlm-2895	137	24	take	take	VERB
ajlm-2895	137	25	responsibility	responsibility	NOUN
ajlm-2895	137	26	for	for	ADP
ajlm-2895	137	27	the	the	DET
ajlm-2895	137	28	integrity	integrity	NOUN
ajlm-2895	137	29	of	of	ADP
ajlm-2895	137	30	its	its	PRON
ajlm-2895	137	31	findings	finding	NOUN
ajlm-2895	137	32	.	.	PUNCT
ajlm-2895	138	1	sources	source	NOUN
ajlm-2895	138	2	of	of	ADP
ajlm-2895	138	3	support	support	NOUN
ajlm-2895	138	4	this	this	DET
ajlm-2895	138	5	research	research	NOUN
ajlm-2895	138	6	received	receive	VERB
ajlm-2895	138	7	no	no	DET
ajlm-2895	138	8	specific	specific	ADJ
ajlm-2895	138	9	grant	grant	NOUN
ajlm-2895	138	10	from	from	ADP
ajlm-2895	138	11	any	any	DET
ajlm-2895	138	12	funding	funding	NOUN
ajlm-2895	138	13	agency	agency	NOUN
ajlm-2895	138	14	in	in	ADP
ajlm-2895	138	15	the	the	DET
ajlm-2895	138	16	public	public	ADJ
ajlm-2895	138	17	,	,	PUNCT
ajlm-2895	138	18	commercial	commercial	ADJ
ajlm-2895	138	19	,	,	PUNCT
ajlm-2895	138	20	or	or	CCONJ
ajlm-2895	138	21	not	not	PART
ajlm-2895	138	22	-	-	PUNCT
ajlm-2895	138	23	for	for	ADP
ajlm-2895	138	24	-	-	PUNCT
ajlm-2895	138	25	profit	profit	NOUN
ajlm-2895	138	26	sectors	sector	NOUN
ajlm-2895	138	27	.	.	PUNCT
ajlm-2895	139	1	data	datum	NOUN
ajlm-2895	139	2	availability	availability	NOUN
ajlm-2895	139	3	all	all	DET
ajlm-2895	139	4	relevant	relevant	ADJ
ajlm-2895	139	5	data	datum	NOUN
ajlm-2895	139	6	that	that	PRON
ajlm-2895	139	7	support	support	VERB
ajlm-2895	139	8	the	the	DET
ajlm-2895	139	9	findings	finding	NOUN
ajlm-2895	139	10	are	be	AUX
ajlm-2895	139	11	available	available	ADJ
ajlm-2895	139	12	in	in	ADP
ajlm-2895	139	13	this	this	DET
ajlm-2895	139	14	article	article	NOUN
ajlm-2895	139	15	.	.	PUNCT
ajlm-2895	140	1	additional	additional	ADJ
ajlm-2895	140	2	supporting	support	VERB
ajlm-2895	140	3	information	information	NOUN
ajlm-2895	140	4	may	may	AUX
ajlm-2895	140	5	be	be	AUX
ajlm-2895	140	6	found	find	VERB
ajlm-2895	140	7	upon	upon	SCONJ
ajlm-2895	140	8	reasonable	reasonable	ADJ
ajlm-2895	140	9	request	request	NOUN
ajlm-2895	140	10	from	from	ADP
ajlm-2895	140	11	the	the	DET
ajlm-2895	140	12	corresponding	corresponding	ADJ
ajlm-2895	140	13	author	author	NOUN
ajlm-2895	140	14	,	,	PUNCT
ajlm-2895	140	15	odilon	odilon	ADP
ajlm-2895	140	16	d.	d.	PROPN
ajlm-2895	140	17	kaboré	kaboré	PROPN
ajlm-2895	140	18	.	.	PUNCT
ajlm-2895	141	1	disclaimer	disclaimer	VERB
ajlm-2895	141	2	the	the	DET
ajlm-2895	141	3	views	view	NOUN
ajlm-2895	141	4	and	and	CCONJ
ajlm-2895	141	5	opinions	opinion	NOUN
ajlm-2895	141	6	expressed	express	VERB
ajlm-2895	141	7	in	in	ADP
ajlm-2895	141	8	this	this	DET
ajlm-2895	141	9	article	article	NOUN
ajlm-2895	141	10	are	be	AUX
ajlm-2895	141	11	those	those	PRON
ajlm-2895	141	12	of	of	ADP
ajlm-2895	141	13	the	the	DET
ajlm-2895	141	14	authors	author	NOUN
ajlm-2895	141	15	and	and	CCONJ
ajlm-2895	141	16	are	be	AUX
ajlm-2895	141	17	the	the	DET
ajlm-2895	141	18	product	product	NOUN
ajlm-2895	141	19	of	of	ADP
ajlm-2895	141	20	professional	professional	ADJ
ajlm-2895	141	21	research	research	NOUN
ajlm-2895	141	22	.	.	PUNCT
ajlm-2895	142	1	the	the	DET
ajlm-2895	142	2	article	article	NOUN
ajlm-2895	142	3	does	do	AUX
ajlm-2895	142	4	not	not	PART
ajlm-2895	142	5	necessarily	necessarily	ADV
ajlm-2895	142	6	reflect	reflect	VERB
ajlm-2895	142	7	the	the	DET
ajlm-2895	142	8	official	official	ADJ
ajlm-2895	142	9	policy	policy	NOUN
ajlm-2895	142	10	or	or	CCONJ
ajlm-2895	142	11	position	position	NOUN
ajlm-2895	142	12	of	of	ADP
ajlm-2895	142	13	any	any	DET
ajlm-2895	142	14	affiliated	affiliated	ADJ
ajlm-2895	142	15	institution	institution	NOUN
ajlm-2895	142	16	,	,	PUNCT
ajlm-2895	142	17	funder	funder	NOUN
ajlm-2895	142	18	,	,	PUNCT
ajlm-2895	142	19	agency	agency	NOUN
ajlm-2895	142	20	,	,	PUNCT
ajlm-2895	142	21	or	or	CCONJ
ajlm-2895	142	22	that	that	PRON
ajlm-2895	142	23	of	of	ADP
ajlm-2895	142	24	the	the	DET
ajlm-2895	142	25	publisher	publisher	NOUN
ajlm-2895	142	26	.	.	PUNCT
ajlm-2895	143	1	the	the	DET
ajlm-2895	143	2	authors	author	NOUN
ajlm-2895	143	3	are	be	AUX
ajlm-2895	143	4	responsible	responsible	ADJ
ajlm-2895	143	5	for	for	ADP
ajlm-2895	143	6	this	this	DET
ajlm-2895	143	7	article	article	NOUN
ajlm-2895	143	8	’s	’s	PART
ajlm-2895	143	9	results	result	NOUN
ajlm-2895	143	10	,	,	PUNCT
ajlm-2895	143	11	findings	finding	NOUN
ajlm-2895	143	12	,	,	PUNCT
ajlm-2895	143	13	and	and	CCONJ
ajlm-2895	143	14	content	content	NOUN
ajlm-2895	143	15	.	.	PUNCT
ajlm-2895	144	1	references	reference	NOUN
ajlm-2895	144	2	ventola	ventola	PROPN
ajlm-2895	144	3	cl	cl	PROPN
ajlm-2895	144	4	.	.	PUNCT
ajlm-2895	145	1	the	the	DET
ajlm-2895	145	2	antibiotic	antibiotic	ADJ
ajlm-2895	145	3	resistance	resistance	NOUN
ajlm-2895	145	4	crisis	crisis	NOUN
ajlm-2895	145	5	.	.	PUNCT
ajlm-2895	146	1	pharmacol	pharmacol	VERB
ajlm-2895	146	2	ther	ther	ADV
ajlm-2895	146	3	.	.	PUNCT
ajlm-2895	147	1	2015;40(4):277–283	2015;40(4):277–283	X
ajlm-2895	147	2	.	.	PUNCT
ajlm-2895	148	1	murray	murray	PROPN
ajlm-2895	148	2	cj	cj	PROPN
ajlm-2895	148	3	,	,	PUNCT
ajlm-2895	148	4	ikuta	ikuta	PROPN
ajlm-2895	148	5	ks	ks	PROPN
ajlm-2895	148	6	,	,	PUNCT
ajlm-2895	148	7	sharara	sharara	NOUN
ajlm-2895	148	8	f	f	X
ajlm-2895	148	9	,	,	PUNCT
ajlm-2895	148	10	et	et	PROPN
ajlm-2895	148	11	al	al	PROPN
ajlm-2895	148	12	.	.	PUNCT
ajlm-2895	148	13	global	global	ADJ
ajlm-2895	148	14	burden	burden	NOUN
ajlm-2895	148	15	of	of	ADP
ajlm-2895	148	16	bacterial	bacterial	ADJ
ajlm-2895	148	17	antimicrobial	antimicrobial	ADJ
ajlm-2895	148	18	resistance	resistance	NOUN
ajlm-2895	148	19	in	in	ADP
ajlm-2895	148	20	2019	2019	NUM
ajlm-2895	148	21	:	:	PUNCT
ajlm-2895	148	22	a	a	DET
ajlm-2895	148	23	systematic	systematic	ADJ
ajlm-2895	148	24	analysis	analysis	NOUN
ajlm-2895	148	25	.	.	PUNCT
ajlm-2895	149	1	lancet	lancet	PROPN
ajlm-2895	149	2	2022;399(10325):629–655	2022;399(10325):629–655	NUM
ajlm-2895	149	3	.	.	PUNCT
ajlm-2895	150	1	https://doi.org/10.1016/s0140-6736(21)02724-0	https://doi.org/10.1016/s0140-6736(21)02724-0	PROPN
ajlm-2895	150	2	pendleton	pendleton	PROPN
ajlm-2895	150	3	jn	jn	PROPN
ajlm-2895	150	4	,	,	PUNCT
ajlm-2895	150	5	gorman	gorman	PROPN
ajlm-2895	150	6	sp	sp	PROPN
ajlm-2895	150	7	,	,	PUNCT
ajlm-2895	150	8	gilmore	gilmore	PROPN
ajlm-2895	150	9	bf	bf	PROPN
ajlm-2895	150	10	.	.	PUNCT
ajlm-2895	151	1	clinical	clinical	ADJ
ajlm-2895	151	2	relevance	relevance	NOUN
ajlm-2895	151	3	of	of	ADP
ajlm-2895	151	4	the	the	DET
ajlm-2895	151	5	eskape	eskape	NOUN
ajlm-2895	151	6	pathogens	pathogen	NOUN
ajlm-2895	151	7	.	.	PUNCT
ajlm-2895	152	1	expert	expert	PROPN
ajlm-2895	152	2	rev	rev	VERB
ajlm-2895	152	3	anti	anti	ADJ
ajlm-2895	152	4	-	-	ADJ
ajlm-2895	152	5	infect	infect	ADJ
ajlm-2895	152	6	ther	ther	ADV
ajlm-2895	152	7	.	.	PUNCT
ajlm-2895	153	1	2013;11(3):297–308	2013;11(3):297–308	X
ajlm-2895	153	2	.	.	PUNCT
ajlm-2895	153	3	https://doi.org/10.1586/eri.13.12	https://doi.org/10.1586/eri.13.12	PROPN
ajlm-2895	153	4	santajit	santajit	PROPN
ajlm-2895	153	5	s	s	PROPN
ajlm-2895	153	6	,	,	PUNCT
ajlm-2895	153	7	indrawattana	indrawattana	PROPN
ajlm-2895	153	8	n.	n.	PROPN
ajlm-2895	153	9	mechanisms	mechanism	NOUN
ajlm-2895	153	10	of	of	ADP
ajlm-2895	153	11	antimicrobial	antimicrobial	ADJ
ajlm-2895	153	12	resistance	resistance	NOUN
ajlm-2895	153	13	in	in	ADP
ajlm-2895	153	14	eskape	eskape	NOUN
ajlm-2895	153	15	pathogens	pathogen	NOUN
ajlm-2895	153	16	.	.	PUNCT
ajlm-2895	153	17	biomed	biome	VERB
ajlm-2895	153	18	res	re	NOUN
ajlm-2895	153	19	int	int	NOUN
ajlm-2895	153	20	.	.	PUNCT
ajlm-2895	154	1	2016;2016(1):2475067	2016;2016(1):2475067	X
ajlm-2895	154	2	.	.	PUNCT
ajlm-2895	155	1	https://doi.org/10.1155/2016/2475067	https://doi.org/10.1155/2016/2475067	PROPN
ajlm-2895	155	2	pankey	pankey	PROPN
ajlm-2895	155	3	ga	ga	PROPN
ajlm-2895	155	4	.	.	PROPN
ajlm-2895	155	5	tigecycline	tigecycline	PROPN
ajlm-2895	155	6	.	.	PUNCT
ajlm-2895	156	1	j	j	PROPN
ajlm-2895	156	2	antimicrob	antimicrob	PROPN
ajlm-2895	156	3	chemother	chemother	PROPN
ajlm-2895	156	4	.	.	PUNCT
ajlm-2895	157	1	2005;56(3):470–480	2005;56(3):470–480	NUM
ajlm-2895	157	2	.	.	PUNCT
ajlm-2895	158	1	https://doi.org/10.1093/jac/dki248	https://doi.org/10.1093/jac/dki248	PROPN
ajlm-2895	158	2	steenbergen	steenbergen	PROPN
ajlm-2895	159	1	jn	jn	PROPN
ajlm-2895	159	2	,	,	PUNCT
ajlm-2895	159	3	alder	alder	PROPN
ajlm-2895	159	4	j	j	PROPN
ajlm-2895	159	5	,	,	PUNCT
ajlm-2895	159	6	thorne	thorne	PROPN
ajlm-2895	159	7	gm	gm	PROPN
ajlm-2895	159	8	,	,	PUNCT
ajlm-2895	159	9	tally	tally	PROPN
ajlm-2895	159	10	fp	fp	PROPN
ajlm-2895	159	11	.	.	PUNCT
ajlm-2895	159	12	daptomycin	daptomycin	PROPN
ajlm-2895	159	13	:	:	PUNCT
ajlm-2895	159	14	a	a	DET
ajlm-2895	159	15	lipopeptide	lipopeptide	ADJ
ajlm-2895	159	16	antibiotic	antibiotic	ADJ
ajlm-2895	159	17	for	for	ADP
ajlm-2895	159	18	the	the	DET
ajlm-2895	159	19	treatment	treatment	NOUN
ajlm-2895	159	20	of	of	ADP
ajlm-2895	159	21	serious	serious	ADJ
ajlm-2895	159	22	gram	gram	NOUN
ajlm-2895	159	23	-	-	PUNCT
ajlm-2895	159	24	positive	positive	ADJ
ajlm-2895	159	25	infections	infection	NOUN
ajlm-2895	159	26	.	.	PUNCT
ajlm-2895	160	1	j	j	PROPN
ajlm-2895	160	2	antimicrob	antimicrob	PROPN
ajlm-2895	160	3	chemother	chemother	PROPN
ajlm-2895	160	4	.	.	PUNCT
ajlm-2895	161	1	2005;55(3):283–288	2005;55(3):283–288	X
ajlm-2895	161	2	.	.	PUNCT
ajlm-2895	162	1	https://doi.org/10.1093/jac/dkh546	https://doi.org/10.1093/jac/dkh546	PROPN
ajlm-2895	162	2	dutronc	dutronc	VERB
ajlm-2895	162	3	h	h	NOUN
ajlm-2895	162	4	,	,	PUNCT
ajlm-2895	162	5	bocquentin	bocquentin	NOUN
ajlm-2895	162	6	f	f	NOUN
ajlm-2895	162	7	,	,	PUNCT
ajlm-2895	162	8	galpérine	galpérine	PROPN
ajlm-2895	162	9	t	t	PROPN
ajlm-2895	162	10	,	,	PUNCT
ajlm-2895	162	11	lafarie	lafarie	NOUN
ajlm-2895	162	12	-	-	PUNCT
ajlm-2895	162	13	castet	castet	NOUN
ajlm-2895	162	14	s	s	NOUN
ajlm-2895	162	15	,	,	PUNCT
ajlm-2895	162	16	dupon	dupon	PROPN
ajlm-2895	162	17	m.	m.	PROPN
ajlm-2895	162	18	le	le	AUX
ajlm-2895	162	19	linézolide	linézolide	PROPN
ajlm-2895	162	20	,	,	PUNCT
ajlm-2895	162	21	premier	premier	ADJ
ajlm-2895	162	22	antibiotique	antibiotique	ADJ
ajlm-2895	162	23	de	de	X
ajlm-2895	162	24	la	la	X
ajlm-2895	162	25	famille	famille	PROPN
ajlm-2895	162	26	des	des	PROPN
ajlm-2895	162	27	oxazolidinones	oxazolidinones	PROPN
ajlm-2895	162	28	.	.	PUNCT
ajlm-2895	163	1	méd	méd	PROPN
ajlm-2895	163	2	mal	mal	ADJ
ajlm-2895	163	3	infect	infect	NOUN
ajlm-2895	163	4	.	.	PUNCT
ajlm-2895	164	1	2005;35(9):427–434	2005;35(9):427–434	X
ajlm-2895	164	2	.	.	PUNCT
ajlm-2895	164	3	https://doi.org/10.1016/j.medmal.2005.09.006	https://doi.org/10.1016/j.medmal.2005.09.006	VERB
ajlm-2895	164	4	gahamanyi	gahamanyi	PROPN
ajlm-2895	164	5	n	n	CCONJ
ajlm-2895	164	6	,	,	PUNCT
ajlm-2895	164	7	umuhoza	umuhoza	PROPN
ajlm-2895	164	8	t	t	PROPN
ajlm-2895	164	9	,	,	PUNCT
ajlm-2895	164	10	saeed	saeed	PROPN
ajlm-2895	164	11	si	si	PROPN
ajlm-2895	164	12	,	,	PUNCT
ajlm-2895	164	13	mayigane	mayigane	PROPN
ajlm-2895	164	14	ln	ln	PROPN
ajlm-2895	164	15	,	,	PUNCT
ajlm-2895	164	16	hakizimana	hakizimana	PROPN
ajlm-2895	164	17	jn	jn	PROPN
ajlm-2895	164	18	.	.	PUNCT
ajlm-2895	165	1	a	a	DET
ajlm-2895	165	2	review	review	NOUN
ajlm-2895	165	3	of	of	ADP
ajlm-2895	165	4	the	the	DET
ajlm-2895	165	5	important	important	ADJ
ajlm-2895	165	6	weapons	weapon	NOUN
ajlm-2895	165	7	against	against	ADP
ajlm-2895	165	8	antimicrobial	antimicrobial	ADJ
ajlm-2895	165	9	resistance	resistance	NOUN
ajlm-2895	165	10	in	in	ADP
ajlm-2895	165	11	sub	sub	ADJ
ajlm-2895	165	12	-	-	ADJ
ajlm-2895	165	13	saharan	saharan	ADJ
ajlm-2895	165	14	africa	africa	PROPN
ajlm-2895	165	15	.	.	PUNCT
ajlm-2895	166	1	appl	appl	PROPN
ajlm-2895	166	2	biosci	biosci	PROPN
ajlm-2895	166	3	.	.	PUNCT
ajlm-2895	167	1	2023;2(2):136–156	2023;2(2):136–156	NUM
ajlm-2895	167	2	.	.	PROPN
ajlm-2895	167	3	https://doi.org/10.3390/applbiosci2020011	https://doi.org/10.3390/applbiosci2020011	PROPN
ajlm-2895	167	4	sum	sum	NOUN
ajlm-2895	167	5	p	p	NOUN
ajlm-2895	167	6	-	-	PUNCT
ajlm-2895	167	7	e	e	NOUN
ajlm-2895	167	8	,	,	PUNCT
ajlm-2895	167	9	petersen	petersen	PROPN
ajlm-2895	167	10	p.	p.	NOUN
ajlm-2895	167	11	synthesis	synthesis	NOUN
ajlm-2895	167	12	and	and	CCONJ
ajlm-2895	167	13	structure	structure	NOUN
ajlm-2895	167	14	-	-	PUNCT
ajlm-2895	167	15	activity	activity	NOUN
ajlm-2895	167	16	relationship	relationship	NOUN
ajlm-2895	167	17	of	of	ADP
ajlm-2895	167	18	novel	novel	ADJ
ajlm-2895	167	19	glycylcycline	glycylcycline	NOUN
ajlm-2895	167	20	derivatives	derivative	NOUN
ajlm-2895	167	21	leading	lead	VERB
ajlm-2895	167	22	to	to	ADP
ajlm-2895	167	23	the	the	DET
ajlm-2895	167	24	discovery	discovery	NOUN
ajlm-2895	167	25	of	of	ADP
ajlm-2895	167	26	gar-936	gar-936	PROPN
ajlm-2895	167	27	.	.	PUNCT
ajlm-2895	168	1	bioorg	bioorg	PROPN
ajlm-2895	168	2	med	med	PROPN
ajlm-2895	168	3	chem	chem	NOUN
ajlm-2895	168	4	lett	lett	PROPN
ajlm-2895	168	5	.	.	PUNCT
ajlm-2895	169	1	1999;9(10):1459–1462	1999;9(10):1459–1462	PROPN
ajlm-2895	169	2	.	.	PUNCT
ajlm-2895	170	1	https://doi.org/10.1016/s0960-894x(99)00216-4	https://doi.org/10.1016/s0960-894x(99)00216-4	PROPN
ajlm-2895	170	2	bauer	bauer	PROPN
ajlm-2895	170	3	g.	g.	PROPN
ajlm-2895	170	4	comparison	comparison	NOUN
ajlm-2895	170	5	of	of	ADP
ajlm-2895	170	6	tetracycline	tetracycline	NOUN
ajlm-2895	170	7	and	and	CCONJ
ajlm-2895	170	8	tigecycline	tigecycline	NOUN
ajlm-2895	170	9	binding	bind	VERB
ajlm-2895	170	10	to	to	ADP
ajlm-2895	170	11	ribosomes	ribosome	NOUN
ajlm-2895	170	12	mapped	map	VERB
ajlm-2895	170	13	by	by	ADP
ajlm-2895	170	14	dimethylsulphate	dimethylsulphate	NOUN
ajlm-2895	170	15	and	and	CCONJ
ajlm-2895	170	16	drug	drug	NOUN
ajlm-2895	170	17	-	-	PUNCT
ajlm-2895	170	18	directed	direct	VERB
ajlm-2895	170	19	fe2	fe2	PROPN
ajlm-2895	170	20	+	+	NOUN
ajlm-2895	170	21	cleavage	cleavage	NOUN
ajlm-2895	170	22	of	of	ADP
ajlm-2895	170	23	16s	16s	PROPN
ajlm-2895	170	24	rrna	rrna	PROPN
ajlm-2895	170	25	.	.	PUNCT
ajlm-2895	171	1	j	j	PROPN
ajlm-2895	171	2	antimicrob	antimicrob	PROPN
ajlm-2895	171	3	chemother	chemother	PROPN
ajlm-2895	171	4	.	.	PUNCT
ajlm-2895	172	1	2004;53(4):592–599	2004;53(4):592–599	X
ajlm-2895	172	2	.	.	X
ajlm-2895	173	1	https://doi.org/10.1093/jac/dkh125	https://doi.org/10.1093/jac/dkh125	PROPN
ajlm-2895	173	2	sum	sum	NOUN
ajlm-2895	173	3	pe	pe	NOUN
ajlm-2895	173	4	,	,	PUNCT
ajlm-2895	173	5	sum	sum	PROPN
ajlm-2895	173	6	fw	fw	PROPN
ajlm-2895	173	7	,	,	PUNCT
ajlm-2895	173	8	projan	projan	NOUN
ajlm-2895	173	9	sj	sj	PROPN
ajlm-2895	173	10	.	.	PUNCT
ajlm-2895	174	1	recent	recent	ADJ
ajlm-2895	174	2	developments	development	NOUN
ajlm-2895	174	3	in	in	ADP
ajlm-2895	174	4	tetracycline	tetracycline	NOUN
ajlm-2895	174	5	antibiotics	antibiotic	NOUN
ajlm-2895	174	6	.	.	PUNCT
ajlm-2895	175	1	curr	curr	PROPN
ajlm-2895	175	2	pharm	pharm	PROPN
ajlm-2895	175	3	des	des	PROPN
ajlm-2895	175	4	.	.	PROPN
ajlm-2895	176	1	1998;4(2):119–132	1998;4(2):119–132	NUM
ajlm-2895	176	2	.	.	PUNCT
ajlm-2895	177	1	https://doi.org/10.2174/138161280401221007113202	https://doi.org/10.2174/138161280401221007113202	NOUN
ajlm-2895	177	2	rose	rise	VERB
ajlm-2895	177	3	we	we	PRON
ajlm-2895	177	4	,	,	PUNCT
ajlm-2895	178	1	rybak	rybak	PROPN
ajlm-2895	178	2	mj	mj	PROPN
ajlm-2895	178	3	.	.	PROPN
ajlm-2895	178	4	tigecycline	tigecycline	PROPN
ajlm-2895	178	5	:	:	PUNCT
ajlm-2895	179	1	first	first	ADV
ajlm-2895	179	2	of	of	ADP
ajlm-2895	179	3	a	a	DET
ajlm-2895	179	4	new	new	ADJ
ajlm-2895	179	5	class	class	NOUN
ajlm-2895	179	6	of	of	ADP
ajlm-2895	179	7	antimicrobial	antimicrobial	ADJ
ajlm-2895	179	8	agents	agent	NOUN
ajlm-2895	179	9	.	.	PUNCT
ajlm-2895	180	1	pharmacotherapy	pharmacotherapy	NOUN
ajlm-2895	180	2	.	.	PUNCT
ajlm-2895	181	1	2006;26(8):1099–1110	2006;26(8):1099–1110	NOUN
ajlm-2895	181	2	.	.	PUNCT
ajlm-2895	182	1	https://doi.org/10.1592/phco.26.8.1099	https://doi.org/10.1592/phco.26.8.1099	PROPN
ajlm-2895	182	2	kasbekar	kasbekar	PROPN
ajlm-2895	182	3	n.	n.	PROPN
ajlm-2895	182	4	tigecycline	tigecycline	PROPN
ajlm-2895	182	5	:	:	PUNCT
ajlm-2895	182	6	a	a	DET
ajlm-2895	182	7	new	new	ADJ
ajlm-2895	182	8	glycylcycline	glycylcycline	ADJ
ajlm-2895	182	9	antimicrobial	antimicrobial	ADJ
ajlm-2895	182	10	agent	agent	NOUN
ajlm-2895	182	11	.	.	PUNCT
ajlm-2895	183	1	am	be	AUX
ajlm-2895	183	2	j	j	PROPN
ajlm-2895	183	3	health	health	PROPN
ajlm-2895	183	4	syst	syst	PROPN
ajlm-2895	183	5	pharm	pharm	PROPN
ajlm-2895	183	6	.	.	PUNCT
ajlm-2895	184	1	2006;63(13):1235–1243	2006;63(13):1235–1243	NUM
ajlm-2895	184	2	.	.	PUNCT
ajlm-2895	185	1	https://doi.org/10.2146/ajhp050487	https://doi.org/10.2146/ajhp050487	PROPN
ajlm-2895	185	2	tygacil	tygacil	NOUN
ajlm-2895	186	1	[	[	X
ajlm-2895	186	2	homepage	homepage	NOUN
ajlm-2895	186	3	on	on	ADP
ajlm-2895	186	4	the	the	DET
ajlm-2895	186	5	internet	internet	NOUN
ajlm-2895	186	6	]	]	PUNCT
ajlm-2895	186	7	.	.	PUNCT
ajlm-2895	187	1	european	european	PROPN
ajlm-2895	187	2	medicines	medicines	PROPN
ajlm-2895	187	3	agency	agency	NOUN
ajlm-2895	187	4	(	(	PUNCT
ajlm-2895	187	5	ema	ema	PROPN
ajlm-2895	187	6	)	)	PUNCT
ajlm-2895	187	7	.	.	PUNCT
ajlm-2895	188	1	[	[	X
ajlm-2895	188	2	cited	cite	VERB
ajlm-2895	188	3	2024	2024	NUM
ajlm-2895	188	4	aug	aug	PROPN
ajlm-2895	188	5	02	02	NUM
ajlm-2895	188	6	]	]	PUNCT
ajlm-2895	188	7	.	.	PUNCT
ajlm-2895	189	1	available	available	ADJ
ajlm-2895	189	2	from	from	ADP
ajlm-2895	189	3	:	:	PUNCT
ajlm-2895	189	4	https://www.ema.europa.eu/en/medicines/human/epar/tygacil	https://www.ema.europa.eu/en/medicines/human/epar/tygacil	PROPN
ajlm-2895	189	5	zhang	zhang	PROPN
ajlm-2895	189	6	y	y	PROPN
ajlm-2895	189	7	,	,	PUNCT
ajlm-2895	189	8	zhou	zhou	PROPN
ajlm-2895	189	9	l	l	PROPN
ajlm-2895	189	10	,	,	PUNCT
ajlm-2895	189	11	zhu	zhu	PROPN
ajlm-2895	190	1	d	d	PROPN
ajlm-2895	190	2	,	,	PUNCT
ajlm-2895	190	3	et	et	PROPN
ajlm-2895	190	4	al	al	PROPN
ajlm-2895	190	5	.	.	PUNCT
ajlm-2895	191	1	in	in	ADP
ajlm-2895	191	2	vitro	vitro	X
ajlm-2895	191	3	activities	activity	NOUN
ajlm-2895	191	4	of	of	ADP
ajlm-2895	191	5	tigecycline	tigecycline	NOUN
ajlm-2895	191	6	against	against	ADP
ajlm-2895	191	7	clinical	clinical	ADJ
ajlm-2895	191	8	isolates	isolate	NOUN
ajlm-2895	191	9	from	from	ADP
ajlm-2895	191	10	shanghai	shanghai	PROPN
ajlm-2895	191	11	,	,	PUNCT
ajlm-2895	191	12	china	china	PROPN
ajlm-2895	191	13	.	.	PUNCT
ajlm-2895	192	1	diagn	diagn	PROPN
ajlm-2895	192	2	microbiol	microbiol	PROPN
ajlm-2895	192	3	infect	infect	VERB
ajlm-2895	192	4	dis	dis	PROPN
ajlm-2895	192	5	.	.	PUNCT
ajlm-2895	193	1	2004;50(4):267–281	2004;50(4):267–281	X
ajlm-2895	193	2	.	.	PUNCT
ajlm-2895	194	1	https://doi.org/10.1016/j.diagmicrobio.2004.08.007	https://doi.org/10.1016/j.diagmicrobio.2004.08.007	PROPN
ajlm-2895	194	2	aryal	aryal	PROPN
ajlm-2895	194	3	s.	s.	PROPN
ajlm-2895	194	4	api	api	PROPN
ajlm-2895	194	5	(	(	PUNCT
ajlm-2895	194	6	analytical	analytical	ADJ
ajlm-2895	194	7	profile	profile	PROPN
ajlm-2895	194	8	index	index	PROPN
ajlm-2895	194	9	)	)	PUNCT
ajlm-2895	194	10	20e	20e	NOUN
ajlm-2895	194	11	test	test	NOUN
ajlm-2895	194	12	–	–	PUNCT
ajlm-2895	194	13	procedure	procedure	NOUN
ajlm-2895	194	14	,	,	PUNCT
ajlm-2895	194	15	uses	use	VERB
ajlm-2895	194	16	and	and	CCONJ
ajlm-2895	194	17	interpretation	interpretation	NOUN
ajlm-2895	195	1	[	[	X
ajlm-2895	195	2	homepage	homepage	NOUN
ajlm-2895	195	3	on	on	ADP
ajlm-2895	195	4	the	the	DET
ajlm-2895	195	5	internet	internet	NOUN
ajlm-2895	195	6	]	]	PUNCT
ajlm-2895	195	7	.	.	PUNCT
ajlm-2895	196	1	microbiology	microbiology	NOUN
ajlm-2895	196	2	info.com	info.com	X
ajlm-2895	196	3	;	;	PUNCT
ajlm-2895	196	4	2019	2019	NUM
ajlm-2895	196	5	[	[	PUNCT
ajlm-2895	196	6	cited	cite	VERB
ajlm-2895	196	7	2024	2024	NUM
ajlm-2895	196	8	aug	aug	NOUN
ajlm-2895	196	9	04	04	NUM
ajlm-2895	196	10	]	]	PUNCT
ajlm-2895	196	11	.	.	PUNCT
ajlm-2895	197	1	available	available	ADJ
ajlm-2895	197	2	from	from	ADP
ajlm-2895	197	3	:	:	PUNCT
ajlm-2895	197	4	https://microbiologyinfo.com/api-20e-test/	https://microbiologyinfo.com/api-20e-test/	PROPN
ajlm-2895	197	5	bauer	bauer	PROPN
ajlm-2895	197	6	aw	aw	PROPN
ajlm-2895	197	7	,	,	PUNCT
ajlm-2895	197	8	kirby	kirby	PROPN
ajlm-2895	197	9	wmm	wmm	PROPN
ajlm-2895	197	10	,	,	PUNCT
ajlm-2895	197	11	sherris	sherris	PROPN
ajlm-2895	197	12	jc	jc	PROPN
ajlm-2895	197	13	,	,	PUNCT
ajlm-2895	197	14	turck	turck	ADV
ajlm-2895	197	15	m.	m.	NOUN
ajlm-2895	197	16	antibiotic	antibiotic	ADJ
ajlm-2895	197	17	susceptibility	susceptibility	NOUN
ajlm-2895	197	18	testing	testing	NOUN
ajlm-2895	197	19	by	by	ADP
ajlm-2895	197	20	a	a	DET
ajlm-2895	197	21	standardized	standardized	ADJ
ajlm-2895	197	22	single	single	ADJ
ajlm-2895	197	23	disk	disk	NOUN
ajlm-2895	197	24	method	method	NOUN
ajlm-2895	197	25	.	.	PUNCT
ajlm-2895	198	1	am	be	AUX
ajlm-2895	198	2	j	j	PROPN
ajlm-2895	198	3	clin	clin	PROPN
ajlm-2895	198	4	pathol	pathol	NOUN
ajlm-2895	198	5	.	.	PUNCT
ajlm-2895	199	1	1966;45(4_ts):493–496	1966;45(4_ts):493–496	NOUN
ajlm-2895	199	2	.	.	PUNCT
ajlm-2895	199	3	https://doi.org/10.1093/ajcp/45.4_ts.493	https://doi.org/10.1093/ajcp/45.4_ts.493	PROPN
ajlm-2895	199	4	société	société	PROPN
ajlm-2895	199	5	française	française	PROPN
ajlm-2895	199	6	de	de	X
ajlm-2895	199	7	microbiologie	microbiologie	NOUN
ajlm-2895	199	8	.	.	PUNCT
ajlm-2895	200	1	casfm2021__v1.0.avril_2021.pdf	casfm2021__v1.0.avril_2021.pdf	PROPN
ajlm-2895	200	2	[	[	X
ajlm-2895	200	3	homepage	homepage	NOUN
ajlm-2895	200	4	on	on	ADP
ajlm-2895	200	5	the	the	DET
ajlm-2895	200	6	internet	internet	NOUN
ajlm-2895	200	7	]	]	PUNCT
ajlm-2895	200	8	.	.	PUNCT
ajlm-2895	201	1	[	[	X
ajlm-2895	201	2	cited	cite	VERB
ajlm-2895	201	3	2024	2024	NUM
ajlm-2895	201	4	aug	aug	NOUN
ajlm-2895	201	5	04	04	NUM
ajlm-2895	201	6	]	]	PUNCT
ajlm-2895	201	7	.	.	PUNCT
ajlm-2895	202	1	available	available	ADJ
ajlm-2895	202	2	from	from	ADP
ajlm-2895	202	3	:	:	PUNCT
ajlm-2895	202	4	https://www.sfm-microbiologie.org/wp-content/uploads/2021/04/casfm2021__v1.0.avril_2021.pdf	https://www.sfm-microbiologie.org/wp-content/uploads/2021/04/casfm2021__v1.0.avril_2021.pdf	NOUN
ajlm-2895	202	5	çalışkan	çalışkan	PROPN
ajlm-2895	202	6	e	e	PROPN
ajlm-2895	202	7	,	,	PUNCT
ajlm-2895	202	8	i̇nce	i̇nce	NOUN
ajlm-2895	202	9	n	n	CCONJ
ajlm-2895	202	10	,	,	PUNCT
ajlm-2895	202	11	akar	akar	PROPN
ajlm-2895	202	12	n	n	CCONJ
ajlm-2895	202	13	,	,	PUNCT
ajlm-2895	202	14	öztürk	öztürk	PROPN
ajlm-2895	202	15	ce	ce	PROPN
ajlm-2895	202	16	.	.	PROPN
ajlm-2895	202	17	investigation	investigation	NOUN
ajlm-2895	202	18	of	of	ADP
ajlm-2895	202	19	tigecycline	tigecycline	ADJ
ajlm-2895	202	20	susceptibility	susceptibility	NOUN
ajlm-2895	202	21	of	of	ADP
ajlm-2895	202	22	multidrug	multidrug	NOUN
ajlm-2895	202	23	-	-	PUNCT
ajlm-2895	202	24	resistant	resistant	ADJ
ajlm-2895	202	25	acinetobacter	acinetobacter	ADJ
ajlm-2895	202	26	baumannii	baumannii	ADJ
ajlm-2895	202	27	isolates	isolate	NOUN
ajlm-2895	202	28	by	by	ADP
ajlm-2895	202	29	disc	disc	NOUN
ajlm-2895	202	30	diffusion	diffusion	NOUN
ajlm-2895	202	31	,	,	PUNCT
ajlm-2895	202	32	agar	agar	NOUN
ajlm-2895	202	33	gradient	gradient	NOUN
ajlm-2895	202	34	and	and	CCONJ
ajlm-2895	202	35	broth	broth	ADJ
ajlm-2895	202	36	microdilution	microdilution	NOUN
ajlm-2895	202	37	tests	test	NOUN
ajlm-2895	202	38	.	.	PUNCT
ajlm-2895	203	1	acta	acta	PROPN
ajlm-2895	203	2	clin	clin	PROPN
ajlm-2895	203	3	croat	croat	PROPN
ajlm-2895	203	4	.	.	PUNCT
ajlm-2895	204	1	2022;61(1):46–51	2022;61(1):46–51	X
ajlm-2895	204	2	.	.	PUNCT
ajlm-2895	204	3	https://doi.org/10.20471/acc.2022.61.01.06	https://doi.org/10.20471/acc.2022.61.01.06	PROPN
ajlm-2895	204	4	kelesidis	kelesidis	PROPN
ajlm-2895	204	5	t	t	PROPN
ajlm-2895	204	6	,	,	PUNCT
ajlm-2895	204	7	karageorgopoulos	karageorgopoulo	NOUN
ajlm-2895	204	8	de	de	PROPN
ajlm-2895	204	9	,	,	PUNCT
ajlm-2895	204	10	kelesidis	kelesidis	PROPN
ajlm-2895	204	11	i	i	PROPN
ajlm-2895	204	12	,	,	PUNCT
ajlm-2895	204	13	falagas	falagas	VERB
ajlm-2895	204	14	me	i	PRON
ajlm-2895	204	15	.	.	PUNCT
ajlm-2895	205	1	tigecycline	tigecycline	VERB
ajlm-2895	205	2	for	for	ADP
ajlm-2895	205	3	the	the	DET
ajlm-2895	205	4	treatment	treatment	NOUN
ajlm-2895	205	5	of	of	ADP
ajlm-2895	205	6	multidrug	multidrug	NOUN
ajlm-2895	205	7	-	-	PUNCT
ajlm-2895	205	8	resistant	resistant	ADJ
ajlm-2895	205	9	enterobacteriaceae	enterobacteriaceae	NOUN
ajlm-2895	205	10	:	:	PUNCT
ajlm-2895	205	11	a	a	DET
ajlm-2895	205	12	systematic	systematic	ADJ
ajlm-2895	205	13	review	review	NOUN
ajlm-2895	205	14	of	of	ADP
ajlm-2895	205	15	the	the	DET
ajlm-2895	205	16	evidence	evidence	NOUN
ajlm-2895	205	17	from	from	ADP
ajlm-2895	205	18	microbiological	microbiological	ADJ
ajlm-2895	205	19	and	and	CCONJ
ajlm-2895	205	20	clinical	clinical	ADJ
ajlm-2895	205	21	studies	study	NOUN
ajlm-2895	205	22	.	.	PUNCT
ajlm-2895	206	1	j	j	PROPN
ajlm-2895	206	2	antimicrob	antimicrob	PROPN
ajlm-2895	206	3	chemother	chemother	PROPN
ajlm-2895	206	4	.	.	PUNCT
ajlm-2895	207	1	2008;62(5):895–904	2008;62(5):895–904	NUM
ajlm-2895	207	2	.	.	PUNCT
ajlm-2895	208	1	https://doi.org/10.1093/jac/dkn311	https://doi.org/10.1093/jac/dkn311	PROPN
ajlm-2895	208	2	zhang	zhang	PROPN
ajlm-2895	208	3	j	j	PROPN
ajlm-2895	208	4	,	,	PUNCT
ajlm-2895	208	5	yu	yu	PROPN
ajlm-2895	208	6	l	l	PROPN
ajlm-2895	208	7	,	,	PUNCT
ajlm-2895	208	8	fu	fu	PROPN
ajlm-2895	208	9	y	y	PROPN
ajlm-2895	208	10	,	,	PUNCT
ajlm-2895	208	11	et	et	PROPN
ajlm-2895	208	12	al	al	PROPN
ajlm-2895	208	13	.	.	PROPN
ajlm-2895	208	14	tigecycline	tigecycline	PROPN
ajlm-2895	208	15	in	in	ADP
ajlm-2895	208	16	combination	combination	NOUN
ajlm-2895	208	17	with	with	ADP
ajlm-2895	208	18	other	other	ADJ
ajlm-2895	208	19	antibiotics	antibiotic	NOUN
ajlm-2895	208	20	against	against	ADP
ajlm-2895	208	21	clinical	clinical	ADJ
ajlm-2895	208	22	isolates	isolate	NOUN
ajlm-2895	208	23	of	of	ADP
ajlm-2895	208	24	carbapenem	carbapenem	NOUN
ajlm-2895	208	25	-	-	PUNCT
ajlm-2895	208	26	resistant	resistant	ADJ
ajlm-2895	208	27	klebsiella	klebsiella	NOUN
ajlm-2895	208	28	pneumoniae	pneumoniae	ADJ
ajlm-2895	208	29	in	in	ADP
ajlm-2895	208	30	vitro	vitro	X
ajlm-2895	208	31	.	.	PUNCT
ajlm-2895	209	1	ann	ann	PROPN
ajlm-2895	209	2	palliat	palliat	PROPN
ajlm-2895	209	3	med	med	PROPN
ajlm-2895	209	4	.	.	PUNCT
ajlm-2895	210	1	2019;8(5):62231–62631	2019;8(5):62231–62631	X
ajlm-2895	210	2	.	.	PUNCT
ajlm-2895	211	1	https://doi.org/10.21037/apm.2019.09.11	https://doi.org/10.21037/apm.2019.09.11	VERB
ajlm-2895	211	2	morosini	morosini	PROPN
ajlm-2895	211	3	m	m	PROPN
ajlm-2895	211	4	-	-	PUNCT
ajlm-2895	211	5	i	i	PROPN
ajlm-2895	211	6	,	,	PUNCT
ajlm-2895	211	7	garcía	garcía	PROPN
ajlm-2895	211	8	-	-	PUNCT
ajlm-2895	211	9	castillo	castillo	PROPN
ajlm-2895	211	10	m	m	PROPN
ajlm-2895	211	11	,	,	PUNCT
ajlm-2895	211	12	coque	coque	PROPN
ajlm-2895	211	13	tm	tm	PROPN
ajlm-2895	211	14	,	,	PUNCT
ajlm-2895	211	15	et	et	PROPN
ajlm-2895	211	16	al	al	PROPN
ajlm-2895	211	17	.	.	PUNCT
ajlm-2895	212	1	antibiotic	antibiotic	ADJ
ajlm-2895	212	2	coresistance	coresistance	NOUN
ajlm-2895	212	3	in	in	ADP
ajlm-2895	212	4	extended	extend	VERB
ajlm-2895	212	5	-	-	PUNCT
ajlm-2895	212	6	spectrum	spectrum	NOUN
ajlm-2895	212	7	-	-	PUNCT
ajlm-2895	212	8	β	β	NOUN
ajlm-2895	212	9	-	-	PUNCT
ajlm-2895	212	10	lactamase	lactamase	NOUN
ajlm-2895	212	11	-	-	PUNCT
ajlm-2895	212	12	producing	produce	VERB
ajlm-2895	212	13	enterobacteriaceae	enterobacteriaceae	NOUN
ajlm-2895	212	14	and	and	CCONJ
ajlm-2895	212	15	in	in	ADP
ajlm-2895	212	16	vitro	vitro	X
ajlm-2895	212	17	activity	activity	NOUN
ajlm-2895	212	18	of	of	ADP
ajlm-2895	212	19	tigecycline	tigecycline	NOUN
ajlm-2895	212	20	.	.	PUNCT
ajlm-2895	213	1	antimicrob	antimicrob	PROPN
ajlm-2895	213	2	agents	agents	PROPN
ajlm-2895	213	3	chemother	chemother	PROPN
ajlm-2895	213	4	.	.	PUNCT
ajlm-2895	214	1	2006;50(8):2695–2699	2006;50(8):2695–2699	NOUN
ajlm-2895	214	2	.	.	PUNCT
ajlm-2895	215	1	https://doi.org/10.1128/aac.00155-06	https://doi.org/10.1128/aac.00155-06	PROPN
ajlm-2895	215	2	bazi	bazi	PROPN
ajlm-2895	215	3	ke	ke	PROPN
ajlm-2895	215	4	,	,	PUNCT
ajlm-2895	215	5	miloudi	miloudi	PROPN
ajlm-2895	215	6	m	m	PROPN
ajlm-2895	215	7	,	,	PUNCT
ajlm-2895	215	8	kamouni	kamouni	PROPN
ajlm-2895	215	9	ye	ye	PROPN
ajlm-2895	215	10	,	,	PUNCT
ajlm-2895	215	11	et	et	PROPN
ajlm-2895	215	12	al	al	PROPN
ajlm-2895	215	13	.	.	PROPN
ajlm-2895	216	1	tigecycline	tigecycline	PROPN
ajlm-2895	216	2	susceptibility	susceptibility	NOUN
ajlm-2895	216	3	among	among	ADP
ajlm-2895	216	4	multi	multi	ADJ
ajlm-2895	216	5	-	-	ADJ
ajlm-2895	216	6	drug	drug	ADJ
ajlm-2895	216	7	resistant	resistant	ADJ
ajlm-2895	216	8	bacteria	bacteria	NOUN
ajlm-2895	216	9	:	:	PUNCT
ajlm-2895	216	10	a	a	DET
ajlm-2895	216	11	7	7	NUM
ajlm-2895	216	12	-	-	PUNCT
ajlm-2895	216	13	year	year	NOUN
ajlm-2895	216	14	retrospective	retrospective	ADJ
ajlm-2895	216	15	study	study	NOUN
ajlm-2895	216	16	.	.	PUNCT
ajlm-2895	217	1	gsc	gsc	PROPN
ajlm-2895	218	1	adv	adv	PROPN
ajlm-2895	218	2	res	re	NOUN
ajlm-2895	218	3	rev	rev	PROPN
ajlm-2895	218	4	.	.	PUNCT
ajlm-2895	219	1	2022;11(1):79–83	2022;11(1):79–83	X
ajlm-2895	219	2	.	.	X
ajlm-2895	220	1	https://doi.org/10.30574/gscarr.2022.11.1.0096	https://doi.org/10.30574/gscarr.2022.11.1.0096	PROPN
ajlm-2895	220	2	menichetti	menichetti	PROPN
ajlm-2895	220	3	f.	f.	PROPN
ajlm-2895	220	4	tigecycline	tigecycline	PROPN
ajlm-2895	220	5	:	:	PUNCT
ajlm-2895	220	6	a	a	DET
ajlm-2895	220	7	new	new	ADJ
ajlm-2895	220	8	treatment	treatment	NOUN
ajlm-2895	220	9	option	option	NOUN
ajlm-2895	220	10	for	for	ADP
ajlm-2895	220	11	intra	intra	ADJ
ajlm-2895	220	12	-	-	ADJ
ajlm-2895	220	13	abdominal	abdominal	ADJ
ajlm-2895	220	14	infections	infection	NOUN
ajlm-2895	220	15	.	.	PUNCT
ajlm-2895	221	1	j	j	PROPN
ajlm-2895	221	2	chemother	chemother	PROPN
ajlm-2895	221	3	.	.	PUNCT
ajlm-2895	222	1	2009;21(suppl	2009;21(suppl	PROPN
ajlm-2895	223	1	1):36–38	1):36–38	NUM
ajlm-2895	223	2	.	.	PUNCT
ajlm-2895	223	3	https://doi.org/10.1179/joc.2009.21.supplement-1.36	https://doi.org/10.1179/joc.2009.21.supplement-1.36	PROPN
ajlm-2895	223	4	ku	ku	PROPN
ajlm-2895	223	5	y	y	PROPN
ajlm-2895	223	6	-	-	PUNCT
ajlm-2895	223	7	h	h	PROPN
ajlm-2895	223	8	,	,	PUNCT
ajlm-2895	223	9	chuang	chuang	PROPN
ajlm-2895	223	10	y	y	PROPN
ajlm-2895	223	11	-	-	PUNCT
ajlm-2895	223	12	c	c	PROPN
ajlm-2895	223	13	,	,	PUNCT
ajlm-2895	223	14	yu	yu	PROPN
ajlm-2895	223	15	w	w	PROPN
ajlm-2895	223	16	-	-	PUNCT
ajlm-2895	223	17	l.	l.	NOUN
ajlm-2895	223	18	in	in	ADP
ajlm-2895	223	19	vitro	vitro	X
ajlm-2895	223	20	activity	activity	NOUN
ajlm-2895	223	21	of	of	ADP
ajlm-2895	223	22	tigecycline	tigecycline	NOUN
ajlm-2895	223	23	against	against	ADP
ajlm-2895	223	24	clinical	clinical	ADJ
ajlm-2895	223	25	isolates	isolate	NOUN
ajlm-2895	223	26	of	of	ADP
ajlm-2895	223	27	extended	extend	VERB
ajlm-2895	223	28	-	-	PUNCT
ajlm-2895	223	29	spectrum	spectrum	NOUN
ajlm-2895	223	30	beta	beta	NOUN
ajlm-2895	223	31	-	-	PUNCT
ajlm-2895	223	32	lactamase	lactamase	NOUN
ajlm-2895	223	33	-	-	PUNCT
ajlm-2895	223	34	producing	produce	VERB
ajlm-2895	223	35	klebsiella	klebsiella	NOUN
ajlm-2895	223	36	pneumoniae	pneumoniae	NOUN
ajlm-2895	223	37	,	,	PUNCT
ajlm-2895	223	38	serratia	serratia	NOUN
ajlm-2895	223	39	marcescens	marcescen	NOUN
ajlm-2895	223	40	and	and	CCONJ
ajlm-2895	223	41	enterobacter	enterobacter	ADJ
ajlm-2895	223	42	cloacae	cloacae	NOUN
ajlm-2895	223	43	.	.	PUNCT
ajlm-2895	224	1	j	j	PROPN
ajlm-2895	224	2	microbiol	microbiol	PROPN
ajlm-2895	224	3	immunol	immunol	PROPN
ajlm-2895	224	4	infect	infect	NOUN
ajlm-2895	224	5	.	.	PUNCT
ajlm-2895	225	1	2008;41(4):332–336	2008;41(4):332–336	X
ajlm-2895	225	2	.	.	PUNCT
ajlm-2895	226	1	miltgen	miltgen	PROPN
ajlm-2895	226	2	g	g	PROPN
ajlm-2895	226	3	,	,	PUNCT
ajlm-2895	226	4	cholley	cholley	NOUN
ajlm-2895	226	5	p	p	NOUN
ajlm-2895	226	6	,	,	PUNCT
ajlm-2895	226	7	martak	martak	NOUN
ajlm-2895	226	8	d	d	PROPN
ajlm-2895	226	9	,	,	PUNCT
ajlm-2895	226	10	et	et	PROPN
ajlm-2895	226	11	al	al	PROPN
ajlm-2895	226	12	.	.	PUNCT
ajlm-2895	226	13	carbapenemase	carbapenemase	NOUN
ajlm-2895	226	14	-	-	PUNCT
ajlm-2895	226	15	producing	produce	VERB
ajlm-2895	226	16	enterobacteriaceae	enterobacteriaceae	NOUN
ajlm-2895	226	17	circulating	circulate	VERB
ajlm-2895	226	18	in	in	ADP
ajlm-2895	226	19	the	the	DET
ajlm-2895	226	20	reunion	reunion	NOUN
ajlm-2895	226	21	island	island	NOUN
ajlm-2895	226	22	,	,	PUNCT
ajlm-2895	226	23	a	a	DET
ajlm-2895	226	24	french	french	ADJ
ajlm-2895	226	25	territory	territory	NOUN
ajlm-2895	226	26	in	in	ADP
ajlm-2895	226	27	the	the	DET
ajlm-2895	226	28	southwest	southwest	PROPN
ajlm-2895	226	29	indian	indian	PROPN
ajlm-2895	226	30	ocean	ocean	PROPN
ajlm-2895	226	31	.	.	PUNCT
ajlm-2895	227	1	antimicrob	antimicrob	PROPN
ajlm-2895	227	2	resist	resist	VERB
ajlm-2895	227	3	infect	infect	ADJ
ajlm-2895	227	4	control	control	NOUN
ajlm-2895	227	5	.	.	PUNCT
ajlm-2895	228	1	2020;9(1):36	2020;9(1):36	X
ajlm-2895	228	2	.	.	PUNCT
ajlm-2895	228	3	https://doi.org/10.1186/s13756-020-0703-3	https://doi.org/10.1186/s13756-020-0703-3	PROPN
ajlm-2895	229	1	reygaert	reygaert	PROPN
ajlm-2895	229	2	wc	wc	PROPN
ajlm-2895	229	3	.	.	PUNCT
ajlm-2895	230	1	an	an	DET
ajlm-2895	230	2	overview	overview	NOUN
ajlm-2895	230	3	of	of	ADP
ajlm-2895	230	4	the	the	DET
ajlm-2895	230	5	antimicrobial	antimicrobial	ADJ
ajlm-2895	230	6	resistance	resistance	NOUN
ajlm-2895	230	7	mechanisms	mechanism	NOUN
ajlm-2895	230	8	of	of	ADP
ajlm-2895	230	9	bacteria	bacteria	NOUN
ajlm-2895	230	10	.	.	PUNCT
ajlm-2895	231	1	aims	aim	VERB
ajlm-2895	231	2	microbiol	microbiol	PROPN
ajlm-2895	231	3	2018;4(3):482–501	2018;4(3):482–501	NUM
ajlm-2895	231	4	.	.	PUNCT
ajlm-2895	232	1	https://doi.org/10.3934/microbiol.2018.3.482	https://doi.org/10.3934/microbiol.2018.3.482	PROPN
ajlm-2895	232	2	oz	oz	X
ajlm-2895	232	3	t	t	PROPN
ajlm-2895	232	4	,	,	PUNCT
ajlm-2895	232	5	guvenek	guvenek	VERB
ajlm-2895	232	6	a	a	DET
ajlm-2895	232	7	,	,	PUNCT
ajlm-2895	232	8	yildiz	yildiz	PROPN
ajlm-2895	232	9	s	s	PROPN
ajlm-2895	232	10	,	,	PUNCT
ajlm-2895	233	1	et	et	PROPN
ajlm-2895	233	2	al	al	PROPN
ajlm-2895	233	3	.	.	PROPN
ajlm-2895	233	4	strength	strength	NOUN
ajlm-2895	233	5	of	of	ADP
ajlm-2895	233	6	selection	selection	NOUN
ajlm-2895	233	7	pressure	pressure	NOUN
ajlm-2895	233	8	is	be	AUX
ajlm-2895	233	9	an	an	DET
ajlm-2895	233	10	important	important	ADJ
ajlm-2895	233	11	parameter	parameter	NOUN
ajlm-2895	233	12	contributing	contribute	VERB
ajlm-2895	233	13	to	to	ADP
ajlm-2895	233	14	the	the	DET
ajlm-2895	233	15	complexity	complexity	NOUN
ajlm-2895	233	16	of	of	ADP
ajlm-2895	233	17	antibiotic	antibiotic	ADJ
ajlm-2895	233	18	resistance	resistance	NOUN
ajlm-2895	233	19	evolution	evolution	NOUN
ajlm-2895	233	20	.	.	PUNCT
ajlm-2895	234	1	mol	mol	ADP
ajlm-2895	234	2	biol	biol	PROPN
ajlm-2895	234	3	evol	evol	NOUN
ajlm-2895	234	4	.	.	PUNCT
ajlm-2895	235	1	2014;31(9):2387–2401	2014;31(9):2387–2401	NUM
ajlm-2895	235	2	.	.	PUNCT
ajlm-2895	236	1	https://doi.org/10.1093/molbev/msu191	https://doi.org/10.1093/molbev/msu191	NOUN
ajlm-2895	236	2	giammanco	giammanco	NOUN
ajlm-2895	237	1	a	a	NOUN
ajlm-2895	237	2	,	,	PUNCT
ajlm-2895	237	3	calà	calà	PROPN
ajlm-2895	237	4	c	c	PROPN
ajlm-2895	237	5	,	,	PUNCT
ajlm-2895	237	6	fasciana	fasciana	PROPN
ajlm-2895	237	7	t	t	PROPN
ajlm-2895	237	8	,	,	PUNCT
ajlm-2895	237	9	dowzicky	dowzicky	PROPN
ajlm-2895	237	10	mj	mj	PROPN
ajlm-2895	237	11	.	.	PUNCT
ajlm-2895	237	12	global	global	ADJ
ajlm-2895	237	13	assessment	assessment	NOUN
ajlm-2895	237	14	of	of	ADP
ajlm-2895	237	15	the	the	DET
ajlm-2895	237	16	activity	activity	NOUN
ajlm-2895	237	17	of	of	ADP
ajlm-2895	237	18	tigecycline	tigecycline	NOUN
ajlm-2895	237	19	against	against	ADP
ajlm-2895	237	20	multidrug	multidrug	NOUN
ajlm-2895	237	21	-	-	PUNCT
ajlm-2895	237	22	resistant	resistant	ADJ
ajlm-2895	237	23	gram	gram	NOUN
ajlm-2895	237	24	-	-	PUNCT
ajlm-2895	237	25	negative	negative	ADJ
ajlm-2895	237	26	pathogens	pathogen	NOUN
ajlm-2895	237	27	between	between	ADP
ajlm-2895	237	28	2004	2004	NUM
ajlm-2895	237	29	and	and	CCONJ
ajlm-2895	237	30	2014	2014	NUM
ajlm-2895	237	31	as	as	ADP
ajlm-2895	237	32	part	part	NOUN
ajlm-2895	237	33	of	of	ADP
ajlm-2895	237	34	the	the	DET
ajlm-2895	237	35	tigecycline	tigecycline	ADJ
ajlm-2895	237	36	evaluation	evaluation	NOUN
ajlm-2895	237	37	and	and	CCONJ
ajlm-2895	237	38	surveillance	surveillance	NOUN
ajlm-2895	237	39	trial	trial	NOUN
ajlm-2895	237	40	.	.	PUNCT
ajlm-2895	238	1	msphere	msphere	PROPN
ajlm-2895	238	2	.	.	PUNCT
ajlm-2895	239	1	2017;2(1):e00310	2017;2(1):e00310	NUM
ajlm-2895	239	2	–	–	PUNCT
ajlm-2895	239	3	e00316	e00316	ADJ
ajlm-2895	239	4	.	.	PUNCT
ajlm-2895	240	1	https://doi.org/10.1128/msphere.00310-16	https://doi.org/10.1128/msphere.00310-16	PROPN
ajlm-2895	240	2	fatima	fatima	PROPN
ajlm-2895	240	3	m	m	PROPN
ajlm-2895	240	4	,	,	PUNCT
ajlm-2895	240	5	afridi	afridi	PROPN
ajlm-2895	240	6	fi	fi	PROPN
ajlm-2895	240	7	,	,	PUNCT
ajlm-2895	240	8	gohar	gohar	PROPN
ajlm-2895	240	9	h.	h.	PROPN
ajlm-2895	240	10	susceptibility	susceptibility	NOUN
ajlm-2895	240	11	of	of	ADP
ajlm-2895	240	12	tigecycline	tigecycline	NOUN
ajlm-2895	240	13	against	against	ADP
ajlm-2895	240	14	carbapenem	carbapenem	PROPN
ajlm-2895	240	15	resistant	resistant	ADJ
ajlm-2895	240	16	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-2895	240	17	.	.	PUNCT
ajlm-2895	241	1	pak	pak	PROPN
ajlm-2895	241	2	j	j	PROPN
ajlm-2895	241	3	med	med	PROPN
ajlm-2895	241	4	dent	dent	NOUN
ajlm-2895	241	5	.	.	PUNCT
ajlm-2895	242	1	2021;10(3):17–23	2021;10(3):17–23	X
ajlm-2895	242	2	.	.	PUNCT
ajlm-2895	242	3	mohanty	mohanty	PROPN
ajlm-2895	242	4	s	s	PROPN
ajlm-2895	242	5	,	,	PUNCT
ajlm-2895	242	6	mahapatra	mahapatra	ADJ
ajlm-2895	242	7	a.	a.	NOUN
ajlm-2895	242	8	in	in	ADP
ajlm-2895	242	9	vitro	vitro	X
ajlm-2895	242	10	activity	activity	NOUN
ajlm-2895	242	11	of	of	ADP
ajlm-2895	242	12	tigecycline	tigecycline	NOUN
ajlm-2895	242	13	against	against	ADP
ajlm-2895	242	14	multidrug	multidrug	NOUN
ajlm-2895	242	15	-	-	PUNCT
ajlm-2895	242	16	resistant	resistant	ADJ
ajlm-2895	242	17	enterobacteriaceae	enterobacteriaceae	NOUN
ajlm-2895	242	18	isolates	isolate	NOUN
ajlm-2895	242	19	from	from	ADP
ajlm-2895	242	20	skin	skin	NOUN
ajlm-2895	242	21	and	and	CCONJ
ajlm-2895	242	22	soft	soft	ADJ
ajlm-2895	242	23	tissue	tissue	NOUN
ajlm-2895	242	24	infections	infection	NOUN
ajlm-2895	242	25	.	.	PUNCT
ajlm-2895	243	1	ann	ann	PROPN
ajlm-2895	243	2	med	med	PROPN
ajlm-2895	243	3	surg	surg	NOUN
ajlm-2895	243	4	.	.	PUNCT
ajlm-2895	244	1	2021;62:228–230	2021;62:228–230	X
ajlm-2895	244	2	.	.	PUNCT
ajlm-2895	245	1	https://doi.org/10.1016/j.amsu.2021.01.010	https://doi.org/10.1016/j.amsu.2021.01.010	PROPN
ajlm-2895	245	2	wang	wang	PROPN
ajlm-2895	245	3	j	j	PROPN
ajlm-2895	245	4	,	,	PUNCT
ajlm-2895	245	5	liu	liu	PROPN
ajlm-2895	245	6	j	j	PROPN
ajlm-2895	245	7	,	,	PUNCT
ajlm-2895	245	8	lin	lin	PROPN
ajlm-2895	245	9	q	q	PROPN
ajlm-2895	245	10	,	,	PUNCT
ajlm-2895	245	11	et	et	PROPN
ajlm-2895	245	12	al	al	PROPN
ajlm-2895	245	13	.	.	PUNCT
ajlm-2895	246	1	a	a	DET
ajlm-2895	246	2	comparative	comparative	ADJ
ajlm-2895	246	3	analysis	analysis	NOUN
ajlm-2895	246	4	of	of	ADP
ajlm-2895	246	5	clinical	clinical	ADJ
ajlm-2895	246	6	outcomes	outcome	NOUN
ajlm-2895	246	7	in	in	ADP
ajlm-2895	246	8	hematological	hematological	ADJ
ajlm-2895	246	9	patients	patient	NOUN
ajlm-2895	246	10	afflicted	afflict	VERB
ajlm-2895	246	11	with	with	ADP
ajlm-2895	246	12	bacteremia	bacteremia	NOUN
ajlm-2895	246	13	attributable	attributable	ADJ
ajlm-2895	246	14	to	to	ADP
ajlm-2895	246	15	carbapenem	carbapenem	NOUN
ajlm-2895	246	16	-	-	PUNCT
ajlm-2895	246	17	resistant	resistant	ADJ
ajlm-2895	246	18	klebsiella	klebsiella	NOUN
ajlm-2895	246	19	pneumoniae	pneumoniae	ADJ
ajlm-2895	246	20	versus	versus	ADP
ajlm-2895	246	21	escherichia	escherichia	NOUN
ajlm-2895	246	22	coli	coli	NOUN
ajlm-2895	246	23	.	.	PUNCT
ajlm-2895	247	1	front	front	ADJ
ajlm-2895	247	2	cell	cell	NOUN
ajlm-2895	247	3	infect	infect	VERB
ajlm-2895	247	4	microbiol	microbiol	NOUN
ajlm-2895	247	5	.	.	PUNCT
ajlm-2895	248	1	2025;15:1600746	2025;15:1600746	NUM
ajlm-2895	248	2	.	.	PUNCT
ajlm-2895	249	1	https://doi.org/10.3389/fcimb.2025.1600746	https://doi.org/10.3389/fcimb.2025.1600746	PROPN
ajlm-2895	249	2	chiu	chiu	PROPN
ajlm-2895	249	3	s	s	PROPN
ajlm-2895	249	4	-	-	PROPN
ajlm-2895	249	5	k	k	PROPN
ajlm-2895	249	6	,	,	PUNCT
ajlm-2895	249	7	huang	huang	PROPN
ajlm-2895	249	8	l	l	PROPN
ajlm-2895	249	9	-	-	PROPN
ajlm-2895	249	10	y	y	PROPN
ajlm-2895	249	11	,	,	PUNCT
ajlm-2895	249	12	chen	chen	PROPN
ajlm-2895	249	13	h	h	PROPN
ajlm-2895	249	14	,	,	PUNCT
ajlm-2895	249	15	et	et	PROPN
ajlm-2895	249	16	al	al	PROPN
ajlm-2895	249	17	.	.	PROPN
ajlm-2895	249	18	roles	role	NOUN
ajlm-2895	249	19	of	of	ADP
ajlm-2895	249	20	ramr	ramr	NOUN
ajlm-2895	249	21	and	and	CCONJ
ajlm-2895	249	22	tet(a	tet(a	NOUN
ajlm-2895	249	23	)	)	PUNCT
ajlm-2895	249	24	mutations	mutation	NOUN
ajlm-2895	249	25	in	in	ADP
ajlm-2895	249	26	conferring	confer	VERB
ajlm-2895	249	27	tigecycline	tigecycline	ADJ
ajlm-2895	249	28	resistance	resistance	NOUN
ajlm-2895	249	29	in	in	ADP
ajlm-2895	249	30	carbapenem	carbapenem	NOUN
ajlm-2895	249	31	-	-	PUNCT
ajlm-2895	249	32	resistant	resistant	ADJ
ajlm-2895	249	33	klebsiella	klebsiella	NOUN
ajlm-2895	249	34	pneumoniae	pneumoniae	ADJ
ajlm-2895	249	35	clinical	clinical	ADJ
ajlm-2895	249	36	isolates	isolate	NOUN
ajlm-2895	249	37	.	.	PUNCT
ajlm-2895	250	1	antimicrob	antimicrob	PROPN
ajlm-2895	250	2	agents	agents	PROPN
ajlm-2895	250	3	chemother	chemother	PROPN
ajlm-2895	250	4	.	.	PUNCT
ajlm-2895	251	1	2017	2017	NUM
ajlm-2895	251	2	;	;	PUNCT
ajlm-2895	252	1	61(8):10	61(8):10	NUM
ajlm-2895	252	2	.	.	PUNCT
ajlm-2895	253	1	https://doi.org/10.1128/aac.00391-17	https://doi.org/10.1128/aac.00391-17	PROPN
ajlm-2895	253	2	chen	chen	PROPN
ajlm-2895	253	3	h	h	PROPN
ajlm-2895	253	4	,	,	PUNCT
ajlm-2895	253	5	jiang	jiang	PROPN
ajlm-2895	253	6	y	y	PROPN
ajlm-2895	253	7	,	,	PUNCT
ajlm-2895	253	8	li	li	PROPN
ajlm-2895	253	9	m	m	PROPN
ajlm-2895	253	10	,	,	PUNCT
ajlm-2895	253	11	et	et	PROPN
ajlm-2895	253	12	al	al	PROPN
ajlm-2895	253	13	.	.	PROPN
ajlm-2895	253	14	acquisition	acquisition	NOUN
ajlm-2895	253	15	of	of	ADP
ajlm-2895	253	16	tigecycline	tigecycline	PROPN
ajlm-2895	253	17	resistance	resistance	NOUN
ajlm-2895	253	18	by	by	ADP
ajlm-2895	253	19	carbapenem	carbapenem	NOUN
ajlm-2895	253	20	-	-	PUNCT
ajlm-2895	253	21	resistant	resistant	ADJ
ajlm-2895	253	22	klebsiella	klebsiella	NOUN
ajlm-2895	253	23	pneumoniae	pneumoniae	ADJ
ajlm-2895	253	24	confers	confer	NOUN
ajlm-2895	253	25	collateral	collateral	ADJ
ajlm-2895	253	26	hypersensitivity	hypersensitivity	NOUN
ajlm-2895	253	27	to	to	ADP
ajlm-2895	253	28	aminoglycosides	aminoglycoside	NOUN
ajlm-2895	253	29	.	.	PUNCT
ajlm-2895	254	1	front	front	ADJ
ajlm-2895	254	2	microbiol	microbiol	PROPN
ajlm-2895	254	3	.	.	PUNCT
ajlm-2895	255	1	2021;12:674502	2021;12:674502	X
ajlm-2895	255	2	.	.	PUNCT
ajlm-2895	256	1	https://doi.org/10.3389/fmicb.2021.674502	https://doi.org/10.3389/fmicb.2021.674502	PROPN
ajlm-2895	256	2	elgendy	elgendy	PROPN
ajlm-2895	256	3	sg	sg	PROPN
ajlm-2895	256	4	,	,	PUNCT
ajlm-2895	256	5	abdel	abdel	PROPN
ajlm-2895	256	6	hameed	hameed	PROPN
ajlm-2895	256	7	mr	mr	PROPN
ajlm-2895	256	8	,	,	PUNCT
ajlm-2895	256	9	el	el	PROPN
ajlm-2895	256	10	-	-	PUNCT
ajlm-2895	256	11	mokhtar	mokhtar	PROPN
ajlm-2895	257	1	ma	ma	PROPN
ajlm-2895	257	2	.	.	PROPN
ajlm-2895	257	3	tigecycline	tigecycline	PROPN
ajlm-2895	257	4	resistance	resistance	NOUN
ajlm-2895	257	5	among	among	ADP
ajlm-2895	257	6	klebsiella	klebsiella	NOUN
ajlm-2895	257	7	pneumoniae	pneumoniae	NOUN
ajlm-2895	257	8	isolated	isolate	VERB
ajlm-2895	257	9	from	from	ADP
ajlm-2895	257	10	febrile	febrile	NOUN
ajlm-2895	257	11	neutropenic	neutropenic	ADJ
ajlm-2895	257	12	patients	patient	NOUN
ajlm-2895	257	13	.	.	PUNCT
ajlm-2895	258	1	j	j	PROPN
ajlm-2895	258	2	med	med	PROPN
ajlm-2895	258	3	microbiol	microbiol	PROPN
ajlm-2895	258	4	.	.	PUNCT
ajlm-2895	259	1	2018;67(7):972–975	2018;67(7):972–975	NUM
ajlm-2895	259	2	.	.	PUNCT
ajlm-2895	260	1	https://doi.org/10.1099/jmm.0.000770	https://doi.org/10.1099/jmm.0.000770	PROPN
ajlm-2895	260	2	navon	navon	NOUN
ajlm-2895	260	3	-	-	PUNCT
ajlm-2895	260	4	venezia	venezia	PROPN
ajlm-2895	260	5	s	s	PROPN
ajlm-2895	260	6	,	,	PUNCT
ajlm-2895	260	7	leavitt	leavitt	X
ajlm-2895	260	8	a	a	DET
ajlm-2895	260	9	,	,	PUNCT
ajlm-2895	260	10	carmeli	carmeli	PROPN
ajlm-2895	260	11	y.	y.	PROPN
ajlm-2895	260	12	high	high	PROPN
ajlm-2895	260	13	tigecycline	tigecycline	PROPN
ajlm-2895	260	14	resistance	resistance	NOUN
ajlm-2895	260	15	in	in	ADP
ajlm-2895	260	16	multidrug	multidrug	NOUN
ajlm-2895	260	17	-	-	PUNCT
ajlm-2895	260	18	resistant	resistant	ADJ
ajlm-2895	260	19	acinetobacter	acinetobacter	ADJ
ajlm-2895	260	20	baumannii	baumannii	PROPN
ajlm-2895	260	21	.	.	PUNCT
ajlm-2895	261	1	j	j	PROPN
ajlm-2895	261	2	antimicrob	antimicrob	PROPN
ajlm-2895	261	3	chemother	chemother	PROPN
ajlm-2895	261	4	.	.	PUNCT
ajlm-2895	262	1	2007;59(4):772–774	2007;59(4):772–774	X
ajlm-2895	262	2	.	.	PUNCT
ajlm-2895	263	1	https://doi.org/10.1093/jac/dkm018	https://doi.org/10.1093/jac/dkm018	PROPN
ajlm-2895	263	2	ahmed	ahme	VERB
ajlm-2895	263	3	nh	nh	PROPN
ajlm-2895	263	4	,	,	PUNCT
ajlm-2895	263	5	baba	baba	PROPN
ajlm-2895	263	6	k	k	PROPN
ajlm-2895	263	7	,	,	PUNCT
ajlm-2895	263	8	clay	clay	NOUN
ajlm-2895	263	9	c	c	NOUN
ajlm-2895	263	10	,	,	PUNCT
ajlm-2895	263	11	lekalakala	lekalakala	NOUN
ajlm-2895	263	12	r	r	NOUN
ajlm-2895	263	13	,	,	PUNCT
ajlm-2895	263	14	hoosen	hoosen	NOUN
ajlm-2895	263	15	aa	aa	NOUN
ajlm-2895	263	16	.	.	PUNCT
ajlm-2895	264	1	in	in	ADP
ajlm-2895	264	2	vitro	vitro	X
ajlm-2895	264	3	activity	activity	NOUN
ajlm-2895	264	4	of	of	ADP
ajlm-2895	264	5	tigecycline	tigecycline	NOUN
ajlm-2895	264	6	against	against	ADP
ajlm-2895	264	7	clinical	clinical	ADJ
ajlm-2895	264	8	isolates	isolate	NOUN
ajlm-2895	264	9	of	of	ADP
ajlm-2895	264	10	carbapenem	carbapenem	PROPN
ajlm-2895	264	11	resistant	resistant	ADJ
ajlm-2895	264	12	acinetobacter	acinetobacter	ADV
ajlm-2895	264	13	baumannii	baumannii	ADJ
ajlm-2895	264	14	complex	complex	NOUN
ajlm-2895	264	15	in	in	ADP
ajlm-2895	264	16	pretoria	pretoria	PROPN
ajlm-2895	264	17	,	,	PUNCT
ajlm-2895	264	18	south	south	PROPN
ajlm-2895	264	19	africa	africa	PROPN
ajlm-2895	264	20	.	.	PUNCT
ajlm-2895	265	1	bmc	bmc	ADJ
ajlm-2895	265	2	res	re	NOUN
ajlm-2895	265	3	notes	note	NOUN
ajlm-2895	265	4	.	.	PUNCT
ajlm-2895	266	1	2012;5(1):215	2012;5(1):215	X
ajlm-2895	266	2	.	.	PUNCT
ajlm-2895	267	1	https://doi.org/10.1186/1756-0500-5-215	https://doi.org/10.1186/1756-0500-5-215	VERB
ajlm-2895	267	2	yin	yin	PROPN
ajlm-2895	267	3	d	d	PROPN
ajlm-2895	267	4	,	,	PUNCT
ajlm-2895	267	5	guo	guo	PROPN
ajlm-2895	267	6	y	y	PROPN
ajlm-2895	267	7	,	,	PUNCT
ajlm-2895	267	8	li	li	PROPN
ajlm-2895	267	9	m	m	PROPN
ajlm-2895	267	10	,	,	PUNCT
ajlm-2895	267	11	et	et	PROPN
ajlm-2895	267	12	al	al	PROPN
ajlm-2895	267	13	.	.	PUNCT
ajlm-2895	267	14	performance	performance	NOUN
ajlm-2895	267	15	of	of	ADP
ajlm-2895	267	16	vitek	vitek	PROPN
ajlm-2895	267	17	2	2	NUM
ajlm-2895	267	18	,	,	PUNCT
ajlm-2895	267	19	e	e	NOUN
ajlm-2895	267	20	-	-	NOUN
ajlm-2895	267	21	test	test	NOUN
ajlm-2895	267	22	,	,	PUNCT
ajlm-2895	267	23	kirby	kirby	PROPN
ajlm-2895	267	24	–	–	PUNCT
ajlm-2895	267	25	bauer	bauer	NOUN
ajlm-2895	267	26	disk	disk	NOUN
ajlm-2895	267	27	diffusion	diffusion	NOUN
ajlm-2895	267	28	,	,	PUNCT
ajlm-2895	267	29	and	and	CCONJ
ajlm-2895	267	30	modified	modify	VERB
ajlm-2895	267	31	kirby	kirby	PROPN
ajlm-2895	267	32	–	–	PUNCT
ajlm-2895	267	33	bauer	bauer	NOUN
ajlm-2895	267	34	disk	disk	NOUN
ajlm-2895	267	35	diffusion	diffusion	NOUN
ajlm-2895	267	36	compared	compare	VERB
ajlm-2895	267	37	to	to	PART
ajlm-2895	267	38	reference	reference	VERB
ajlm-2895	267	39	broth	broth	ADJ
ajlm-2895	267	40	microdilution	microdilution	NOUN
ajlm-2895	267	41	for	for	ADP
ajlm-2895	267	42	testing	testing	NOUN
ajlm-2895	267	43	tigecycline	tigecycline	NOUN
ajlm-2895	267	44	susceptibility	susceptibility	NOUN
ajlm-2895	267	45	of	of	ADP
ajlm-2895	267	46	carbapenem	carbapenem	NOUN
ajlm-2895	267	47	-	-	PUNCT
ajlm-2895	267	48	resistant	resistant	ADJ
ajlm-2895	267	49	k.	k.	NOUN
ajlm-2895	267	50	pneumoniae	pneumoniae	NOUN
ajlm-2895	267	51	and	and	CCONJ
ajlm-2895	267	52	a.	a.	NOUN
ajlm-2895	267	53	baumannii	baumannii	NOUN
ajlm-2895	267	54	in	in	ADP
ajlm-2895	267	55	a	a	DET
ajlm-2895	267	56	multicenter	multicenter	ADJ
ajlm-2895	267	57	study	study	NOUN
ajlm-2895	267	58	in	in	ADP
ajlm-2895	267	59	china	china	PROPN
ajlm-2895	267	60	.	.	PUNCT
ajlm-2895	268	1	eur	eur	PROPN
ajlm-2895	268	2	j	j	PROPN
ajlm-2895	268	3	clin	clin	PROPN
ajlm-2895	268	4	microbiol	microbiol	PROPN
ajlm-2895	268	5	infect	infect	VERB
ajlm-2895	268	6	dis	dis	PROPN
ajlm-2895	268	7	.	.	PUNCT
ajlm-2895	269	1	2021;40(6):1149–1154	2021;40(6):1149–1154	NOUN
ajlm-2895	269	2	.	.	PUNCT
ajlm-2895	270	1	https://doi.org/10.1007/s10096-020-04123-z	https://doi.org/10.1007/s10096-020-04123-z	PROPN
ajlm-2895	270	2	zarkotou	zarkotou	PROPN
ajlm-2895	270	3	o	o	PROPN
ajlm-2895	270	4	,	,	PUNCT
ajlm-2895	270	5	pournaras	pournaras	PROPN
ajlm-2895	270	6	s	s	PART
ajlm-2895	270	7	,	,	PUNCT
ajlm-2895	270	8	altouvas	altouvas	NOUN
ajlm-2895	270	9	g	g	NOUN
ajlm-2895	270	10	,	,	PUNCT
ajlm-2895	270	11	et	et	PROPN
ajlm-2895	270	12	al	al	PROPN
ajlm-2895	270	13	.	.	PROPN
ajlm-2895	270	14	comparative	comparative	ADJ
ajlm-2895	270	15	evaluation	evaluation	NOUN
ajlm-2895	270	16	of	of	ADP
ajlm-2895	270	17	tigecycline	tigecycline	ADJ
ajlm-2895	270	18	susceptibility	susceptibility	NOUN
ajlm-2895	270	19	testing	testing	NOUN
ajlm-2895	270	20	methods	method	NOUN
ajlm-2895	270	21	for	for	ADP
ajlm-2895	270	22	expanded	expand	VERB
ajlm-2895	270	23	-	-	PUNCT
ajlm-2895	270	24	spectrum	spectrum	NOUN
ajlm-2895	270	25	cephalosporinand	cephalosporinand	ADJ
ajlm-2895	270	26	carbapenem	carbapenem	NOUN
ajlm-2895	270	27	-	-	PUNCT
ajlm-2895	270	28	resistant	resistant	ADJ
ajlm-2895	270	29	gram	gram	NOUN
ajlm-2895	270	30	-	-	PUNCT
ajlm-2895	270	31	negative	negative	ADJ
ajlm-2895	270	32	pathogens	pathogen	NOUN
ajlm-2895	270	33	.	.	PUNCT
ajlm-2895	271	1	j	j	PROPN
ajlm-2895	271	2	clin	clin	PROPN
ajlm-2895	271	3	microbiol	microbiol	PROPN
ajlm-2895	271	4	.	.	PUNCT
ajlm-2895	272	1	2020;50(11):3747–3750	2020;50(11):3747–3750	X
ajlm-2895	272	2	.	.	PUNCT
ajlm-2895	273	1	https://doi.org/10.1128/jcm.02037-12	https://doi.org/10.1128/jcm.02037-12	PROPN
ajlm-2895	273	2	qu	qu	PROPN
ajlm-2895	273	3	j	j	PROPN
ajlm-2895	273	4	,	,	PUNCT
ajlm-2895	273	5	zong	zong	PROPN
ajlm-2895	273	6	z	z	PROPN
ajlm-2895	273	7	,	,	PUNCT
ajlm-2895	273	8	yu	yu	PROPN
ajlm-2895	273	9	r	r	PROPN
ajlm-2895	273	10	,	,	PUNCT
ajlm-2895	273	11	hu	hu	PROPN
ajlm-2895	273	12	t	t	PROPN
ajlm-2895	273	13	,	,	PUNCT
ajlm-2895	273	14	ye	ye	PROPN
ajlm-2895	273	15	h	h	NOUN
ajlm-2895	273	16	,	,	PUNCT
ajlm-2895	273	17	lü	lü	PROPN
ajlm-2895	273	18	x.	x.	NOUN
ajlm-2895	273	19	impact	impact	NOUN
ajlm-2895	273	20	of	of	ADP
ajlm-2895	273	21	test	test	NOUN
ajlm-2895	273	22	methodology	methodology	NOUN
ajlm-2895	273	23	,	,	PUNCT
ajlm-2895	273	24	media	medium	NOUN
ajlm-2895	273	25	type	type	NOUN
ajlm-2895	273	26	and	and	CCONJ
ajlm-2895	273	27	ion	ion	NOUN
ajlm-2895	273	28	content	content	NOUN
ajlm-2895	273	29	on	on	ADP
ajlm-2895	273	30	the	the	DET
ajlm-2895	273	31	susceptibility	susceptibility	NOUN
ajlm-2895	273	32	of	of	ADP
ajlm-2895	273	33	acinetobacter	acinetobacter	ADJ
ajlm-2895	273	34	spp	spp	NOUN
ajlm-2895	273	35	.	.	PUNCT
ajlm-2895	274	1	to	to	PART
ajlm-2895	274	2	tigecycline	tigecycline	VERB
ajlm-2895	274	3	.	.	PUNCT
ajlm-2895	275	1	j	j	PROPN
ajlm-2895	275	2	antimicrob	antimicrob	PROPN
ajlm-2895	275	3	chemother	chemother	PROPN
ajlm-2895	275	4	.	.	PUNCT
ajlm-2895	276	1	2014;69(6):1710–1711	2014;69(6):1710–1711	NOUN
ajlm-2895	276	2	.	.	PUNCT
ajlm-2895	277	1	https://doi.org/10.1093/jac/dkt546	https://doi.org/10.1093/jac/dkt546	PROPN
ajlm-2895	277	2	fernández	fernández	PROPN
ajlm-2895	277	3	-	-	PUNCT
ajlm-2895	277	4	mazarrasa	mazarrasa	PROPN
ajlm-2895	277	5	c	c	PROPN
ajlm-2895	277	6	,	,	PUNCT
ajlm-2895	277	7	mazarrasa	mazarrasa	PROPN
ajlm-2895	277	8	o	o	NOUN
ajlm-2895	277	9	,	,	PUNCT
ajlm-2895	277	10	calvo	calvo	PROPN
ajlm-2895	277	11	j	j	PROPN
ajlm-2895	277	12	,	,	PUNCT
ajlm-2895	277	13	arco	arco	PROPN
ajlm-2895	277	14	a	a	DET
ajlm-2895	277	15	del	del	PROPN
ajlm-2895	277	16	,	,	PUNCT
ajlm-2895	277	17	martínez	martínez	NOUN
ajlm-2895	277	18	-	-	PUNCT
ajlm-2895	277	19	martínez	martínez	PROPN
ajlm-2895	277	20	l.	l.	PROPN
ajlm-2895	277	21	high	high	PROPN
ajlm-2895	277	22	concentrations	concentration	NOUN
ajlm-2895	277	23	of	of	ADP
ajlm-2895	277	24	manganese	manganese	NOUN
ajlm-2895	277	25	in	in	ADP
ajlm-2895	277	26	mueller	mueller	PROPN
ajlm-2895	277	27	-	-	PUNCT
ajlm-2895	277	28	hinton	hinton	PROPN
ajlm-2895	277	29	agar	agar	NOUN
ajlm-2895	277	30	increase	increase	NOUN
ajlm-2895	277	31	mics	mic	NOUN
ajlm-2895	277	32	of	of	ADP
ajlm-2895	277	33	tigecycline	tigecycline	NOUN
ajlm-2895	277	34	determined	determine	VERB
ajlm-2895	277	35	by	by	ADP
ajlm-2895	277	36	etest	et	ADJ
ajlm-2895	277	37	.	.	PUNCT
ajlm-2895	278	1	j	j	PROPN
ajlm-2895	278	2	clin	clin	PROPN
ajlm-2895	278	3	microbiol	microbiol	PROPN
ajlm-2895	278	4	.	.	PUNCT
ajlm-2895	279	1	2009;47(3):827–829	2009;47(3):827–829	NUM
ajlm-2895	279	2	.	.	PUNCT
ajlm-2895	280	1	https://doi.org/10.1128/jcm.02464-08	https://doi.org/10.1128/jcm.02464-08	PROPN
ajlm-2895	280	2	jones	jones	PROPN
ajlm-2895	280	3	rn	rn	PROPN
ajlm-2895	280	4	,	,	PUNCT
ajlm-2895	280	5	ferraro	ferraro	PROPN
ajlm-2895	280	6	mj	mj	PROPN
ajlm-2895	280	7	,	,	PUNCT
ajlm-2895	280	8	reller	reller	NOUN
ajlm-2895	280	9	lb	lb	NOUN
ajlm-2895	280	10	,	,	PUNCT
ajlm-2895	280	11	schreckenberger	schreckenberger	NOUN
ajlm-2895	280	12	pc	pc	NOUN
ajlm-2895	280	13	,	,	PUNCT
ajlm-2895	280	14	swenson	swenson	PROPN
ajlm-2895	280	15	jm	jm	PROPN
ajlm-2895	280	16	,	,	PUNCT
ajlm-2895	280	17	sader	sader	PROPN
ajlm-2895	280	18	hs	hs	PROPN
ajlm-2895	280	19	.	.	PROPN
ajlm-2895	280	20	multicenter	multicenter	NOUN
ajlm-2895	280	21	studies	study	NOUN
ajlm-2895	280	22	of	of	ADP
ajlm-2895	280	23	tigecycline	tigecycline	ADJ
ajlm-2895	280	24	disk	disk	NOUN
ajlm-2895	280	25	diffusion	diffusion	NOUN
ajlm-2895	280	26	susceptibility	susceptibility	NOUN
ajlm-2895	280	27	results	result	VERB
ajlm-2895	280	28	for	for	ADP
ajlm-2895	280	29	acinetobacter	acinetobacter	ADJ
ajlm-2895	280	30	spp	spp	NOUN
ajlm-2895	280	31	.	.	PUNCT
ajlm-2895	281	1	j	j	PROPN
ajlm-2895	281	2	clin	clin	PROPN
ajlm-2895	281	3	microbiol	microbiol	PROPN
ajlm-2895	281	4	.	.	PUNCT
ajlm-2895	282	1	2007;45(1):227–230	2007;45(1):227–230	NUM
ajlm-2895	282	2	.	.	PUNCT
ajlm-2895	283	1	https://doi.org/10.1128/jcm.01588-06	https://doi.org/10.1128/jcm.01588-06	PROPN
ajlm-2895	283	2	casal	casal	PROPN
ajlm-2895	283	3	m	m	PROPN
ajlm-2895	283	4	,	,	PUNCT
ajlm-2895	283	5	rodríguez	rodríguez	VERB
ajlm-2895	283	6	f	f	PROPN
ajlm-2895	283	7	,	,	PUNCT
ajlm-2895	283	8	johnson	johnson	PROPN
ajlm-2895	283	9	b	b	PROPN
ajlm-2895	283	10	,	,	PUNCT
ajlm-2895	283	11	et	et	PROPN
ajlm-2895	283	12	al	al	PROPN
ajlm-2895	283	13	.	.	PUNCT
ajlm-2895	283	14	influence	influence	NOUN
ajlm-2895	283	15	of	of	ADP
ajlm-2895	283	16	testing	testing	NOUN
ajlm-2895	283	17	methodology	methodology	NOUN
ajlm-2895	283	18	on	on	ADP
ajlm-2895	283	19	the	the	DET
ajlm-2895	283	20	tigecycline	tigecycline	ADJ
ajlm-2895	283	21	activity	activity	NOUN
ajlm-2895	283	22	profile	profile	NOUN
ajlm-2895	283	23	against	against	ADP
ajlm-2895	283	24	presumably	presumably	ADV
ajlm-2895	283	25	tigecycline	tigecycline	VERB
ajlm-2895	283	26	-	-	PUNCT
ajlm-2895	283	27	non	non	ADJ
ajlm-2895	283	28	-	-	ADJ
ajlm-2895	283	29	susceptible	susceptible	ADJ
ajlm-2895	283	30	acinetobacter	acinetobacter	ADJ
ajlm-2895	283	31	spp	spp	NOUN
ajlm-2895	283	32	.	.	PUNCT
ajlm-2895	284	1	j	j	PROPN
ajlm-2895	284	2	antimicrob	antimicrob	PROPN
ajlm-2895	284	3	chemother	chemother	PROPN
ajlm-2895	284	4	.	.	PUNCT
ajlm-2895	285	1	2009;64(1):69–72	2009;64(1):69–72	X
ajlm-2895	285	2	.	.	PUNCT
ajlm-2895	286	1	https://doi.org/10.1093/jac/dkp169	https://doi.org/10.1093/jac/dkp169	PROPN
ajlm-2895	286	2	hope	hope	PROPN
ajlm-2895	286	3	r	r	PROPN
ajlm-2895	286	4	,	,	PUNCT
ajlm-2895	286	5	mushtaq	mushtaq	PROPN
ajlm-2895	286	6	s	s	PROPN
ajlm-2895	286	7	,	,	PUNCT
ajlm-2895	286	8	james	james	PROPN
ajlm-2895	286	9	d	d	PROPN
ajlm-2895	286	10	,	,	PUNCT
ajlm-2895	286	11	et	et	PROPN
ajlm-2895	286	12	al	al	PROPN
ajlm-2895	286	13	.	.	PROPN
ajlm-2895	286	14	tigecycline	tigecycline	PROPN
ajlm-2895	286	15	activity	activity	NOUN
ajlm-2895	286	16	:	:	PUNCT
ajlm-2895	286	17	low	low	ADJ
ajlm-2895	286	18	resistance	resistance	NOUN
ajlm-2895	286	19	rates	rate	NOUN
ajlm-2895	286	20	but	but	CCONJ
ajlm-2895	286	21	problematic	problematic	ADJ
ajlm-2895	286	22	disc	disc	NOUN
ajlm-2895	286	23	breakpoints	breakpoint	NOUN
ajlm-2895	286	24	revealed	reveal	VERB
ajlm-2895	286	25	by	by	ADP
ajlm-2895	286	26	a	a	DET
ajlm-2895	286	27	multicentre	multicentre	NOUN
ajlm-2895	286	28	sentinel	sentinel	ADJ
ajlm-2895	286	29	survey	survey	NOUN
ajlm-2895	286	30	in	in	ADP
ajlm-2895	286	31	the	the	DET
ajlm-2895	286	32	uk	uk	PROPN
ajlm-2895	286	33	.	.	PROPN
ajlm-2895	286	34	j	j	PROPN
ajlm-2895	286	35	antimicrob	antimicrob	PROPN
ajlm-2895	286	36	chemother	chemother	PROPN
ajlm-2895	286	37	.	.	PUNCT
ajlm-2895	287	1	2010;65(12):2602–2609	2010;65(12):2602–2609	NOUN
ajlm-2895	287	2	.	.	PUNCT
ajlm-2895	288	1	https://doi.org/10.1093/jac/dkq370	https://doi.org/10.1093/jac/dkq370	PRON
ajlm-2895	288	2	lall	lall	PROPN
ajlm-2895	288	3	s	s	PROPN
ajlm-2895	288	4	,	,	PUNCT
ajlm-2895	288	5	bhat	bhat	PROPN
ajlm-2895	288	6	v	v	PROPN
ajlm-2895	288	7	,	,	PUNCT
ajlm-2895	288	8	biswas	biswas	PROPN
ajlm-2895	288	9	s	s	PROPN
ajlm-2895	288	10	,	,	PUNCT
ajlm-2895	288	11	khattry	khattry	PROPN
ajlm-2895	288	12	n.	n.	PROPN
ajlm-2895	288	13	comparative	comparative	ADJ
ajlm-2895	288	14	evaluation	evaluation	NOUN
ajlm-2895	288	15	of	of	ADP
ajlm-2895	288	16	in	in	ADP
ajlm-2895	288	17	vitro	vitro	X
ajlm-2895	288	18	activity	activity	NOUN
ajlm-2895	288	19	of	of	ADP
ajlm-2895	288	20	tigecycline	tigecycline	NOUN
ajlm-2895	288	21	using	use	VERB
ajlm-2895	288	22	the	the	DET
ajlm-2895	288	23	disc	disc	NOUN
ajlm-2895	288	24	diffusion	diffusion	NOUN
ajlm-2895	288	25	method	method	NOUN
ajlm-2895	288	26	and	and	CCONJ
ajlm-2895	288	27	the	the	DET
ajlm-2895	288	28	vitek-2	vitek-2	NUM
ajlm-2895	288	29	compact	compact	ADJ
ajlm-2895	288	30	in	in	ADP
ajlm-2895	288	31	clinical	clinical	ADJ
ajlm-2895	288	32	isolates	isolate	NOUN
ajlm-2895	288	33	at	at	ADP
ajlm-2895	288	34	a	a	DET
ajlm-2895	288	35	tertiary	tertiary	ADJ
ajlm-2895	288	36	care	care	NOUN
ajlm-2895	288	37	cancer	cancer	NOUN
ajlm-2895	288	38	center	center	NOUN
ajlm-2895	288	39	.	.	PUNCT
ajlm-2895	289	1	med	med	ADJ
ajlm-2895	289	2	lab	lab	NOUN
ajlm-2895	289	3	j.	j.	PROPN
ajlm-2895	289	4	2024;18(4):17–21	2024;18(4):17–21	PROPN
ajlm-2895	289	5	.	.	PUNCT
ajlm-2895	290	1	che	che	PROPN
ajlm-2895	290	2	hamzah	hamzah	PROPN
ajlm-2895	290	3	am	am	PROPN
ajlm-2895	290	4	,	,	PUNCT
ajlm-2895	290	5	yeo	yeo	PROPN
ajlm-2895	290	6	cc	cc	PROPN
ajlm-2895	290	7	,	,	PUNCT
ajlm-2895	290	8	puah	puah	PROPN
ajlm-2895	290	9	sm	sm	PROPN
ajlm-2895	290	10	,	,	PUNCT
ajlm-2895	290	11	et	et	PROPN
ajlm-2895	290	12	al	al	PROPN
ajlm-2895	290	13	.	.	PROPN
ajlm-2895	290	14	tigecycline	tigecycline	PROPN
ajlm-2895	290	15	and	and	CCONJ
ajlm-2895	290	16	inducible	inducible	ADJ
ajlm-2895	290	17	clindamycin	clindamycin	NOUN
ajlm-2895	290	18	resistance	resistance	NOUN
ajlm-2895	290	19	in	in	ADP
ajlm-2895	290	20	clinical	clinical	ADJ
ajlm-2895	290	21	isolates	isolate	NOUN
ajlm-2895	290	22	of	of	ADP
ajlm-2895	290	23	methicillin	methicillin	NOUN
ajlm-2895	290	24	-	-	PUNCT
ajlm-2895	290	25	resistant	resistant	ADJ
ajlm-2895	290	26	staphylococcus	staphylococcus	NOUN
ajlm-2895	290	27	aureus	aureus	NOUN
ajlm-2895	290	28	from	from	ADP
ajlm-2895	290	29	terengganu	terengganu	PROPN
ajlm-2895	290	30	,	,	PUNCT
ajlm-2895	290	31	malaysia	malaysia	PROPN
ajlm-2895	290	32	.	.	PUNCT
ajlm-2895	291	1	j	j	PROPN
ajlm-2895	291	2	med	med	PROPN
ajlm-2895	291	3	microbiol	microbiol	PROPN
ajlm-2895	291	4	.	.	PUNCT
ajlm-2895	292	1	2019;68(9):1299–1305	2019;68(9):1299–1305	NUM
ajlm-2895	292	2	.	.	PUNCT
ajlm-2895	293	1	https://doi.org/10.1099/jmm.0.000993	https://doi.org/10.1099/jmm.0.000993	PROPN
ajlm-2895	293	2	pfaller	pfaller	PROPN
ajlm-2895	293	3	ma	ma	PROPN
ajlm-2895	293	4	,	,	PUNCT
ajlm-2895	293	5	huband	huband	PROPN
ajlm-2895	293	6	md	md	PROPN
ajlm-2895	293	7	,	,	PUNCT
ajlm-2895	293	8	streit	streit	PROPN
ajlm-2895	293	9	jm	jm	PROPN
ajlm-2895	293	10	,	,	PUNCT
ajlm-2895	293	11	flamm	flamm	PROPN
ajlm-2895	293	12	rk	rk	PROPN
ajlm-2895	293	13	,	,	PUNCT
ajlm-2895	293	14	sader	sader	PROPN
ajlm-2895	293	15	hs	hs	PROPN
ajlm-2895	293	16	.	.	PROPN
ajlm-2895	293	17	surveillance	surveillance	NOUN
ajlm-2895	293	18	of	of	ADP
ajlm-2895	293	19	tigecycline	tigecycline	ADJ
ajlm-2895	293	20	activity	activity	NOUN
ajlm-2895	293	21	tested	test	VERB
ajlm-2895	293	22	against	against	ADP
ajlm-2895	293	23	clinical	clinical	ADJ
ajlm-2895	293	24	isolates	isolate	NOUN
ajlm-2895	293	25	from	from	ADP
ajlm-2895	293	26	a	a	DET
ajlm-2895	293	27	global	global	ADJ
ajlm-2895	293	28	(	(	PUNCT
ajlm-2895	293	29	north	north	PROPN
ajlm-2895	293	30	america	america	PROPN
ajlm-2895	293	31	,	,	PUNCT
ajlm-2895	293	32	europe	europe	PROPN
ajlm-2895	293	33	,	,	PUNCT
ajlm-2895	293	34	latin	latin	PROPN
ajlm-2895	293	35	america	america	PROPN
ajlm-2895	293	36	and	and	CCONJ
ajlm-2895	293	37	asia	asia	PROPN
ajlm-2895	293	38	-	-	PUNCT
ajlm-2895	293	39	pacific	pacific	PROPN
ajlm-2895	293	40	)	)	PUNCT
ajlm-2895	293	41	collection	collection	NOUN
ajlm-2895	293	42	(	(	PUNCT
ajlm-2895	293	43	2016	2016	NUM
ajlm-2895	293	44	)	)	PUNCT
ajlm-2895	293	45	.	.	PUNCT
ajlm-2895	294	1	int	int	PROPN
ajlm-2895	294	2	j	j	PROPN
ajlm-2895	294	3	antimicrob	antimicrob	PROPN
ajlm-2895	294	4	agents	agent	NOUN
ajlm-2895	294	5	.	.	PUNCT
ajlm-2895	295	1	2018;51(6):848–853	2018;51(6):848–853	X
ajlm-2895	295	2	.	.	PUNCT
ajlm-2895	296	1	https://doi.org/10.1016/j.ijantimicag.2018.01.006	https://doi.org/10.1016/j.ijantimicag.2018.01.006	NOUN
ajlm-2895	296	2	yang	yang	PROPN
ajlm-2895	296	3	q	q	PROPN
ajlm-2895	296	4	,	,	PUNCT
ajlm-2895	296	5	xu	xu	PROPN
ajlm-2895	296	6	y	y	PROPN
ajlm-2895	296	7	-	-	PUNCT
ajlm-2895	296	8	c	c	PROPN
ajlm-2895	296	9	,	,	PUNCT
ajlm-2895	296	10	kiratisin	kiratisin	PROPN
ajlm-2895	296	11	p	p	X
ajlm-2895	296	12	,	,	PUNCT
ajlm-2895	296	13	dowzicky	dowzicky	PROPN
ajlm-2895	296	14	mj	mj	PROPN
ajlm-2895	296	15	.	.	PUNCT
ajlm-2895	296	16	antimicrobial	antimicrobial	ADJ
ajlm-2895	296	17	activity	activity	NOUN
ajlm-2895	296	18	among	among	ADP
ajlm-2895	296	19	gram	gram	NOUN
ajlm-2895	296	20	-	-	PUNCT
ajlm-2895	296	21	positive	positive	ADJ
ajlm-2895	296	22	and	and	CCONJ
ajlm-2895	296	23	gram	gram	NOUN
ajlm-2895	296	24	-	-	PUNCT
ajlm-2895	296	25	negative	negative	ADJ
ajlm-2895	296	26	organisms	organism	NOUN
ajlm-2895	296	27	collected	collect	VERB
ajlm-2895	296	28	from	from	ADP
ajlm-2895	296	29	the	the	DET
ajlm-2895	296	30	asia	asia	PROPN
ajlm-2895	296	31	-	-	PUNCT
ajlm-2895	296	32	pacific	pacific	PROPN
ajlm-2895	296	33	region	region	NOUN
ajlm-2895	296	34	as	as	ADP
ajlm-2895	296	35	part	part	NOUN
ajlm-2895	296	36	of	of	ADP
ajlm-2895	296	37	the	the	DET
ajlm-2895	296	38	tigecycline	tigecycline	ADJ
ajlm-2895	296	39	evaluation	evaluation	NOUN
ajlm-2895	296	40	and	and	CCONJ
ajlm-2895	296	41	surveillance	surveillance	NOUN
ajlm-2895	296	42	trial	trial	NOUN
ajlm-2895	296	43	:	:	PUNCT
ajlm-2895	296	44	comparison	comparison	NOUN
ajlm-2895	296	45	of	of	ADP
ajlm-2895	296	46	2015	2015	NUM
ajlm-2895	296	47	results	result	NOUN
ajlm-2895	296	48	with	with	ADP
ajlm-2895	296	49	previous	previous	ADJ
ajlm-2895	296	50	years	year	NOUN
ajlm-2895	296	51	.	.	PUNCT
ajlm-2895	297	1	diagn	diagn	PROPN
ajlm-2895	297	2	microbiol	microbiol	PROPN
ajlm-2895	297	3	infect	infect	VERB
ajlm-2895	297	4	dis	dis	PROPN
ajlm-2895	297	5	.	.	PUNCT
ajlm-2895	298	1	2017;89(4):314–323	2017;89(4):314–323	X
ajlm-2895	298	2	.	.	PUNCT
ajlm-2895	298	3	https://doi.org/10.1016/j.diagmicrobio.2017.08.014	https://doi.org/10.1016/j.diagmicrobio.2017.08.014	PROPN
ajlm-2895	298	4	khalili	khalili	PROPN
ajlm-2895	298	5	h	h	PROPN
ajlm-2895	298	6	,	,	PUNCT
ajlm-2895	298	7	dashti	dashti	NOUN
ajlm-2895	298	8	-	-	PUNCT
ajlm-2895	298	9	khavidaki	khavidaki	PROPN
ajlm-2895	298	10	s	s	NOUN
ajlm-2895	298	11	,	,	PUNCT
ajlm-2895	298	12	khaleghi	khaleghi	PROPN
ajlm-2895	298	13	s	s	PROPN
ajlm-2895	298	14	,	,	PUNCT
ajlm-2895	298	15	maleki	maleki	VERB
ajlm-2895	298	16	z	z	NOUN
ajlm-2895	298	17	,	,	PUNCT
ajlm-2895	298	18	rasoolinejad	rasoolinejad	NOUN
ajlm-2895	298	19	m.	m.	NOUN
ajlm-2895	298	20	evaluation	evaluation	NOUN
ajlm-2895	298	21	of	of	ADP
ajlm-2895	298	22	tigecycline	tigecycline	ADJ
ajlm-2895	298	23	activity	activity	NOUN
ajlm-2895	298	24	against	against	ADP
ajlm-2895	298	25	methicillin	methicillin	NOUN
ajlm-2895	298	26	-	-	PUNCT
ajlm-2895	298	27	resistante	resistante	NOUN
ajlm-2895	298	28	staphylococcus	staphylococcus	NOUN
ajlm-2895	298	29	aureus	aureus	NOUN
ajlm-2895	298	30	isolated	isolate	VERB
ajlm-2895	298	31	from	from	ADP
ajlm-2895	298	32	biological	biological	ADJ
ajlm-2895	298	33	samples	sample	NOUN
ajlm-2895	298	34	.	.	PUNCT
ajlm-2895	299	1	iran	iran	PROPN
ajlm-2895	299	2	j	j	PROPN
ajlm-2895	299	3	pharm	pharm	PROPN
ajlm-2895	299	4	res	re	VERB
ajlm-2895	299	5	.	.	PUNCT
ajlm-2895	300	1	2010;9(1):61–65	2010;9(1):61–65	NUM
ajlm-2895	300	2	.	.	PUNCT
ajlm-2895	301	1	putnam	putnam	PROPN
ajlm-2895	301	2	sd	sd	PROPN
ajlm-2895	301	3	,	,	PUNCT
ajlm-2895	301	4	sader	sader	PROPN
ajlm-2895	301	5	hs	hs	PROPN
ajlm-2895	301	6	,	,	PUNCT
ajlm-2895	301	7	farrell	farrell	PROPN
ajlm-2895	301	8	dj	dj	PROPN
ajlm-2895	301	9	,	,	PUNCT
ajlm-2895	301	10	jones	jones	PROPN
ajlm-2895	301	11	rn	rn	PROPN
ajlm-2895	301	12	.	.	PROPN
ajlm-2895	301	13	sustained	sustain	VERB
ajlm-2895	301	14	antimicrobial	antimicrobial	ADJ
ajlm-2895	301	15	activity	activity	NOUN
ajlm-2895	301	16	of	of	ADP
ajlm-2895	301	17	tigecycline	tigecycline	NOUN
ajlm-2895	301	18	against	against	ADP
ajlm-2895	301	19	methicillin	methicillin	NOUN
ajlm-2895	301	20	-	-	PUNCT
ajlm-2895	301	21	resistant	resistant	ADJ
ajlm-2895	301	22	staphylococcus	staphylococcus	NOUN
ajlm-2895	301	23	aureus	aureus	NOUN
ajlm-2895	301	24	(	(	PUNCT
ajlm-2895	301	25	mrsa	mrsa	NOUN
ajlm-2895	301	26	)	)	PUNCT
ajlm-2895	301	27	from	from	ADP
ajlm-2895	301	28	united	united	PROPN
ajlm-2895	301	29	states	states	PROPN
ajlm-2895	301	30	medical	medical	ADJ
ajlm-2895	301	31	centers	center	NOUN
ajlm-2895	301	32	from	from	ADP
ajlm-2895	301	33	2004	2004	NUM
ajlm-2895	301	34	through	through	ADP
ajlm-2895	301	35	2008	2008	NUM
ajlm-2895	301	36	.	.	PUNCT
ajlm-2895	302	1	j	j	PROPN
ajlm-2895	302	2	chemother	chemother	PROPN
ajlm-2895	302	3	.	.	PUNCT
ajlm-2895	303	1	2010;22(1):13–16	2010;22(1):13–16	X
ajlm-2895	303	2	.	.	PUNCT
ajlm-2895	304	1	https://doi.org/10.1179/joc.2010.22.1.13	https://doi.org/10.1179/joc.2010.22.1.13	PROPN
ajlm-2895	304	2	prasad	prasad	PROPN
ajlm-2895	304	3	p	p	X
ajlm-2895	304	4	,	,	PUNCT
ajlm-2895	304	5	sun	sun	PROPN
ajlm-2895	304	6	j	j	PROPN
ajlm-2895	304	7	,	,	PUNCT
ajlm-2895	304	8	danner	danner	PROPN
ajlm-2895	304	9	rl	rl	PROPN
ajlm-2895	304	10	,	,	PUNCT
ajlm-2895	304	11	natanson	natanson	PROPN
ajlm-2895	304	12	c.	c.	PROPN
ajlm-2895	304	13	excess	excess	ADJ
ajlm-2895	304	14	deaths	death	NOUN
ajlm-2895	304	15	associated	associate	VERB
ajlm-2895	304	16	with	with	ADP
ajlm-2895	304	17	tigecycline	tigecycline	NOUN
ajlm-2895	304	18	after	after	ADP
ajlm-2895	304	19	approval	approval	NOUN
ajlm-2895	304	20	based	base	VERB
ajlm-2895	304	21	on	on	ADP
ajlm-2895	304	22	noninferiority	noninferiority	NOUN
ajlm-2895	304	23	trials	trial	NOUN
ajlm-2895	304	24	.	.	PUNCT
ajlm-2895	305	1	clin	clin	PROPN
ajlm-2895	305	2	infect	infect	PROPN
ajlm-2895	305	3	dis	dis	PROPN
ajlm-2895	305	4	.	.	PUNCT
ajlm-2895	306	1	2012;54(12):1699–1709	2012;54(12):1699–1709	X
ajlm-2895	306	2	.	.	PUNCT
ajlm-2895	307	1	https://doi.org/10.1093/cid/cis270	https://doi.org/10.1093/cid/cis270	PROPN